26 March 2024
RCGP Raises Concerns the NHS Long Term Plan Will Fall Short for GPs
The College responds to new National Audit Office report showing improvements are needed in the NHS Long Term Workforce Plan.
Professor Kamila Hawthorne, Chair of the Royal College of GPs, said: "When the NHS launched their workforce plan, we warned that the devil would be in the detail - today’s report make shows that many of those details fall far short of what is needed for patients struggling to access our services, and hard-working GP teams working in the face of intense workload and workforce pressures.
19 March 2024
25,000 People to Benefit After NICE Recommends New Ulcerative Colitis Treatment
New one-a-day pill recommended on the same day the treatment was granted a licence by the MHRA
Thousands of people could be set to benefit after NICE today (Monday, 11 March) recommended a new one-a-day pill as an option for treating severe ulcerative colitis.
NICE’s final guidance on etrasimod (also known as Velsipity and made by Pfizer) is being published on the same day that the treatment was granted a licence by the Medicines and Healthcare Products Regulatory Agency (MHRA).
18 March 2024
'More Must Be Done to Tackle Health Inequalities' Says College Chair
College Chair Professor Kamila Hawthorne responds to research from the King’s Fund on the impact of poverty on NHS services.
Professor Kamila Hawthorne, Chair of the Royal College of GPs, said: “General practice is the bedrock of the NHS with GPs and our teams making the vast majority of patient contacts - so when our service is under pressure, it has ramifications across the health service. This is what we’re seeing in this report, and our patients living in some of the country's most deprived areas, who are often our most vulnerable, are feeling the impact most.
12 March 2024
NICE Publishes Final Draft Guidance on Enhertu After Commercial Discussions Conclude Without a Price to Make it a Cost-Effective Use of NHS Resource
NICE has published final draft guidance that does not recommend Enhertu (also called trastuzumab deruxtecan and made by Daiichi Sankyo) for treating advanced HER2-low breast cancer in adults.
The decision follows the conclusion of negotiations between NHS England and the company that sought to agree a commercial arrangement to make Enhertu available at a cost-effective price for the NHS.
NICE’s appraisal of Enhertu had been paused since December 2023 while these discussions took place.
8 March 2024
RCGP Strengthens 'Red Lines' on Physician Associates Working in General Practice
Following discussion at its UK governing Council meeting today, the Royal College of General Practitioners has strengthened and updated its position on the role and regulation of Physician Associates (PAs) working in general practice.
The Council confirmed the College’s existing ‘red lines’ on PAs, and voted to add two more, explicitly stating that the training and retention of GPs must be prioritised and that the responsibilities and skills required by GPs to supervise PAs must be recognised and resourced.
5 March 2024
New Treatment Option Available Today for Womb Cancer
Professor Kamila Hawthorne, Chair of the Royal College of GPs, has responded to the latest campaign from UKHSA and NHS England urging parents to ensure their children catch up on missed vaccinations. Professor Hawthorne said:
“Recent outbreaks of measles, as highlighted by the RCGP Research and Surveillance Centre’s own data, shows that engagement with the Childhood Vaccination Programme, one of the great successes of the NHS, has unfortunately decreased, and has left us vulnerable to the spread of potentially life-changing conditions, such as measles. Maintaining high vaccination rates is a top priority for GPs and our teams – and this campaign is timely and vital.
5 March 2024
RCGP Urges Higher Childhood Vaccination Uptake
Professor Kamila Hawthorne, Chair of the Royal College of GPs, has responded to the latest campaign from UKHSA and NHS England urging parents to ensure their children catch up on missed vaccinations. Professor Hawthorne said:
“Recent outbreaks of measles, as highlighted by the RCGP Research and Surveillance Centre’s own data, shows that engagement with the Childhood Vaccination Programme, one of the great successes of the NHS, has unfortunately decreased, and has left us vulnerable to the spread of potentially life-changing conditions, such as measles. Maintaining high vaccination rates is a top priority for GPs and our teams – and this campaign is timely and vital.
20 February 2024
'Demand For Care is Outstripping Our Resources' Says College Chair
Professor Kamila Hawthorne, Chair of the Royal College of GPs, has responded to the latest NHS Digital data on general practice workforce and GP appointments. Professor Hawthorne said:
"These latest figures show GPs and their teams continue to work harder than ever, under highly difficult circumstances, to ensure their patients receive the vital care and services they need. It is clear that intense workloads are now the new normal and that without immediate action to alleviate the pressures on primary care, the future of the profession – and the care we’re able to deliver to patients - is uncertain.
19 February 2024
RCGP Chair Calls for Help for Overseas GP Trainees to Stay in the NHS
In a letter to the Guardian, College Chair Professor Kamila Hawthorne lays out how overseas GPs are penalised by the visa process and calls on all political parties to commit to change this in the upcoming General Election.
13 February 2024
College Chair Responds to the Times Health Commission
Responding to recommendations made by the Times Health Commission, Professor Kamila Hawthorne, Chair of the Royal College of General Practitioners, said:
“This report makes some important recommendations that sound eminently sensible, and we're pleased the College was able to give evidence to the Commission. The Commission clearly recognises the enormous burden currently being placed on staff right across the NHS, and the impact this is having on patients, as well as the vital role general practice and wider primary care has in keeping the NHS safe and sustainable.
6 February 2024
Updated NICE Guidance Recommends More Targeting of Antibiotics to Those at the Highest Risk of Suspected Sepsis
NICE recommends better targeting of antibiotics for suspected sepsis to ensure the right people receive treatment
NICE has today (Wednesday, 31 January) recommended better targeting of antibiotics for suspected sepsis to ensure the right people receive treatment as soon as possible but the medicines are not overused, which can lead to antibiotic resistance.
2 February 2024
The Public Have a Clear Message for All Political Parties - Prioritise General Practice in Your Manifestos
College Chair Professor Kamila Hathorne has written the following op-ed in the Daily Express this morning, alongside a double-page spread detailing the pressures facing GPs and their teams and recent College polling showing public support for investing more in general practice.
Our patients are waiting too long to see us – and when they do, we don’t have enough time to give them the holistic care they need, and have the conversations that can really unlock the root of a health complaint.
30 January 2024
RCGP Leads Way in Promoting Safety, Effectiveness and Importance of MMR Vaccination
Figures from the RCGP’s Research and Surveillance Centre and UKHSA have shown a worrying increase in measles presentations, with spikes in the West Midlands and London. The College has been at the forefront of promoting the safety, effectiveness and importance of the MMR vaccination and urging parents to ensure their children’s vaccinations are up-to-date. RCGP Chair, Kamila Hawthorne spoke to BBC Radio 4’s Today Programme last week, and LBC’s breakfast programme this morning – she also penned the following op-eds over the weekend.
30 January 2024
More Than 4 in 5 Members of the Public Believe that the Next Government Must Take Action to Solve the Problems Facing General Practice
General practice is set to be a key general election battleground with more than 4 in 5 respondents to a public poll commissioned by the Royal College of GPs saying that they want the political parties to set out detailed plans to solve the problems facing general practice.
The survey also found that over 3 in 5 (61%) respondents identified NHS care as one of the most important factors in how they will cast their vote, ranking it above the economy, housing and the climate crisis. When asked which part of NHS care they would like to see prioritised, over half (55%) said general practice, with slightly more (59%) saying urgent and emergency care, which includes GP out of hours services; 40% said surgery, 37% said mental health care and 33% said dentistry.
23 January 2024
300 People to Benefit from New Treatment for Advanced Breast Cancer Recommended by NICE Following Price Deal
Around 300 people are set to benefit following NICE’s recommendation of talazoparib for treating a type of locally advanced or metastatic breast cancer in final draft guidance published today (19 January 2024).
The recommendation reverses NICE’s earlier draft decision not to recommend talazoparib for adults with BRCA 1 or 2 mutated HER2-negative locally advanced or metastatic breast cancer after prior chemotherapy. It follows the offer of an increased discount to the price of talazoparib, also called Talzenna, by the company (Pfizer).
22 January 2024
College Calls For ‘More Investment in General Practice, Not Less’
Responding to Lib Dem research showing that funding for general practice has, in real terms, fallen by £350m since 2019, Professor Kamila Hawthorne, Chair of the Royal College of GPs, said:
“General practice is the bedrock of the NHS, and investing in it leads both to better health outcomes for patients and delivers amazing value to the NHS. We now know that for every £1 invested in primary care, at least £14 is delivered in productivity across the working community – so it makes absolutely no sense that spending on general practice is falling in real terms.
16 January 2024
1.4 million More People at Risk of Severe COVID-19 to Have Access to Antiviral Paxlovid
A further 1.4 million people who have an increased risk for progression to severe COVID-19 will be eligible for Paxlovid if they test positive following updated NICE final draft guidance published today (11 January 2024).
NICE already recommends Paxlovid (also called nirmatrelvir plus ritonavir and made by Pfizer) for an estimated 3.9 million people who do not need supplemental oxygen for COVID-19 and who have an increased risk for progression to severe COVID-19. This includes people with certain cancers, people who have had haematological stem cell transplant or who have a haematological disease and people with liver or kidney disease.
10 January 2024
‘Damp and Mould Can Have a Serious Impact on a Person’s Health’ says College Chair
Professor Kamila Hawthorne, Chair of the Royal College of GPs, featured in The Guardian today commenting on the health risks of damp and mould exposure. Professor Hawthorne said:
"Having significant damp and mould in a home can have a serious impact on a person’s health – especially if that person has an existing condition such as asthma or is in a high-risk group for respiratory infection. Aside from respiratory problems and potential damage to the immune system, living in inadequate housing conditions can take a pronounced psychological toll, causing considerable stress and affecting one’s mental health.
9 January 2024
General Practice Had Busiest November on Record, Latest Figures Show
The RCGP has responded to the latest general practice data from NHS England, which shows general practice had the busiest November on record. Professor Kamila Hawthorne, Chair of the Royal College of GPs, said:
“These latest figures show that GPs and our teams are working harder than ever to make sure patients receive the care and services they need under really difficult circumstances. The data makes clear that need for our care continues to spiral, yet we still have fewer qualified, full-time equivalent GPs than before the pandemic – and we need practical action to address this.
3 January 2024
‘Unwarranted GP Bashing Only Makes Our Situation Worse’ Says College Chair
College Chair, Professor Kamila Hawthorne, featured in inews today commenting on the growing abuse levied against GPs due to the issues in access seen across the NHS.
“GPs go into general practice because they want to care for patients, and we want to do our best for them. In reality, more patients are being seen in general practice than ever before, but our workloads are escalating at the same time as we have a severe shortage of GPs, so we are facing a daily battle to meet demand.
2 January 2024
Two Digital Technologies Recommended to Address Unmet Need in Rehabilitation Programmes for People with COPD
More people with chronic obstructive pulmonary disease (COPD) could soon access rehabilitation programmes after draft guidance from NICE conditionally recommended two technologies to provide digital services to NHS patients.
According to NHS Digital, approximately 1.17 million people in England have been diagnosed as living with COPD in 2021. It is estimated that a further 2 million remain undiagnosed.
COPD is a long-term and progressive respiratory condition that causes breathlessness, a persistent chesty cough, persistent wheezing and frequent chest infections. COPD includes chronic bronchitis and emphysema.
20 December 2023
Patients Appreciate a 'Mixed-Method' Approach to GP Consultations' Says College Chair
College Chair, Professor Kamila Hawthorne, featured in The Independent responding to a study on patient preferences for accessing care in general practice.
“This study shows that patients appreciate a mixed-method approach to accessing GP care and services - and it has been the College's position some time that how patients access our care should be a shared decision between the clinician and patient.
19 December 2023
Millions Of People with Cardiovascular Disease Could Benefit from a New Cholesterol Treatment Target Recommendation
Up to 2.1 million people with cardiovascular disease (CVD) could benefit from a new cholesterol target outlined in NICE guidance for the first time.
Updated final guidance published today (Thursday 14 December 2023) introduces a new target for cholesterol levels for people who have had a heart attack or stroke to reduce the risk of them having another.
CVD is the cause of 1 in 4 deaths in England. Secondary prevention is treatment for people who have already had an adverse health incident because of CVD, such as a heart attack or stroke.
15 December 2023
RCGP Scotland Response to The General Practice Workforce Survey
Responding to today's workforce update from NHS Education for Scotland, Dr Chris Provan, Chair of RCGP Scotland said:
"The data released lays bare the failure to adequately staff general practice in Scotland, and reflects the deeply challenging frontline environment in which GPs are currently working.
12 December 2023
RCGP Cymru Wales Responds to Senedd Report on Gynaecological Cancers
RCGP Cymru Wales has responded to the Senedd Health and Social Services Committee's report on gynaecological cancers:
"The report makes sobering reading and raises important challenges for general practice. We would never want our patients to feel that their concerns have not been taken seriously, and our responsibility to keep up to date with NICE Guidelines is a key part of our duty of care to our patients. We are already creating additional professional education opportunities in this field.
5 December 2023
NICE Draft Updated Guideline Recommends More Treatment Choices for Menopause Symptoms
New evidence shows that cognitive behavioural therapy (CBT) can help reduce menopause symptoms including hot flushes and night sweats, depressive symptoms and problems sleeping NICE has said in its draft updated guideline on menopause published today (17 November 2023).
CBT was found to reduce the frequency and severity of hot flushes and night sweats and should be considered alongside or as an alternative to HRT, the draft guidance says.
It was also found to help sleep problems related to menopause, including, how long it takes to fall asleep and how long before waking.
2 December 2023
RCGP Open to Learning from Other Countries - But New Initiatives Must Be Backed Up by Resource
Professor Kamila Hawthorne, Chair of the Royal College of GPs, said: "Some of the ideas floated over the weekend are aligned with our manifesto ask for funding for community health centres and some areas in the UK have been able to adopt a similar model already - and it's encouraging that the Shadow Secretary of State seems to understand the burden of bureaucracy currently facing GPs, and wants to address it.
“We’re open to sharing ideas with and learning from other countries to explore what initiatives work and what don’t as we try to ensure patients receive the best possible care in a way that helps keeps the health service sustainable. Our understanding is that the innovative approach to primary care services in Australia has come with significant resources for infrastructure and workforce -
28 November 2023
NICE Gets Ready to Assess New Dementia Treatments
NICE’s methods and processes for evaluating new treatments for use in the NHS are appropriate for the new class of Alzheimer’s drugs but key issues need to be considered, a new report has found.
Recent breakthroughs in our understanding of the disease have begun to shed light on its complex nature and new treatments have begun to emerge including DMDTs (disease-modifying dementia treatments). These treatments aim to alter the course of disease progression and reduce its substantial impact.
17 November 2023
Exploring a Range of Potential Treatments for Menopause 'Helpful', Says RCGP
Professor Kamila Hawthorne, Chair of the Royal College of GPs, appears in today’s Guardian responding to the latest NICE evidence review for menopause treatment. Professor Hawthorne said:
“Menopause can be a very difficult time for women, and the impact on their health and wellbeing can be significant. This is something GPs take extremely seriously and will always consider a patient's individual health factors and circumstances, along with clinical guidelines, when developing a treatment plan, in conversation with them.
14 November 2023
NICE Recommends Life Changing Technology is Rolled Out to People with Type 1 Diabetes
Thousands of people with type 1 diabetes could be offered wearable technology to help them manage their condition following the publication of final draft guidance by NICE.
An independent NICE committee has recommended people whose diabetes is not controlled with their current device despite best possible management with an insulin pump, or real-time or intermittently scanned continuous glucose monitoring, are offered a hybrid closed loop system.
Hybrid closed loop systems comprise a continuous glucose monitor sensor attached to the body. This transmits data to a body-worn insulin pump. It calculates how much insulin needs to be automatically delivered into the body to keep blood glucose levels within a healthy range.
13 November 2023
GPs Are Trying Their Best for All Their Patients, Says College Chair
Kamila Hawthorne, Chair of the Royal College of General Practitioners, appears in today’s media, hitting back at claims that older patients are finding it difficult to see their GP. Professor Hawthorne said:
“GPs and our teams are working incredibly hard, right across the country, to ensure our patients receive the safe, timely and appropriate care they need. Last month, more than 32 million consultations were delivered, up nearly 5 million from September 2019, all with 827 fewer fully qualified, full time GPs.
7 November 2023
NICE Launches First Modular Update to Its Methods and Processes
NICE’s methods and processes now include a proportionate approach to technology appraisals, and a new way of updating recommendations on COVID-19 treatments.
The first modular update to NICE’s health technology evaluations manual is now live.
This update follows a consultation held earlier on two changes to its manual:
- Incorporating NICE’s proportionate approach to technology appraisals into the manual.
- A revised approach to updating technology appraisal recommendations for COVID-19 medicines.
1 November 2023
'GPs Are Trying to Do Their Very Best for Patients', Says College Chair
Professor Kamila Hawthorne, Chair of the Royal College of GPs, has responded to the latest NHS data on patient complaints in primary care.
She said: “This is sad and troubling to hear, but we are not surprised that a substantial number are related to difficulties in accessing GP care and long waits for appointments. Patients should be able to see a GP when they need one and we share their frustrations and worries when they struggle to get appointments. The unfortunate reality is that our hard working and committed GPs often end up the ‘fall guys’ for the government’s failure to appropriately resource and fund primary care.
31 October 2023
First NICE-Recommended Treatment for Parkinson's Set to Benefit Hundreds
Around 900 adults with advanced Parkinson's are set to benefit from new treatment foslevodopa–foscarbidopa after NICE approved it for NHS use in final draft guidance published today (26 October 2023).
NICE has recommended foslevodopa–foscarbidopa (also called Produodopa and made by AbbVie) as an option for treating advanced Parkinson’s, a progressive disorder that affects the nervous system and the parts of the body controlled by the nerves.
The treatment is delivered by an infusion pump, which gives the medicine over 24 hours. The device is small, completely portable and can be refilled at home, which is convenient for patients and their carers, and helps people manage their symptoms effectively.
30 October 2023
'We Must Guard Against a Two-Tier System', Says College Chair
College Chair Professor Kamila Hawthorne appears in today’s Guardian responding to a survey by Pulse which found that nearly half of NHS GPs reported rising workloads due to patients making greater use of private healthcare services. Professor Hawthorne said:
“No patient should need to pay for care and services that they are entitled to free of charge on the NHS and we must guard against creating a two-tier system that favours those who can afford to pay and disadvantages those who can’t.
24 October 2023
First Treatment to be Recommended by NICE at The Same Time it is Approved for Advanced Lymphoma in the UK
More than 700 people set to benefit from new treatment option for advanced lymphoma.
NICE has recommended glofitamab as a new treatment option for adults with relapsed or refractory diffuse large B cell lymphoma after 2 or more systemic treatments in final guidance published today (17 October 2023).
Today’s recommendation for its use in the NHS coincides with glofitamab receiving its licence from the Medicines and Healthcare Products Regulatory Agency (MHRA).
19 October 2023
The 'Destruction of General Practice and Demonisation of GPs Has to Stop', Says College Chair as She Outlines General Election Manifesto at the RCGP Annual Conference
The UK’s leading GP will issue a stark warning to the next government as she gives her inaugural keynote speech to the RCGP Annual Conference in Glasgow this Thursday (19 October).
Addressing more than 1300 family doctors and primary healthcare professionals, Professor Kamila Hawthorne – Chair of the Royal College of GPs - will tell ‘any future government, regardless of what it looks like’ that the ‘destruction of general practice and the demonisation of hard-working GPs and their teams must stop.’
19 October 2023
People Who Have Had a Stroke Should Be Offered Additional Rehabilitation to Help Them Recover NICE Says in Updated Guidance
People who have had a stroke and who have continuing impairment or limitations on their activities should be offered additional rehabilitation to help them recover, NICE has said in updated guidance published today.
The recommendations are made today (18 October 2023) in NICE’s updated guideline on stroke rehabilitation in adults.
The guideline says that people who have had a stroke should be offered, needs-based rehabilitation for at least 3 hours a day on at least 5 days of the week covering a range of multidisciplinary therapy including physiotherapy, occupational therapy and speech and language therapy.
This is an increase in rehabilitation compared with NICE’s original guideline published in 2013.
18 October 2023
College Urges Caution Over Proposed ‘Menopause Checks’ For 40-Year-Olds
College Chair Kamila Hawthorne has responded to a new ‘manifesto’ from the All Party Parliamentary Group on menopause, recommending a ‘Menopause Health Check at 40’.
She said: “GPs want to provide the very best care and support to patients at every stage of their lives, and we work very hard to ensure that this is individualised to their specific needs.
“Every woman’s experience of the menopause will be different, and we can see how the All Party Parliamentary Group might think that a ‘Menopause Health Check’ for every woman aged 40 would be a good thing. However, it is hard to see how GPs and their teams could take on this additional work, given the workload and workforce pressures we are currently buckling under.
9 October 2023
NICE Recommends Healthcare Professionals Ask People About Gambling, In New Draft Guidance Out for Consultation
New NICE draft guidance on identifying, assessing and managing harmful gambling published
Health professionals should ask people about gambling if they attend a health check or GP appointment with a mental health problem, in a similar way to how people are asked about their smoking and alcohol consumption, according to new draft guidance from NICE.
NICE has identified that when people present at appointments with depression, anxiety, or thoughts about self-harm or suicide or in relation to a possible addiction (for example, alcohol or drug misuse) they may be at increased risk of harm from gambling and NICE recommends this needs to be identified and addressed by healthcare professionals.
09 October 2023
Trainee Survey Must Be a 'Wake-Up Call' to Politicians, Says College
College Chair Kamila Hawthorne has responded to the latest King’s Fund annual GP trainee survey by issuing an impassioned plea for greater support for our future - and current GPs.
She said:
“Our fantastic trainees are our future. They are a unique and valuable workforce that our profession and our patients will be relying on to keep general practice afloat in the years to come. We are indebted to them for choosing general practice and we owe it to them to launch them into stimulating and long careers where they can flourish and get job satisfaction. We need to nurture and support them.
26 September 2023
NICE Draft Guidance Recognises Potential of New Targeted Treatment for Type of Advanced Breast Cancer
NICE has today (26 September 2023) published draft guidance for public consultation that does not recommend trastuzumab deruxtecan for treating advanced HER2-low breast cancer in adults.
NICE’s independent appraisal committee has asked the company for more information ahead of its next meeting. This includes further analyses looking at how much benefit trastuzumab brings for people’s length of life, more evidence that the benefit of treatment continues even when the disease becomes worse and more analyses looking at the outcomes that people experience on standard care given in the NHS.
25 September 2023
Seven in Ten GPs Seeing 'Worrying' Rise in Patients with Cost of Living-Related Problems, Says College Survey
Seven out of ten GPs are seeing a ‘worrying’ rise in the number of patients seeking help with problems linked to the rising cost-of-living, according to the UK’s largest membership body representing family doctors.
Seventy-three percent of GPs who responded to the survey by the Royal College of GPs said they had noticed a visible increase in patients presenting with problems associated with poor diet and poverty, compared to last year.
19 September 2023
More People Could Be Offered Genetic Testing for Genes Linked to Ovarian Cancer in New Draft NICE Guideline for Public Consultation
A new draft NICE guideline for inherited ovarian cancer published today (15 September 2023), recommends more people are tested for genes linked to ovarian cancer.
Anyone can carry a gene linked to ovarian cancer, including women, men, trans and non-binary people, and can pass it on to their children.13 September 2023
To Prevent a Health Crisis This Winter We Must Ensure Primary Care is Not Overlooked, Says College Chair
Responding to the government’s latest proposals for the winter relief plan, Professor Kamila Hawthorne, Chair of the Royal College of General Practitioners, said the following.
“The winter pressures that GPs and their teams face are too often overshadowed by the focus and funding hospitals receive, so it was encouraging that I was at the table with secondary care colleagues today.
12 September 2023
NICE Committee Recommends Tirzepatide as New Treatment Option for People with Type 2 Diabetes
Around 180,000 people with difficult to manage type 2 diabetes could benefit from a new treatment option recommended by NICE
Tirzepatide, also known as Mounjaro and developed by Eli Lilly, has been recommended in final draft guidance issued by NICE today (Friday 8 September 2023) for treating poorly controlled type 2 diabetes in adults alongside diet and exercise.
According to research by Diabetes UK, more than five million people in the UK are living with diabetes. The charity estimates around 90% of people with diabetes have type 2.
5 September 2023
College Co-Signs Letter from Chief Medical Officer on School Attendance and Health
College co-signs letter from Chief Medical Officer on school attendance and health
College Council recently approved ‘five principles to promote school attendance’, and today, we have signed a letter with the Chief Medical Officer in England and leading health professionals on school attendance and mild illness. We hope this letter will support GPs in their work with families, including when it is fine for children and young people to attend school with a mild illness, such as a minor cough or cold.
5 September 2023
More People Could Be Treated Out of Hospital This Winter Through New Draft NICE Guidance to Help Identify and Manage Acute Respiratory Infections
Consultation launched on draft guidance for the assessment and management of acute respiratory infections in people over 16
More people could be treated out of hospital in the NHS’s new respiratory hubs and virtual wards following new NICE draft guidance on the initial assessment and management of suspected acute respiratory infections (ARIs) published today (Friday, 1 September).
The draft guideline covers diagnosing and managing suspected ARIs, including pneumonia, respiratory viruses, and flu in adults. It does not cover people with COVID-19. It aims to improve initial assessments and access to face-to-face appointments as well as the management of conditions to help reduce hospital admissions.
24 August 2023
The Daily Experience of a GP Has Changed Dramatically and This Is Impacting Patient Care, Says College Chair
Responding to the latest data on appointments in general practice, Professor Kamila Hawthorne, Chair of the Royal College of GPs said: “These latest appointment figures demonstrate the continued and rising pressures facing general practice. Hardworking GPs and their dedicated teams are delivering tens of millions of appointments per month, with over two thirds face-to-face, despite a clear deficit in workforce and a growing demand for treatment in both volume and complexity.
29 August 2023
Around 100,000 Fewer Colonoscopies Expected to Take Place Each Year Following Updated NICE Guidance
Tens of thousands of people a year could be spared the need for a colonoscopy following new guidance from NICE.
People with signs or symptoms of colorectal cancer should be offered a home test with quantitative faecal immunochemical tests (FIT) from 1 of 2 technologies (HM-JACKarc or OC-Sensor). This could lead to faster diagnosis, with fewer people referred to secondary care for an unnecessary colonoscopy. People who require follow up investigation can then be prioritised for referral leading to colonoscopy services focusing on those people who need them most.
24 August 2023
GP Numbers are 'Flatlining' and We Need Urgent Action to Turn This Round, Says College Chair
Responding to the latest data on general practice workforce, Professor Kamila Hawthorne, Chair of the Royal College of GPs said:
“Winter will arrive all too soon and with it will come the peak season for our patients’ health issues and the additional pressures this creates for general practice. These latest figures show that we are far from prepared, with the number of full-time equivalent, fully qualified GPs continuing to flatline.
22 August 2023
NICE Draft Guidance Recommends Novel Treatment for Debilitating Inherited Skin Condition
Around 670 people in England with painful and debilitating skin wounds caused by a rare inherited disorder are set to benefit from a new treatment to help the skin wounds heal faster.
NICE has recommended birch bark extract (also called Filsuvez and made by Amryt Pharmaceuticals) for treating skin wounds associated with dystrophic and junctional epidermolysis bullosa in final draft guidance published today (18 August 2023) as part of its highly specialised technologies programme.
This is the first time NICE has recommended a treatment for EB.
21 August 2023
'More GPs are the Solution to Safe Patient Care' Says College
Responding to the latest Pulse survey on the impact of rising patient numbers in general practice, Professor Kamila Hawthorne, Chair of the Royal College of GPs said:
'No two appointments in general practice are the same and patient contact numbers will vary depending on which clinical healthcare staff member is seeing the patient, practice and patient circumstances, and clinical judgement. Practices will manage this in the best way they can, based on their knowledge of their local patient population. However, there comes a point where demand exceeds capacity and GPs can no longer guarantee safe care to their patients, so we urgently need to find a range of solutions to this.
15 August 2023
Digital Services to Enable Easier Access to Weight Management Support
Four digital programmes can be used to help the NHS deliver specialist weight management services to support the use of medication in England, NICE has said in draft guidance.
People being referred to these services will meet the criteria for accessing weight management medication: they have at least 1 weight-related comorbidity such as diabetes or high blood and a body mass index (BMI) of at least 35.0 kg/m2, or at a lower threshold in certain circumstances.
14 August 2023
GPs Will Only Cancel Appointments as a 'Last Resort', Says College Chair
Professor Kamila Hawthorne, Chair of the Royal College of GPs, has responded to a survey by Pulse magazine on GP practices being forced to stop routine appointments.
She said: “This survey makes for sad, but unsurprising, reading. GPs want to do the very best we can for all our patients and will only cancel routine appointments as a last resort, but the truth is that we cannot work any harder.
8 August 2023
Improved Access to Diagnostics Will Undoubtedly Support GPs in Their Referral Decisions Says College Chair
Responding to the latest NHS England initiative to fast-track tests and checks for respiratory and heart conditions by allowing GP practices to directly order diagnostic checks, Professor Kamila Hawthorne, Chair of the Royal College of GPs, said: “Any initiative to accelerate the process by which patients can be diagnosed and begin to receive any necessary treatment should be seen as positive. For patients with respiratory and cardiovascular conditions this is particularly vital given the long-term, and sometimes life-threatening, nature of these illnesses.
3 August 2023
Safe, Timely and Appropriate Care Can Be Delivered Both in Person and Remotely, Says College Chair
Responding to the latest Pulse survey on the number of GPs able to offer patients a face-to-face appointment, Professor Kamila Hawthorne, Chair of the Royal College of GPs, said: “Safe, timely and appropriate care can be delivered both in person and remotely. We know some patients prefer seeing their GP face to face, and many GPs prefer this way of consulting, but some patients find remote care a convenient and effective way of accessing GP services.
1 August 2023
College Responds to BMJ Investigation into Medical Royal Colleges and Industry Sponsorship
An article in today’s BMJ alleges that Medical Royal Colleges, including the RCGP, ‘do not always disclose publicly’ the funding they receive from pharmaceutical and medical device companies.
We have co-operated fully with the BMJ in its investigation, and you can read our full response below.
“GPs and their teams are at the forefront of delivering whole-person care for their patients. They have the broadest curriculum of any medical specialty, and need to demonstrate continued professional development, reflective of the full breadth of the curriculum, throughout their career.
27 July 2023
The Trends We've Seen Over the Past Year Can't Be Allowed to Continue, Says College Chair
“These latest figures show yet again the true extent of both the workforce and workload crises our GPs are having to cope with in their provision of safe, timely and appropriate care to their patients. Our teams have been working continuously under intense workload and workforce pressures in recent years, but the latest data shows just how serious these pressures have become.
25 July 2023
GPs and Our Teams Can’t Work Any Harder - We Need More Doctors and More Time to Care, Says College Chair
College Chair Professor Kamila Hawthorne has responded to figures out today from the Lib Dems claiming that patients in some parts of the country are waiting up to four weeks for a GP appointment. Our full statement is below.
Professor Kamila Hawthorne, Chair of the Royal College of GPs, said: "No patient should ever have to wait this amount of time for an appointment, regardless of where they live, and we share our patients' frustration and distress when they struggle to access our care.
18 July 2023
More Evidence Needed to Recommend Type 2 Diabetes Treatment Tirzepatide
More evidence is needed on the clinical and cost-effectiveness of a new treatment option for people with type 2 diabetes before it could be recommended for NHS use, a NICE committee has said.
Tirzepatide, also known as Mounjaro and developed by Eli Lilly, has not been recommended in draft guidance issued by NICE today (Tuesday 27 June) for treating type 2 diabetes in adults alongside diet and exercise.
Tirzepatide is taken weekly by injection. The company has positioned tirzepatide as an option later in the treatment pathway to offer the NHS an alternative to glucagon like peptide 1 (GLP-1) receptor agonists such as dulaglutide, liraglutide and semaglutide (ozempic/rybelsus) which are already recommended for use in the NHS.
14 July 2023
We Mustn't Get Complacent About Measles, Warns RCGP Chair
In response to UK Health and Security Agency data, published today, and its warning that there is risk of an outbreak of measles in London, Professor Kamila Hawthorne, Chair of the Royal College of GPs said: "The Childhood Vaccination Programme is one of the great successes of the NHS, but the MMR vaccine can only work to reduce transmission of these viruses in communities, if enough people have it. Maintaining high vaccination rates is a top priority for GPs and our teams, and as a society, we mustn't become complacent. In 2017, the UK achieved measles elimination status, but unfortunately, this has been reversed in part by a lack of vaccination take up, and we have seen more cases of measles this year so far, than in the whole of 2022.
12 July 2023
NICE Recommends Extending Use of Tests for Colorectal Cancer Which Could Reduce Waiting Time for Colonoscopies
Doctors have been advised to offer people with signs or symptoms of colorectal cancer a home test to reduce the waiting times for a colonoscopy, NICE has said in draft guidance.
NICE’s diagnostic advisory committee has recommended the use of the HM-JACKarc or OC-Sensor quantitative faecal immunochemical tests (FIT) in draft guidance release for consultation today (Wednesday 5 July 2023).
11 July 2023
RCGP Chair Responds to the GMC’s Annual National Training Survey
Responding to the GMC’s annual national training survey which found GP trainers and trainees were at high risk of burnout, Professor Kamila Hawthorne, Chair of the Royal College of GPs said: "Our trainees are the future and our patients and our profession are depending on them. However, the College has been warning for years that without urgent action to address excessive workforce and workload pressures in general practice, more trainees will leave the profession before or shortly after they qualify.
20 June 2023
Decision Aid to Guide Healthcare Professional-Patient Discussions on Sleeping Pill Prescriptions Published
Patient decision aid on medicines associated with dependence or withdrawal symptoms published
People who have been prescribed sleeping medications benzodiazepines and Z-drugs (zolpidem or zopiclone) could benefit from a new patient decision aid designed to help them make an informed choice about their treatment in discussion with their GP or pharmacist.
19 June 2023
Prescription Anti-Depressants Play a Vital Role in the Treatment Oof Mental Health Conditions, Says College Chair
Responding to a BBC Panorama investigation into the prescription of anti-depressants, Professor Kamila Hawthorne, Chair of the Royal College of GPs said:
"When prescribed appropriately, evidence shows that antidepressants can be an effective treatment for many patients suffering from mental health conditions such as depression and anxiety – but wherever possible we don’t want patients to have to rely on medication long term, and most patients don’t want that either.
13 June 2023
One-Stop-Shop for AI And Digital Regulations for Health and Social Care Launched
New online advice service launched to help the NHS and wider care system adopt and make use of new digital and artificial intelligence
A new online advice service to help the NHS and wider care system adopt and make use of new digital and artificial intelligence (AI) technologies has launched today.
The AI and Digital Regulations Service provides guidance for NHS and social care adopters and digital health innovators.
The service offers:
- a website providing centralised, curated and up-to-date regulatory content for both developers and adopters of AI and data-driven technologies; and
- access to specialist support for both developers and adopters from the service partners.
7 June 2023
Pilots to Provide Greater Access to Obesity Drugs in Primary Care May Benefit Some Patients, But Must Be Backed with Adequate Resources – Says College Chair
Responding to the announcement of a two-year pilot that will explore ways to make the obesity drug Semaglutide accessible to patients outside of hospital settings, Professor Kamila Hawthorne, Chair of the Royal College of General Practitioners said: “GPs play an important and active role in supporting patients living with obesity to reduce their weight through healthy lifestyle changes, and lower their risk of serious health complications such as diabetes, heart disease and cancer. However, for some patients, other factors are at play that make weight loss more difficult, and other interventions may be necessary.
6 June 2023
First Treatment to Target Heart Condition Set to Benefit Thousands as NICE Draft Guidance Approves NHS Use
NICE has approved mavacamten, the first treatment that specifically targets a heart condition called obstructive hypertrophic cardiomyopathy (HCM). It means around 7,000 people will now be able to access the treatment on the NHS.
NICE’s final draft guidance recommends mavacamten (also called Camzyos and made by Bristol-Myers Squibb) as an add-on to standard care that aims to control symptoms of the disease.
Clinical trial evidence suggests that mavacamten plus standard care is more effective than standard care alone, and that it may avoid or postpone the need for invasive surgery.
6 June 2023
Inadequate Infrastructure is Harming General Practice – College Chair
Speaking to Health Service Journal, College Chair Professor Kamila Hawthorne outlined the principal findings of the College’s latest report on general practice infrastructure.
Kamila drew attention to the fundamental structural inadequacies of many practices in the UK, and the impact this is having on the recruitment and retention of staff, as well as the care provided to patients.
31 May 2023
145,000 People in England to Have Further Treatment Choice for Preventing Migraine Attacks
NICE has for the first time recommended an oral treatment for preventing migraines.
Rimegepant (also called Vydura and made by Pfizer) is recommended as an option for preventing episodic migraine in adults where at least 3 previous preventive treatments have failed, opening the way for up to 145,000 people to choose it on the NHS in England.
The final draft guidance recommends rimegepant for adults who have at least 4 migraine attacks per month but less than 15.
26 May 2023
It is Not Too Late to Turn This Dire Situation Around, Says College Chair
Responding to the latest GP workforce data from NHS Digital, Professor Kamila Hawthorne, Chair of the of GPs said: “GPs and our teams are working incredibly hard to deliver safe, timely and appropriate care for our patients, in the face of unsustainable workforce and workload pressures.
“We are delivering millions more appointments than before the pandemic, with almost half offered on the day of booking - but with 898 fewer fully-qualified, full-time equivalent GPs than we did in 2019. In some areas, GPs are now responsible for more than 2,500 patients.23 May 2023
Testing Could Help Prevent Further Strokes in People with Gene Variant
People who have had an ischaemic stroke or transient ischaemic attack (TIA) should have a genetic test to find out whether they can be treated with a drug which reduces the risk of further strokes, NICE has said.
New draft guidance from NICE published today (Friday, 19 May 2023) has recommended clinicians offer laboratory-based genotype testing to people if treatment with the drug clopidogrel is being considered.
NICE currently recommends clopidogrel can be used as an option for treating people at risk of a secondary stroke but this treatment is not suitable for those with certain variations in a gene called CYP2C19 because they cannot convert the drug to the active form.
18 May 2023
Good Progress on Efforts to Expand Wider Practice Team – But Pledge to Boost GP Numbers Mustn’t Be Forgotten
Responding to the Government’s announcement that it has met its target to employ 26,000 primary healthcare professionals in general practice, Professor Kamila Hawthorne, Chair of the Royal College of GPs said: “General practice is a multi-disciplinary service, with patients receiving good and appropriate care from a wide range of clinical staff, including GPs, nurses and pharmacists. It is positive to see efforts to expand the wider practice team realised, and patients will certainly benefit, but there was another pledge in the Government’s 2019 manifesto - for 6,000 more GPs by 2024 - and on this, things have gone backwards.
16 May 2023
Hundreds of Children with Type 2 Diabetes to be Offered Choice of Two Life Changing Technologies
Hundreds of children with type 2 diabetes who currently manage their condition with the ‘burdensome’, ‘tiring’, and ‘stressful’ task of finger prick testing several times a day could be offered a choice between two ‘life changing’ technologies to virtually automate the process, NICE has said.
For the first time new guidance from NICE recommends the use of real-time continuous glucose monitoring (rtCGM) or intermittently scanned glucose monitoring (isCGM) devices for some children living with type 2 diabetes who are currently using finger prick testing and insulin therapy.
15 May 2023
College Calls for Greater Transparency Around Self-Testing Kits
The Royal College of GPs is calling on UK regulators to ensure self-testing kits are independently validated, and approved with a quality mark, so that patients are protected from tests that are not proven to have benefits for them. The College also says that manufacturers of self-tests should hold responsibility for patient aftercare - and not simply promote general practice as the default provider for this.
9 May 2023
GP Access Recovery Plan Not the Silver Bullet That We Desperately Need - Says College Chair
Responding to details of NHS England’s GP access recovery, Professor Kamila Hawthorne, Chair of the Royal College of GPs said: "GPs and our teams want to deliver safe, timely and appropriate care for our patients, and we get as frustrated as they do when they struggle to access our services. As such, whatever can be done to improve patients' access to our services should be explored.
8 May 2023
RCGP Response to Government Plan on GP Access
Responding to initial details of the GP access recovery plan, announced by the government today, Professor Kamila Hawthorne, Chair of the Royal College of GPs, said: "GPs and our teams want to deliver safe, timely and appropriate care for our patients, and we get as frustrated as they do when they struggle to access our services. When this happens, it is not the fault of GP teams who are delivering 6% more appointments than before the pandemic, with almost half offered on the same day they are booked, but with 852 fewer GPs than in 2019. GP practices already aim to see all emergencies on the same day they call us.
2 May 2023
Two New Personalised Immunotherapy Treatments for Aggressive Forms of Blood Cancer Recommended for the Cancer Drugs Fund
NICE recommends two CAR-T therapies, both given as one-off infusions, to treat aggressive forms of blood cancer
Hundreds of people with aggressive forms of blood cancer are set to benefit after two personalised immunotherapy (CAR-T) treatments were today (Thursday, 27 April) recommended by NICE for the Cancer Drugs Fund (CDF).
CAR-T therapy is a treatment in which a person’s own immune system cells (T-cells) are altered in a laboratory to attach to and kill cancer cells. The two treatments are both given as a one-off treatment straight into the blood stream.
The treatments could benefit up to 600 people in total each year in England.
1 May 2023
Urgent Action Needed to Reverse Shocking Decline in Our Family Doctor Service, Says College Chair.
The College has issued the following response to figures from the House of Commons Library showing that each GP in England saw an average 8,534 patients last year – up from 8,351 in 2019.
Professor Kamila Hawthorne, Chair of the Royal College of GPs, said: “These figures are yet another demonstration of how hard our GPs are working and trying their absolute best to deliver safe, timely and appropriate care to patients in the most difficult circumstances. They also show the need for urgent action to reverse the shocking decline in our family doctor service.
25 April 2023
NICE Collaborates with International Partner Agencies to Streamline the Confidential Marking Process
NICE, the Canadian Agency for Drugs and Technologies in Health and the US’s Institute for Clinical and Economic Review have today (24 April 2023) announced they are changing the way confidential information about health technologies is handled to streamline processes and increase transparency.
Health technology evaluations must strike a critical balance between ensuring transparency of the evidence and decision-making and protecting confidential information. The 3 organisations operate in different health systems but share common aims and values. Given these similarities, NICE, CADTH and ICER have been working together to create a more consistent approach to handling clinical data. Today they have publishjoint statement setting out the changes.
25 April 2023
GPs Need More Time with Patients – But Short Appointments Aren’t Always Inappropriate
Responding to analysis of GP consultation length by the Lib Dems, published today, Professor Kamila Hawthorne, Chair of the Royal College of GPs said: “GPs and our teams are working exceptionally hard in the face of intense workload and workforce pressures to ensure their patients receive safe, timely and appropriate care. Over the timeframe the Lib Dems have analysed, 345.8 million consultations were delivered in general practice and almost 40% lasted longer than 10 minutes – more than half, if you exclude those with an unknown length.
18 April 2023
Without General Practice, the Rest of the NHS Will Collapse Says College Chair
Responding to a report from the Office for National Statistics on the impact of winter pressures, Professor Kamila Hawthorne, Chair of the Royal College of GPs said: “GPs and their hard-working practice teams are working tirelessly to deliver safe and timely care for patients, but we simply do not have enough staff to meet demand that is growing in both volume and complexity.
12 April 2023
We Need More GPs and Less Box-Ticking, College Chair Tells New Statesman
RCGP Chair Professor Kamila Hawthorne spoke to The New Statesman about her career and her aspirations for general practice in the UK. Kamila promoted the role of a GP in tackling health inequalities, and called for the Government to take urgent action in order for GPs to have the time and resource they need to provide continuous care to patients.
11 April 2023
NICE Final Draft Guidance Recommends olaparib for Early Breast Cancer and Metastatic Prostate Cancer Following New Commercial Deals
Ground-breaking commercial deals for anti-cancer medicine olaparib have paved the way for hundreds to benefit in final draft guidance published today (6 April 2023) by NICE that recommends it for some types of early breast cancer and advanced prostate cancer.
The deals negotiated by NHS England and company AstraZeneca have enabled NICE to recommend olaparib as a clinically and cost-effective option:
- for adults with HER2-negative, high-risk early breast cancer who have inherited faults in their BRCA1 or BRCA2 genes, after surgery and chemotherapy
and
- for adults with previously treated hormone-relapsed metastatic prostate cancer who have the same BRCA mutations.
3 April 2023
RCGP Co-Signs Safety Alert on Menopause Care
The RCGP has issued a safety alert with the British Menopause Society, Faculty of Sexual and Reproductive Health, Royal College of Obstetricians and Gynaecologists, Society for Endocrinology and Royal College of Nursing’s Women’s Health Forum on menopause care.
Commenting on this, Professor Kamila Hawthorne, Chair of the Royal College of GPs, said: “The College has recently co-signed a safety alert with other members of the British Menopause Society, following our concerns about an increasing number of menopausal women being prescribed oestrogen at a dose that is higher than clinical guidelines.
4 April 2023
NICE Recommends Genetic Test to Prevent Newborn Babies Going Deaf
A genetic test to establish if a newborn baby is vulnerable to deafness if treated with a commonly used antibiotic has been recommended by NICE in final guidance.
If babies develop a neonatal bacterial infection doctors and midwives would usually give the antibiotic gentamicin.
However, the use of gentamicin carries the risk of hearing loss if the baby has the m.1555A>G genetic variant. Other alternative antibiotics are available but cannot be more widely used because they are associated with an increased risk of antimicrobial resistance.
28 March 2023
There Are Simply Not Enough GPs to Deliver the Care and Services We Are Trained for Says Royal College
Responding to the British Social Attitudes Survey from The Kings Fund and The Nuffield Trust, Professor Kamila Hawthorne, Chair of the Royal College of GPs said: "General practice is the bedrock of the NHS but there are simply not enough GPs or other members of practice staff to deliver the care and services we are trained for - and the impact of this on patients is reflected in today's report.
28 March 2023
NICE Identifies Improvements for People With Acute Kidney Injury in Updated Quality Standard
An updated quality standard published today (23 March 2023) by NICE outlines improvements in care for people who have or are at risk of acute kidney injury.
Acute kidney injury is a sudden, potentially reversible, loss of kidney function associated with high mortality.
27 March 2023
RCGP Statement on Partnership with Novo Nordisk
The RCGP has ended its partnership with Novo Nordisk following the ABPI's decision to suspend the company for breaches of its code of practice. All outstanding funds paid to the College by Novo Nordisk will be returned.
The College works with a variety of partners, including those in the pharmaceutical sector, to develop educational resources to support GPs and other healthcare professionals deliver high-quality patient care.
21 March 2023
Four Innovative Tests for Diagnosing UTIs Could Help in the Fight Against Antimicrobial Resistance
Innovative tests with the potential to help people with a urinary tract infection (UTI) receive the correct course of antibiotics more quickly could soon be considered for use in the NHS.
A NICE committee has seen promise in four tests which produce results in under an hour and can be carried out by a healthcare professional outside of a conventional laboratory in a primary or community care setting.
The technologies’ developers claim they can identify the presence of bacteria in a urine sample in less than 40 minutes. One can identify within minutes the strain of bacterial infection present. Another goes on to test which antibiotics are most appropriate to treat the infection.
17 March 2023
College Responds to Health Education England's Report on GP Speciality Training
Responding to Health Education England's proposals in its report Training for the Future - Enhancing Delivery of GP Speciality Training, Professor Kamila Hawthorne, Chair of the Royal College of GPs said: "It’s important that specialty GP training evolves to reflect both changes in healthcare and society. As such, we are pleased to see the focus in this report on continuing to support GPs to become experts in delivering holistic care and recognising their individual training needs, while preparing them for the priorities of modern practice, particularly tackling local health needs and delivering high quality complex care in growing areas of need, such as mental health, new technology applied to primary care, and health inequalities.
14 March 2023
NICE Recommended Weight-Loss Drug to Be Made Available in Specialist NHS Services
Thousands of people will soon be able to be prescribed a drug to help them lose weight as part of their treatment in an NHS specialist weight management service.
The drug can help people using it to reduce their weight by over 10 per cent when used with support of a multidisciplinary team. These professionals are experts on coaching people on lifestyle interventions and will also monitor the drug’s potential side-effects.
14 March 2023
A Quarter of GP Practices Could Close Because of Workload Pressures, Warns Royal College of GPs
General practice is on a cliff-edge with one in four practices at risk of closing, warns the Royal College of GPs as it launches a new report highlighting the current workload and workforce pressures facing GPs and their teams, and the impact these are having on patients.
GPs and their hard-working staff carried out 4.6 million (9%) more appointments in December 2022 and January 2023 compared to in 2019, however, the number of fully qualified full-time-equivalent GPs has dropped by 843 in the same period.
7 March 2023
Eight Digitally Enabled Therapies to Treat Depression and Anxiety in Adults Conditionally Recommended By NICE
Eight digital enabled therapies to treat depression and anxiety disorders in adults have been conditionally recommended by NICE in draft guidance issued today (Wednesday 1 March 2023).
A consultation has begun on the decision to conditionally recommend the digital enabled therapies which address depression and anxiety disorders, including PTSD and body dysmorphia. Each of the digital technologies includes the support and involvement of an NHS Talking Therapies clinician and use CBT techniques.
The eight therapies are conditionally recommended while further evidence is generated. They are the 6th and 7th early value assessments to have been undertaken using a new NICE rapid assessment process that seeks to identify promising medical technology for rapid deployment into the NHS.
26 February 2023
College Gives Media a Behind-The-Scenes Look at Workload and Workforce Pressures Facing GPs
Dr Karen Forshaw, Chair of RCGP's South Yorkshire and North Trent Faculty and Dr Thomas Patel Campbell, Chair of RCGP's Humber and the Ridings Faculty, spoke to The Mail Online about challenges facing general practice, and how highly GPs value their relationships with patients.
The College will continue to work with the media to promote the excellent patient care delivered by our members and their teams, despite immense workload and workforce pressures. We will also continue to defend our members against negative and unwarranted criticism.
28 February 2023
NICE Recommends 3 Treatments for COVID-19 in Final Draft Guidance
Everyone with COVID-19 at highest risk of developing severe disease will have access to clinically and cost-effective treatments, under final draft guidance published by NICE today.
People at highest risk of developing severe disease include those who are immunosuppressed (for example, as a result of chemotherapy or having had an organ transplant), or who have other conditions such as heart disease, respiratory disease, diabetes, or neurological condition23 February 2023
Latest GP Data Shows Tough Winter in General Practice, Says College Chair
Commenting on the latest NHS GP workforce and workload data, Professor Kamila Hawthorne, Chair of the Royal College of GPs, said: “Today’s data shows what a tough winter it’s been in general practice, and we know from what our members on the frontline are telling us, they continue to face intense workload and workforce pressures.
21 February 2023
NICE Says Evidence That COVID-19 Treatment Evusheld is Effective in Protecting Vulnerable Adults Against Current Variants is Lacking as it Announces New Rapid Update Process for COVID-19 Medicines
NICE has today (16 February 2023) issued draft guidance for public consultation which does not recommend Evusheld for preventing COVID-19 in adults who are unlikely to have an adequate immune response to COVID-19 vaccination, or who can’t be vaccinated.
Evusheld is not recommended for vulnerable adults who are at high risk of severe COVID-19 because there is not enough evidence of its effectiveness against current variants and those likely to be circulating in the next 6 months.
20 February 2023
GP Referrals to Specialist Services Must Be Taken Seriously, Says College Chair
Responding to research from Healthwatch England that found GP referrals to specialists have been rejected, cancelled or lost by hospitals, Professor Kamila Hawthorne, Chair of the Royal College of GPs said: Professor Kamila Hawthorne, Chair of the Royal College of GPs said: "GPs take their responsibility to refer appropriately and in a timely way very seriously. When doing so they will take into account the various factors impacting on a patient's health, their family and medical history and clinical guidelines, as well as pressures on local onward services. It is a professional letter that is written carefully and thoughtfully. With this in mind, it's essential that GP referrals made to specialist care are taken seriously and not rejected without a very good reason.
14 February 2023
NICE Recommends Genetic Test to Prevent Newborn Babies Going Deaf
A genetic test to establish if a newborn baby is vulnerable to deafness if treated with a commonly used antibiotic has been recommended by NICE in draft guidance.
If babies develop a neonatal bacterial infection doctors and midwives would usually give the antibiotic gentamicin.
However the use of gentamicin carries the risk of hearing loss if the baby has the m.1555A>G genetic variant. Other alternative antibiotics are available but cannot be more widely used because they are associated with an increased risk of antimicrobial resistance.
8 February 2023
Digital Mental Health Tech for Children and Young People Recommended by NICE in First Rapid Healthtech Guidance
Four digital technologies that can help children and young people with mild to moderate symptoms of anxiety or low mood have been recommended for use in the NHS once they achieve regulatory approval.
The guided self-help digital cognitive behavioural therapy (CBT) technologies can be used as an initial treatment option for those aged 5 to 18 while evidence is being generated.
These technologies will be able to be used once they have been given Digital Technology Assessment Criteria (DTAC) approval by NHS England.
7 February 2023
General Practice is Understaffed, Underfunded and Overstretched - and We and Our Patients Deserve More, Says College
Responding to the latest GP workforce and workload data published by NHS Digital, Professor Kamila Hawthorne, Chair of the Royal College of GPs, said: “Today’s figures highlight the hard work of GPs and our teams to deliver care and services to our patients in the face of intense workload and workforce pressures. In December, more than 27m consultations were delivered in general practice, with nearly half delivered on the same day they were booked - but numbers of fully qualified, full-time equivalent GPs has fallen by 754 since 2019.
31 January 2023
NICE Urges Professionals to Correctly Gather Information on People’s Alcohol Drinking Habits to Ensure Those Who Need Help Are Not Missed
Thousands of people asked each year could be missing out on brief interventions to help curb problem drinking, or a potential referral to specialist alcohol services.
To help address this NICE is recommending that people being asked about how much and how often they drink alcohol should have the information added to a validated questionnaire to identify if they need help, NICE has said.
30 January 2023
New Stats Show Government Must Urgently Address GP Pressures and Rising Cost of Living
Responding to ONS figures on the impact of winter pressures between 22 November to 18 November last year, Professor Kamila Hawthorne, Chair of the Royal College of GPs, said: “It’s as frustrating for GPs and our teams as our patients when they are unable to access our care and services in a safe, timely and appropriate way. But this is not due to lack of trying on the part of GP teams, who are consistently delivering more consultations every month than before the pandemic and are doing so with falling numbers of fully-trained, full time equivalent GPs. It is a result of years of under-funding in general practice and poor workforce planning.
24 January 2023
Adults With Depression Who Want to Quit Antidepressants Should Be Given Support on How to Do it Safely Over Time, Says NICE
Adults with depression who want to stop taking antidepressants should have the dose of their medication reduced in stages to reduce the likelihood and severity of withdrawal symptoms, NICE has said.
A new draft quality standard, which sets out priority areas for quality improvement for the care of adults with depression, includes a statement to help adults who want to come off the medication permanently.
The independent advisory committee, which includes experts in treating adults with depression, has recommended the staged withdrawal of antidepressants.
23 January 2023
Pharmacy Services Must Not Be Seen As ‘GPs on the Cheap’, Says College Chair
College Chair Professor Kamila Hawthorne has issued the following response to a new report by the All-Party Parliamentary Group on Pharmacy, calling for action to relieve funding pressures for pharmacists and new powers to help with NHS backlogs.
Professor Hawthorne said: “Our high street and online pharmacist colleagues do an excellent job for their communities and are providing invaluable support to many GP practice teams against a backdrop of huge workload and workforce pressures, so it is right that they are given the support they need to stay viable and available for people with minor illnesses and ailments.17 January 2023
Statins Could Be a Choice for More People to Reduce Their Risk of Heart Attacks and Strokes, Says NICE
New evidence on the safety of statins means more people could benefit from them, new NICE draft guidance says.
Draft updated guidance from NICE published 12 January 2023 recommends that the risk threshold at which statins should be offered to prevent cardiovascular events such as heart disease and strokes remains unchanged, but they can also now be considered for people at a lower threshold.
Up until now people with a 10% or higher risk over 10 years of a cardiovascular event should be offered a statin under current NICE guidance.
09 January 2023
General Practice Reduces Pressures Across NHS - But Must Be Resourced and Staffed to Fulfil This Function
Responding to an interview with Shadow Secretary of State for Health, Wes Streeting, published in The Times today, Professor Kamila Hawthorne, Chair of the Royal College of GPs, said: "A good health service relies on a robust, functioning general practice service. GPs and our teams make the vast majority of NHS patient contacts and in doing so, we alleviate pressure across the health service, including in A&E. This is largely through the important 'gatekeeper' role we hold, ensuring as many people as possible receive the care they need close to home - but we're working under intense workload and workforce pressures, and the service is struggling.
10 January 2023
New “Artificial Pancreas” Technology Set to Change the Lives of People Having Difficulty Managing Their Type 1 Diabetes
Around 105,000 people with type 1 diabetes could benefit from NICE’s draft recommendation
People who are struggling to manage their type 1 diabetes could be offered new technology to help them control their condition with little human input.
In draft guidance, an independent NICE committee has recommended the use of hybrid closed loop systems for managing blood glucose levels in type 1 diabetes – technology that has been described as a step towards an artificial pancreas.
06 January 2023
GP Partnership Model Works Well for Patients, the NHS and the Taxpayer – But it Needs Sufficient Resource and Staffing
Responding to an interview with Shadow Secretary of State for Health, Wes Streeting, published in The Times today, Professor Kamila Hawthorne, Chair of the Royal College of GPs, said: "A good health service relies on a robust, functioning general practice service. GPs and our teams make the vast majority of NHS patient contacts and in doing so, we alleviate pressure across the health service, including in A&E. This is largely through the important 'gatekeeper' role we hold, ensuring as many people as possible receive the care they need close to home - but we're working under intense workload and workforce pressures, and the service is struggling.
4 January 2023
NICE Recommends Enhertu for More People with Advanced Breast Cancer
Hundreds more people eligible for breast cancer drug Enhertu as NICE recommends it for earlier stage disease, in final draft guidance.
Today’s decision means NICE has recommended all 18 treatments for breast cancer it has looked at since 2018.
There is no cure for advanced breast cancer, so treatment aims to stop the disease getting worse, extend life, and maintain or improve quality of life for as long as possible.
Clinical trial evidence shows that Enhertu increases how long people have before their cancer gets worse compared with standard care with trastuzumab emtansine.
02 January 2023
Hardworking GPs Must Not Be Blamed for Lack of Appointments, Says College
The College has responded to a Liberal Democrat survey claiming that patients are turning to ‘DIY’ treatments due to lack of GP appointments. You can read it below.
Professor Kamila Hawthorne, Chair of the Royal College of GPs, said: “We understand patients’ distress and frustrations when they are unable to get a GP appointment, but the blame must not be put onto hardworking GPs and their teams who are doing their absolute best in extremely difficult circumstances to meet the healthcare needs of their patients.
27 December 2022
NICE Recommends a Weekly Injection for Treating Growth Failure in Children
This recommendation comes from a pilot to develop simpler, faster evaluations for the appraisal of some treatments.
Children being treated for growth disturbance could be spared the pain and discomfort caused by daily injections after NICE recommended a new weekly treatment option called somatrogon.
It will be an option for children and young people aged three years and over who are being treated for a condition called growth disturbance caused by insufficient secretion of growth hormone.
27 December 2022
RCGP Responds to Latest GP Workload and Workforce Figures
Commenting on the latest GP workload and workforce figures from NHS England, Professor Kamila Hawthorne, Chair of the Royal College of GPs said: “Nearly 33m appointments were delivered in November, 18% more than November 2019, and with over 41% delivered on the same day they were booked. These figures show just how hard GPs and our teams are continuing to work to deliver timely and appropriate patient care during an exceptionally busy winter - and it’s only just begun.
20 December 2022
More Than 5,200 People Could Benefit After NICE Broadens Recommendation on Chronic Lung Disease Treatment
NICE broadens recommendation on chronic lung disease treatment
NICE has today (Wednesday, 14 December) recommended that nintedanib to treat idiopathic pulmonary fibrosis (IPF) be extended to more people.
The treatment is currently recommended for people with a forced vital capacity (FVC) value of 50 to 80 percent of expected normal capacity.
13 December 2022
College and Leading Health Experts Launch Latest Strep-A Guidance to Support Busy GPs
The College has worked with leading health organisations across the UK to publish new guidance on Strep A, bringing everything together in one place to support busy GP teams.
We understand that parents are concerned - and we don’t want to discourage them from seeking help if they think their child has a serious case of Strep A – but we know that many surgeries are struggling to cope with the additional demand on top of the existing workload and workforce pressures in general practice.9 December 2022
College Issues Advice on Strep A in Joint Statement With RCPCH And RCEM
The Royal College of General Practitioners, Royal College of Paediatrics and Child Health (RCPCH) and Royal College of Emergency Medicine (RCEM) are issuing advice in a joint statement for worried parents and healthcare professionals working during a very tough winter.
The latest data from the UK Health Security Agency (UKHSA) shows that cases of Group A Strep infection, including scarlet fever, continues to remain higher than we would typically see at this time of year. Currently, there is no evidence that a new strain is circulating. This increase is most likely related to high amounts of circulating bacteria and social mixing. Please be assured that the situation is being closely monitored and assessed.
6 December 2022
Targeted Treatment for Rare Form of Aggressive Lung Cancer Gets NICE Approval
Mobocertinib recommended as a treatment for a rare and aggressive form of lung cancer
More than 100 people are set to benefit after NICE published final draft gui
Mobocertinib (Exkivity, Takeda) is a treatment for people with the epidermal growth factor receptor (EGFR) exon 20 insertion gene mutation-positive form of advanced non-small-cell lung cancer (NSCLC), who have already received platinum-based chemotherapy.
5 December 2022
‘Digital’ Health Checks Must Be Evidence-Based and Robustly Evaluated, Says RCGP
Commenting on plans from the Department of Health and Social Care to trial ‘at home’ NHS Health Checks, Professor Kamila Hawthorne, Chair of the Royal College of GPs, said:
"Health checks can play an important role in prevention and early diagnosis, but they must be based on evidence that the checks improve health outcomes for our patients. Offering patients the opportunity to carry out health checks, or some aspects of health checks, for themselves at home has merit – some sexual health services already offer users at-home self-testing options, for example, and some patients already have equipment at home such as blood pressure monitors -– so is worth exploring. This initiative has potential to encourage people to take more of an active interest in their own health.
29 November 2022
New Life-Extending Treatment for Rare Forms of Advanced Gastroesophageal Cancer Recommended By NICE
Around 3,000 people could be eligible for a new life-extending combination therapy to treat rare forms of gastroesophageal cancer after NICE published final draft guidance today (24 November 2022).
Nivolumab (also known as Opdivo and made by Bristol Myers Squibb) given alongside chemotherapy has been recommended as an option for untreated HER2-negative, advanced or metastatic gastric, gastro-oesophageal junction or oesophageal adenocarcinoma if the tumours express PD-L1.24 November 2022
Government Needs to Address Root Cause of GP Pressures – Not Undermine the Hard Work of GP Teams, Says New College Chair
New RCGP Chair Kamila Hawthorne has hit out at the publication of data allowing ‘arbitrary comparisons’ between GP practices, despite latest figures showing that GP teams have delivered a record number of patient consultations.
Responding to the latest GP workload and workforce data, published by NHS Digital this morning, Professor Hawthorne said: “Today’s figures show GPs and their teams delivered a record 36.1 million consultations in October, almost 40% of these on the day they were booked and more than 71% delivered in-person, the highest proportion since before the pandemic.
15 November 2022
NICE Final Draft Guidance Adds Further Treatment Option for Triple-Negative Breast Cancer
NICE has today (8 November 2022) published final draft guidance which recommends pembrolizumab as an option for people with a type of breast cancer called triple-negative breast cancer
The draft guidance recommends pembrolizumab (also called Keytruda and made by MSD) as an option with chemotherapy to try to reduce the size of the tumour before surgery (neoadjuvant treatment), and on its own as treatment after surgery (adjuvant treatment), for adults with triple-negative early breast cancer at high risk of recurrence or locally advanced breast cancer.
18 November 2022
The Job of a GP Will Become ‘Manageable’ Again, College Chair Martin Marshall Tells Members as He Steps Down
Professor Martin Marshall steps down as College Chair today after three years.
Speaking to the College’s Annual General meeting, he reflected on his experience of leading the RCGP through the turbulence of the pandemic. He said that the College would continue its work to make the job of being a GP ‘manageable’ again and to ‘return to a time when GPs can deliver the best quality, personalised care that our patients need without a detrimental impact on our own health and wellbeing’.
With the College set to mark its 70th anniversary this Saturday (19 November), he said the College’s mission remained the same as in 1952: to deliver compassionate care with knowledge.
15 November 2022
NICE Final Draft Guidance Adds Further Treatment Option for Triple-Negative Breast Cancer
NICE has today (8 November 2022) published final draft guidance which recommends pembrolizumab as an option for people with a type of breast cancer called triple-negative breast cancer
The draft guidance recommends pembrolizumab (also called Keytruda and made by MSD) as an option with chemotherapy to try to reduce the size of the tumour before surgery (neoadjuvant treatment), and on its own as treatment after surgery (adjuvant treatment), for adults with triple-negative early breast cancer at high risk of recurrence or locally advanced breast cancer.
8 November 2022
NICE Conditionally Recommends Digital Cognitive Behaviour Therapies for Use in the NHS to Help Children and Young People with Symptoms of Mild to Moderate Anxiety
Draft guidance released for consultation today (Friday 4th Nov) states the technologies can be used with support from a mental health professional, while further evidence is generated to check if the benefits they offer are realised in practice.
The five self-guided products offer games, videos and quizzes, based on CBT principles, help children and young people learn techniques to better understand and manage their symptoms of anxiety and low mood with the support of a mental health practitioner.
1 November 2022
Chief Operating Officer Appointed New RIBA Chief Executive
The College has today announced that Chief Operating Officer Dr Valerie Vaughan-Dick MBE will be leaving in January 2023 to take up the role of Chief Executive Officer at the Royal Institute of British Architects.
1 November 2022
Good News PM Has Scrapped Missed Appointment Charging Plans - He Must Now Address GP Pressures
Commenting on the news that Prime Minister Rishi Sunak has abandoned his proposal to charge patients for missed GP appointments, Professor Martin Marshall, Chair of the Royal College of GPs, said: “We’re pleased to hear this development. Charging patients for missed appointments would not have worked, would have disadvantaged some of our most vulnerable patients, and would simply have been tinkering at the edges given the scale of the crisis facing GPs and our teams.
27 October 2022
New PM Must Act Fast to Address Intense Workload and Workforce Pressures in General Practice
Responding to the latest NHS general practice workforce and consultation data, Professor Martin Marshall, Chair of the Royal College of GPs said: "It's important that the new Prime Minister and Health Secretary take note of today's general practice data and urgently act to address the intense workload and workforce pressures facing our profession, and the impact this is having on patients.
25 October 2022
NICE Partners with International Health Technology Assessment Bodies to Boost Collaboration on Shared Opportunities and Challenges
SIX health technology assessment (HTA) bodies from three continents are to collaborate on a range of topics that will benefit people accessing healthcare around the world.
The signatories to the arrangement, who will continue to remain independent of one another, are:
- National Institute for Health and Care Excellence (NICE)
- Canadian Agency for Drugs and Technologies in Health (CADTH)
- Australian Government Department of Health and Aged Care
- Healthcare Improvement Scotland
- Health Technology Wales
- All Wales Therapeutics & Toxicology Centre
24 October 2022
RCGP Statement on Patients’ Access to Their GP Records
The RCGP has been engaging closely with NHS England over plans to grant patients automatic access to their prospective records from 1 November 2022. The College has always supported the principle of expanded record access and the benefits that patient access to records offers in terms of self-management, health outcomes and patient satisfaction. However, we have also recognised the additional risks that automation brings and over the past year we have consistently highlighted the importance of practice preparedness, safe redaction technology and consideration of the most vulnerable patients.
4 October 2022
NICE Review Does Not Recommend Routine Funding for Duchenne Muscular Dystrophy Gene Therapy Ataluren in Draft Guidance
NICE has today (30 September) published draft guidance for public consultation which does not recommend ataluren (also called Translarna and made by PTC Therapeutics) for treating Duchenne muscular dystrophy (DMD) caused by a nonsense mutation.
Today’s decision follows NICE’s commitment to re-evalutate ataluren and decide whether it should be available for routine funding on the NHS following a 6-year period during which it was available under a managed access agreement (MAA). This agreement, which ends in January 2023, meant that people could have the treatment while more data to resolve issues about its effectiveness was collected. Around 60 children have been able to have ataluren under this arrangement.
30 September 2022
College Concerns Over Future of White Paper on Health Inequalities
Professor Martin Marshall, Chair of the Royal College of GPs, said: “Reports that the Government is considering dropping plans to tackle inequalities in health are deeply concerning.
“Practices serving more deprived populations receive around 7% less funding per patient and have around 10% more patients per GP, than those serving more affluent populations.”27 September 2022
1,500 People Set to Receive New Skin Cancer Treatment that Reduces the Risk of it Returning and Spreading
Around 1,500 people aged 12 years and over with melanoma are set to benefit from pembrolizumab (also called Keytruda and made by MSD), a drug that reduces the chance of it returning, following final draft NICE guidance published today (23 September 2022).
Melanoma is the most common form of skin cancer. It develops from melanocytes (cells in the skin’s epidermis) and pembrolizumab is an immunotherapy treatment which helps the body’s immune system to fight the cancer cells.
21 September 2022
More Expectations Without Addressing GP Workforce Shortage Not Best Way Forward, Says RCGP
Responding to the announcement on GP access being made by Secretary of State for Health and Social Care, Thérèse Coffey, Prof Martin Marshall, Chair of the Royal College of GPs, said: “It’s a shame that the Health Secretary didn’t talk to the College and to our members on the frontline before making her announcement because we could have informed her of what is really needed to ensure a GP service that meets the needs of patients and is fit for the future.
20 September 2022
Broughshane Doctor Wins GP of the Year Award
The Royal College of General Practitioners, which represents over 1400 GPs across Northern Ireland, is proud to announce that Dr Laura Bunting, Broughshane Medical Centre, has been awarded GP of the Year 2022.
RCGPNI’s GP of the Year Award is nominated and judged by patients, to recognise the tireless work GPs and their practice teams have done throughout this pandemic, going above and beyond to support patients.
13 September 2022
General Practice Must Be a ‘Top Priority’ For the New Health Secretary
Responding to the appointment of Dr Thérèse Coffey as the new Secretary of State for Health and Social Care, Professor Martin Marshall, Chair of the Royal College of GPs, said: "We welcome the new Health Secretary to her role and look forward to working with her and her team to ensure we have a robust general practice service that is able to provide high quality care for patients, which supports staff and can continue to keep the NHS sustainable. This must be a top priority for the new Health Secretary given that she has made it clear that she is serious about ensuring the NHS remains able to deliver good, timely, safe and appropriate care and services to patients now and in the future.
6 September 2022
NICE Recommends Transplant with Good Bacteria Taken from Poo to Resolve Recurrent Clostridium Difficile Infections
Experts estimate that 450 to 500 people could be treated using FMT for multiple recurrences of C. diff infections each year.
Hundreds of people with recurrent bacterial infections could be treated with gut bacteria taken from a healthy donor’s poo.
NICE has recommended a faecal microbiota transplant (FMT) is offered to people who have been treated for two or more Clostridium difficile (C. diff) infections without success.
30 August 2022
Practice Closures Show How General Practice is Struggling and Needs Support, Says College
The College has responded to an investigation by Pulse magazine showing 474 GP practices have closed since 2013.
Professor Martin Marshall, Chair of the Royal College of GPs, said: “The impact of a practice closing can be considerable for its patients and neighbouring practices. As such, a decision to close a practice will be one of the most difficult a GP partner can make. There may be many reasons for a practice to close, in some instances it may be that it is merging with another in order to pool resources, but when the reason for closing a practice is workload pressures, and not being able to fill vacancies, then this needs to be addressed as a matter of urgency.
29 August 2022
Statins Study ‘Reassuring’ For Patients and Clinicians, Says College
Commenting on a study in the Lancet on statins, Professor Martin Marshall, Chair of the Royal College of GPs, said: “This study should be reassuring to clinicians and to patients taking or considering taking statins that the risk of muscle pain is low and usually does not outweigh the benefits of statin use.
23 August 2022
Action to Tackle Cost of Living Crisis ‘Cannot Fall to GPs to Facilitate’
Responding to plans for GPs to become responsible for assessing patients’ eligibility for financial cost of living support, Professor Martin Marshall, Chair of the Royal College of GPs, said: “There is a clear link between poverty and health, and rising energy and food bills clearly risk the health of our patients. As GPs we are already seeing the results of this in our surgeries, and it is likely we will continue to do so as we approach what is likely to be a very difficult winter.
16 August 2022
NICE Publishes First Draft Guidance from its Early Value Assessment Pilot Project Recommending Smartphone-Linked ECG Device
It is the first recommendation to be issued by NICE’s diagnostics advisory committee via its Early Value Assessment pilot project.
NICE has today (Friday 12 August 2022) issued draft guidance recommending KardiaMobile 6L for measuring cardiac QT interval in people having antipsychotic medication.
People taking antipsychotic medication may need testing for heart problems before starting treatment and at regular intervals during their treatment. Detecting heart problems such as rhythm disturbances can inform the choice of medicines, their dosing, whether to stop them, and potentially avoid severe cardiac events.
12 August 2022
Urgent Support Needed for General Practice to Get Through Winter, Says RCGP
Responding to the latest measures set out by NHS England to address forthcoming winter pressures in the health service, Dr Gary Howsam, Vice Chair of the Royal College of GPs, said: “The entire NHS is facing an incredibly difficult winter ahead. We certainly support measures to ease pressures facing colleagues in hospitals and improve patient access to these services during this time, but we also need to see more being done to help general practice get through what is likely to be a very tough period.
9 August 2022
College Statement Following the Death of GP Gail Milligan
Dr Gary Howsam, Vice Chair of the Royal College of GPs, said:
“We are shocked and saddened by the tragic death of our colleague Dr Gail Milligan. Our thoughts are with her family and friends, her colleagues at her practice and in Thames Valley Faculty, and her patients. The loss of Dr Milligan will be felt deeply by our College and our profession.
2 August 2022
Charging For Missed Appointments Won’t Address Intense GP Pressures
Responding to pledges to introduce charges for missed NHS appointments, Dr Gary Howsam, Vice Chair of the Royal College of GPs said: "GPs and our teams are working under intense workload and workforce pressures, delivering increasingly complex care to increasing numbers of patients while numbers of qualified, full time equivalent family doctors is falling despite the Government’s manifesto promise of 6,000 more GPs by 2024.
28 July 2022
Latest GP Statistics Show Intensity of Working in General Practice ‘Unsustainable and Unsafe’ for Patients and Staff
Responding to the latest general practice workforce and workload data: Professor Martin Marshall, Chair of the Royal College of GPs, said: “Despite repeated promises to boost GP numbers, today’s figures show that we have more than 1,500 fewer qualified, full-time equivalent GPs than we did five years ago. The result is a chronically over-stretched and under-resourced general practice service, with GPs and their teams working to their absolute limits to deliver increasingly complex care to the ever-rising number of patients that need it.
26 July 2022
Patient Access to Their Records
This week, NHS England wrote to GPs to confirm that from 1st November 2022, patients at practices in England using TPP and EMIS systems will be granted automatic access to their prospective records via patient facing apps.
21 July 2022
RCGP Joins Other Medical Royal Colleges and the Academy of Medical Royal Colleges in Calling for the Next PM And Leader of the Conservative Party to Make Health and Care a Priority
With the election of the leader of the Conservative Party coming down to two candidates, the RCGP has signed a joint statement calling on them both to commit to make health and care a priority.
There is a crisis in general practice and the RCGP will continue to work with politicians from across Parliament to call on them to deliver a bold new plan to help GPs and their patients.
19 July 2022
NICE Recommends Piqray and Trodelvy, Maintaining 100% Approvals of Breast Cancer Drugs Since 2018
An agreement with the companies on the price of 2 breast cancer treatments, Piqray and Trodelvy, has paved the way for NICE to be able to make them available immediately to around 3,450 people on the NHS and maintaining NICE’s 100% approval rate of breast cancer drugs since 2018.
In final draft guidance published today (Thursday 14 July 2022) NICE has recommended Piqray (also called alpelisib and made by Novartis Pharmaceuticals UK), used with the hormonal therapy fulvestrant, for treating hormone receptor-positive, HER2-negative, PIK3CA-mutated locally advanced or metastatic breast cancer that has grown after treatment with combined hormonal therapy and a cancer growth inhibitor.
19 July 2022
GP Patient Survey Reflects ‘Overstretched’ Service Working Under Intense and Unsustainable Pressure
Responding to the latest GP Patient Survey, Professor Martin Marshall, Chair of the Royal College of GPs, said:
“These findings reflect an over-stretched service, with GPs and our teams doing our best for patients under intense workload and workforce pressures.
12 July 2022
More Than 4,600 GPs Demand Health Secretary Takes Action to Address GP Pressures That Are Impacting on Patient Care
The Secretary of State for Health and Social Care in England, Sajid Javid, needs to take urgent action to support GPs and their teams so that they can deliver the care patients need, more than 4,600 GPs and GP trainees are demanding.
In a letter to the Secretary of State, 4620 GPs and GP trainees have called on the Government to implement the College’s new plan to improve general practice in England. They say this is needed to address the surging workload and workforce pressures facing GPs and their teams that is impacting the care they are able to deliver to patients - and prevent a potential mass exodus of nearly 19,000 GPs from the service in the next five years, according to the latest data from a recent College survey of members.
28 June 2022
New Treatment to Increase the Chances of a Successful Kidney Transplant Recommended By NICE
A new treatment that increases the chance of a successful kidney transplant has been recommended by NICE in final draft guidance.
Imlifidase (also known as Idefirix and made by Hansa Biopharma) has been recommended for people who are waiting for a kidney transplant and who are highly sensitised to human leukocyte antigens (HLAs) to prevent the body rejecting the donor organ.
The company estimates there are over 100 people eligible for imlifidase in England and Wales.
HLAs are a type of molecule in the body which play an important role in the immune systems response to foreign substances.
23 June 2022
College Response to Detection of Poliovirus in the UK
The College has responded to recent reports that the poliovirus has been detected in the UK.
Professor Martin Marshall, Chair of the Royal College of GPs, said: "It is concerning to hear reports that the poliovirus has been identified in the UK, after its eradication in 2003, but it’s important to note that there are currently no confirmed cases of polio in the UK.
“The NHS childhood vaccination programme, which includes the polio vaccination, is critical to protect children – and wider society - against serious and potentially fatal diseases. It’s important that children are up to date with their all their inoculations, and if, for whatever reasons, they are not, we’d encourage parents to contact their GP practice to arrange for them to be vaccinated.
21 June 2022
NICE Recommends Step-Change Targeted Treatment for People with Early Breast Cancer
Around 4,000 people are set to benefit from a step-change in treatment for early breast cancer following today’s (17 June 2022) provisional approval by NICE of abemaciclib in combination with hormone therapy as an option after surgery.
NICE’s final draft guidance recommends abemaciclib (also called Verzenios and made by Eli Lilly) for people with hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence who have had surgery to remove their tumour.
Results from a clinical trial showed that people having abemaciclib with hormone therapy had a more than 30% better chance of their cancer not coming back following surgery compared with people having hormone therapy alone.
17 June 2022
Prescribing ‘Core Skill’ For GPs and Vast Majority of Prescriptions Not ‘Unnecessary’, Says RCGP
The College has responded to comments by Prof Sir Stephen Powis, Medical Director for NHS England, at the NHS Confed Expo on “unnecessary prescriptions”.
Professor Martin Marshall, Chair of the Royal College of GPs, said: “Prescribing is a core skill for GPs and is a key part of our training. When developing a treatment plan, GPs will take into account a patient’s individual health needs and medical history, as well as clinical guidance – and we will consider the various treatment options, including alternatives to drug therapies, in conversation with the patient about the risks and benefits of each.
14 June 2022
Hundreds of Thousands Set to Benefit as NICE Final Draft Guidance Recommends New Treatment to Prevent Heart Attacks and Strokes in People with Raised Blood Fats
NICE has today (10 June 2022) published final draft guidance which recommends icosapent ethyl for reducing the risk of cardiovascular events such as heart attacks and strokes in adults who have raised levels of a type of blood fat called triglycerides.
It means that around 425,000 people could now benefit from the first licensed treatment shown to reduce the risk of heart attacks and strokes in people with controlled low-density lipoprotein cholesterol (LDL-C – sometimes called “bad” cholesterol) who are taking a statin and who have raised levels of triglycerides.
10 June 2022
Fit Note Changes 'Positive Step' in Reducing GP Bureaucracy
Dr Gary Howsam, Vice Chair of the Royal College of GPs, said:
"The College has supported the idea of allowing other healthcare professionals working in general practice, where appropriate, to issue fit notes, and it is good to see that this will soon become a reality.
7 June 2022
NICE Recommends Potentially Life-Changing Treatment for People with Short Bowel Syndrome
Teduglutide (also known as Revestive and made by Takeda) is available for people who are in a stable condition following surgery to remove an abnormal bowel.
In adults, this surgery may be needed for a range of conditions, including Crohn’s disease. In premature babies and children, it is often because of surgery for necrotising enterocolitis or other conditions. Some children can be born with a short bowel.
31 May 2022
GP Pressures Being Felt Across the Country, but Some Areas More Impacted Than Others
Responding to research from the Nuffield Trust, covered by the BBC today, on regional variation in GP-patient ratios, Professor Martin Marshall, Chair of the RCGP, said:
“The size of the fully-qualified GP workforce is falling whilst the number of patients continues to grow – as a result, the ratio of patients to GPs has increased significantly over recent years. Whilst this is happening across the country, some regions are being affected worse than others as they face greater difficulties recruiting new GPs and other staff.
31 May 2022
NICE Sets Out Further Details on Menopause Guideline Update
NICE has outlined what aspects of menopause care will be updated in upcoming guidance, including areas where more research is needed.
The ‘scope’ of the menopause guideline, published on Friday 27 May, sets out new areas of evidence which NICE will look at and consider either making new recommendations or updating existing ones. The following areas have been identified for inclusion in the scope
30 May 2022
College Reaction to Dr Arora case
The College has issued the following statement in reaction to the GMC ruling on Dr Manjula Arora.
“We are deeply concerned about Dr Arora’s case and whilst we welcome the decision by the GMC to review the ruling, we will be asking for answers as to why the case was allowed to get through their screening processes and end in a Fitness to Practise Hearing and receiving a sanction.
24 May 2022
NICE Recommends Offering App-Based Treatment for People with Insomnia Instead of Sleeping Pills
Hundreds of thousands of people suffering from insomnia who would usually be prescribed sleeping pills could be offered an app-based treatment programme instead, NICE has said.
NICE has recommended Sleepio as an effective alternative to sleeping pills, which would save the NHS money as well as reducing prescriptions of medicines such as zolpidem and zopiclone that can be dependency forming. Economic analysis found that healthcare costs were lower at one year when using Sleepio, mostly because of fewer GP appointments and sleeping pills prescribed.
18 May 2022
Home Office Bureaucracy Causing 100s of New NHS Trained GPs to Face Hurdles to Stay and Work in the UK During Workforce Crisis
GP trainees from overseas should be given indefinite leave to remain in the UK following successful completion of their GP training, the Royal College of GPs said today.
In a letter to Home Secretary Priti Patel, the College calls on her to urgently rectify the visa regulations for all trainee GPs from overseas, to stop them facing potential deportation at the end of their specialty training and the NHS losing desperately needed fully-qualified GPs.
17 May 2022
More Than 400 People Could Benefit from Life-Extending Advanced Lung Cancer Treatment After It Was Recommended for Routine Use on the NHS
Durvalumab recommended as an option for treating non-small-cell lung cancer (NSCLC
NICE has published a draft final appraisal document (FAD) recommending Durvalumab (Imfinzi, AstraZeneca) as an option for treating non-small-cell lung cancer (NSCLC) in adults.
More than 400 people in England with locally advanced unresectable NSCLC, whose tumours express PD-L1 on 1% or more of cells and whose disease has not progressed following concurrent platinum-based chemoradiation, could receive the immunotherapy treatment.
11 May 2022
RCGP Highlights GP Pressures and the Impact They Are Having on Patient Care in Daily Express
The following comment piece by RCGP Chair Professor Martin Marshall has been published in today’s Daily Express and featured on the front page of the newspaper.
It highlights the intense workload and workforce pressures facing general practice and the impact this is having on GPs and patients.
The double-page article also runs comments from GP Nick Brown and Vice Chair Gary Howsam, highlighting that general practice needs urgent support. The Express’ editorial comment states: “Losing yet more burnt out GPs from the profession can only make a dire situation worse. This health emergency needs to be sorted out – and quickly – because GPs are suffering, and patients too.”
10 May 2022
GP Numbers Falling While Patient Numbers Rise Is Making Workload ‘Unsustainable’, Says College
Responding to research published by the Lib Dems showing that on average every GP is responsible for 2,200 patients, Professor Martin Marshall, Chair of the Royal College of GPs, said:
“The size of the qualified GP workforce is falling whilst numbers of patients - and complexity of care being delivered in general practice - continue to grow. As a result, the ratio of patients to GPs has increased significantly over recent years.
3 May 2022
Healthier Lifestyle Can Help to Ease Osteoarthritis Symptoms Says NICE
Exercise has an important role to play in helping people living with osteoarthritis NICE says in draft updated guidelines published today (29th April 2022) on the care and management of people with the condition.
Clinical evidence shows that when people with osteoarthritis are offered tailored exercises, such as muscle strengthening and aerobic exercise, they can achieve good health outcomes.
Healthcare professionals should support people with osteoarthritis and who are overweight by helping them choose a weight loss goal to help manage symptoms. Losing weight can have a significant impact on health outcomes for a range of conditions, but it can also help to reduce joint pain for people with osteoarthritis.
3 May 2022
Latest Consultation Rates Show GP Teams Are 'Working Exceptionally Hard' In Difficult Circumstances
Responding to the latest consultation figures, Professor Martin Marshall, Chair of the Royal College of GPs, said:
“It is clear from today’s figures that GPs and our teams are continuing to work exceptionally hard, delivering more than 30m patient consultations in March – more than in the same month before the pandemic – with 44% on the same day they were booked. The data shows that GP teams are trying their best in the face of intense workload and workforce pressures to ensure their patients receive timely and appropriate care.
26 April 2022
NICE Reaches Important Milestone in the UK’s Efforts to Tackle Antimicrobial Resistance
Two new antimicrobial drugs - cefiderocol and ceftazidime–avibactam - are close to becoming the first to be made available as part of the UK’s innovative subscription-style payment model after NICE published draft guidance estimating their value to the NHS.
The NICE evaluations of cefiderocol and ceftazidime–avibactam form part of a project with NHS England and NHS Improvement and the Department of Health and Social Care (DHSC) that aims to incentivise research into and development of antimicrobials by testing new approaches to evaluating and paying for them.
The drugs will only be used to treat patients with severe drug-resistant infections who would otherwise have limited or no other treatment options.
20 April 2022
Ban on ‘Conversion Therapy’ Should Protect All LGBT People
The RCGP has spoken out against Government proposals to ban so-called conversion therapy on the basis of sexual orientation but not gender identity.
The following letter has been published in The Guardian on 13 April:
The RCGP is one of 20 health organisations signatory to a memorandum of understanding opposing conversion therapy, so we were disappointed by the Government’s proposal to ban the practice for lesbian, gay and bisexual people in England and Wales – but not for trans people.
19 April 2022
Over 700 People a Year Could Benefit from a New Potentially Life-Extending Lung Cancer Drug Which Targets a Specific Genetic Mutation
New potentially life-extending lung cancer drug which targets a specific genetic mutation recommended by NICE
An innovative and potentially life-extending drug for treating people with a specific gene mutation of advanced non-small-cell lung cancer (NSCLC) has been recommended by NICE and will be available to patients from today (Thursday, 14 April).
The drug has been recommended for routine use across the NHS in England through Project Orbis, a programme to review and approve promising cancer drugs helping patients access treatments faster.
16 April 2022
RCGP Statement on Sodium Valproate Use
Responding to a Sunday Times investigation, published today, on continued use of sodium valproate for women of child-bearing age, Professor Martin Marshall, Chair of the Royal College of GPs, said:
“The use of sodium valproate is strictly regulated given the terrible effects it can have on the children born to women taking it during pregnancy. It should not be prescribed to women of child-bearing age unless they are on a pregnancy prevention plan or there are exceptional circumstances.
12 April 2022
Keep the Size of Your Waist to Less Than Half of Your Height, Updated NICE Draft Guideline Recommends
Keep the size of your waist to less than half of your height, updated NICE draft guideline recommends
People are being encouraged to keep their waist measurement to less than half their height to reduce the risk of potential health problems, according to recommendations in an updated NICE draft guideline.
For the first time, this update encourages adults with a body mass index (BMI) below 35 kg/m² (obesity class 2) to measure their own waist-to-height ratio.
7 April 2022
NICE Says New Triple Negative Advanced Breast Cancer Drug Too Expensive for NHS Use
NICE has today, 7 April 2022, issued draft guidance which does not recommend sacituzumab govitecan for treating locally advanced or metastatic triple negative breast cancer.
The draft guidance, which is available for public consultation until 29 April 2022, says that, although sacituzumab govitecan increases how long people have before their disease gets worse and how long they live compared with chemotherapy, at its current price it is too expensive to be considered a cost-effective use of NHS resources.
5 April 2022
Thousands of People Set to Benefit from First New Treatment for Osteoporosis for Over a Decade
Thousands of people in England and Wales with severe osteoporosis who are at high risk of fracture are set to benefit from a new treatment – romosozumab – after NICE recommended it for people after menopause in final draft guidance published today (Friday 1 April) by NICE.
Over 20,000 people could be eligible for the treatment according to the company. Clinical trial evidence showed that romosozumab (also known as EVENITY and made by UCB) followed by alendronic acid is more effective at reducing the risk of fractures than alendronic acid alone.
31 March 2022
GPs Need Support to Manage Sustained Rises in Need for Care, Highlights Consultation Data
Responding to the latest NHS Digital GP consultation data, Professor Martin Marshall, Chair of the Royal College of GPs, said the following.
“Today's figures show that GPs and our teams are continuing to work flat out to deliver more consultations with patients than in the same month pre-pandemic, with almost half of these delivered on the same day.
25 March 2022
Pregnant Women to Be Offered First Test to Help Diagnose Pre-Eclampsia
Midwives caring for pregnant women can use one of four blood tests to help diagnose suspected preterm pre-eclampsia, NICE has said in new draft diagnostic guidance.
The independent NICE diagnostic advisory committee has recommended four tests that can be used between 20 to 36 weeks and 6 days of pregnancy to help make decisions about caring for women presenting with suspected preterm pre-eclampsia.
Pre‑eclampsia is a potentially serious complication of pregnancy, thought to be related to problems with the development of the placenta
22 March 2022
Rise in Prescribing Anti-Anxiety Medications Suggests More Patients Are Open to Seeking Help for Mental Health Concerns Says College
Responding to a BJGP study: the rise in prescribing for anxiety in the UK primary care between 2003 and 2018, Professor Martin Marshall, Chair of the Royal College of GPs, said the following.
“Evidence shows that antidepressants can be effective drugs when used appropriately, so this research should not be a cause for alarm – indeed, it is most likely to suggest that more people are seeking medical help for anxiety-related conditions, as well as improvement in the identification and diagnosis of them.
22 March 2022
NICE Recommends Elosulfase Alfa for Routine NHS Use for Patients with Rare Life-Limiting Metabolic Disorder
People with a rare condition that steadily worsens often leaving them dependent on a wheelchair and with shortened life expectancy, can now benefit from the first treatment to slow its progression.
NICE has today (21 March 2022) published final draft guidance recommending elosulfase alfa (also called Vimizin and made by BioMarin) for routine use in the NHS for the treatment of mucopolysaccharidosis type 4A (also known as MPS 4A and Morquio A syndrome).
Elosulfase alfa becomes the first disease modifying treatment recommended by NICE for routine NHS use for people with this rare, severely life-limiting condition.
16 March 2022
NICE Publishes Comprehensive Quality Standard Designed to Improve the Diagnosis and Assessment of Fetal Alcohol Spectrum Disorder
NICE’s latest quality standard published today (16 March 2022) sets out how health and care services can improve the diagnosis, assessment, and prevention of fetal alcohol spectrum disorder (FASD).
The quality standard highlights five key areas for improvement:
15 March 2022
NICE Draft Guidance Does Not Recommend Pembrolizumab Plus Chemotherapy for Triple Negative Breast Cancer
Draft guidance published today (8 March 2022) by NICE for public consultation does not recommend pembrolizumab plus chemotherapy for treating triple negative breast cancer that has spread to other parts of the body.
The evidence showed that pembrolizumab plus chemotherapy is more effective than paclitaxel or nab-paclitaxel, although the long-term benefit is uncertain. In addition, there was no trial data directly comparing pembrolizumab plus chemotherapy with atezolizumab plus chemotherapy, another targeted treatment which NICE already recommends.
Therefore, the cost-effectiveness estimates are higher than NICE normally considers an acceptable use of NHS resources.
11 March 2022
Accelerated Citizen Access to GP Data
The RCGP has always been clear that we are supportive of the principles of expanding patients’ access to their GP records and the benefits that such access offers in improving self-management opportunities, health outcomes and patient experience.
We are committed to working to support patients to access and make best use of their GP records. However, patient access to their records is not without risk and we have a responsibility to represent our most vulnerable patients in highlighting the associated safeguarding risks. These include the risk of possible harm to patients or third parties and to the clinician-patient relationship due to error, coercion or missed opportunities for appropriate clinical oversight and communication.
8 March 2022
Over 500 people a year can access a new life extending lung cancer treatment after NICE recommends its use within the Cancer Drugs Fund
An innovative life-extending drug for treating mutation-positive locally advanced or metastatic non-small-cell lung cancer (NSCLC) in adults is being recommended by NICE as an option for use within the Cancer Drugs Fund.
An innovative life-extending drug for treating mutation-positive locally advanced or metastatic non-small-cell lung cancer (NSCLC) in adults is being recommended by NICE as an option for use within the Cancer Drugs Fund.
4 March 2022
Urgent Rescue Package and Adequate Staffing Needed to Keep General Practice Sustainable for The Future, Says College in Response to Policy Exchange Report
Professor Martin Marshall, Chair of the Royal College of GPs has responded to the Policy Exchange report ‘At your service’ published today.
He said: “The College agrees with Policy Exchange that a comprehensive rescue package is urgently needed for general practice. GPs and our teams are working harder than ever to deliver care and services for patients under intense workload and workforce pressures, which as this report rightly acknowledges, have only been exacerbated by the pandemic.
1 March 2022
NICE Draft Guidance Recommends Tucatinib for Advanced Breast Cancer
Taken as two 150 mg tablets twice daily together with anti-cancer medicines trastuzumab and capecitabine, tucatinib works by blocking a specific area of the HER2 gene in cancer cells, which stops the cells from growing and spreading.
Around 400 people with advanced breast cancer are set to benefit from a new treatment after NICE today (25 February 2022) published final draft guidance which recommends tucatinib as an option for treating HER2-positive breast cancer that has spread in people who have already tried 2 or more anti-HER2 treatments.
25 February 2022
Covid-19 Vaccine Rollout Praise for GPs and Teams
The College has responded to a report by the National Audit Office on the roll out of the Covid-19 vaccination programme in England. The report notes how GP and community pharmacist teams have administered many more doses than originally planned – 71% up to the end of October 2021, compared with a planned 56%. It also highlights that those interviewed for the report highlighted the ‘goodwill, flexibility, and dedication’ that had been required to set up and run vaccination sites at such pace and scale.
22 February 2022
NICE Recommends New Diagnostic Devices for Men with Suspected Prostate Cancer in Draft Guidance
Four new diagnostic devices for men with suspected prostate cancer, which reduce the chances of biopsy related sepsis, have been recommended for use by NICE.
The new diagnostics guidance looks at local anaesthetic transperineal (LATP) prostate biopsy, using the freehand needle positioning devices PrecisionPoint, EZU-PA3U device, Trinity Perine Grid, and UA1232 puncture attachment, which are recommended as options for helping to diagnose prostate cancer.
15 February 2022
Mental Health Care is a Priority for GPs Says College Responding to Telegraph Article
The College has responded to an article in The Telegraph on falling numbers of counselling referrals.
Professor Martin Marshall, Chair of the Royal College of GPs, said: “Ensuring patients receive the most appropriate mental health care is a priority for GPs and our teams, and there has been a notable increase in patients presenting with mental health conditions throughout the pandemic.15 February 2022
More Than 100 People a Year in England Could Benefit From New Endometrial Cancer Treatment Within The Cancer Drugs Fund
Innovative new drug for treating endometrial cancer in adults recommended by NICE as an option for use within the Cancer Drugs Fund
An innovative new drug for treating advanced or recurrent endometrial cancer in adults who have had platinum-based chemotherapy is being recommended by NICE as an option for use within the Cancer Drugs Fund.
NICE has today (Tuesday, 8 February) published its final appraisal document on dostarlimab, an immunotherapy treatment which could benefit 124 people a year in England as a second-line treatment for endometrial cancer with high microsatellite instability or mismatch repair deficiency.
8 February 2022
NHS Backlog Needs Radical Ideas – But Also, Understanding That Pressures Are Not Confined to Hospitals
Responding to NHS England and the Department of Health and Social Care’s Elective Recovery Plan, published today, Professor Martin Marshall, Chair of the Royal College of GPs, said the following.
“The growing NHS backlog is putting patients in a desperate situation and it’s obvious that radical and urgent solutions are needed. Today’s Elective Recovery Plan is therefore constructive towards tackling this growing crisis that patients continue to face.
8 February 2022
First Gene Therapy for Rare Genetic Neurodegenerative Disorder in Children, Recommended in NICE Draft Guidance
Children with a rare, fatal, genetic disorder will be able to benefit from a new one-off treatment under new NICE guidance.
Gene therapy atidarsagene autotemcel (also called Libmeldy and made by Orchard Therapeutics) will be available for some children with the rare, life-limiting inherited neurodegenerative condition metachromatic leukodystrophy (MLD).
Atidarsagene autotemcel is the first ever treatment for MLD and the draft guidance looks at its use in children with late infantile or early juvenile forms of MLD. It is thought there are around 5 children born each year in England with MLD.
1 February 2022
Supporting Vaccination, but Not Mandates – A Welcome Decision
The College supports the decision by the Government not to require mandatory Covid-19 vaccinations for NHS staff.
Professor Martin Marshall, Chair of the Royal College of GPs, said the following.
“The College is strongly supportive of Covid-19 vaccination. It is the best protection we have against the virus, and we would urge all NHS to get vaccination. But, in common with many other health organisations, we have always opposed mandatory vaccinations as a term of employment in the NHS – this is why we called for a delay to this plan, and as such the Government’s decision today is welcome.
1 February 2022
NICE Publishes New Combined Methods and Processes Manual and Topic Selection Manual for Its Health Technology Evaluation Programmes
Changes to the way medicines and other health technologies are evaluated by NICE have now been incorporated into NICE’s new combined methods and processes manual and topic selection manual published today (31 January 2022).
The changes outlined in the manuals will come into effect from 1 February 2022 for new evaluations and will give patients earlier access to innovative new treatments by allowing greater flexibility over decisions about value for money and consideration of a broader evidence base.
The new manuals cover how topics are chosen (topic selection), the steps and stages in each evaluation (processes), and how evidence is collected and considered (methods) and have been produced following one of the largest and most comprehensive reviews of all aspects of NICE’s health technology evaluations ever undertaken.
29 January 2022
‘Exceptional’ General Practice Works Well for Patients, the NHS, and the Taxpayer, Says College in Response to Times Article
The College has responded to an article in today’s Times newspaper (29 January) speculating on the future of general practice.
Professor Martin Marshall, Chair of the Royal College of GPs, said: "General practice is the bedrock of the NHS, delivering the majority of NHS care close to home where patients want it and where it is most cost-effective, and in turn alleviating pressures elsewhere in the service. GPs and our teams are delivering more patient consultations, with shorter waits, than before the pandemic. They are doing this alongside leading multiple mass vaccination programmes and in the face of intense workload and workforce pressures.
25 January 2022
Self-Harm Is Everyone’s Business, NICE Says in New Draft Guideline
Responding the CQC's latest report ‘Ethnic minority-led GP practices: impact and experience of CQC regulation’, Professor Martin Marshall, Chair of the Royal College of GPs, said the following.
“We know from extensive feedback from our own members that GPs from ethnic minorities are facing considerable challenges with inspections. In November 2020, the College wrote to the Care Quality Commission to establish how concerns were being addressed, followed by a roundtable debate in which ethnic minority GPs shared their experiences of having their practices inspected by the CQC.
20 January 2022
RCGP Responds to CQC’s ‘Ethnic Minority-Led GP Practices: Impact and Experience of CQC Regulation’ Report
All professionals working across the health and social care system have a role to play in supporting people who self-harm and the issue should not just be seen as the responsibility of those with mental health expertise, NICE has said in a new draft guideline.
In the first new guideline for 11 years looking at self-harm, the independent NICE committee has drawn up new recommendations for people working in settings from primary care to psychiatry.
The assessment, management and preventing recurrence of self-harm guideline provides information, for the first time, for people working in education and criminal justice settings.
18 January 2022
RCGPNI: Exceptional Achievement for General Practice As Half a Million Receive Booster Jab in Community
Chair of the Royal College of General Practitioners in Northern Ireland, Dr Laurence Dorman has praised the exceptional contribution of GPs and practice teams across Northern Ireland, as we reach the milestone of 500,000 booster jabs delivered in general practice.
The Kilkeel GP further commented:
“Today, we celebrate as we reach an incredible milestone where 500,000 booster vaccination jabs have been delivered by GPs and practice teams. This is testament to the passion and tireless work of my GP colleagues, who have, once again, stepped up as part of the emergency response to COVID-19. It is important to remember that this Herculean effort took place while maintaining routine patient care.”
11 January 2022
Efforts Need ‘Stepping Up’ To Meet 26,000 Extra Practice Staff Target
RCGP analysis of figures from NHS Digital show that as of September 2021 an estimated 9,500 full-time equivalent staff members (excluding GPs and practice nurses) directly delivering patient care had been recruited across Primary Care Networks as part of the Government’s manifesto pledge to recruit 26,000 members of the wider practice team by 2024.
Commenting on the data, Professor Martin Marshall, Chair of the Royal College of GPs, said: “General practice is a team-based specialty in which are is provided for patients from both general practitioners and from other health professionals in order to best meet a patient’s health needs.
6 January 2022
RCGP Responds to Health and Social Care Committee Report on NHS Backlog
Responding to the Health and Social Care Committee’s report “Clearing the backlog caused by the pandemic”, Professor Martin Marshall, Chair of the Royal College of GPs, said the following.
“The NHS backlog is impacting directly on the care of patients on waiting lists, as well as increasing pressure on all parts of the health service, not least general practice. Whilst patients are waiting for treatment or operations in secondary care, their health is under the care of GPs and our teams in the community.
4 January 2022
GP Staff Access to Covid Testing ‘Vital’ Says RCGP
Responding to reports of shortages of Covid tests, Professor Martin Marshall, Chair of the Royal College of GPs, said the following.
"Covid testing is key to ensuring GPs and other healthcare professionals are safe to deliver frontline patient care.
16 December 2021
Limited Recovery from Long-COVID One Year After Hospitalisation
People who were hospitalised with COVID-19 and continued to experience symptoms at five months show limited further recovery one year after hospital discharge.
The latest results of the PHOSP-COVID study have been released as a pre-print on medRxiv today.
This has also confirmed earlier research that people who were less likely to make a full recovery from COVID-19 were female, obese, and required invasive mechanical ventilation to support their breathing during their hospital stay.
The study is led by the National Institute for Health Research (NIHR) Leicester Biomedical Research Centre and jointly funded by the NIHR and UK Research and Innovation (UKRI).
29 December 2021
Children and Young People Set to Benefit from New Treatment for Peanut Allergy
Children and young people aged between 4 and 17 with a peanut allergy could be set to benefit from Palforzia, a new treatment which can help build up their tolerance to peanut, after NICE recommended its use in draft guidance published today (23 December 2021).
Peanut allergy is one of the most common food allergies in children and is estimated to affect between 0.5% and 2% of children in the UK.
21 December 2021
Updated Workload Prioritisation Guidance During the Accelerated Booster Campaign
The College has published updated guidance on workload prioritisation for practices during the implementation of the accelerated booster vaccination campaign.
21 December 2021
NICE Recommends Offering PrEP to People at High Risk of HIV For First Time
People at the highest risk of catching HIV should be offered Pre Exposure Prophylaxis (PrEP), NICE has recommended for the first time.
The announcement today (Wednesday 15 December 2021) comes as NICE launches a consultation on its draft guideline on reducing sexually transmitted infections.
NICE’s recommendation is backed up by the government’s HIV Action Plan to hit zero new transmissions of HIV by 2030.
17 December 2021
Immuno-Suppressed Patients a Priority for Vaccination Teams
Responding to a BBC report on difficulties some immune-suppressed patients are facing accessing their booster jab, Professor Martin Marshall, Chair of the Royal College of GPs, said the following.
Professor Marshall said: “GPs, our teams and colleagues right across the health service are working hard to ensure as many people as possible receive a booster jab to maximise their protection against Covid-19. As well as being massive in scale – today alone more than 745,000 vaccines have been delivered – it is a very complex vaccination programme.
14 December 2021
NICE Approves First Long-Acting Injectable HIV-1 Treatment
NICE has published draft guidance recommending the first long-acting injectable treatment for HIV-1 infection in adults.
Today’s draft guidance is the first time NICE has made recommendations about the use of an HIV treatment since these came under NICE’s remit in 2019.
It is estimated that around 13,000 people will now be eligible for treatment with cabotegravir with rilpivirine in England.
Current treatment for HIV-1 is lifelong antiretroviral tablets taken each day. The aim is to keep the number of virus particles in the blood (the viral load) so low that it cannot be detected or transmitted between people.6 December 2021
RCGP Scotland Survey Results Reveal GPs Are Concerned About Being Able to Deliver Patient Care Effectively This Winter
A survey of RCGP Scotland members has revealed GPs are concerned that mounting workload pressures will negatively affect their ability to deliver patient care during winter.
A total of 73% of GPs responding to the College's Annual Tracking Survey admitted to being worried that their workloads would negatively affect their ability to provide care for their patients in the coming months.7 December 2021
NICE Creates New Menu of Treatment Options for Those Suffering from Depression
People with depression should make the choice on what treatment option is right for them, in discussion with their healthcare professional, NICE says in new draft guidance.
An independent NICE guideline committee has developed the first guideline for 12 years to identify, treat and manage depression in adults.
It has looked at the evidence on the treatment of new depressive episodes, chronic depression, preventing relapse, patient choice, and the organisation of, and access to, mental health services.
3 December 2021
RCGP Responds to NHS England Letter on Expanded Booster Programme
RCGP responds to an NHS England letter on the expanded Covid-19 booster programme.
Responding to an NHS England letter on the expanded Covid-19 booster programme:
Dr Gary Howsam, Vice Chair of the Royal College of GPs, said: “GPs and our teams have played a vital role in the Covid vaccination programme since its inception. Booster jabs provide further protection against Covid-19, and it makes sense for GP teams, that are highly experienced at delivering complex vaccination programmes on a mass scale, to be involved in in delivering them, ensuring patients are as protected as they can be against the virus.
30 November 2021
Over 600 People Set to Benefit from Innovative Lung Cancer Treatment Within The Cancer Drugs Fund
More than 600 people could benefit from an innovative drug for a form of lung cancer as NICE publishes final draft guidance recommending osimertinib within the Cancer Drugs Fund.
Osimertinib (also known as Tagrisso and made by AstraZeneca) is recommended for people with early-stage (1b to 3a) non-small-cell lung cancer (NSCLC) who have had surgery to remove their tumour and who have epidermal growth factor receptor (EGFR) gene mutations.
Current clinical trial evidence shows that compared with active monitoring, adjuvant treatment with osimertinib reduces the risk of the disease coming back by 80%. It may also lower the risk of dying from their cancer. However, this evidence is uncertain because information from the trial was released early, and the data is still immature. For this reason the drug is recommended for use within the CDF rather than in routine NHS commissioning.
30 November 2021
Booster Expansion ‘Sensible’ – Now GPs and Teams Need Support to Manage Escalating Workload to Deliver it
Responding to the announced changes to the Covid-19 booster vaccination programme, Dr Gary Howsam, Vice Chair of the Royal College of GPs, said:
“People will be understandably concerned about the Omicron variant, particularly given we know relatively little about it at this point. The emergence of the variant does show the pandemic is far from over and being cautious is a sensible approach, at least until we know more.
23 November 2021
NICE Draft Guidance Recommends New Treatment for Spinal Muscular Atrophy as Part of a Managed Access Agreement
Around 1,500 people in England with the rare genetic disorder spinal muscular atrophy are set to benefit from a new treatment after NICE today (19 November 2021) published draft guidance recommending risdiplam (also called Evrysdi and made by Roche) as part of a managed access agreement (MAA).
The MAA is a special arrangement between NHS England and NHS Improvement and the company Roche. It will allow people to access treatment with risdiplam while more data is collected to address the uncertainties identified by the independent NICE committee. After this NICE will decide whether or not to recommend it for routine use on the NHS and update the guidance. It will be available through the MAA until then.
11 November 2021
RCGP, NICE and SIGN Update Long Covid Guidance
Dr Gail Allsopp, RCGP lead for long Covid, said: “The prolonged health effects that some patients experience after contracting COVID-19 can have a terrible impact on their lives – and as GPs, we want to do everything we can to help them.
“This revised guidance on ‘long Covid’, updated jointly by the RCGP, NICE and SIGN, reflects the latest evidence and ongoing research into Post-Covid syndrome, which we must remember is still a relatively new condition that we are learning more about all the time. It includes additions to the most commonly reported symptoms, as well as reflecting the impact ‘long Covid’ can have on a patient’s overall quality of life, including the potential for increased risk of reduced performance and/or increased absence at school or work. Other new recommendations include encouraging patients to be fully vaccinated against Covid-19 to reduce the risk of catching the virus again.
16 November 2021
NICE Does Not Recommend Elusulfase Alfa for NHS Use Following Evaluation of New Evidence
NICE has today (12 November 2021) published draft guidance for public consultation which does not recommend elosulfase alfa (also called Vimizin and made by BioMarin) for the treatment of mucopolysaccharidosis type 4A (also known as MPS 4A and Morquio A syndrome).
Today’s draft guidance follows an evaluation of new evidence on the use of elosulfase alfa through research and the collection of ‘real-world’ data as part of a managed access agreement which has made the treatment available on the NHS since 2015.
Clinical trial evidence and data from the managed access agreement shows some long-term benefits with elosulfase alfa treatment which suggest the condition becomes stable.
12 November 2021
College Hits Back at Claims That GP Access is Increasing Pressure on A&E
Professor Martin Marshall, Chair of the Royal College of GPs, has written to Health and Social Care Secretary Sajid Javid in response to comments made at the Health Select Committee’s inquiry into clearing the backlog caused by the pandemic.
The letter has attracted coverage in today’s Guardian and elsewhere. The College will continue to defend hardworking GPs and their teams against criticism.
9 November 2021
NICE Recommend Dapagliflozin for People with Chronic Kidney Disease
Dapagliflozin belongs to a group of medicines called ‘sodium glucose co-transporter-2 (SGLT2) inhibitors. It is the first SGLT2 inhibitor to be recommended through NICE’s technology appraisal process for CKD.
In draft guidance published today (5 November 2021) NICE has recommended dapagliflozin as an option for treating certain people with chronic kidney disease (CKD) in adults.
It is estimated by the company that there are around 91,000 people who could be eligible for this treatment in England.
29 October 2021
Restricting Where GPs Can and Can’t Work Won’t Solve GP Shortage, Says College
The College features in a front-page lead story in today’s Times on plans to ‘restrict’ where GPs can and can’t work. We make the point that the chronic shortage of GPs is affecting the entire UK.
Professor Martin Marshall, Chair of the Royal College of GPs, said: “GPs have been under significant workforce pressures for the last decade, and this is affecting all areas of the UK. However, we know that areas of high deprivation tend to have some of the most pronounced GP shortages. The paradox is that people living in more deprived areas also tend to have a greater number of long-term health conditions and more complex health needs, and therefore often require greater access to GP care and services.
2 November 2021
NICE ME/CFS guideline outlines steps for better diagnosis and management
NICE has today (29 October 2021) published its updated guideline on the diagnosis and management of myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome (ME/CFS).
It is estimated that there are over 250,000 people in England and Wales with ME/CFS, with about 2.4 times as many women affected as men.
The guideline covers every aspect of ME/CFS in children, young people and adults from its identification and assessment before and after diagnosis to its management, monitoring and review.
29 October 2021
General Practice Can’t Afford to Lose GPs to Early Retirement Because of Undoable Workload Pressure, Warns College
New NHS Digital workforce figures show nearly four in 10 GPs (38%) are aged 50 or over.
Responding to Liberal Democrat analysis of the data in the Guardian today warning of a ‘mass exodus’ of GPs, Professor Martin Marshall, Chair of the Royal College of GPs, said: “When GPs are approaching retirement age, it doesn’t necessarily mean they’re going to leave the profession straightaway, but against the backdrop of intense workload and workforce pressures, coupled with current overbearing scrutiny from some sections of the media and politicians, it’s an increasingly realistic prospect and a huge concern.
26 October 2021
NICE Calls for Healthcare Professionals to Use Shared Decision Making Best Practice To Highlight the Risks of Medicines Associated With Dependence
NICE is advising doctors, nurses and pharmacists to discuss with patients the risks of prescribing them medicines including opioids, sleeping pills and antidepressants.
Some people taking these dependence-forming medicines will find them difficult to stop and they will need the support of healthcare professionals to safely reduce their dose until they are no longer required. The process can be difficult and may take several months or more.
18 October 2021
Focus On Access Ignores Other Challenges in General Practice, Says College in Response to NHSE Announcement on ‘Rescue’ Measures for General Practice
Please read on for our response to today’s announcement from NHS England on GP access
Professor Martin Marshall, Chair of the Royal College of GPs, said: “We knew we were unlikely to get a silver bullet to solve all the challenges GPs and our teams are facing, but we hoped to see more tangible solutions to improve the care that can be delivered to patients. Our hardworking members will see this package as a missed opportunity that will do little to improve the intense pressures that are preventing them from giving their patients the care they need and deserve.
19 October 2021
World Evidence Based Healthcare Day 2021: Learn How a Collaboration Between NICE and Australian Academics Helped Shape the Evidence Based Rapid COVID-19 Guidelines
Online event will lift the lid on how the two organisations worked together during the pandemic
As part of the second annual World Evidence Based Healthcare (EBHC) Day 2021, NICE and Guidelines International Network (GIN) will be hosting a free 90-minute interactive event to give an insight on how global health care agencies have come together in response to the pandemic.
18 October 2021
General Practice is a Team Profession, Says RCGP
Responding to a recent article in The Times about the latest NHS Digital data detailing the number of consultations delivered by GPs:
Professor Martin Marshall, Chair of the Royal College of GPs, said:
"General practice is a team profession. Sometimes a GP is not the most appropriate healthcare professional for a patient's health needs and we work with highly skilled nurses, pharmacists, physios, mental health therapists, and increasingly link workers, to ensure patients get the best care for them. Working within multi-disciplinary teams also frees up GPs’ time to see patients who really need their medical expertise, particularly those with complex health needs.
12 October 2021
NICE Recommends First Treatment in Two Decades for Sickle Cell Disease
Hundreds of people will be eligible for a new treatment for sickle cell disease following draft guidance.
For the first time in 20 years, a new therapy for sickle cell disease is to be made available on the NHS. Crizanlizumab (Adakveo, Novartis) is recommended by NICE as a treatment option for preventing recurrent sickle cell crises in people aged 16 or over. More than 300 people a year are expected to receive the treatment via a Managed Access Agreement (MAA), increasing to more than 450 people in subsequent years.
11 October 2021
GPs Are Stretched Beyond Endurance: The Government Needs to Publicly Support and Resource the Profession
Read Martin Marshall’s opinion piece published in today’s Daily Express, defending the profession against the continuing media criticism about access to face to face appointments, and explaining the urgent need for government to support an understaffed and exceptionally overworked general practice.
4 October 2021
People With Advanced or Metastatic Urothelial Cancer to Get Life-Extending Treatment
Around 130 people per year with untreated locally advanced or metastatic urothelial cancer will be eligible for a new life-extending treatment after NICE published final draft guidance today (30 September 2021) recommending atezolizumab.
Atezolizumab (also known as Tecentriq and made by Roche) has been recommended by NICE for people whose tumour expresses PD-L1 (a protein which prevents the body’s immune system killing the cancer cells) at a level of 5% of more and when platinum-containing chemotherapy is unsuitable.
30 September 2021
Misconception That GPs Aren’t Seeing Patients Face-To-Face, Shows New Data
Responding to today’s NHS Digital data on appointments in general practice, Professor Martin Marshall, Chair of the Royal College of GPs, said:
“Today's figures show that it’s a misconception that GPs and other members of our team aren’t seeing patients face-to-face. Huge numbers of GP appointments are being made every day, almost half on the same day they are booked, with a higher proportion being made in person in August than July and all in line with infection control measures to keep patients safe.
28 September 2021
‘Part Time’ Working in General Practice Often Means Working Longer Than Full Time Hours, Says College
Please see below our reaction to the Daily Mail’s reporting of fewer appointments being delivered in general practice on Fridays.
Professor Martin Marshall, Chair of the Royal College of GPs, said: "To keep general practice working safely and effectively for patients, we need to look after the doctors who deliver their care. Far from reducing the availability and quality of patient care, flexible working, which allows GPs to work 'less than full time', enables highly-trained family doctors to remain in the workforce, delivering the care that our patients need and deserve.
22 September 2021
College Hits Back at Anti-GP Media Coverage on Prescribing
Sections of today’s media are once again criticising GPs, this time for their prescribing skills. You can read the full College response below.
The College will continue to defend hardworking GPs against the current onslaught of criticism - and continue our calls on the four governments of the UK to invest properly in general practice and provide better support for GPs in delivering patient care
Professor Martin Marshall, Chair of the Royal College of GPs, said: “Prescribing is a core skill for GPs and many of our nurse and pharmacist colleagues in primary care, and doing whatever we can to prescribe the most appropriate medicine for our patients, in an evidence-based way, is something we strive to do on a daily basis – and in the vast majority of cases, this review shows this is happening.
21 September 2021
NICE and PHE Recommend All Employers Give Mental Health Training for Managers
All managers should be given the skills to support employees with mental health issues, NICE and PHE have said in new guidance.
Reducing stigma and equipping managers with skills to have conversations with employees about mental health is likely to facilitate conversations that address concerns about their mental wellbeing, the guideline says.
NICE and Public Health England’s guideline on Mental Wellbeing at Work covers how to create the right conditions to support mental wellbeing at work through an environment and culture of participation, equality, safety and fairness in the workplace based on open communication.
20 September 2021
GPs and Patients are ‘On the Same Side’ Over Face to Face Appointments – But Chronic GP Shortages Make it Hard to Guarantee Safe Care, Says College
Please read below for our reaction to the Daily Mail’s campaign on face to face appointments.
We will continue to challenge unfair criticism of hardworking GPs in the media and elsewhere - and continue our calls on the Government to invest in general practice so that GPs can give patients the safe care they need.
Professor Martin Marshall, Chair of the Royal College of GPs and a GP in East London, said:
“GPs go into general practice to care for patients. We’re on the same side and we share their frustrations when they face long waiting times for an appointment or trying to get through to the surgery. They should have access to high quality GP care when they need it - but that care must also be safe, and the chronic shortage of GPs is making this increasingly difficult to guarantee.
14 September 2021
NICE Recommends Treatment for People with Juvenile Idiopathic Arthritis
NICE has today (9 September 2021) published final draft guidance which recommends tofacitinib (also known as Xeljanz and made by Pfizer) as an option for treating active polyarticular juvenile arthritis and juvenile psoriatic arthritis in people 2 years and older.
The treatment is available for young people whose arthritis has not responded well enough to disease-modifying antirheumatic drugs (DMARDs) and only if:
- a tumour necrosis factor (TNF)-alpha inhibitor is not suitable or does not control the condition well enough, and
- the company provides tofacitinib according to the commercial arrangement
Clinical evidence shows that tofacitinib is effective when compared with a placebo and indirect comparisons suggest it has a similar effect to other treatments for the same indication.
10 September 2021
Media Vitriol is Harming Patient Trust as Well as GP Morale, Says College
We are outraged at the media coverage on remote consultations that is running in some of the nationals and online today.
College Chair Martin Marshall has a written an opinion piece in HSJ, defending hardworking GPs who - largely as a result of remote consultations - have continued to deliver essential care and services to patients throughout the pandemic.
He hits back at the ‘constant barrage of vitriol’ against GPs in the media and makes the point that the real issue in general practice is not about face-to-face versus remote consultations, but about chronic GP shortages caused by more than a decade of under-investment.
You can read it in full here:
7 September 2021
NICE Approves Ground-Breaking Cholesterol-Lowering Drug Inclisiran
NICE has today (1 September 2021) issued draft final guidance recommending the novel anti-cholesterol drug inclisiran (Leqvio and made by Novartis) for people with primary hypercholesterolaemia or mixed dyslipidaemia who have already had a cardiovascular event such as a heart attack or stroke.
Today’s decision follows agreement on a population-level commercial deal between NHS England and NHS Improvement and Novartis which will make inclisiran available with a discount to its list price.
3 September 2021
Winter Flu Vaccine Programme ‘Cannot Fail’ Says College in Response to Delivery Delays
Reacting to the news that supplies of winter flu vaccine might be delayed for up to two weeks, Dr Gary Howsam, Vice Chair of the Royal College of GPs, said:
“This is news we really didn’t want to hear. With over 36 million people eligible for the flu vaccine on the NHS this year, GPs need the supply chain to run like clockwork. They are already under enormous pressure and still waiting for details of how the Covid booster campaign will align with everything else they need to do this winter.
31 August 2021
NICE Announces Next Steps For ME/CFS Guideline
NICE recognises the importance to patients of the updated guideline on the diagnosis and management of myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome (ME/CFS) and is keen to move forwards as quickly as possible.
Following the pause to the publication of the guideline NICE has today, 27 August 2021, announced that it is to hold a roundtable event to better understand the issues raised and determine how it can gain support for the guideline to ensure effective implementation.
28 August 2021
College Continues to Push Back Against Media Criticism of GPs
College Chair Professor Martin Marshall has a letter published in today’s Times, reiterating the message that the crisis in general practice is not about how much GPs earn – but about excessive workload and workforce shortages.
24 August 2021
NICE Draft Guidance Extends Recommendation for Sapropterin to Pregnant Women and People Aged Up to 22 Years with Rare Inherited Metabolic Condition Phenylketonuria
NICE has today (20 August 2021) issued final draft guidance which now recommends sapropterin (also called Kuvan and made by BioMarin) as an option for treating phenylketonuria (PKU) in pregnant women until they give birth as well as for treating the condition in people until they turn 22.
Usually diagnosed in children, PKU is a rare, inherited, chronic and life-long metabolic condition. It is caused by the deficiency of an enzyme which breaks down phenylalanine, a compound which occurs naturally in protein-rich foods such as milk, eggs and meat. Phenylalanine in high concentrations is toxic to the central nervous system.
23 August 2021
Protect Patients by Looking After Hardworking GPs Who Provide Their Care, Says College
We have responded to a study on worsening GP turnover, published today by the University of Manchester.
Professor Martin Marshall, Chair of the Royal College of GPs and a GP in East London, said: “These figures are hugely worrying – not just for general practice but for patients and the rest of the NHS. Unfortunately, they only confirm what we have been saying for many years.
“Pressures in the NHS are not confined to hospitals. Even before the pandemic, the job of GPs was largely undoable but the profession is now at breaking point.17 August 2021
NICE Draft Guidance Recommends Abemaciclib for Advanced Breast Cancer
NICE has today (12 August 2021) published draft guidance which recommends twice-daily pill abemaciclib (also called Verzenios and made by Eli Lilly) as an option for adults with a type of breast cancer called hormone receptor-positive, HER2-negative breast cancer which has spread to other parts of the body.
The positive recommendation follows an improved patient access scheme from the company. This, taken together with further economic modelling data provided by the company, means that abemaciclib can now be recommended as a cost-effective use of NHS resources.
13 August 2021
Partnership Fund Tackles Factors Behind Common Health Problems
Three Major Research Projects Have Won Support from a £50 Million-Plus Funding Partnership.
The UK Prevention Research Partnership (UKPRP) is to invest £19 million-plus over five years in three successful consortia that aim to understand and influence social, economic and environmental factors that affect health.
UKPRP is a group of 12 funders including UK Research and Innovation councils, charities, and UK health and social care departments.
The new awards follow a £25 million-plus investment in eight similar projects made by the partnership in 2019.
10 August 2021
New Collaboration Between NICE and the Academic Health Science Network Will Help Embed Innovations into the Healthcare System for the Benefit of Patients
The agreement will draw on the strengths, skills, and resources of both organisations in order to seize every opportunity to support the healthcare system in adopting evidence-based healthcare and innovations.
NICE and the Academic Health Science Network (AHSN) have today (4 August) announced a two-year agreement to support the use of the best evidence-based healthcare in the NHS to improve the lives of patients.
6 August 2021
College Sounds SOS For General Practice – and Calls for Rescue Plan
An emergency rescue package is needed for crisis-torn general practice if patients are to receive the care they need once the pandemic is over, the UK’s leading GP warns today.
Professor Martin Marshall, Chair of the Royal College of GPs, says that the job of GPs was ‘largely undoable’ even before COVID-19, but that general practice is now ‘at breaking point’.
4 August 2021
NICE Approves First Treatment in Pilot of New Approach to Cost-Comparison Fast Track Appraisals
As part of the recovery from the COVID-19 pandemic, NICE has been working hard to find new ways to develop and publish guidance affected by the work programme pause in 2020, while also delivering the planned programme for 2021.
To address this, a new approach to the cost comparison fast track appraisal process is being piloted this summer for the review of selected low-risk appraisals.
The pilot programme works by using a subset of the appraisal committee to assess low-risk treatments, comparing them to similar therapies that have already been appraised by NICE. This sub-committee is then able to make a recommendation without requiring a full committee meeting.
2 August 2021
Children and Young People with Severe Complex Needs Require Coordinated Health, Social and Education Services, Says NICE in Draft Guideline
NICE has today (2 August 2021) opened consultation on its draft guideline on disabled children and young people up to 25 with severe complex needs. The draft guideline will support joined up and coordinated health, social and education services for these people and their families.
The draft guideline is built on the principles and requirements set out in the Special Educational Needs and Disability (SEND) Code of Practice, and will help professionals from across the health, social and education services to collaborate to deliver the best care for disabled children and young people with severe complex needs.
27 July 2021
Patients With Rare Bile Duct Cancer Set to Benefit from Life Extending Treatment
Some people who have a rare form of bile duct cancer are set to benefit from life-extending treatment
Some people who have a rare form of bile duct cancer are set to benefit from life-extending treatment pemigatinib after NICE published final draft guidance today (22nd July 2021).
Pemigatinib (also known as Pemazyre and made by the Incyte Corporation) is recommended within its conditional marketing authorisation for treating locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (FGFR2) fusion or rearrangement.
20 July 2021
RCGP and BMA Statement on the Latest Plans for GPDPR
Health Minister Jo Churchill has today written to all GPs in England, setting out plans for the next steps for the GP Data for Planning and Research (GPDPR) programme and extending the timeframe beyond 1 September.
The RCGP and BMA have been closely involved in discussions over the steps that are necessary before any data collection can commence under GPDPR, and welcome the commitments made in these latest plans.
20 July 2021
NICE Opens Consultation on Draft Pelvic Floor Dysfunction Guideline Recommendations
NICE has published its draft guideline on the prevention and non-surgical management of pelvic floor dysfunction and is seeking stakeholder comments on the draft recommendations.
The draft guideline covers the prevention, assessment, and non-surgical management of pelvic floor dysfunction in women aged 12 and over. Pelvic floor dysfunction covers a variety of symptoms including urinary and faecal incontinence, emptying disorders of the bladder or bowel, pelvic organ prolapse, sexual dysfunction, and chronic pelvic pain.
The draft recommendations advise that women of all ages should be encouraged to do pelvic floor muscle training to help prevent the symptoms of pelvic floor dysfunction.
20 July 2021
GPs and Teams Advise Patients on Lifestyle Choices but ‘Prescribing’ Certain Foods ‘Inappropriate’, Says RCGP
Responding to the National Food Strategy, published today, particularly on the proposal for GPs to prescribe fruit and veg to patients, Professor Martin Marshall, Chair of the Royal College of GPs, said the following.
“Living a healthy lifestyle generally leads to better health outcomes for patients, and that includes taking regular exercise, eating well, getting enough sleep, drinking in accordance with guidelines, and not smoking.
13 July 2021
NICE to Produce Rapid Guideline to Diagnose and Treat Rare Blood Clotting Condition Associated with COVID-19 Vaccination
NHS England has asked NICE to develop a guideline on the management and follow up of blood clots and low platelet counts associated with COVID-19 vaccination.
Vaccine-induced immune thrombocytopenia and thrombosis (VITT) is a syndrome of immune-driven blood clots (thrombosis) and low platelet counts (thrombocytopenia), which has been reported in rare cases after receiving COVID-19 vaccines.
9 July 2021
Safety of Patients and Healthcare Professionals Must Be Paramount as Restrictions Eased, Says RCGP
Ahead of current plans to ease Covid-19 restrictions on 19 July, Professor Martin Marshall, Chair of the Royal College of GPs, said: "As social distancing restrictions are eased later this month, it’s inevitable that we will face an increase in the number of people being infected with Covid-19 - the Health Secretary himself has suggested we will potentially see 100,000 new cases a day. This will have significant implications for general practice, the wider NHS, and public health in general."
6 July 2021
NICE Recommends Adoption of Absorbable Stitches with Antibacterial Protection for Use on the NHS
NICE estimates an average cost saving of £13.62 per patient to the NHS as a result of reduced surgical site infections compared with current standard absorbable stitches.
NICE has today issued Medical Technologies Guidance which recommends the adoption of Plus Sutures, the first absorbable stitches with antibacterial protection.
Until now the NHS has used standard absorbable stitches for wound closure after a surgical procedure.
Plus Sutures developed by Ethicon, part of Johnson & Johnson Medical Devices Companies, are marketed as the first and only stitches with antibacterial protection.
30 June 2021
Details of Booster Campaign Needed 'Urgently', Says RCGP
Responding to news from the Department of Health and Social Care about a COVID-19 booster vaccination campaign this Autumn, Professor Martin Marshall, Chair of the Royal College of GPs, said the following.
“GPs and our teams have worked incredibly hard to protect as many patients as possible from COVID-19. The vaccination is our route out of this pandemic, and 75% of the programme has been delivered in primary care."
29 June 2021
NICE Opens Consultation on Draft Pelvic Floor Dysfunction Guideline Recommendations
NICE has today (28 June 2021) published its draft guideline on the prevention and non-surgical management of pelvic floor dysfunction and is seeking stakeholder comments on the draft recommendations.
The draft guideline covers the prevention, assessment, and non-surgical management of pelvic floor dysfunction in women aged 12 and over. Pelvic floor dysfunction covers a variety of symptoms including urinary and faecal incontinence, emptying disorders of the bladder or bowel, pelvic organ prolapse, sexual dysfunction, and chronic pelvic pain.
The draft recommendations advise that women of all ages should be encouraged to do pelvic floor muscle training to help prevent the symptoms of pelvic floor dysfunction.
23 June 2021
Pandemic Pressures Taking Their Toll on GP Future Career Plans, Says RCGP
Responding to research on GPs’ career intentions published in the BMJ, Professor Martin Marshall, Chair of the Royal College of GPs, said the following.
“These figures reflect what we are hearing from our members in general practice. The intense workload and workforce pressures that GPs and our teams have been working under, which far pre-date COVID-19 but have been exacerbated by the pandemic, are taking their toll."
22 June 2021
Shared Decision Making Underpins Good Healthcare
Shared decision making between service users and healthcare professionals is an integral part of healthcare, says NICE, in new guideline recommendations published today.
The new recommendations advise that shared decision making should be part of everyday practice across all healthcare settings. The guideline sets out ways for healthcare professionals to work with people using services to make decisions about their treatment and care, and to ensure this is best practice at an organisational level.
16 June 2021
RCGP Responds to NHS England's Long COVID Plan 2021/2022
Dr Gail Allsopp, Clinical Lead for Clinical Policy for the Royal College of GPs, said the following.
“GPs and our teams are the forefront of delivering physical, psychological, and emotional support to an increasing number of patients suffering with long term symptoms of COVID-19."
15 June 2021
NICE Recommends Several Treatment Options to Help Thousands with Moderate Rheumatoid Arthritis
Around 25,000 people with moderate rheumatoid arthritis that has not responded to conventional therapies are set to benefit from the recommendations announced today
NICE has today (10th June) published final draft guidance which recommends several treatment options for around 25,000 people with moderate rheumatoid arthritis that have not responded to conventional therapies.
Adalimumab, etanercept and infliximab, taken with methotrexate have been recommended for use within the NHS. Adalimumab and etanercept can also be used as monotherapy when methotrexate is contraindicated or not tolerated.
8 June 2021
Pause in GP Data Sharing Scheme Must Be Used to ‘Properly Communicate’ with Patients and Clinicians
Responding to the announcement that NHS Digital’s GP Data for Planning and Research programme will be paused, following calls for this by the College, Professor Martin Marshall, Chair of the Royal College of GPs, said the following.
"We’re pleased that the Government has announced a delay to the GPDPR programme following the concerns that the College, the BMA and others have raised over the past few weeks.
8 June 2021
NICE Draft Guidance Does Not Recommend Risdiplam for Treating Spinal Muscular Atrophy
NICE has today (2 June 2021) published draft guidance for public consultation which does not recommend risdiplam (also called Evrysdi and made by Roche) for treating the rare genetic disorder spinal muscular atrophy (SMA).
SMA is a progressive neuromuscular condition affecting the nerves in the spinal cord controlling movement. This leads to muscle weakness, progressive loss of movement, and difficulty breathing and swallowing.
SMA can be grouped into 5 main types (types 0 to 4), based on the age of onset and the maximum motor function reached. SMA type 1 is one of the most severe forms of SMA and people with it usually die before the age of 2 if untreated. Because SMA is a progressive disorder, everyone will experience more severe symptoms over time regardless of type.
4 June 2021
College Writes to Health Secretary Calling for Immediate Delay to Patient Data Proposals
The College has today written to Health Secretary Matt Hancock calling for an immediate delay to the GP Data for Planning and Research (GPDPR) programme.
This follows on from our letter to NHS Digital last Friday, urging them to communicate better with the public about the new arrangements for data collection. An appropriate level of communication has not yet begun and time is now running out before the 23 June deadline for patients to register Type 1 opt-outs.
1 June 2021
NICE Updates Recommendations for Two COVID-19 Therapeutics
NICE has updated its advice on two therapeutics for managing COVID-19 – remdesivir and colchicine.
These updated recommendations form part of the managing COVID-19 guideline, which was first published in March. This guideline is a ‘living guideline’ which can be continuously updated to incorporate the latest evidence and keep abreast of new developments.
We have published an update to the conditional recommendation for using remdesivir in COVID-19 patients in hospital settings. We now advise that remdesivir should be considered for hospitalised patients, aged 12 years and over or weighing 40 kilograms or more, who are on low-flow supplemental oxygen (delivered through a face mask or nasal canula). Previously we advised that remdesivir should be considered for patients on supplemental oxygen but not on invasive mechanical ventilation. The update reflects a slightly different approach to our data analysis based on evidence that the use of remdesivir is more beneficial earlier in the course of disease. The length of treatment with remdesivir remains unchanged at 5 days.
27 May 2021
NHS Pressures Are Not Just About Hospitals, Says RCGP as GPs Deliver Record Numbers of Consultations
The BBC is running a day of coverage on pressures in general practice. College Chair Martin Marshall featured on Radio 4’s flagship Today Programme earlier this morning and College spokespeople will be appearing throughout the day calling for more resources and support for hardworking GPs.
Professor Martin Marshall, Chair of the Royal College of GPs, said: “GPs and our teams are working flat out, delivering record numbers of consultations - almost 13 million in the last four weeks. This is in addition to their remarkable contribution to the COVID-19 vaccination programme, with 75% of vaccines currently being delivered in general practice alone.25 May 2021
Patients with Rare Blood Disorders to Receive New Treatment Option, Says NICE
Hundreds of people with two rare blood disorders will soon have access to a new treatment regimen following guidance from NICE.
In final guidance published 20 May 2021, NICE has recommended ravulizumab (Ultomiris, Alexion Pharmaceuticals) as a treatment for paroxysmal nocturnal haemoglobinuria (PNH). Draft guidance published 19 May 2021 also recommends the treatment for atypical haemolytic uraemic syndrome (aHUS).
Currently, people with symptomatic PNH or aHUS only have one treatment option available on the NHS, eculizumab, which was also recommended by NICE and is delivered intravenously every 2 weeks.
19 May 2021
College Sets Record Straight on NHSE Letter
Professor Martin Marshall, Chair of the Royal College of GPs, said the following.
"The strength of feeling amongst GPs since the publication of NHS England’s letter last week has been palpable. Its tone was misjudged, and the rigid expectations it sent out that practices should make changes at such short notice showed a lack of understanding of the pressures facing the profession. This is demoralising at a time when GPs are under more pressure than ever before and are feeling the strain of more than a year on the frontline of the pandemic effort. GPs need praise for their incredible efforts and support to keep on going.
"The RCGP was not invited to comment on the letter before it was issued. It gave GP practices just three days to make significant changes to their ways of working when GPs and their teams are exhausted, working under intense workload and workforce pressures.
18 May 2021
Colorectal Cancer Patients with Rare Mutations to Benefit from Life-Extending Treatment
NICE recommends pembrolizumab for colorectal cancer patients with rare mutations
A potentially life-extending treatment for some people with untreated metastatic colorectal cancer, who have specific mutations in their cancer cells, has been approved for routine commissioning by NICE in draft guidance published today (14 May 2021)
The draft guidance recommends pembrolizumab (also called Keytruda and made by Merck Sharp & Dohme) for untreated metastatic colorectal cancer with high microsatellite instability (MSI) or mismatch repair (MMR) deficiency.
High MSI or MMR deficiency occurs in around 4 per cent of metastatic colorectal cancer patients. Around 450 people will be eligible for this treatment in England according to the guidance. Colorectal cancer with high MSI or MMR deficiency is associated with a poorer outlook and a greater risk of death.
14 May 2021
College Response to NHS England Letter
Professor Martin Marshall, Chair of the Royal College of GPs, said the following.
“GP services have been available throughout the pandemic, with GPs and our teams working incredibly hard, transforming the way they deliver care in line with official guidance, in order to keep patients safe and help stop the spread of Covid-19. Face to face appointments have been facilitated where necessary and that more than half of consultations in general practice are being conducted in person is testament to GPs’ dedication to their patients.
11 May 2021
Avelumab not Recommended as a Maintenance Treatment of Urothelial Cancer After Platinum-Based Chemotherapy
NICE has issued draft guidance which does not recommend avelumab for maintenance treatment of locally advanced or metastatic urothelial cancer after platinum-based chemotherapy.
NICE has today (06 May 2021) issued draft guidance which does not recommend avelumab for maintenance treatment of locally advanced or metastatic urothelial cancer after platinum-based chemotherapy.
Approximately 750 people with this type of urothelial cancer would have been eligible for avelumab as a maintenance treatment.
5 May 2021
GPs at Forefront of Delivering Mental Health Care During Pandemic, Says RCGP
Responding to new ONS figures on depression in adults, Professor Martin Marshall, Chair of the Royal College of GPs, said the following.
“Today’s figures show the impact the pandemic has had on many patients’ mental health – and GPs and our teams are on the front line of caring for them. We see in our surgeries both the direct mental health impact of the pandemic on patients who may have had COVID-19 or are suffering with longer term symptoms of the virus - and the indirect impact, for example on those who have mental health problems associated with the social and/or economic impact of lockdown restrictions.
4 May 2021
New Draft Guidance Aims to Achieve Fairer Outcomes for Looked-After Children and Young People
Looked after children and young people should be considered ‘one of their own’ by carers, in order to help them to reach their full potential, new NICE draft guidelines say.
Looked after children and young people should be considered ‘one of their own’ by carers, in order to help them to reach their full potential, new NICE draft guidelines say.
The draft guideline recommends that the looked-after person is surrounded by a care network consisting of positive relationships supported by genuine caring – where carers treat the looked-after person as ‘one of their own’. Supporting continuity of relationships with social workers, considering programmes to support mentoring relationships, and providing funding to enable contact with friends are also recommended.
30 April 2021
Increase in GP Practice Closures Highlights Workload and Workforce Pressures Facing General Practice, Says RCGP
Responding to new data from Pulse that shows nearly 800 GP practices have closed in the last 8 years, Professor Martin Marshall, Chair of the Royal College of GPs, said the following.
“That nearly 800 GP practices have closed over the last eight years – almost 100 in the last year during the pandemic – is a concern and likely to be distressing for the millions of patients who have lost the practice they are familiar with. Some of the closures will be due to practices merging, or working in different ways, but some practices will have had no choice but to close due to intense workforce and workload pressures – and this must be addressed urgently.
27 April 2021
NICE Recommends New Treatment for Rare Blood Disorder
Hundreds of people with a rare blood disorder have access to a new treatment regimen following draft guidance from NICE.
In draft guidance published 15 April 2021, NICE has recommended ravulizumab (Ultomiris, Alexion Pharmaceuticals) as a treatment for paroxysmal nocturnal haemoglobinuria (PHN).
Currently, people with symptomatic PHN only have one treatment option available on the NHS, eculizumab, which is delivered intravenously every 2 weeks.
22 April 2021
Six-Week Post-Natal Checks Continued Throughout COVID-19 Pandemic, Says RCGP
Responding to a recent survey by the NCT on post-natal care during the COVID-19 pandemic, Dr Victoria Tzortziou Brown, Joint Honorary Secretary of the Royal College of GPs, said the following.
“Maternal postnatal checks are important opportunities for women to discuss any physical and mental health concerns that they may have, as well as to ensure their baby is healthy and thriving. GPs and our teams have been working incredibly hard throughout the pandemic to deliver the care and services our patients rely on us for – including maternal post-natal checks - in as safe a way as possible. It’s encouraging that a similar number of new mothers are being offered, and are coming forward for, their six-week post-natal check as before the pandemic.
20 April 2021
NICE Launches Ambitious Strategy to Provide Quicker Access to New Treatments and Innovations
NICE will transform key elements of its approach to ensure efficiency and speed while maintaining robust, trusted methods.
NICE will speed up patients’ access to the latest and most effective treatments, and dynamic guideline recommendations will be put in the hands of healthcare professionals more quickly under plans unveiled by NICE in its 5-year strategy launched today (Monday 19 April 2021).
NICE will transform key elements of its approach to ensure efficiency and speed while maintaining robust, trusted methods.
12 April 2021
Latest PRINCIPLE Trial Findings ‘Exciting And Important’ for Patient Care, Says RCGP
Responding to the latest findings of the PRINCIPLE trial of COVID-19 treatments, published by the University of Oxford, Professor Simon de Lusignan, Medical Director for the RCGP’s Research and Surveillance Centre, said the following.
“We’re learning about COVID-19 all the time. This is helping us to treat patients with the virus, lessen the severity of their symptoms and aid their rehabilitation in the community – and this is only possible due to high quality research, being conducted using primary care patient data. The RCGP’s Research and Surveillance Centre has played a key role in recruiting participants and getting this trial off the ground. Practices have identified eligible people and offered them the opportunity to participate in this research. They have arranged virology testing, using Public Health England’s Colindale laboratory, and helped with follow up data about recovery and any hospitalisation.
13 April 2021
NICE Recommends Range of Effective Treatments for People with Chronic Primary Pain and Calls on Healthcare Professionals to Recognise and Treat a Person’s Pain as Valid and Unique to Them
People with chronic primary pain should be offered a range of treatments to help them manage their condition, NICE has said in its guideline on the assessment and management of chronic pain published today (7 April).
Dr Paul Chrisp, director of the Centre for Guidelines at NICE, said: “We want this guideline to make a positive difference to people with chronic pain, and their families and carers.
“It highlights that achieving an understanding of how pain is affecting a person’s life and those around them and knowing what is important to the person is the first step in developing an effective care and support plan that recognises and treats a person’s pain as valid and unique to them.”8 April 2021
RCGP Responds to Change in JCVI Guidance Regarding Astrazeneca Vaccine for Under-30s
Professor Martin Marshall, Chair of the Royal College of GPs, responds to news from the MHRA and JCVI about the safety of the Oxford-AstraZeneca vaccination for COVID-19.
He said:
"Today's announcement from the MHRA, and also the EMA, should be taken as reassurance for patients that overall, the benefits of taking the AstraZeneca vaccine for COVID-19 outweigh the risks. The cautionary change the JCVI is recommending is that for adults aged 18-29 with no underlying conditions that could put them at greater risk of COVID-19, other vaccines should be offered, if available.
6 April 2021
RCGP Insists Vaccination Certificates Must Have ‘Zero Impact’ on GP Workload
Any introduction of Covid-19 vaccination certificates or passports must have ‘zero impact’ on GP workload, to allow GPs to continue to focus on delivering vital patient care the Royal College of GPs has said.
In evidence submitted to the Government’s review into a possible COVID-status Certification Scheme, the RCGP has expressed concerns that involving GPs and other members of the practice team in facilitating such a certificate, would only intensify ‘worryingly high’ workload pressures already facing the profession.
1 April 2021
RCGP Response to Commission on Race and Ethnic Disparities Report
Responding to the Commission on Race and Ethnic Disparities report, Professor Martin Marshall, Chair of the Royal College of GPs, said: “The suggestion in this report, that structural racism is not embedded within UK society, does not tally with the experiences of many members from Black, Asian and ethnic minority communities who have reached out to the College over the last year.
30 March 2021
NICE Publishes Single Guideline for Managing COVID-19
One year on from the first national lockdown, NICE has today (23 March) published a single guideline for the management of COVID-19 in children and adults.
In response to ongoing developments throughout the pandemic, NICE has produced numerous rapid COVID-19 guidelines to help healthcare workers respond to the ongoing pandemic. Feedback has indicated that users would now find it useful for all essential information about managing COVID-19 to be included in a single piece of guidance.
26 March 2021
Medical Assessments for Prospective Foster Carer and Adopters Statement
The Department for Education have highlighted to us the challenges faced by some as they try to obtain medical assessments as part of an adoption or fostering process. We have signed a joint statement the with BMA to support GPs in considering requests for these important medical assessments.
23 March 2021
Triple Therapy Recommended by NICE for Patients with Multiple Myeloma
The therapy has been recommended after a confidential discount was agreed between NHS England and the drug manufacturer Amgen.
A new second line triple therapy is to be offered to NHS patients in England with multiple myeloma after NICE recommended its use.
Carfilzomib with dexamethasone and lenalidomide could be offered to around 2,000 patients with multiple myeloma who have had at least one previous therapy, which include bortezomib.
Clinical trial evidence shows that carfilzomib with lenalidomide and dexamethasone gives longer periods of remission and people live longer, compared with the current second line treatment lenalidomide plus dexamethasone.
20 March 2021
RCGP Hails Work of General Practice in Achieving ‘Incredible’ Vaccination Milestone
Responding to the news that 50% of the UK adult population have received their first dose of the Covid-19 vaccine, Professor Martin Marshall, Chair of the Royal College of GPs, said: “The hard work of GPs and our teams – along with colleagues across the NHS – to deliver the Covid-19 vaccination programme has been outstanding and ensured that vulnerable patients across the UK are protected from this terrible virus.
16 March 2021
Children and Young People Need Accurate, Accessible Information About Their Healthcare
New draft guidance from NICE published today recommends ensuring children and young people are fully informed about their health so that they are empowered to take an active role in their healthcare.
The healthcare system can be intimidating to younger patients, and poor experiences may lead to anxiety around engaging with the system later in life and poorer health outcomes. This draft guidance aims to improve the healthcare experience of babies, children, and young people with the hope that this can improve their health outcomes and wellbeing.
11 March 2021
‘Capsule Endoscopies’ to Detect Bowel Cancer Are a Welcome Innovation – But Must Be Robustly Evaluated, Says College
The College has responded to NHS England’s announcement of miniature cameras ‘no bigger than a pill’ being trialled to check for bowel cancer.
Professor Martin Marshall, Chair of the Royal College of GPs and a GP in East London, said:
“We’re aware that some patients are reluctant to seek help for certain cancers because the diagnostic tests available can be invasive, so this is a fascinating development and we will be very interested to see the results of the trial."
8 March 2021
NICE Approves Life-Changing Gene Therapy for Treating Spinal Muscular Atrophy
A new and potentially curative one-off gene therapy for babies with the rare genetic disorder spinal muscular atrophy (SMA) is set to become the most expensive treatment ever approved by NICE.
NICE’s draft guidance published today (8 March 2021) recommends £1.79 million treatment Zolgensma (also called onasemnogene abeparvovec and made by Novartis Gene Therapies) for babies aged up to 12 months with type 1 SMA, This is one of the severest forms of the inherited condition and the life-expectancy of people with it is usually less than 2 years.
The draft guidance also recommends Zolgensma for babies with SMA before they develop symptoms as part of a managed access arrangement while further data is collected.
5 March 2021
GP Teams Working ‘Incredibly Hard’ to Vaccinate Group 6 Patients, Says RCGP
Responding to claims that some patients in Group 6 of the JCVI’s priority list are being ‘denied’ vaccines, Professor Martin Marshall, Chair of the Royal College of GPs, said: "GPs and our teams have been pulling out all the stops to vaccinate patients, with more than 20m people now having now received their first dose, and 75% of those in England being delivered in primary care. As long as there is vaccine supply, general practice will continue to play a key role in the vaccination programme until the whole population is protected from Covid-19.
1 March 2021
Hundreds of People Set to Benefit as NICE Recommends Selective Internal Radiation Therapy for Treating Advanced Liver Cancer
Hundreds of people with advanced liver cancer (also called hepatocellular carcinoma or HCC) are set to benefit after NICE today (26 February 2021) published final draft guidance recommending a cancer treatment called selective internal radiation therapy (SIRT) as an option for treating the condition
SIRT is a way of giving radiation treatment for cancer via tiny radioactive beads (called microspheres) that are injected into the artery supplying blood to the tumour via a catheter from the femoral artery. This helps to minimise the risk of radiation damage to healthy surrounding tissues.
1 March 2021
College Calls on Care Quality Commission for Action to Address Impact of Inspections on BAME GPs
RCGP Council has called on the Care Quality Commission for a series of measures to look at the impact of its inspections on GPs from Black Asian and Minority Ethnic communities.
Following an impassioned debate that included BAME GPs’ lived experiences of having their practices inspected by the CQC, Council members voted overwhelmingly to support all three parts of a motion, proposed by Dr Sonali Kinra and seconded by Dr Margaret Ikpoh, calling on the CQC to:
22 February 2021
NICE Recommends Treatment Options for Severe Pregnancy Sickness in New Draft Guidance
Nausea and vomiting, often referred to as morning sickness, is common in pregnancy. Close to 80% of pregnant women experience these symptoms, with most conditions improving or stopping completely by around 16 to 20 weeks.
In many cases, at-home remedies such as ginger can help to alleviate symptoms, but in a small percentage of pregnant women, the condition can be more serious. Between 0.3 and 3.6% of pregnant women experience excessive nausea and vomiting known as hyperemesis gravidarum, which can sometimes lead to hospitalisation.
16 February 2021
RCGP Scotland responds to the Health and Sport Committee's Report on Primary Care
Responding to today's publication of the Scottish Parliament's Health and Sport Committee's report, 'What should primary care look like for the next generation? Phase II', Dr David Shackles, Joint Chair of RCGP Scotland said:
"GPs and the wider multidisciplinary primary care team work exceptionally hard day in, day out, to meet the varied and complex needs of their patients. While we agree that improvements can and should be made to ensure that primary care can deliver patient-centred care now and in the future, it is simply not the case that this will be achieved by extending the opening times of GP surgeries. This recommendation by the Committee also does not reflect the hard work of our colleagues in the Out of Hours service who ensure that primary care in Scotland is available to patients 24 hours a day, 7 days a week.
16 February 2021
Skin Cancer Drug Recommended for Routine NHS Use
An appeal period has now opened until 26 February 2021.
NICE has today (Friday 12 February 2021) issued final draft guidance which recommends the routine use of nivolumab (Opdivo; Bristol-Myers Squibb) as an option after surgery for some people with melanoma.
For the last two years nivolumab was recommended for use within the Cancer Drugs Fund as an option for the adjuvant treatment of completely resected melanoma in adults with lymph node involvement or metastatic disease.
14 February 2021
RCGP Responds to ‘Fantastic Achievement’ of Giving 15m People Their First Dose of the Covid-19 Vaccine
Responding to today’s news that 15m people have received their first dose of Covid-19 vaccination in the UK:
Professor Martin Marshall, Chair of the Royal College of GPs, said: “The success of the Covid vaccination programme so far is down to the people delivering it. GPs and our teams - along with colleagues across the NHS - have been working incredibly hard, vaccinating our most vulnerable patients to protect them from Covid-19, and we’re hugely thankful for their efforts.
9 February 2021
Thousands of Lung Cancer Patients to Benefit from Life-Extending Treatment
A potentially life-extending treatment for some people with non-squamous, non-small-cell lung cancer (NSCLC) will now be available on the NHS following its approval by NICE in draft guidance published today.
The draft guidance means pembrolizumab (Keytruda, Merck Sharp & Dohme) with pemetrexed and platinum chemotherapy will be available as a first-line treatment option for adults whose tumours have no epidermal growth factor receptor (EGFR)-positive or anaplastic lymphoma kinase (ALK)-positive mutations.
8 February 2021
GPs Need to be on the Frontline of Patient Care, Not Spending Time on ‘Cumbersome Red Tape’, Says College on Vaccine Passports
The College has responded to comments made by Nadhim Zahawi, Minister for Vaccine Deployment, dismissing proposals for UK vaccine passports but saying that ‘vaccine proof’ for other countries could be provided via the NHS and GPs.
Professor Martin Marshall, Chair of the Royal College of GPs and a GP in East London, said: “We’re encouraged by the Vaccine Minister’s assurances that UK vaccine passports will not be introduced as we share many of his concerns.
2 February 2021
First Analysis of Primary Prevention Research Landscape Published
The detailed analysis highlights the need for multi-disciplinary capability for research into whole-system influences on behaviour and public health.
Non-communicable diseases like cancer, diabetes and heart disease have a huge impact on our quality of life and put pressure on the NHS and other services, especially as our society lives longer.
We want to prevent these diseases, and it is understood that the social and physical environments play a vital role in their development.
However, the interplay between these factors is complex, making the development of effective health interventions difficult.
28 January 2021
GPs Highlight Issues Over Vaccine Supply and Rollout
Responding to the decision to open Trust-based vaccine clinics to those aged 65-69, RCGPNI Chair Dr Laurence Dorman said: "We fully support the principle of vaccinating as many people as possible, as quickly as possible and it is encouraging to see such high demand for appointments since the booking portal launched on Wednesday night. However, we have concerns about the speed of vaccine rollout to those people in higher priority groups.
26 January 2021
NHS Patients to Benefit from First Full Access Deal in Europe for New CAR-T Therapy Recommended by NICE
NICE has agreed a managed access agreement, via the Cancer Drugs Fund with manufacturer Kite, so more data can be collected while patients can access the treatment.
NHS patients are to be among the first in the world to be offered access to a cutting-edge cancer treatment after NICE recommended its use.
From today NHS clinicians in England will be able to consider the treatment for some patients with a form of lymphoma, a cancer that attacks the immune system.
19 January 2021
Good Progress Being Made by GPs And Teams Delivering Covid Vaccination Programme, Says College
Commenting on the status of the roll out of the Covid vaccination programme at a community level, Professor Martin Marshall, Chair of the Royal College of GPs, said: “GPs and our teams – along with colleagues across the NHS - are working incredibly hard to vaccinate patients, starting with those most vulnerable to the virus, and we’re making good progress with more than 4m patients now protected from Covid-19.
19 January 2021
National Consortium to Study Threats of New SARS-Cov-2 Variants
A new national research project to study the effects of emerging mutations in SARS-CoV-2 will be launched with £2.5 million funding from UK Research and Innovation (UKRI).
The ‘G2P-UK’ National Virology Consortium* will study how mutations in the virus affect key outcomes such as:
- how transmissible it is
- the severity of COVID-19 it causes
the effectiveness of vaccines and treatments.
15 January 2021
Deprioritising ‘Non-Essential’ Work Should Have Minimal Impact on Patient Care, Says RCGP
Professor Martin Marshall, Chair of the Royal College of GPs, said: “GPs and our teams are working incredibly hard delivering the COVID vaccination programme alongside the delivery of the expanded flu vaccine programme and the vital care services that our patients rely on us for.
12 January 2021
Treatment for Men with Enlarged Prostate is Recommended by NICE for NHS Adoption
Final guidance from NICE recommends the PLASMA system
Men who suffer with an enlarged prostate could now be treated with technology which reduces the risks of serious complications, NICE has said in final guidance.
The PLASMA system uses electrodes to cut out prostate tissue and stop any local bleeding afterwards.
Clinical outcomes are the same as the conventional monopolar transurethral resection of the prostate (mTURP), but PLASMA avoids the risk of transurethral resection syndrome and reduces the need for blood transfusion and the length of hospital stay. This means that the treatment costs are less than for mTURP – saving hospitals up to £534 per procedure.
8 January 2021
Vital that GPs and Their Teams are Offered Covid-19 Vaccinations, Says RCGP
Professor Martin Marshall, Chair of the Royal College of GPs, said: “GPs and our teams are currently working incredibly hard delivering two mass vaccination programmes, as well as the care and services our patients rely on us for – much of which cannot be delivered remotely.
“It’s imperative that GPs, our teams and others involved in delivering the vaccination programme have the opportunity to receive the Covid vaccine in a timely manner. This won’t just protect us from this terrible virus, allowing us to continue working on the frontline delivering patient care, but also patients and our families. General practice has been doing an excellent job, playing a leading role in vaccinating more than 1.5m patients – but there is long road ahead of us, and the last thing we want to see is the workforce depleted as staff fall ill due to Covid-19 at a time when we need all hands-on deck.
5 January 2021
NICE Collaboration on Streamlined Licensing and Patient Access Process for New Medicines Opened on January 1st
Companies can now submit medicines for the new Innovative Licensing and Access Pathway (ILAP) following close collaboration between the NICE, drug regulators, the NHS and equivalent organisations in Scotland.
The new route for the approval of medicines aims to smooth the journey from clinical trials through to NHS patients through closer collaboration and planning between the agencies involved in each step. It will mean NHS patients will have access to innovative new medicines sooner.
31 December 2020
Red Tape Must Not Prevent Retired GPs Returning to the Frontline, Says College
Professor Martin Marshall, Chair of the Royal College of GPs, said: “Recently retired GPs - and other healthcare professionals - signed up in droves to help with efforts to tackle the Covid-19 vaccination programme. These are people with huge amounts of skill and experience to offer, yet in many cases, this valuable resource is being under-utilised.
22 December 2020
NICE, RCGP and SIGN Publish Guideline on Managing the Long-Term Effects Of COVID-19
NICE, the Royal College of General Practitioners (RCGP) and the Scottish Intercollegiate Guidelines Network (SIGN) have today (18 December 2020) published a guideline on the management of the long-term effects of COVID-19 (also known as Long COVID).
The guideline covers the care of people who have signs and symptoms that develop during or after an infection consistent with COVID-19, that continue for more than 4 weeks and are not explained by an alternative diagnosis. It provides recommendations based on the current evidence and expert consensus, and will be adapted as new evidence emerges.
14 December 2020
Patients Should Be Assured That the Pfizer/Biontech COVID Vaccine Is Safe, Says RCGP
Responding to the Pfizer/BioNTech COVID vaccine receiving approval for use in the UK Professor Martin Marshall, Chair of the Royal College of GPs, said: “The safety of vaccines, as well as their efficacy, is paramount, so it’s excellent news that the Pfizer/BioNTech vaccine has been approved for use in the UK. This should offer optimism for further vaccines in development. Given the logistical challenges around delivery and storage associated with the Pfizer/BioNTech vaccine, it is likely the focus of its delivery will be in hospital hubs and mass vaccination centres. However, we’re awaiting details of this and how it will work – including if and how general practice will be involved, even if not directly delivering this particular vaccine.
15 December 2020
Azithromycin Has No Benefit for Hospitalised COVID-19 Patients
The ‘RECOVERY’ trial has released a preliminary analysis showing azithromycin, an antibiotic, had no meaningful clinical benefit for patients hospitalised with COVID-19.
The ‘Randomised Evaluation of COVid-19 thERapY’ (RECOVERY) trial was funded by UK Research and Innovation (UKRI). It is part of the UKRI/Department of Health and Social Care/National Institute for Health Research (NIHR) COVID-19 rapid research response.
To provide real-time information in the pandemic, the results are available as a preprint on medRxiv. Full results will be made available as a peer-reviewed publication once follow-up has been completed for all participants.
14 December 2020
COVID Vaccination Programme an ‘Enormous Challenge’ But General Practice Has an ‘Excellent Track Record’ of Delivering Mass Vaccination Programmes, Says RCGP
Commenting on the start of the roll out of COVID-19 vaccinations being delivered in general practice, Professor Martin Marshall, Chair of the Royal College of GPs, said: "GPs and our teams are about to embark on an enormous challenge, delivering the COVID-19 vaccination programme in the community whilst also delivering the expanded flu vaccine programme and the usual care and services our patients rely on us for.
8 December 2020
Innovative Technology to Detect Abnormal Heart Rhythms Recommended by NICE for NHS Use While Further Data is Collected
Zio ZT is the first assessment, via the NICE digital health technologies guidance development pilot project, to be recommended for NHS use with the caveat that further data must be collected.
NICE has today published medical technology guidance which recommends the Zio XT service for detecting abnormal heart rhythms, only if NHS organisations collect further evidence of its benefits.
Patients will have access to this promising new technology for three years while more data is collected to address evidence gaps about its benefit. After this time, NICE’s committee will review the technology with the new evidence and make a final recommendation on whether to recommend Zio XT for routine use on the NHS.
4 December 2020
Urgent Update on Pfizer/Biontech Vaccine and the Involvement of GPs
The College has received information from NHS England this evening that general practice will have a much earlier role in delivery of the Pfizer/BioNTech vaccine than originally anticipated - and potentially as early as next week.
A letter from NHSE Primary Care Director Nikki Kanani has been sent to all practices in England and there will be a further update on Monday, but GPs will be involved initially through PCN groupings as the beginning of a general mobilisation of practices.
1 December 2020
New Option for People with Difficult-To-Treat Multiple Myeloma Is Recommended for Use in Cancer Drugs Fund by NICE
Around 5,700 cases of multiple myeloma are diagnosed each year in the UK
NICE has recommended a new option for people with difficult-to-treat multiple myeloma.
Isatuximab, administered as an intravenous infusion, plus pomalidomide and dexamethasone is recommended for use within the Cancer Drugs Fund as an option for treating relapsed and refractory multiple myeloma in adults.
It will be offered as a treatment option to those people who have
29 November 2020
Nearly Half of General Practice Consultations Being Delivered Face to Face: RCGP Responds to Mail On Sunday Criticism
Responding to a Mail on Sunday article on GP access Dr Gary Howsam, Vice Chair of the Royal College of GPs, said: “General practice services have been available throughout the pandemic, but they are being delivered differently in order to help stop the spread of Covid-19, keep patients and staff safe and allowing GPs and our teams to keep working, delivering essential care - all in line with official guidance from NHS England.
24 November 2020
NICE Recommends New Chemotherapy-Free Treatment Option for People with Untreated Chronic Lymphocytic Leukaemia
More than 1,000 people each year will benefit from NICE's recommendation
NICE has today (Tuesday 10 November 2020) recommended a new chemotherapy-free treatment option for people with untreated chronic lymphocytic leukaemia (CLL) in final draft guidance.
The recommendation of venetoclax plus obinutuzumab is set to benefit more than 1,000 people each year. The new fixed 12-month chemotherapy-free treatment will be offered to people with CLL who have not received any prior treatments.
20 November 2020
Expansion of the Flu Vaccination Programme is 'Sensible' but Will be a 'Huge Challenge', Says RCGP
Responding to NHS England’s confirmation of the expansion of the flu vaccination programme Professor Martin Marshall, Chair of the Royal College of GPs, said: “The expansion of this winter’s flu vaccination programme to include patients aged 50-64 is sensible, and is something the College has supported since its announcement this Summer. Flu can be a horrible and serious illness. We want to avoid as many patients as possible succumbing to flu this winter, while we are in the midst of the Covid-19 pandemic and resources are even more stretched than usual, and the flu jab is the best protection against it.
17 November 2020
NICE Recommends Innovative Treatment for Severe Blood Disorder for NHS Use
Caplacizumab, with plasma exchange and immunosuppression, will be used to treat acute acquired thrombotic thrombocytopenic purpura.
A brand-new treatment – the first for 25 years – for a rare blood disorder has been recommended by NICE for routine use on the NHS.
Caplacizumab with plasma exchange and immunosuppression will be used to treat acute acquired thrombotic thrombocytopenic purpura (aTTP).
Caplacizumab, also known as Cablivi and manufactured by Sanofi, will be used to treat an acute episode of acquired TTP in adults, and in young people aged 12 years and over, who weigh at least 40 kg.
9 November 2020
Vaccine News ‘Positive’ But Still Questions That Need Answers, Says RCGP
Commenting on the news from Pfizer/BioNTech about the effectiveness of their COVID-19 vaccine, Professor Martin Marshall, Chair of the Royal College of GPs, said: “That such progress has been made in developing a vaccine for Covid-19 is positive news. A safe and effective vaccine would be a vital tool in allowing people to start living more normally again, preventing people from becoming sick and ultimately saving lives.
10 November 2020
NICE to Become Single Point of Access for Covid-19 Guidance and Advice
NICE has today (6 November) announced that it is to host a new, single point of advice on caring for people with Covid-19 and the management of Covid-19 in a variety of clinical settings.
The initiative will see NICE bringing together NHS England and NHS Improvement’s specialty guides on Covid-19 with its own Covid-19 rapid guidelines. Together they will create a single point of access to national advice on the clinical management of Covid-19 to support frontline health and care staff across the country.
5 November 2020
General Practice Is Open Says Royal College of GPs As England Enters Second National Lockdown
As England goes into a second national lockdown, the Royal College of GPs is making it clear to patients that general practice is open and that general practice services are available, albeit being delivered differently than usual in many cases.
The RCGP is urging patients, if sick, to continue accessing general practice - and other NHS - care throughout the second national lockdown, brought into effect today until 2 December.
3 November 2020
NICE, SIGN and RCGP Set Out Further Details About the UK Guideline on Management of the Long-Term Effects of COVID-19
NICE, the Scottish Intercollegiate Guidelines Network (SIGN) and the Royal College of General Practitioners (RCGP) have today (30 October 2020) given more details about the forthcoming guideline on post-COVID syndrome.
The guideline scope published today defines post-COVID syndrome (also known as Long COVID) as signs and symptoms that develop during or following an infection consistent with COVID-19 which continue for more than 12 weeks and are not explained by an alternative diagnosis. It says the condition usually presents with clusters of symptoms, often overlapping, which may change over time and can affect any system within the body. It also notes that many people with post-COVID syndrome can also experience generalised pain, fatigue, persisting high temperature and psychiatric problems.
28 October 2020
Link Between HRT and Breast Cancer 'Complex' but Much Evidence to Suggest it is Safe, Says RCGP
Responding to a new study published by BMJ providing new estimates of the increased risks of breast cancer associated with use of different hormone replacement therapy (HRT) preparations in the UK Professor Martin Marshall, Chair of the Royal College of GPs, said: “The menopause can be a very difficult time for some women. HRT can help to control unpleasant and distressing menopausal symptoms that some women experience, and as such drastically improve their quality of life.
27 October 2020
GPs Frustrated by Delay in Flu Vaccine Supply
RCGPNI Chair Dr Laurence Dorman said: “GPs across the region are incredibly disappointed and frustrated by the announcement that there are delays with the supply of the flu vaccine this year.
“GPs and their teams have worked incredibly hard in recent weeks and months to prepare for an unprecedented flu campaign. Our colleagues have set up safe clinics in church halls, community centres and car parks, providing drive-through options for vulnerable patients and delivering a significant number of vaccines to patients while adhering to public health guidance. Many of these clinics were performed on Saturdays and on weekday evenings, highlighting the dedication and flexibility of our staff.
20 October 2020
Medical Leaders Fear Imminent End of All Non-Urgent Operations as Pressures Increase to Manage COVID-19
Medical Royal Colleges in Northern Ireland have come together to urge the public to play their part in stopping the spread of COVID-19, in order to protect vital health services.
As the rate of infection continues to increase, the Health Minister and Health & Social Care Chiefs are being forced to make difficult decisions around what services will continue to be provided during the imminent winter period.
20 October 2020
NICE Draft Guidance Recommends Siponimod for Treating Secondary Progressive Multiple Sclerosis
NICE has today (15 October 2020) issued draft guidance which now recommends siponimod (also called Mayzent and made by Novartis) for treating secondary progressive multiple sclerosis (MS).
Siponimod, which is taken orally, is licensed to treat secondary progressive MS in adults with evidence of active disease (where people have relapses or features of inflammatory activity that show up on imaging). Around 11,000 people with secondary progressive MS will now be eligible for treatment with Siponimod.
Clinical trial results show that siponimod reduces the number of relapses and slows worsening disability compared with placebo.
16 October 2020
GPs Should Be Proud, and Patients Reassured, That Vast Majority of GP Practices Rated ‘Good’ or ‘Outstanding’, Says RCGP
Responding to the Care Quality Commission’s State of Care report 2019/20, Professor Martin Marshall, Chair of the Royal College of GPs, said: “That the vast majority – 94% - of GP practices continue to be rated good or outstanding is a remarkable achievement given the intense workload and workforce pressures they have been working under. This is something GPs and their teams across the country should be proud of, and their patients reassured they are receiving good, safe care.
13 October 2020
NICE Proposes Simplifying How Medicines and Medical Devices Are Selected for Evaluation
As part of the work underway to review the methods and processes NICE uses to develop guidance on medicines, medical devices and diagnostics, NICE has launched a public consultation on proposals for changing how it selects the topics it will develop guidance on.
The proposals clarify the criteria that would see a device or diagnostic selected for NICE guidance development. In particular, these include where the costs and impacts are expected to be significantly cost incurring or cost saving, or there is uncertainty about the likely cost or the impact it would have on the healthcare system.
7 October 2020
Plans for Long-Covid Clinics ‘Encouraging’, Says RCGP
Responding to an NHS England announcement on plans to address the treatment and management of ‘long covid’, Professor Martin Marshall, Chair of the Royal College of GPs, said:
“Long-Covid is a dreadful condition for many of the patients who are suffering from it, and like all other aspects of Covid-19, we are starting to understand more about it…..
6 October 2020
Scientists Discover What Happens in Our Brains When Guessing
Researchers have identified how cells in our brains work together to join up memories of separate experiences, allowing us to make educated guesses in everyday life.
By studying both human and mouse brain activity, they report that this process happens in a region of the brain called the hippocampus.
The study, published in the scientific journal ‘Cell’, also reveals that brain cells can link different memories while we are resting or sleeping, a process that may be important in creativity.
4 October 2020
College Writes to Health Secretary with Concerns Over Supply and Demand of Flu Vaccines
College Chair Martin Marshall has written to Matt Hancock, Secretary of State for Health and Social Care in England, following reports from RCGP members of flu vaccine shortages and their concerns for patients in ‘at risk’ groups such as the elderly, those with pre-existing conditions, and pregnant women.
29 September 2020
NICE Board Agrees to Stimulate Action Following Publication of Independent Medicines and Medical Devices Safety Review Report
NICE to reinforce the importance of collaborative working with system partners to ensure a more integrated approach to safety recommendations made in NICE guidance
The NICE board has agreed more work will be carried out with regulators and professional organisations to reinforce the use of NICE guidance.
The report of the Independent Medicines and Medical Devices Safety (IMMDS) Review in July, entitled First Do No Harm, found that had NICE guidance been followed more closely then much of the subsequent harm suffered by patients may have been avoided.
28 September 2020
College Sets Record Straight on Face to Face Appointments
Here is our full response to the patient survey on face to face appointments in today’s Daily Mail.
Professor Martin Marshall, Chair of the Royal College of GPs, said: “Throughout the pandemic general practice has remained open and GPs and our teams are working hard to care for both COVID and non-COVID patients.
“GPs are following Government guidance and have done everything they’ve needed to do to minimise the spread of the virus and ensure the safety of patients and frontline health professionals.
22 September 2020
NICE Joins Global Alliance to Shine Spotlight on Evidence-Based Healthcare
Tuesday 20 October will be the inaugural World Evidence-based Healthcare Day
Today NICE and six other global leaders in evidence-based healthcare, who are major organisations of World Evidence-based Healthcare, are launching a worldwide initiative to create awareness of the need for better evidence to inform healthcare policy, practice and decision making in order to improve health outcomes globally.
The inaugural World Evidence-based Healthcare (EBHC) Day will be held on 20 October 2020 and spotlights the global impact of EBHC on health research, policy, practice and patient outcomes.
18 September 2020
College Response to Legal Challenge in Respect of RCGP Council’s Decision (in February 2020) to Maintain its Position Opposing a Change in the Law on Assisted Dying
RCGP Chair Professor Martin Marshall said: “We are very disappointed to hear of this action, especially as we were transparent about our methodology and decision-making processes from the outset of the consultation.
15 September 2020
Improved Agreement Means NICE Now Recommends Lung Cancer Treatment
Thousands of people with non-small-cell lung cancer (NSCLC) will benefit from draft guidance published today by NICE.
New draft guidance recommends osimertinib (also called Tagrisso and made by AstraZeneca) at two different places in the treatment pathway for locally advanced or metastatic epidermal growth factor receptor (EGFR)-positive NSCLC.
14 September 2020
‘Insult’ to GPs to Imply They Haven’t Been Doing Their Job Properly During Pandemic, Says RCGP
Responding to NHS England’s letter to GP practices about access to GP services, Professor Martin Marshall, Chair of the Royal College of GPs, said: “General practice is open and has been throughout the pandemic. GPs have been delivering a predominantly remote service in order to comply with official guidance and help stop the spread of Covid-19.
8 September 2020
Be Aware of the Signs of Abuse and Neglect in Adult Care Homes, Says NICE
Staff and visitors can play a vital role in the identification and prevention of abuse and neglect in care homes for adults says NICE, in a draft guideline published today.
In addition to mandatory training for staff, the guideline covers what abuse and neglect look like, how to recognise the warning signs and what actions to take if abuse or neglect is suspected. It also calls on health and social care practitioners to provide information about what abuse and neglect may look like to residents and their families and carers.
The new guideline will provide practical advice for residents, staff and anyone who spends time with adults in care homes, including family, friends or professionals who may visit.
4 September 2020
College Responds to Jeremy Hunt’s Call for Weekly COVID-19 Testing for all NHS Staff
Dr Jonathan Leach, Honorary Secretary of the Royal College of GPs, said: “GPs and our teams are committed to delivering care to patients despite the challenging circumstances presented by the COVID pandemic, but they must be well enough to do so, and testing of frontline staff makes that possible. As such, weekly testing of NHS staff on a voluntary basis seems sensible - we know that testing reduces doubt and anxiety for frontline healthcare professionals, as well as reassurance for patients who may be, understandably, worried about the current situation.
1 September 2020
Unprecedented National Effort by UK Immunologists to Search for Answers on COVID-19
Three new UK-wide studies, bringing together scientists from 17 research institutions, will receive £8.4 million from UK Research and Innovation (UKRI) and the National Institute for Health Research (NIHR) to understand immune responses to the novel coronavirus.
25 August 2020
GP ‘Gut Feeling’ Should Not Be Ignored, Says RCGP
Responding to research published in the British Journal of General Practice on the role of GPs’ ‘gut feelings’ in diagnosing cancer, Dr Jonathan Leach, Honorary Secretary of the Royal College of GPs, said: “GPs consider a huge variety of factors when making a patient diagnosis. As well as more obvious physical symptoms, non-verbal cues can often indicate that something is wrong – not necessarily what the patient has made an appointment to speak about. This ‘gut feeling’ or intuition is something that GPs develop by having close, trusting relationships with patients that are often built over time, and isn’t something that should be ignored.
25 August 2020
NICE Extends Consultation Period for New Quality Standard on Fetal Alcohol Spectrum Disorder
NICE has today (20 August, 2020), released its draft quality standard on fetal alcohol spectrum disorder (FASD) for further public consultation.
In line with recommendations by the UK's Chief Medical Officer and the Royal College of Obstetrics and Gynaecology, the quality standard looks at the assessment and diagnosis of FASD, as well as prevention.
Healthcare professionals are encouraged to discuss the risks of alcohol consumption with expectant mothers and to share information on supportive care if needed, such as counselling or help to stop drinking.
20 August 2020
GP Patient Relationship Important When Discussing Issues Such as Weight, Says RCGP
Responding to a new report published by the Local Government Association, Professor Martin Marshall, Chair of the Royal College of GPs, said: “GPs know that obesity can have serious consequences for our patients’ health – we also know there is not always a quick fix for overweight patients to address their weight. There may be multiple physical and psychological factors to take into account, as well as lifestyle.
18 August 2020
Continuity of Care Must Be at The Forefront of Minds as Plans Are Made for How Patients Access GP Services Post-COVID
Responding to a new study in the British Journal of General Practice ‘Primary medical care continuity and patient mortality: a systematic review’ Professor Martin Marshall, Chair of the Royal College of GPs, said: “When considering the future of general practice, it’s vital that we place continuity of care at the forefront of our minds.
"We know the trusted GP-patient relationship is something many patients value most about general practice. It is unique, often built over time – and it allows GPs to deliver the holistic, relationship-based care that they excel at delivering. And this study in the British Journal of General Practice adds to the mounting evidence that continuity of care can benefit patients in many ways.
11 August 2020
GP Practices Preparing for Expanded Flu Vaccination Programme but Need Assurance About Supply, Says RCGP
Professor Martin Marshall, Chair of the Royal College of GPs, said: “The College is supportive of measures to expand the flu vaccination programme this year as a precaution to stop the NHS, including general practice, becoming overwhelmed should there be second wave of COVID-19 this winter. The two main challenges were always going to be procuring enough supply of the vaccine, and logistics of delivering it to patients on a scale potentially twice as big as usual.
11 August 2020
CCGs Should Work with GP Practices to Ensure Patients Who Need Face to Face Consultations Continue to Be Able to Have Them, Says RCGP
Professor Martin Marshall, Chair of the Royal College of GPs, said: "Throughout the pandemic GPs and our teams have been working differently to normal delivering care to patients with both COVID and non-COVID conditions. Whilst most care has been delivered remotely during lockdown, to help stop the spread of the virus, and keep practice staff and other patients safe, face to face appointments will have been facilitated where necessary.
5 August 2020
More Than 10,000 Aspiring Medics Sign Up for Virtual GP Work Experience During COVID-19 Crisis
The Royal College of GPs’ free, virtual and interactive general practice work experience platform, launched during the COVID-19 pandemic, has received 10,000 registrations within its first three months.
The interactive Observe GP video platform is aimed at aspiring medics aged 16+ who wish to learn more about general practice. Initially developed by the RCGP to provide an innovative way for students to shadow the primary care team, the platform has allowed them to insight of what it’s like to work in general practice from their homes while the country has been in lockdown.
4 August 2020
Commonly Used Treatments for Chronic Pain Can Do More Harm Than Good and Should Not Be Used, Says NICE in Draft Guidance
A number of commonly used drug treatments for chronic primary pain have little or no evidence that they work and shouldn’t be prescribed, NICE has said in its draft clinical guideline published today (3 August 2020) on the assessment and management of chronic pain in over 16s.
Instead, the draft guideline, which is now open to public consultation until 14 September 2020, says that people with a type of chronic pain called chronic primary pain should be offered supervised group exercise programmes, some types of psychological therapy, or acupuncture.
3 August 2020
'Patchy' Access to Chronic Pain Management Therapies Must Be Addressed if New NICE Guidelines Are To Make a Difference
Responding to the National Institute for Health and Care Excellence’s (NICE) draft clinical guideline published today on the assessment and management of chronic pain in over 16s Professor Martin Marshall, Chair of the Royal College of GPs, said: "Diagnosing and managing the care of patients in chronic pain can be challenging in general practice, not least because in many cases pain starts as an acute problem, which becomes chronic at a later stage. Once diagnosis has been made, there is also currently a lack of access to some of the evidence-based interventions, that could be of benefit for patients, recommended in these guidelines.
28 July 2020
NICE Publishes New COVID-19 Rapid Guideline on Arranging Planned Care in Hospitals and Diagnostic Services
NICE has today (27 July 2020) published a guideline on the arrangements the NHS should put in place for patients needing elective surgery and other planned treatments and procedures (including diagnostics and imaging) during the COVID-19 pandemic.
The latest in its series of COVID-19 rapid guidelines, the guideline makes recommendations about how these services should be organised in order to balance the risks associated with COVID-19 with the potential harms that can arise from delays in elective treatment and diagnostic procedures. It promotes a flexible approach based on individual circumstances and the type of procedure and aims to support the prompt recovery of elective care, while advocating shared decision-making, balancing the risks and benefits.
24 July 2020
Flu Vaccination Programme Expansion ‘Sensible’ But GPs Need Assurance About Supply, Says RCGP
Responding to the Government’s announcement of an expansion to the annual flu vaccination programme, Professor Martin Marshall, Chair of the Royal College of GPs, said: “The flu jab is the best protection we have against influenza and it is essential that as many people in at-risk groups – for example, older people, pregnant women and people with long term conditions or learning difficulties - get their vaccination when the season begins later in the year.
21 July 2020
General Practice Must Be Central to NHS Spending Plans During Pandemic Recovery
In response to the prime minister’s pledge of an additional £3 billion of funding to help the NHS prepare for a potential second wave of COVID-19, Professor Martin Marshall, Chair of the Royal College of GPs, said: “Today’s announcement is a welcome step in the right direction to help support general practice and all other sectors of the NHS, as they inevitably manage a huge amount of additional pressure and challenges, as a result of COVID-19, particularly as we approach our busy winter period.
19 July 2020
Providing Mask Exemption Notes ‘Not A Good Use of GPs’ Time’, Says RCGP
Responding to reports that GPs are being asked to provide notes to exempt patients from wearing face coverings, Professor Martin Marshall, Chair of the Royal College of GPs, said:
"The College is, on balance, supportive of face coverings being mandatory in enclosed spaces, such as shops and public transport. However, we need to see clear guidance about the reasons that people might be exempt from wearing masks, and how they are expected to prove this, if challenged.
15 July 2020
World-Leading Study into Long-Term Health Impacts of COVID-19 Launched by UKRI and NIHR
Today, UKRI and NIHR are announcing £8.4 million funding for one of the world’s largest studies into the long-term physical and mental health impacts of coronavirus on hospitalised patients. Results from the UK-wide study will inform the development of new and better measures to treat and rehabilitate patients hospitalised with COVID-19.
14 July 2020
Comprehensive Plans to Deal with Winter Pressures and Potential COVID-19 Second Wave ‘Vital’, Says College
Responding to the Academy of Medical Sciences' report Preparing for a challenging winter, Professor Martin Marshall, Chair of the Royal College of GPs, said: “Winter is always a busy time for general practice, as it is across the NHS, as GPs and our teams deal with many patients suffering from flu and other common winter illnesses in the community. A second wave of COVID-19, on top of these challenges, would put the NHS under considerable pressure, so it’s sensible to look at potential worst case scenarios, as this report does, so that we can plan and put mitigating measures in place.
7 July 2020
Innovation Through HTA: Theme for HTAi 2021 Annual Meeting Announced
Health Technology Assessment International (HTAi) has announced the theme for the 2021 Annual Meeting which will be held from 19-23 June in Manchester.
Co-hosts NICE, the All Wales Therapeutics and Toxicology Centre (AWTTC) and Healthcare Improvement Scotland (HIS) have recorded a welcome message for conference delegates which will set out plans for the event.
Focussing on ‘Innovation through HTA’, HTAi along with the local hosts and the International Scientific Programme Committee have created a programme that examines the challenges of embedding innovation in the health service.
6 July 2020
College Responds to Mail on Sunday Criticising GPs Over Remote Appointments
Today’s Mail on Sunday (5 June) features an article criticising GPs for new ways of working during the pandemic. We issued a statement to the MoS but the article has been selectively edited to include only one of our lines, so here it is in full.
30 June 2020
Cancer Patients to Benefit from New Histology Independent Treatment
Entrectinib (Rozlytrek, Roche), a revolutionary treatment for a range of cancers, is the second histology independent drug to be recommended by NICE for use on the Cancer Drugs Fund (CDF).
As a histology independent treatment, entrectinib targets all solid tumours that have a certain genetic mutation (a neurotrophic tyrosine receptor kinase (NTRK) gene fusion), regardless of where the cancer originated in the body.
26 June 2020
Statement of Solidarity and Support for BAME Colleagues and Communities
The Royal College of General Practitioners believes that all forms of racism are abhorrent and must not be tolerated. The tragic death of George Floyd - adding to the disproportionate number of black people killed by police in the US - and the response and subsequent activism by the Black Lives Matter movement have made us all hold up a mirror to ourselves and recognise that we are all part of structural racism.
Now is the time to act and we all need to work together to change.23 June 2020
NICE Publishes Latest COVID-19 Guidance on Renal Transplantation
NICE has published new rapid COVID-19 guidance for children, young people and adults who need or who have had a kidney transplant, and people who are donating a kidney (live donors).
The new recommendations aim to minimise the risk of infection for patients and living donors before, during and after transplantation. They emphasise the importance of communication between patients and their specialists to ensure they can make informed decisions and understand the implications of transplantation and donation during the COVID-19 pandemic.
21 June 2020
GPs Predict ‘Huge Surge’ in Patients with Post Traumatic Stress Disorder Due to COVID-19
The Royal College of GPs has reworked its learning materials - initially developed to help GP practices provide targeted support to military veterans returning from war zones and trying to adjust to civilian life – to create specific resources for family doctors helping their patients come to terms with the pandemic and its aftermath.
16 June 2020
Royal Colleges Connect with Health Minister on New Blueprint for NI's Health System
Medical leaders from the Royal College of GPs, Royal College of Surgeons, Royal College of Physicians Edinburgh and Royal College of Emergency Medicine met with the Health Minister, Robin Swann to discuss his plan to rebuild Northern Ireland's health service.
The Rebuilding Health and Social Care Services – Strategic Framework is a direct response to the Coronavirus pandemic and incorporates the collaboration, learning and innovation that emerged over the last three months, to address a historically disjointed health and social care system.
11 June 2020
Primary Care Voices Essential in Government Rebuild Plans Say RCGPNI
GPs in Northern Ireland have played an amazing role throughout this pandemic and like others working in our healthcare system from domestic care right through to intensive care should be commended for their bravery and commitment.
As part of the overall primary care response to COVID-19 GPs stepped up to work in the COVID Assessment Centres in NI as a means of separating patients with Covid-19 symptoms from those with non-COVID symptoms in our surgeries.
9 June 2020
Did Life Emerge in the ‘Primordial Soup’ Via DNA or RNA? Maybe Both
Scientists have long debated which genetic information carrier – DNA or RNA – started life on Earth, but a new study suggests life could have begun with a bit of both. The research, led by scientists from the Medical Research Council (MRC) Laboratory of Molecular Biology (LMB), in Cambridge, shows for the first time how some of the building blocks of both DNA and RNA could have spontaneously formed and co-existed in the ‘primordial soup’ on Earth.
The work challenges one of the leading hypotheses for the advent of life – the ‘RNA world’ theory, which arose in the 60s and has gained wide acceptance.
8 June 20208 June 2020
Covid-19 is Creating an 'Epidemic of Loneliness', Says RCGP in Response to 'Undetected' Home Deaths
College Chair Martin Marshall appears in the Guardian's front page story today, commenting on cases of people dying alone at home during COVID-19, but whose deaths are going unnoticed
Professor Martin Marshall, Chair of the Royal College of GPs, said: "The COVID-19 pandemic is also creating an epidemic of loneliness, not just for older people, and sadly there are some people who will fall through the net.2 June 2020
NICE Recommends Treatment for Type of Small-Cell Lung Cancer
A new treatment option for patients with extensive-stage small-cell lung cancer has been approved by NICE.
In new draft guidance, atezolizumab (also called Tecentriq and made by Roche) with carboplatin and etoposide has been recommended as an option for untreated extensive-stage small-cell lung cancer (ES-SCLC).
Around 2400 people in England have ES-SCLC, of whom around 1200 people will be eligible for treatment with atezolizumab with carboplatin and etoposide.
1 June 2020
Relaxation of Lockdown Measures is not a 'Green Light' to Return to Previous Way of Life, College Warns Patients
The College is urging patients to remain cautious following the publication of latest Government advice allowing shielded patients to go outdoors as long as social distancing rules are observed.
Professor Martin Marshall, Chair of the Royal College of GPs, said:
"Shielded patients are feeling the greatest and most serious impact of lockdown, and this slight relaxation of restrictions could bring positive benefits for their mental, as well as physical, health.
26 May 2020
Improved Deal Means New Treatment for a Type of Advanced Breast Cancer Can Be Recommended by NICE
Draft guidance published today (22 May 2020) by NICE recommends atezolizumab for treating people with a type of breast cancer, called triple negative breast cancer, that has spread to other parts of the body.
The positive recommendation follows consultation on NICE’s previous draft guidance which did not recommend atezolizumab. The company has agreed to provide a larger discount to the list price of the drug following a deal with NHS England & NHS Improvement.
21 May 2020
Shift on NHS Surcharge for NHS and Care Workers 'Common Sense', Says RCGP
Responding the Government's decision to exempt health and care workers from overseas from the NHS surcharge, Professor Martin Marshall, Chair of the Royal College of GPs, said: "General practice, the wider NHS and care sectors rely on people from all over the world to deliver essential care to patients. This has never been more apparent that during the current COVID-19 pandemic.
19 May 2020
NICE Publishes Rapid COVID-19 Guidelines on Chronic Kidney Disease and Interstitial Lung Disease
NICE has today (15 May) published 2 new rapid COVID-19 guidelines. The first is on chronic kidney disease (CKD) and the second on interstitial lung disease.
The guidelines aim to help healthcare professionals determine what care should be provided for people without COVID-19 infection or with confirmed or suspected COVID-19 infection safely and enable services to make the best use of NHS resources.
16 May 2020
RCGP Calls on Health Secretary to Move Away From 'Hitting Targets' to Testing 'The Right People at the Right Time' to Ease Lockdown and Avoid a Second Wave of COVID-19
The government’s testing strategy for COVID-19 needs to shift away from "arbitrary numbers and targets", and focus on wider access for health professionals and the public, if the UK is to ease lockdown and avoid a second wave of infection, the Royal College of GPs has warned today.
12 May 2020
NICE Draft Guidance Recommends New Treatment Option for People with Early Breast Cancer
NICE has today (7 May 2020) published draft guidance which recommends trastuzumab emtansine (also called Kadcyla and made by Roche) as an option for some people with HER2-positive early breast cancer.
Around 7000 people diagnosed each year in England with early breast cancer have HER2-positive disease. HER2, which stands for human epidermal growth factor receptor 2, is a protein on the surface of cancer cells which makes them grow and divide.
Trastuzumab emtansine is a type of targeted cancer drug. Trastuzumab attaches to the HER2 receptor allowing the emtansine to go into the cancer cell where it becomes active and kills the cancer cell.
7 May 2020
RCGPNI Calls on Government to Implement Dedicated GP Technology Plan
Access to basic IT hardware and software is preventing some GPs from carrying out remote consultations with their patients during the COVID-19 outbreak, according to the results of a Northern Ireland technology survey released today by the Royal College of GPs in NI.
The April 2020 survey of just over 100 GPs in Northern Ireland found that 40% of GPs have not been able to practice remotely from home during the pandemic, with almost a third of these (31%) stating access to technology as the reason.
4 May 2020
NICE Publishes Latest Wave of COVID-19 Guidelines
The first is on the care of children and young people who are immunocompromised and the second on antibiotics for pneumonia in adults in hospital.
COVID-19 rapid guideline: children and young people who are immunocompromised
The guideline on immunocompromised children and young people has been developed for children and young people aged 17 and under who may or may not have COVID-19. It emphasises that COVID-19 usually causes a mild, self-limiting illness in children and young people, even in those who are immunocompromised.
3 May 2020
Age Alone Not 'Sophisticated Criteria' To Determine Next Stage of Lockdown Restrictions, Says RCGP
Responding to a query from The Sunday Times about the extent to which age should be a factor in decisions about the next stage of lockdown restrictions during the COVID-19 pandemic, Professor Martin Marshall, Chair of the Royal College of GPs, said: “The College is not involved in discussions as to what the next stages of lockdown during the COVID-19 pandemic will be – this will be a decision for Governments across the four nations of the UK.
28 April 2020
NICE Publishes Two New COVID-19 Guidelines
NICE has published 2 new rapid COVID-19 guidelines on the care of patients with suspected and confirmed COVID-19.
They cover the management of disorders of the digestive system (gastrointestinal and liver conditions) that are treated with drugs that affect the immune response and the care of people in hospital who develop heart problems (acute myocardial injuries) as a consequence of COVID-19 infection.
27 April 2020
College Urges Parents Not to Shun Childhood Vaccinations During COVID-19 For Fear Of 'Burdening' the NHS
College Chair Professor Martin Marshall has a letter in today's Guardian encouraging parents to take up the routine vaccination programme for their children while the pandemic is ongoing
You can read it in full here
A vaccine is likely to make a major contribution to getting us out of the COVID-19 crisis. We know this because vaccines have provided the answer to many other infective crises in the past.
Vaccinations are some of the most important health interventions people can have.
The NHS childhood vaccination programme protects children for life from potentially deadly diseases, such as measles, polio and tuberculosis.21 April 2020
COVID-19 Therapy, Vaccine, Epidemiology and Policy Development Research Boosted by Twenty-One New Projects
Twenty-one new studies into the novel coronavirus have been funded by the UK government, including the first clinical drug trial in primary care, vaccine and therapy development, and studying epidemiology, disease transmission, behavioural interventions and policy approaches to COVID-19.
19 April 2020
RCGP Calls on Government for 'Remote Care' Plan for Patients During COVID-19
Access to basic IT hardware and software is preventing some GPs from carrying out remote consultations with their patients during the COVID-19 outbreak, according to the results of a survey released today by the Royal College of GPs.
The survey of more than 1,000 GPs across the UK found that around 50% of GPs have not been able to practice remotely from home during the pandemic, with the vast majority (63%) stating to access to technology as a reason. Of those GPs who have been managing to work remotely from home, 55% reported difficulties with VPN connectivity as a key barrier.
VPN software allows GPs to access their practice's computer systems, including patients records.
14 April 2020
NICE Publishes New COVID-19 Guidelines on Cystic Fibrosis, Chronic Obstructive Pulmonary Disease (COPD) and Dermatological Conditions Treated with Drugs Affecting the Immune Response
NICE has published 3 new rapid guidelines on the care of patients with suspected and confirmed COVID-19, and in patients without COVID-19. The guidelines have been designed to maximise the safety of patients whilst enabling services to make the best use of NHS resources.
They cover the care of patients with cystic fibrosis, COPD and dermatological conditions treated with drugs affecting the immune response.
9 April 2020
Risk of 'Serious Consequences' if Non-COVID Conditions Unmanaged or Untreated, Warns College
Commenting on the dangers of non-COVID conditions or illnesses being unmanaged or untreated during the COVID-19 pandemic, and urging patients who are seriously ill to seek medical care, Professor Martin Marshall, Chair of the Royal College of GPs, has said:
"Despite the COVID-19 pandemic, patients of all ages, are still living with long-term health conditions and becoming sick from non-COVID-related illnesses, which if left unmanaged or untreated could have serious consequences. We have seen this happen in previous pandemics.
7 April 2020
NICE Publishes New COVID-19 Guidelines on Severe Asthma, Pneumonia, Rheumatological Disorders and Symptom Management
They cover the management of patients with severe asthma, pneumonia, rheumatological autoimmune, inflammatory and metabolic bone disorders and the management of COVID-19 symptoms in the community.
NICE has published 4 new rapid guidelines on the active management of patients with suspected and confirmed COVID-19, and in patients without COVID-19. The guidelines have been designed to maximise the safety of patients whilst enabling services to make the best use of NHS resources.
2 April 2020
New Guidance Provides Much-Needed Clarity for GPs on PPE, Says College
Responding to new guidance on personal protective equipment (PPE) for frontline clinicians, Professor Martin Marshall, Chair of the Royal College of GPs, said: "It is crucial that healthcare professionals on the frontline of tackling the COVID-19 pandemic are confident that they are able to work as safely as possible.
31 March 2020
NICE Updates Rapid COVID-19 Guideline on Critical Care
We have listened to concerns raised by patient groups about the application of our rapid COVID-19 critical care guideline.
The guideline said that all adults on admission to hospital, irrespective of COVID-19 status, should be assessed for frailty using the Clinical Frailty Scale (CFS) and that comorbidities and underlying health conditions should be considered.
It said that the risks and benefits and likely outcomes should be discussed with patients, carers or advocates and families using decision support tools (where available) so that they can make informed decisions about their treatment wherever possible.
31 March 2020
Covid-19 Testing for Frontline NHS Staff Will Ensure GPs Can Provide Care When They Are Well, Says RCGP
The RCGP has responded to the Government's launch of coronavirus tests for frontline NHS staff.
Dr Jonathan Leach, Joint Honorary Secretary Royal College of GPs, said: "The College has been calling for the testing of frontline NHS staff since the outbreak of COVID-19 so we welcome this move. GPs and their teams are committed to delivering care to patients in these challenging circumstances, but they must be well enough to do so, and this new measure will help make that possible.
24 March 2020
NICE Publishes First Rapid COVID-19 Guidelines
New guidelines cover the management of patients in critical care, the management of patients who are having kidney dialysis and the management of patients who are receiving systemic anticancer treatments.
NICE has published its first 3 rapid guidelines on the care of people with suspected and confirmed COVID-19, and in patients without COVID-19.
These guidelines have been developed to maximise patient safety whilst making the best use of NHS resources and protecting staff from infection. The guideline has been developed using the interim process and methods for developing rapid guidelines on COVID-19 and recommendations are based on evidence and expert opinion.
19 March 2020
RCGP Calls for Priority COVID-19 Testing for Healthcare Professionals
Professor Martin Marshall, Chair of the Royal College of GPs, said: "The College has been making a strong case that COVID-19 testing for healthcare professionals should be a priority.
We know there are a significant number of healthcare colleagues who are following official advice and self-isolating, and only able to perform limited clinical tasks to support their colleagues. Testing would clarify whether they are safe to return to frontline patient care, where we know many would prefer to be.
17 March 2020
Around 10,000 People Could Benefit from New Migraine Drug as NICE Says It’s Cost-Effective
NICE has today (12 March 2020) published final draft guidance which recommends fremanezumab (also called Ajovy and made by Teva Pharmaceuticals) for preventing chronic migraine.
The draft guidance recommends fremanezumab for preventing chronic migraine in adults where at least 3 previous preventive treatments have failed, opening the way for up to 10,000 people to receive it on the NHS in England.
11 March 2020
GPs Must Receive 'Significant Share' of Emergency Funding to Tackle COVID-19, Says College Chair
Responding to the Budget, Professor Martin Marshall said: "We welcome the Government's urgent action to support the NHS in these particularly challenging times – and it is essential that a significant share of the emergency funding is made available for GPs on the frontline of patient care.
10 March 2020
Epidemic Preparedness Workshop Explores Key Role of Interdisciplinary Research
On 21 February MRC, the Academy of Medical Sciences and the InterAcademy Partnership, published the findings from a two-day meeting on epidemic preparedness held in October 2019. The workshop set out to explore the evidence required for effective epidemic preparedness, prevention and response, particularly in low- and middle-income countries, and how interdisciplinary research can best be facilitated to meet these evidence needs.
Emergence of infections is influenced by a multiplicity of factors: biological, environmental, behavioural, social, cultural, health system-related and political.
6 March 2020
Dismissing 'Sin Taxes' Unhelpful in Drive to Better Public Health, Says RCGP
Responding to The King's Fund's briefing on the success of fiscal and regulatory measures for improving health, Dr Gary Howsam, Vice Chair of the Royal College of GPs, said:
"The College has supported the use of so-called 'sin taxes' on items such as sugary drinks, alcohol and tobacco to tackle preventable chronic diseases for some time – and we agree with the King's Fund that dismissing these interventions as being too paternalistic is unhelpful as we strive for better public health across society.
3 March 2020
NICE Recommends New ‘Chemotherapy-Free’ Treatment for Lymphoma
A new treatment option for patients with previously treated follicular lymphoma (grade 1 to 3A) has been approved by NICE.
The new drug, lenalidomide (Revlimid, Celgene), fights cancer cells in a different way to current treatments, interfering with cell processes to halt the growth of tumours and stopping them from producing their own blood vessels.
27 February 2020
GP Workforce Figures Still Moving in the 'Wrong Direction', Says RCGP
Responding to the latest NHS Digital data on GP workforce Professor Martin Marshall, Chair of the Royal College of GPs, said: "GP numbers are continuing to move in the wrong direction with the number of fully-qualified, full-time equivalent GPs falling by 277 in a year.
"When you include GP trainees, numbers are more positive – and it is excellent that we have more GPs in training than ever before - but we are still only making slight headway in terms of the 6,000 target pledged during the General Election – and trainees, while qualified doctors, are in GP training to learn, so we should be cautious about relying on them for service delivery.
25 February 2020
Researchers Wanted to Study the Public’s Views of Health-Related Quality of Life
Applications close on Wednesday 4 March 2020
Researchers have been asked to express their interest in running a study of the UK public’s valuation of health-related quality of life.
NICE is backing the collection of new data to resolve concerns about the existing EQ-5D-5L value set for England.
EQ-5D-5L is a questionnaire designed to measure health-related quality of life. The new study will gather the public’s views about which aspects of health matter the most. The results of the study will be used to create a value set, which converts questionnaire responses into a number called a utility value. This information is used to inform many of NICE’s decisions about whether treatments provide good value for money.
21 February 2020
Royal College of GPs Remains Opposed to Change in the Law on Assisted Dying
The Royal College of General Practitioners will continue to oppose a change in the law on assisted dying, following a consultation of its members. The decision was ratified by the RCGP's governing Council today.
The member survey was conducted independently by Savanta ComRes. 6,674 members from across the UK responded to the online survey - 13.47% of those consulted*.
Members were asked whether RCGP should change its current position of opposing a change in the law on assisted dying:
18 February 2020
Wireless Device Recommended for Treating People with Overactive Bladder
Axonics SNS has potential to save the NHS around £6,200 per patient if the device lasts more than six years
People with an overactive bladder could have a rechargeable wireless device fitted to ease their condition, NICE has said in new draft guidance.
Inserted under the skin in the upper buttock, the Axonics sacral neuromodulation (SNM) stimulates the sacral nerve with an electric current via an electrode (thin wire). The electrode is attached to an implantable pulse generator which stimulates the nerves associated with bladder function. The aim of the stimulation is to make the bladder work in a more controllable way; a bit like a pacemaker for the heart.
11 February 2020
Statement on Covid-19 (coronavirus)
Latest statement from the Royal College of GPs on Statement on Covid-19 (coronavirus).
Professor Martin Marshall, Chair of the Royal College of GPs, said: "We're closely monitoring updates from relevant authorities, such as Public Health England (PHE) and equivalent organisations in Scotland, Wales and Northern Ireland.
"The current threat to the UK is still considered moderate and while eight cases of coronavirus have been confirmed in the UK, NHS England and PHE are assuring patients that there are robust arrangements in place to manage the situation.
11 February 2020
Appeal Panel Rules That NICE Needs to Request Evidence for Erenumab Effectiveness in Subgroup of People With Chronic Migraine
NICE has today (4 February 2020) published the outcome of the appeal against its final draft guidance (FAD) on erenumab (also called Aimovig and made by Novartis) for preventing chronic migraine.
The independent appeal panel upheld one appeal point: the committee unreasonably failed to consider the cost-effectiveness of erenumab versus best supportive care in people with chronic migraine who had failed to benefit from the comparator drug (botulinum toxin) or when it is contra-indicated.
6 February 2020
New GP Contract 'Catalyst' To Deliver Promised Funding and Workforce to General Practice, Says RCGP
Responding to the new GP contract negotiated by the General Practitioners Committee of the BMA and NHS England, Professor Martin Marshall, Chair of the Royal College of GPs, said:
"This is an encouraging contract and we thank our colleagues at the General Practitioners Committee of the BMA for their negotiations on our behalf.
4 February 2020
Nasal Spray Medicine for Treatment-Resistant Depression Not Recommended by NICE
More evidence on the clinical and cost effectiveness of esketamine needed
A nasal spray for treatment-resistant depression has not been recommended by NICE because of uncertainties over its clinical and cost effectiveness.
Esketamine (also called Spravato and made by Janssen) with a selective serotonin reuptake inhibitor (SSRI) or serotonin-norepinephrine reuptake inhibitor (SNRI) is not recommended, within its marketing authorisation, for adults with treatment-resistant depression that has not responded to at least two different antidepressants in the current moderate to severe depressive episode.
31 January 2020
Statement on Wuhan Novel Coronavirus
The Royal College of GPs has updated its statement on Wuhan Novel Coronavirus
Professor Martin Marshall, Chair of the Royal College of GPs, said: "We're closely monitoring updates from relevant authorities, such as Public Health England (PHE) and equivalent organisations in Scotland, Wales and Northern Ireland.
28 January 2020
Digital and Mobile Interventions Could Support Regular Health Services in Helping People Stop Smoking and Reduce Their Risk of Obesity, Says NICE
Health professionals can consider digital and mobile interventions as a supplement to regular services to support behaviour change in people at risk of developing chronic conditions.
In a new draft guideline, NICE says that digital interventions such as apps, wearable devices and online programmes and websites may help people achieve health goals. This includes helping people to be more physically active, manage their weight, quit smoking, reduce alcohol intake or reduce unsafe sexual behaviour.
24 January 2020
Wuhan Novel Coronavirus
In response to the current Wuhan Novel Coronavirus outbreak College Chair Professor Martin Marshall has issued the following statement today.
Professor Martin Marshall, Chair of the Royal College of GPs, said: "We're closely monitoring updates from relevant authorities, such as Public Health England (PHE). The current threat to the UK is considered low, and NHS England and PHE are assuring patients that there are robust arrangements in place to manage the emerging situation.
"Patients should not be alarmed as it is still more likely that anyone with flu-like symptoms will have the flu.
21 January 2020
Nice Encourages Further Data Collection On ‘Game Changing’ Histology Independent Cancer Drugs
Larotrectinib (also called Vitrakvi and made by Bayer), a new treatment for a range of cancers, can’t be recommended for use in the NHS because at its current price, it doesn’t have the potential to be cost-effective.
Another histology independent treatment, entrectinib (made by Roche), which NICE is also appraising could become the first histology independent treatment to be available to patients, provided it receives its marketing authorisation. NICE will be able to say more on this following a preliminary decision on its European licence.
16 January 2020
Energy Conference Cancelled After College Concerns
The College has announced today that an oil and gas conference due to take place at its headquarters has been cancelled
Professor Martin Marshall, Chair of the Royal College of GPs, said: “We deeply regret that a booking was accepted to host an event at our headquarters that conflicts with the College’s longstanding commitment to combat the impact of climate change on the environment and on the health of our patients.
12 January 2020
Missed GP Appointments Are Frustrating – But There May Be Underlying Reasons Why Patients Don't Turn Up, Says College
Read our full response to a story in today's Sunday Times on numbers of patients who book – then miss - GP appointments
Professor Martin Marshall, Chair of the Royal College of GPs, said: "Missed appointments are very frustrating, especially when GPs could be seeing other patients - but, for some patients, there may be more complex reasons for non-attendance.
7 January 2020
Additional Evidence Needed to Assess Histology-Independent Cancer Drugs Says Paper Co-Authored by NICE Staff
Additional evidence collection will be needed to assess histology-independent cancer drugs - a new kind of cancer treatment - a paper published and co-authored by NICE staff has said.
The paper, published in the British Medical Journal, looks at how histology-independent cancer drugs might be appraised by organisations such as NICE.
Reliable evidence is needed to inform NICE recommendations and the paper explores how histology-independent cancer drugs present a challenge for its technology appraisal process.
5 January 2020
Long Waiting Times for GP Appointments Are Unacceptable, Says College, as It Calls on Government to Prioritise General Practice Which Has Been 'Running on Empty for Too Long'
Read our full statement on this week's front page story in the Sunday Times on waiting times for GP appointments.
Professor Martin Marshall, Chair of the Royal College of GPs, said: "It is totally unacceptable to expect patients to wait weeks for a GP appointment. Patients -and GPs - deserve better.
"However, the situation in which we find ourselves has not happened overnight, and the College has been sounding the alarm bells for many years.
30 December 2019
RCGP Response to J Meirion Thomas in The Daily Telegraph
The RCGP has responded to J Meirion Thomas' article ‘Part-time GPs are a symptom of failure' in the Daily Telegraph on Thursday 19 December. An abridged version of this letter has been published today.
30 December 2019
Cold Infections May Be Less Frequent in People with the Flu
People were less likely to catch either influenza or a common cold-causing rhinovirus if they were already infected with the other virus, a new study by scientists from the MRC-University of Glasgow Centre for Virus Research has found.
Understanding how these distinct viruses inhibit each other could help public health planning to improve forecasting models that predict respiratory disease outbreaks and strategies for controlling disease spread, say the scientists.
24 December 2019
Use of Out-Of-Area Rehabilitation Placements for Adults with Complex Psychosis Should Be Curtailed Says NICE
A new draft NICE guideline published today (20 December 2019) on the rehabilitation of adults with complex psychosis and related mental health conditions says they should have access to rehabilitation services in their local area and the use of out-of-area placements limited.
A new draft NICE guideline published today (20 December 2019) on the rehabilitation of adults with complex psychosis and related mental health conditions says they should have access to rehabilitation services in their local area and the use of out-of-area placements limited.
23 December 2019
RCGP Calls for More GPs And More Time with Patients in Response to OECD Report
Commenting on the recent OECD's recent 'Health at a Glance 2019' report, Professor Martin Marshall, Chair of the Royal College of GPs, said: "It's concerning that the UK has one of the lowest proportion of doctors per person in Europe - particularly in terms of those later in their careers, who are highly experienced.
"While it's unclear from these figures how many are GPs, we know from our own research that the number of patients per GP has risen over the last decade - and although we have more GPs in training that ever before, even more are leaving the profession and overall numbers are falling.17 December 2019
‘Not Too Late to Get a Flu Jab,' Says RCGP Chair
Commenting on the latest flu figures from the RCGP's Research and Surveillance Centre, Professor Martin Marshall, Chair of the Royal College of GPs, said:
"Almost 8,000* patients went to their GP with influenza-like-illness last week (2-8 December) - up 1,500 on the previous week, according to data from the RCGP's Research and Surveillance Centre.
"Winter is certainly upon us and our Research and Surveillance Centre figures show rates of influenza-like-illness are higher than the five-year average, although still within levels that would be expected at this time of year. The rise is particularly notable in patients aged 5-14, and in practices in the north of England.
9 December 2019
Address Severe GP Shortages to Keep the NHS Safe for Patients, Says RCGP
Responding to the latest NHS Digital data on GP workforce Professor Martin Marshall, Chair of the Royal College of GPs, said:
"General practice has experienced a workforce and workload crisis for a long time, resulting in many of the more experienced GPs burning out long before retirement. As a significant proportion of the workforce approach retirement age, effective retention strategies have to be implemented to keep people in the profession longer. It's the only way more experienced GPs can have safe, sustainable careers in the NHS, both delivering patient care, and mentoring the next generation of GPs.
10 December 2019
Long Hospital Waiting Lists Are Adding to GP Pressures and Encouraging Patients to Go Private, Says NI's Top GP
The new Chair of the Royal College of General Practitioners in Northern Ireland (RCGPNI) has expressed concerns that patients are now waiting up to five years for operations, leaving some feeling that they have 'no option' but to pay for private healthcare.
Kilkeel GP Dr Laurence Dorman says that patients who cannot afford to pay are at risk of being 'left behind' because lengthy waiting lists for specialist consultations or interventions are causing patients to turn to NI's private health care system.
4 December 2019
Better GP Access to Diagnostic Tests and More People Across the NHS Needed to Improve Cancer Care, Says RCGP
Responding to a new study from Cancer Research UK, Professor Martin Marshall, Chair of the Royal College of GPs, said: "GPs are doing a good job of referring patients we suspect of having cancer in a timely way. Research shows that nearly 80% of all cancer cases are now referred after only one or two consultations – and this is happening despite the widely acknowledged workload crisis in general practice."
3 December 2019
Drastic Action Needed to Reverse Declining GP Numbers Trend, Says RCGP
Responding to the latest NHS Digital GP workforce stats, Professor Martin Marshall, Chair of the Royal College of GPs, said:
"We have 340 fewer full-time equivalent GPs than we did a year ago, and more than 1,000 fewer than we did in 2015. These numbers are going in the wrong direction - this is disappointing, it is serious and we need to see drastic action taken to reverse this trend.
27 November 2019
GPs Need to 'Take Better Care of Themselves' in Order to Provide the Best Possible Care to Patients, Says New College Chair
Professor Martin Marshall, the new Chair of the Royal College of GPs, is calling for GPs to be given the 'space' they need to look after their own health so that they can provide safe care to patients.
Outlining his priorities for the next three years, Prof Marshall – a practising GP in Newham, East London – says that tackling GP workload and promoting GP wellbeing are critical if patients are to receive the 'whole person, relationship-focused, care' they deserve.
He is calling for urgent action to recruit, support and retain more GPs and more members of the wider primary care workforce – as well as practical help to support GP teams with new ways of working.
26 November 2019
Home Visits Are a Core Part of General Practice - and Invaluable for Some Vulnerable Patients, Says RCGP
The RCGP has responded to the Local Medical Committee decision on the future of home visits.
Professor Martin Marshall, Chair of the Royal College of GPs, said: "Home visits are a core part of general practice and for some of our more complex and vulnerable patients, they might be the only means of seeing their GP.
22 November 2019
Urgent Reform of Tax System Needed so That All GPs are Treated Fairly, Says College
Responding to NHS pension proposals, Professor Helen Stokes-Lampard, Chair of the RCGP said:
"We are relieved to hear that NHS England and the Department of Health and Social Care are joining forces to address the pension tax crisis. At a time when we already have a severe shortage of GPs and our family doctor service is stretched to its limits, this is increasing the pressure by restricting GPs in the work they do."
19 November 2019
Promising Therapy for Common Form of Eczema Identified in Early-Stage Trial
A therapy that targets the immune system showed promise for treating atopic dermatitis – the most common form of eczema – in a small proof-of-concept trial, led by scientists from the MRC Human Immunology Unit at the University of Oxford.
The positive results seen in the 12 patients treated with the therapy, called etokimab, have led to a currently underway 300-person clinical trial.
15 November 2019
New Report on Doctors' Wellbeing Strengthens Case for Urgent Action to Tackle GP Pressures and Workload, Says College
Responding to the GMC's independent Caring for Doctors, Caring for Patients report, RCGP Chair Professor Helen Stokes-Lampard said:
"If our doctors are healthy, our patients are much more likely to receive the best possible care, and it is really encouraging to see a report that so explicitly makes the link between the wellbeing of doctors and patient care.
12 November 2019
Extra GP Appointments 'Cannot Happen Overnight' and Must be Backed by Investment and Support for GPs And Their Practices, Says College
The College has responded to the Conservative Party's pledge to create 50m additional GP appointments by 2024/25.
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said: "Waiting times for a GP appointment have become the national conversation - and GPs are as frustrated as our patients, especially when we are working flat out to try and keep up with rising demand at the same time as we have a severe shortage of GPs and practice staff.
8 November 2019
Parents Must Not Panic – Or Blame GPs For Flu Vaccine Shortages, Says College
The Royal College of GPs has responded to Public Health England's announcement on shortages of flu nasal spray - particularly affecting schools – and advising parents to have children vaccinated at their GP surgery instead.
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said: "This is not the news we wanted to hear, but we must urge parents not to panic - and not to blame GPs if their surgery is unable to cope with the extra demand.
5 November 2019
Scientists Developing Diagnostic Test to Detect Antibiotic Resistance in Less than 45 Minutes
Scientists are developing a low cost, rapid diagnostic sensor test which aims to show the susceptibility of bacteria to antibiotics within 45 minutes.
NHS laboratory testing of samples can take up to two days and the test aims to allow doctors to be able to prescribe the correct antibiotic to a patient for an infection more quickly.
28 October 2019
RCGP Scotland comment on Increasing Undergraduate Education in Primary Care
Commenting on the release of Professor John Gillies' report on Undergraduate Medical Education in Scotland, Dr Carey Lunan, Chair of RCGP Scotland, said:
"It is essential that the Scottish Government does all it can to expand the GP workforce to manage the rising volume and complexity of their workload. This announcement will go some way towards achieving that.
29 October 2019
MRC And NIHR Join Forces to Support GACD Projects
MRC and the National Institute for Health Research (NIHR) have joined forces to invest over £6m in five implementation science projects focused on tackling diabetes and hypertension in low- and middle-income countries (LMICs). These projects will unite with over 25 international research projects from across 40 different countries in a landmark collaboration under the Global Alliance for Chronic Diseases (GACD).
24 October 2019
'Vote Winning Gimmicks' Not the Answer to Long Waiting Times for GP Appointments, RCGP Chair Tells Politicians
In her final major speech as Chair of the Royal College of General Practitioners, Professor Helen Stokes-Lampard will sound a warning to politicians not to resort to 'vote-winning gimmicks' as a way of reducing waiting times for GP appointments.
Professor Stokes-Lampard will say that the solution to unacceptable waiting times is not 'arbitrary targets that prioritise what politicians want over what patients really need’.
22 October 2019
Cell Therapy Safe to Use in Liver Patients, Clinical Trial Suggests
Liver disease patients could one day benefit from a new cell therapy that has just completed its first clinical safety trial, led by researchers at the MRC Centre for Regenerative Medicine at the University of Edinburgh.
The study, published in Nature Medicine, tested the potential treatment in patients with liver cirrhosis – where long term damage produces scarring – and found the therapy had no significant adverse effects.
Now the team is conducting the next stage of the trial to gauge the effectiveness of the treatment based on white blood cells, called macrophages, which are key to normal liver repair.
16 October 2019
Appropriately-Prescribed Statins Are Safe and Effective, Says RCGP
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, has responded to analysis of research into statins published by the BMJ today.
She said: "Evidence has shown that statins are safe drugs and an effective preventative measure against heart conditions when prescribed and used appropriately.
15 October 2019
Another Treatment Option for Ovarian Cancer Approved for The Cancer Drugs Fund
An ovarian cancer treatment, designed to help maintain the effects of chemotherapy, has been approved by NICE for use in the Cancer Drugs Fund (CDF).
Rucaparib can now be offered to women with relapsed ovarian, fallopian tube or peritoneal cancer, that has responded to platinum-based chemotherapy. Taken as a tablet, twice daily, it slows the progression of cancer by preventing cancer cells repairing so slowing down the tumour’s growth.
14 October 2019
College Celebrates Innovative GPs and Patients
GPs, their teams and patients with ground-breaking ideas developed in the real-world high-pressure environment of primary care have been recognised by the Royal College of General Practitioners with RCGP Bright Ideas Awards.
Bright Ideas Awards were established to inspire, celebrate and recognise fresh thinking in primary care.
8 October 2019
NICE Looks to Company to Ensure a New Treatment for Advanced Breast Cancer with Significant Unmet Need is Cost-Effective
Draft guidance published today (3 October 2019) by NICE does not recommend atezolizumab (also called Tecentriq and made by Roche) for treating people with a type of breast cancer called triple A breast cancer that has spread to other parts of the body and who can’t have surgery to remove it.
Given by injection every 2 weeks with nab-paclitaxel, a type of chemotherapy, atezolizumab works by blocking the activity of a protein called PD-L1 which is produced in larger amounts on cancerous cells than normal cells. By blocking PD-L1 it helps the person’s own immune cells to attack the cancer.
7 October 2019
Research Could Indicate More Older People Seeking Help for Mental Health Conditions Says RCGP
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, has responded to findings of research by the University of East Anglia into antidepressant use in older people.
She said: "This increase in anti-depressant use among older people could indicate a greater awareness and acceptance of mental health conditions in society, and show more people over 65 are seeking help for mental health problems which in the past may have been ignored or under-treated - which are both encouraging.
1 October 2019
Migraine Drug Not Cost-Effective NICE Says in Final Draft Guidance
NICE has said that a new drug for preventing migraine is not a cost-effective use of NHS resources, in final draft guidance published today (26 September 2019).
The draft guidance looks at erenumab (also called Aimovig and made by Novartis) for preventing chronic and episodic migraine in adults who have 4 episodes or more of migraine every month and where at least 3 other preventive treatments haven’t worked.
26 September 2019
Parents Need to Be Aware of The Clear-Cut Evidence on Vaccination Safety, Says RCGP
Responding to today's NHS Digital figures on routine childhood vaccination rates, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said
"Even a small drop in the take-up of vaccinations is disheartening and very concerning. Our efforts to eradicate potentially serious - but entirely preventable diseases - had been going so well, but we are now seeing a rise in the numbers of cases of measles and mumps.
24 September 2019
World-Leading Genomics Project to Give Insights into Health and Diseases
In a major advance for public health and the UK’s global leadership in genomics, a £200m public-private collaboration will support the complete sequencing of the genetic code of all 500,000 participants in the UK Biobank health research resource.
UK Biobank, which is funded primarily by the MRC and the Wellcome Trust, is already a uniquely rich data resource that has dramatically increased our understanding of the factors that contribute to the development of disease. This Whole Genome Sequencing (WGS) project is the single most ambitious sequencing programme ever undertaken, anywhere in the world. It will be game-changing by making large-scale sequence data available to the global scientific community to help understand, diagnose, treat and prevent life-changing diseases, such as cancer and dementia.
12 September 2019
Renewed Debate Around Prescription Charges Welcome, Says College
Responding to a pledge by Labour to end prescription charges in England, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said:
"We have always been supportive of any safe and sensible measures to reduce medication costs for patients and ensure access to necessary medication is equitable, so it's encouraging to have a renewed debate around a review of prescription charges.
17 September 2019
Children with Rare Inherited Condition to Benefit From Drug Through Managed Access Agreement
It is estimated that in the UK there are around 30 to 50 children living with the condition
A drug which slows the decline of a rare inherited condition affecting children is to be made available on the NHS.
NICE’s Highly Specialised Technology committee is supporting a positive recommendation for cerliponase alfa (Brineura, BioMarin) for children with neuronal ceroid lipofuscinosis type 2 (CLN2) – a very rare inherited condition affecting between one and six babies each year in the UK – in the context of a managed access agreement.
Cerliponase alfa is an enzyme replacement therapy administered directly into the brain via a surgically implanted permanent access device.
12 September 2019
Introducing the New Training Portfolio
The Royal College of GPs has announced that it has partnered with FourteenFish to bring GP trainees a brand new Training Portfolio in 2020.
Over the past year, the RCGP has been considering options for replacing the current Trainee ePortfolio – and our decision to partner with FourteenFish has been based on feedback and requests from members.
The new Training Portfolio will be easier to use and should save time for both trainees and trainers. It will include an integrated mobile app, allowing trainees to record learning logs and review existing entries on the go, even without an internet connection.
10 September 2019
NICE Recommends Novel Gene Therapy Treatment for Rare Inherited Eye Disorder
It's estimated that 86 people would be eligible for treatment with voretigene neparvovec in England
A novel gene therapy treatment for rare inherited eye disorder has been recommended by NICE for use on the NHS.
The draft highly specialized technologies guidance recommends voretigene neparvovec (also called Luxturna and made by Novartis Pharmaceuticals UK) for people with vision loss caused by inherited retinal dystrophy from confirmed RPE65 gene mutations and who have enough viable retinal cells.
5 September 2019
Six-Week Check for New Mothers Must Be Funded, Says RCGP
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, has responded to a report from the National Childbirth Trust.
She said: "Having a baby is usually a very special time but it can lead to a whole host of physical and mental health concerns for new mothers, and it's essential they feel comfortable discussing these with their GP and other healthcare professionals, and that they receive the appropriate support.
27 August 2019
NICE To Work with Company on Addressing Issues in Appraisals of Cannabidiol for Treating Difficult to Control Epilepsies
NICE has announced its intention to work with GW Pharma to address the issues highlighted by its independent appraisal committee in its evaluation of cannabidiol for treating 2 types of severe treatment-resistant epilepsy.
NICE’s draft guidance, also published today, does not recommend the drug (also called Epidyolex and made by GW Pharma), used with clobazam, for treating Dravet and Lennox-Gastaut syndromes, types of epilepsy which begin in early childhood and which are lifelong and difficult to control.
23 August 2019
System-Wide Approach to Tackling Falling Childhood Vaccination Rates Welcome, Says RCGP
Responding to the Government's childhood vaccination strategy, launched today, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said:
"Vaccinations are simple, easy and highly effective health interventions and in most cases, they protect for life. Across the NHS we are doing a good job of getting this message across to patients, and in the UK we actually have high take-up rates of many vaccinations.
"But we are still suffering from the now entirely debunked MMR scandal of the nineties, and it is potentially disastrous that as a result so many young people are now susceptible to serious, often life-threatening infectious diseases, such as measles, that we could have completely eradicated in this country if this had never happened.
20 August 2019
UK Joins Forces with International Experts to Tackle Global Challenges
UK researchers and innovators will work with counterparts across the planet to tackle global challenges such as Ebola outbreaks, the impact of subpolar ocean currents on global climate, and the effect of Artificial Intelligence (AI) on society and individuals’ happiness and wellbeing following a major funding announcement.
Innovative UK companies will also be supported to develop into new markets following the announcement of the second wave of UK Research and Innovation’s (UKRI) Fund for International Collaboration today, Friday 9 August 2019.
19 August 2019
Disingenuous to Suggest GPs Are Shirking Responsibilities to Patients, Says RCGP
Responding to media reports on GP surgery opening hours today, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said: "GPs and our teams are working under intense resource and workforce pressures - and it is disingenuous to insinuate that we are in some way shirking our responsibilities to patients.
13 August 2019
New Lung Cancer Treatment Option Approved By NICE
Another new life-extending treatment for some people with lung cancer is to be made available on the Cancer Drugs Fund (CDF) following its approval by NICE in draft guidance published today (8 August 2019).
Immunotherapy drug pembrolizumab (also known as Keytruda) used with chemotherapy drugs carboplatin and paclitaxel will now be an option for adults with squamous non-small-cell lung cancer (NSCLC) which has spread to other parts of the body and who haven’t had any previous treatments.
12 August 2019
Promises of More GPs Must Be Delivered to Avoid Waiting Times Getting Worse, Says College
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, has responded to a survey by Pulse magazine that has found patients are waiting for more than two weeks on average for a routine GP appointment.
She said: "Our patients should be able to see a GP when they need to – and the fact that this is becoming increasingly difficult is frustrating for GPs and our teams, as we know it is for them.
6 August 2019
Offer Daily Aspirin to Those with Inherited Genetic Condition to Reduce the Risk of Colorectal Cancer
Aspirin taken daily for 2 years or more could reduce the risk of colorectal cancer in people with Lynch syndrome (LS), says NICE in new draft updated guidance.
People with LS have an increased lifetime risk – estimated to be four out of five people – of developing colorectal cancer.
Regular screening with colonoscopy and polypectomy to identify pre-cancerous cells has until now been the main strategy to detect early colorectal cancer in people with LS and offer appropriate management.
4 August 2019
RCGP Welcomes Pledge to Overhaul GPs' Pension Arrangements
Responding to Prime Minister Boris Johnson's pledge to overhaul GPs' pensions arrangements today, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said:
"General practice is currently facing intense workforce pressures and current pensions arrangements are exacerbating these, so it is good to see the Government taking this issue seriously.
30 July 2019
Innovative Treatment for Gynaecological Cancers Approved for Cancer Drugs Fund
Olaparib, a medicine that has previously been used at a later stage in the treatment of advanced ovarian cancer, has now been approved by NICE as a first-line maintenance treatment.
This positive recommendation affects adults with BRCA mutation-positive, advanced high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer that has responded to chemotherapy.
25 July 2019
Not Possible to Deliver Truly Holistic Care In 10 Minutes Says College
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs has responded to research indicating that up to a third of GPs have been unable to properly diagnose patients because of short appointment times.
She said: "It has been clear for some time that the standard 10-minute appointment is no longer fit for purpose. As GPs, we want to be able to deliver truly holistic care to our patients after considering all the physical, psychological and social factors potentially impacting on their health.
16 July 2019
Superbug MRSA Susceptible to Existing Antibiotics
Methicillin-resistant Staphylococcus aureus (MRSA) has become a serious problem, forcing doctors to turn to antibiotics other than penicillin or penicillin derivatives, or to different drug cocktails, which are often less effective in treating hospital and community based infections.
But new MRC funded research from scientists at the University of Cambridge and the Wellcome Sanger Institute has found that some MRSA infections could be tackled - and by using existing antibiotics.
11 July 2019
Patient Satisfaction Results Are 'Testament to the Incredible Efforts' of Primary Care Teams, Says College
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, has responded to the 2019 GP Patient Survey.
She said: "It is testament to the incredible efforts of GPs and their teams that patient satisfaction in general practice has remained so high – especially given the intense resource pressures currently facing our profession and the strenuous circumstances our colleagues are working under.
9 July 2019
Device for Preventing and Relieving Pain of Cluster Headaches Approved by NICE in Draft Guidance
A handheld device that delivers a small electric current has been recommended by NICE for the prevention and treatment of cluster headaches, a rare but painful type of headache that affects around 100,000 people in the UK.
The recommendation is made in NICE’s draft medtech guidance published today (5 July) for public consultation. It highlights that using gammaCore in addition to standard care (sumatriptan, zolmitriptan and oxygen) could save the NHS £450 per patient in the first year compared to standard care alone.
4 July 2019
Take Steps to Keep Symptoms Under Control and Help Prevent 'Back to School Asthma', Says RCGP
The RCGP has responded to findings published in the BMJ linking 'back to school asthma' with an increase in health service appointments.
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said: "Asthma is an extremely distressing condition affecting one in 11 children, but in the majority of cases can be well-managed by parents with the support of GPs and our teams who are highly trained to identify symptoms, prescribe appropriately and monitor treatment to help patients of all ages.
2 July 2019
People with Dementia Should be Offered Activities That Can Help Promote Wellbeing
People living with dementia should be offered activities such as exercise, aromatherapy, art, gardening, baking, reminiscence therapy, music therapy, mindfulness and animal assisted therapy to help promote their wellbeing.
The recommendation comes in NICE’s updated quality standard on dementia published today (28 June 2019).
It says people living with dementia and people involved in their care should be given the opportunity to talk about their life experiences, preferences, interests, strengths with a healthcare professional. This can help the person living with dementia to choose activities to promote wellbeing that suit their preferences and needs.
1 July 2019
Primary Care Networks Have Undeniable Benefits, But There Is No 'One Size Fits All' Approach to Solving GP Pressures, Says College
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, has responded to the launch of Primary Care Networks (PCNs) in England.
She said: "Primary Care Networks are essentially groups of practices working together and aiming to work with other agencies to deliver improved care for patients - and collaboration can have great benefits, particularly at a time when general practice is facing such intense resource and workforce pressures.
24 June 2019
Innovative Treatment for Inflammatory Eye Condition Recommended for Use on the NHS
People with recurrent non-infectious uveitis affecting the back of the eye could benefit from a new treatment option, the fluocinolone acetonide implant, as a result of new NICE guidance published today.
The treatment, which is injected into the eye, lasts 3 years. This could mean fewer hospital visits for patients who receive current treatments: including corticosteroid injections, immunosuppressants, and dexamethasone and adalimumab implants.
Clinical trial results suggest the fluocinolone acetonide implant may improve clearness of vision for people with uveitis and help prevent the disease returning.
22 June 2019
RCGP to Consult Members on Assisted Dying
The Royal College of General Practitioners will consult its 53,000 members as to what its stance should be on whether there should be a change in the law on assisted dying.
The decision was made by the College's governing Council, which met today.
The College last consulted its members on the issue in 2013. The result, announced in February 2014, was that the College should not change its stance, and as such, its current position is that it is opposed to any change in the law on assisted dying.
18 June 2019
Prevent No-Deal Brexit and Safeguard the NHS, RCGP Urges Tory Leader Hopefuls
The Royal College of General Practitioners has written an open letter to the next leader of the Conservative Party – and next Prime Minister of the UK – calling on them to safeguard the NHS and avoid a 'no deal' Brexit in the best interests of patient care.
In the letter, which has been sent to all remaining candidates in the leadership race - Boris Johnson, Jeremy Hunt, Michael Gove, Sajid Javid, Dominic Raab and Rory Stewart - Professor Helen Stokes-Lampard, RCGP Chair has written:
12 June 2019
Ghost Patients 'Nothing Sinister' – and the Insinuation GPs Are Complicit in Fraud Is 'Shocking’, Says RCGP
Responding to reports that the NHS Counter Fraud Authority has launched an investigation into 'ghost patients' on GP lists, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said:
"The insinuation that GPs – some of the most trusted professionals in society - are complicit in defrauding the health service is shocking and will be incredibly hurtful for hard-working GPs and their teams who are struggling to deliver care to more than a million patients a day across the country, with insufficient time, resources or workforce to do so.
11 June 2019
Employers Encouraged to Help Their Staff Become Active in Fight Against Obesity
A fit and energised workforce is less likely to be off sick and more satisfied in their jobs
Highlighting a lunchtime yoga or spin class at a local gym, offering subsidised gym memberships and encouraging the use of stairs instead of using the lift are just some of the ways employers can encourage their staff to be more active, NICE has said.
Organisations are also urged to provide information about safe active travel routes to work, as well as producing physical activity programmes for the workplace to encourage employees to be more active and reduce sedentary behaviour.
11 June 2019
RCGP Welcomes 'Pragmatic' NICE Physical Activity Quality Standard
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, has responded to a new physical activity quality standard from NICE.
She said: "Exercise can have a hugely positive impact on our physical and mental health, so making it easier for people to be more active as part of their daily routine – both at work and in their leisure time - is key to helping patients live a long and healthy life.
4 June 2019
MRC Festival of Medical Research Programme Launched Today
The annual MRC Festival of Medical Research takes place from 13–23 June 2019. To find MRC Festival activities near you to attend, take a look at the MRC Festival programme.
The MRC Festival takes place in England, Scotland, Wales and Africa where a wide range of free public activities involving scientists from research establishments, including MRC units, centres and institutes, will showcase MRC-funded research.
3 June 2019
Focus on Retention in Interim NHS People Plan Welcome and Necessary, Says RCGP
Responding to NHS England and NHS Improvement’s interim NHS People Plan, published today, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said: "The NHS long-term plan contains aspirations that will be good for patients, but delivering it will depend on having the workforce – including thousands more GPs - to do so.
"We welcome the focus on retaining existing, experienced GPs in the workforce, and appreciate the commitment in today's plan to address barriers to this, such as current pensions rules, and on making the NHS a workplace that people want to work in.
29 May 2019
15-Minute Minimum Consultations, Continuity of Care Through 'Micro-Teams', And An End To Isolated Working: This Is The Future Of General Practice
An end to the standard 10-minute GP consultation to allow family doctors to spend more time with patients with complex needs is core to the Royal College of GPs' vision for the future of general practice.
It states that by 2030 face-to-face GP consultations will be at least 15 minutes, with longer for those patients who need it.
23 May 2019
RCGP to Honour Pioneering Psychoanalysts Who Transformed GP Training with Blue Plaque at Former London Home
Celebrated psychoanalysts, Michael and Enid Balint, who had a profound influence on the development of general practice around the world, will be honoured by the Royal College of General Practitioners with a blue plaque at their former Regents Park home this week.
The psychoanalysts worked with groups of pioneering GPs in the 1950s, holding teaching and research seminars to explore the dynamics of the doctor-patient relationships and its role in diagnosis and treatment.
21 May 2019
NICE Recommends First Ever Treatment for Children with Rare Muscle-Wasting Condition
Children with the rare genetic disorder spinal muscular atrophy (SMA) can now be treated with nusinersen after NICE today (15 May) recommended it following agreement of a deal between the company, Biogen, and NHS England.
SMA affects the nerves in the spinal cord controlling movement. This causes muscle weakness, progressive loss of movement, and difficulty breathing and swallowing.
People with the most severe forms of SMA usually die before the age of 2. There are currently no active treatments targeting the underlying cause of SMA so the condition is managed through supportive care which aims to minimise the impact of disability, address complications and improve quality of life.
14 May 2019
New Evidence on Thyroid Hormones 'Powerful', but Patients Should Not Stop Taking Prescribed Medication, Says College
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, has responded to an article in the BMJ about thyroid hormones.
She said: "Prescribing is a core skill for GPs and we will always aim to take into account the physical, psychological and social factors potentially affecting a patient before recommending any form of medication – as well as taking into account relevant clinical guidelines.
14 May 2019
Lower Price for MS Drug Paves the Way for Positive Recommendation From NICE
A new, lower price for a drug to treat a rarer form of multiple sclerosis in adults has paved the way for its approval by NICE
In its final draft guidance published today (9 May 2019), NICE has reversed its previous draft decision not to recommend ocrelizumab (Ocrevus, Roche) for treating primary progressive multiple sclerosis (PPMS) in adults.
7 May 2019
New GP Workforce Figures 'Disheartening but Unsurprising', Says RCGP
Responding to new figures from the BBC and Nuffield Trust about falling GP number, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said: "These figures are disheartening but will be unsurprising for GPs – and their patients - across the country who are feeling the impact of relentless workforce pressures in general practice on a daily basis.
7 May 2019
New NICE Guideline Will Help Doctors Recognise and Refer People with Suspected Neurological Conditions
NICE’s new guideline is the first to offer comprehensive information on neurological conditions to help non-specialist healthcare professionals to identify people who should be referred for specialist assessment and care.
Published today (1 May 2019) the guideline makes recommendations about which symptoms and signs should prompt a referral for further neurological assessment. It also covers some examinations, assessment tools and investigative tests for helping to decide whether a person with a suspected neurological condition should have further investigation or be referred to a specialist.
3 May 2019
Urgent Investment Needed to Alleviate 'Intense Resource and Workforce Pressure' on GP Out-Of-Hours Services, Says RCGP
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, has responded to an investigation about out-of-hours GP services.
She said: "Patients should be able to access safe, high-quality care whenever they need it through routine GP services and GP out of hours services - and these services should be well-resourced and staffed appropriately by both clinical and non-clinical workers, to meet demand
30 April 2019
NICE Launches Online Resource to Help Development and Adoption of New Health Technologies
HealthTech Connect, a new online resource provided by NICE to help identify and support new health technologies as they move from inception to adoption in the UK health and care system was formally launched today (29 April).
Developed by NICE with help from a range of partner organisationsi and funding from NHS England, HealthTech Connect is for health technologies (medical devices and diagnostic and digital health technologies) that:
28 April 2019
Child Obesity 'Mustn't Be Swept Under the Carpet', Says RCGP
Commenting on research being presented at the European Congress on Obesity in Glasgow, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said:
"Nobody wants to think of themselves or their child as overweight or unhealthy, but the stark truth is that overweight and obese children face numerous, serious health-related problems – both physical and mental – in the years ahead, if their weight is not addressed.
23 April 2019
Offer Women a Choice of Procedure to Terminate Their Pregnancy
All women should be able to access both medical and surgical procedures to terminate their pregnancy, says NICE in draft guidance.
Developed with the Royal College of Obstetricians and Gynaecologists (RCOG), the draft guideline aims to improve the organisation of termination of pregnancy services and make it easier for women to access them.
This includes aiming to provide women with an initial appointment within 1 week of requesting one and undertaking the procedure within 1 week of the appointment.
23 April 2019
New Cancer Referral Figures are 'Testament to the Hard Work and Dedication of GPs and Their Teams', Says College
The RCGP has paid tribute to dedicated family doctors in its response to NHS England's announcement that cancer checks have topped two million for the first time.
Prof Helen Stokes-Lampard, Chair of the Royal College of GPs, said: "This is excellent news that is testament to the hard work and dedication of GPs and their teams around the country – as well as being very reassuring for our patients.
16 April 2019
New Approach to Tackle Ebola and Other Deadly Infections
Medical Research Council scientists have isolated therapeutic antibodies from healthy volunteers exposed to the Ebola vaccine but not Ebola virus itself, suggesting that protective therapies could be developed from people who are disease-free.
The researchers, from the MRC Human Immunology Unit at the University of Oxford, say their findings could apply to other infectious diseases from MERS to SARS and avian influenza, paving the way to a fast and cost-effective approach to developing new antibody therapies. Their study was published in the journal Cell Reports.
13 April 2019
Time For Care 'One Part' Of Much Bigger Solution That is Needed on GP Workforce and Workload
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said: "NHS England's evaluation of the Time for Care programme suggests it is making a real difference to some GP practices, and it is reassuring to know that NHS England are listening to our concerns about GP workload and taking action to help tackle this.
"However, most of our hard-working, hard-pressed GPs will still tell a different story of working longer and longer hours and seeing more patients per day to try and cope with demand, which continues to increase in both volume and complexity.
9 April 2019
Promising lung cancer treatment approved for Cancer Drugs Fund
A promising new lung cancer treatment will be available on the NHS through the Cancer Drugs Fund, thanks to a new NICE recommendation.
NICE has today published draft final guidance recommending durvalumab (Imfinzi, AstraZeneca).
It will be made available on the NHS in England immediately for people with locally advanced unresectable non-small-cell lung cancer, who have already had platinum-based chemoradiation.
8 April 2019
Widespread Debate Needed On 'Disease Mongering' and Overdiagnosis Of Patients, Says RCGP in Response to BMJ Evidence-Based Medicine Paper on Definitions of Disease
Prof Helen Stokes-Lampard, Chair of the Royal College of GPs, said:
"Disease mongering is scaremongering and it has the potential to cause huge strain for the NHS and other healthcare systems around the world.
2 April 2019
NICE Publishes a Summary of Its Guidance and Other Safety Advice on Valproate
NICE has today (28 March) published a summary for healthcare professionals bringing together all its recommendations and other safety advice on the drug valproate.
Valproate is licensed for use in epilepsy and bipolar disorder. It is also used off-label for depression, neuropathic pain, dementia and migraine.
Children born to women who take valproate during pregnancy are at significant risk of birth defects and persistent developmental disorders. If valproate is taken during pregnancy, up to 4 in 10 babies are at risk of developmental disorders, and approximately 1 in 10 are at risk of birth defects.
28 March 2019
Rising Prescription Numbers Not 'Automatically a Bad Thing', Says RCGP
Responding to new prescription data published by NHS Digital today, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said:
"Prescribing is a core skill for GPs, and we will only prescribe medication to a patient after a full and frank discussion with them, considering their unique circumstances, and if we genuinely believe they will be of benefit to their patient.
26 March 2019
Thousands Set to Benefit from Blood Pressure Treatment Under New NICE Guidance
NICE has published its draft updated guideline on the diagnosis and treatment of high blood pressure (hypertension) for public consultation.
In the biggest change to NICE’s previous guidance published in 2011, the level of a person’s cardiovascular disease risk at which treatment for high blood pressure can be started has been reduced.
The draft guideline recommends that blood pressure lowering drugs should be offered to people aged under 80 with a diagnosis of stage 1 hypertension who have a 10% or greater risk of developing cardiovascular disease within the next 10 years.
17 March 2019
We Must Never Give Up on Building the GP Workforce Says College
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, has responded to a new workforce report by The Health Foundation, The King's Fund, and Nuffield Trust.
She said: "We agree with the writers of this report that the GP workforce faces significant challenges, but we disagree that these are insurmountable. We must not, under any circumstances, give up on our aims and endeavours to build the GP workforce – achieving these is vital for the future of the NHS, and patient care.
19 March 2019
Nine-Month Treatment Regimen for Multi-Drug Resistant Tuberculosis Is as Effective as 20-Months
A nine to 11-month treatment regimen is as effective in treating multi-drug resistant tuberculosis (MDR-TB) as the 20 to 24-month regimen recommended in 2011 WHO guidelines, according to new research conducted by a team of researchers, including MRC scientists.
The final results of stage 1 of the STREAM trial, which is the world’s first randomised phase 3 clinical trial to test the efficacy, safety and economic impact of a standardised shorter MDR-TB regimen, are published today in the New England Journal of Medicine.
17 March 2019
Workforce Boost Needed to Increase Patient Satisfaction with NHS Care, Says College
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, has responded to analysis of the 2018 British Social Attitudes (BSA) survey.
She said: "GPs and our teams want to provide the best care that we possibly can for our patients, so it's always disappointing to hear that some people are not always satisfied with the services they are receiving.
12 March 2019
890 More Children and Adults Eligible for Cochlear Implants on the NHS Each Year
Hundreds more people with severe to profound deafness will be eligible for cochlear implants each year, due to updated NICE guidance
The update comes after a review of the definition of severe to profound deafness which is used to identify if a cochlear implant might be appropriate.
Meindert Boysen, Director of the Centre for Technology Evaluation, said: “The appraisal committee listened to stakeholder concerns regarding the eligibility criteria for cochlear implants being out of date. Upon review it was concluded this needed to be updated.”
8 March 2019
New Draft Guideline on Hypertension Needs Careful Consideration, Says College
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, has responded to a new NICE draft guideline on the diagnosis and treatment of hypertension.
She said: "Taking steps to prevent cardiovascular disease in patients is vital to help safeguard their long-term health and wellbeing, and it is a key pledge in the NHS long-term plan. But many GPs do also have concerns about overdiagnosis and the unintended harms of prescribing medication to groups of patients when the benefits may be limited.
5 March 2019
NICE Says Drug to Treat Batten Disease Cannot Be Recommended for NHS Use Because Company Is Unable to Address Concerns About Long-Term Effectiveness
NICE has published draft guidance which confirms its earlier decision not to recommend cerliponase alfa (also called Brineura and made by Biomarin) for children with Batten disease – a very rare inherited condition affecting between 1 and 6 babies each year in the UK.
The decision comes at the end of year-long negotiations between the company and NHS England during which the company was unable to price the treatment at a level that would have addressed the problems highlighted during NICE’s assessment of it.
27 February 2019
Striking the Balance on Antibiotics Prescribing 'Extremely Challenging', Says RCGP
Responding to two papers published in the BMJ on antibiotics prescribing, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said: "GPs are in an incredibly difficult position when it comes to antibiotics prescribing. We are under huge pressure not to prescribe - and publicly vilified when we are deemed to do so too readily - yet, we know that in some cases antibiotics are a matter of life or death.
26 February 2019
New Research Suggests a Simple Blood Test Could Improve the Early Detection of Lung Cancer
New research led by scientists at the MRC Toxicology Unit suggests that by analysing levels of DNA in the blood, the early detection of lung cancer could be improved.
The study, published in the journal Disease Models and Mechanisms, found that in preliminary tests using mice, a blood test could measure the circulating levels of DNA in the blood which cancer cells shed as they grow and multiply, and could even predict the presence of tumours in the lungs before they became cancerous.
25 February 2019
UK General Practice Helps Avoid US-Style 'Opioid Crisis', Says RCGP
Responding to an investigation into opioid prescribing, published in The Sunday Times this morning, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said:
"When pain evolves from being an response to something to being chronic, it frequently becomes a long-term condition in its own right and unfortunately there is no easy cure. The challenge for doctors is to help patients to manage their pain to allow them to have the best possible quality of life and for some patients opioid-based drugs provide relief - sometimes they are the only things that do.
19 February 2019
NICE Draft Guidance Recommends Pertuzumab for New Breast Cancer Indication After Improved Price Offer from Company
NICE has published final draft guidance recommending pertuzumab (Perjeta, Roche) for treating early HER2-positive breast cancer in people whose disease has spread to their lymph nodes.
This positive recommendation is for people who have had surgery for their breast cancer and whose cancer has already spread to their lymph nodes. The estimated 2700 people in this subgroup have a higher risk of their cancer returning.
13 February 2019
Daffodils Set the Standard for End of Life Care
GP surgeries will now be able to display a 'daffodil mark' as a sign of commitment to improving end of life care, as part of a new partnership between the Royal College of GPs and the terminal illness charity Marie Curie.
The mark, synonymous with the charity, is based on a new set of criteria called the Daffodil Standards – a set of eight quality improvement statements designed to support primary care teams in delivering care to patients living with an advanced, serious illness or at the end of their lives, and their loved ones.
12 February 2019
NICE Updates Guideline on Alcohol Education in Schools
NICE is updating its guideline on Alcohol interventions in secondary and further education.
New draft recommendations will support the Department for Education’s (DfE) plan to make alcohol education a compulsory component of personal, social and health education (PSHE) in all state-funded schools in England from September 2020.
The guideline, developed with Public Health England, advises a positive approach to alcohol education; inviting classroom discussion and wider school policies to embed a ‘whole-school approach’ to PSHE.
7 February 2019
RCGP Welcomes CMO Advice for Parents on Screen Time For Children
Responding to a new report on the impact of screen time on children and advice for parents, published by the Chief Medical Officer for England, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said: "Technology plays a huge role in our everyday lives, and for many children and young people, their entire life has never been accompanied by ready access to a smartphone, computer, or similar device in their pocket.
29 January 2019
New Era for UK Superbug Research: 20 Year Vision and Five Year Action Plan
The UK’s new 20 year vision and five year National Action Plan (2019-2024) for containing, controlling and mitigating antimicrobial resistance has been announced by Health Secretary Matt Hancock at the World Economic Forum at Davos today. The plans, which cover health, animals, the environment and the food chain, set out how the UK will continue to make substantial, tangible progress towards preventing the spread and improving treatments for superbugs. UK Research and Innovation (UKRI) councils have helped to shape the future ‘One health’ research and innovation priorities, which are a core feature of the vision and five year plan.
28 January 2019
RCGPNI Patient Group Encourages Patients to Use Health System Wisely
The Patient Group associated with the Royal College of General Practitioners Northern Ireland has today launched an information leaflet and campaign that aims to encourage patients to get the most from their health and social care services and to use them wisely.
General practice and other health care services are under immense strain, facing workforce and workload challenges while struggling to meet increasing demand from patients.
22 January 2019
A New Role for the Brain’s Support Cells in Controlling Circadian Rhythms of Animal Behaviour
Astrocytes, ‘caretaker’ cells that surround and support neurons in the brain, play a much more important role in circadian rhythms, the body’s 24-hour internal clock, than previously understood.
The MRC-funded study published today in the journal Science, found that these star-shaped cells, previously thought of as just supporting neurons in regulating circadian rhythms, can actually lead the tempo of the body’s internal clock and have been shown for the first time to be able to control patterns of daily behaviour in mammals.
21 January 2019
College Breaks Down Mental Health Stigmas in New Exhibition
Art installations highlighting the importance of breaking down mental health stigmas have been unveiled at the Royal College of GPs.
The news comes as today marks 'Blue Monday' - widely recognised as the UK's most depressing day of the year after the indulgences of Christmas and the end of the festive holidays.
The three pieces, which are part of a wider College exhibition called What Once Was Imagined (WOWI), highlight the realities of living with mental health problems, such as depression and anxiety – two of the most common conditions currently being diagnosed in the UK.
15 January 2019
New Migraine Drug Not Cost-Effective NICE Says in Draft Guidance
NICE has said that a new drug for preventing migraine is not a cost effective use of NHS resources, in draft guidance published today.
The guidance looks at erenumab (also called Aimovig and made by Novartis) for preventing chronic and episodic migraine in adults who have 4 episodes or more of migraine every month and where at least 3 other preventive treatments haven’t worked.
Costing around £5,000 per year (not including a confidential price discount which would have applied if NICE had recommended the drug) erenumab is the first treatment to target the process by which proteins cause blood vessels in the brain to swell, leading to the symptoms of migraine.
11 January 2019
Missed Appointments Can Indicate Something Is Wrong, Says College
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, has responded to a study in BMC Medicine on missed appointments.
She said: "Patients with long-term conditions need regular monitoring and treatment and advice tailored to their unique health needs, so missing appointments and not being able to access that support has the potential to have a devastating impact on their wellbeing.
8 January 2019
Third Biological Treatment Gives More Choice for People with Severe Asthma
Another potentially life-changing treatment should be available to people with a severe form of asthma, NICE says.
Draft guidance published today says that benralizumab is cost-effective for use on the NHS in England and Wales by some adults who have severe eosinophilic asthma and have struggled to control it with inhalers.
7 January 2019
NHS Long Term Plan 'Aspirational' Says RCGP - But More GPs and Increased Funding for General Practice are Needed Urgently
Reacting to the NHS Long Term Plan launched today, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said: "The aspirations of today's plan are good for patients, and set a constructive direction of travel for the NHS and it is also good to see such a strong commitment to increasing resource for community care – but family doctors will now want to see the detail of what this means for frontline GPs and their teams over the coming months and years as they deliver care to over a million patients every day.
1 January 2019
Gene Variations That Reduce Ability to Store Fat Around the Hips Linked to Higher Risk of Diabetes and Heart Attacks
People who are less likely to put on excess fat around their hips due to their genes are at higher risk of type 2 diabetes and heart attacks, according to a new study led by scientists from the Medical Research Council (MRC) Epidemiology Unit at the University of Cambridge.
19 December 2018
Feast Your Eyes, Not Your Waistline, Say GPs in New Art Exhibition
Patients are being encouraged not to over-indulge this Christmas with the unveiling of a thought-provoking art installation at the Royal College of GPs.
'Feast' is a jacket made entirely from the leftover packaging from an average family Christmas Day dinner.
The meal typically contains around 7,000 calories - more than double the recommended daily allowance for men and women.
25 December 2018
NICE Recommends a CAR T-Cell Therapy for Adults with Some Types of Non-Hodgkin Lymphoma
NICE has published final draft guidance recommending a breakthrough cancer treatment, called CAR T-cell therapy, for adults with certain types of non-Hodgkin lymphoma.
Axicabtagene-ciloleucel, also known as Yescarta and manufactured by Kite, a Gilead company, is part of a new wave of personalised medicine.
The therapy is for adults with relapsed or refractory diffuse large B-cell lymphoma or primary mediastinal large B-cell lymphoma, two aggressive subtypes of non-Hodgkin lymphoma. It will be offered to people whose disease has not responded after two or more rounds of chemotherapy or relapsed after a stem cell transplant19 December 2018
College Defends GPs Over 'Morning Sickness' Accusations
RCGP Chair, Professor Helen Stokes-Lampard, has had a letter published in the Times newspaper today, in response to an article criticising GPs over the care of pregnant women with severe vomiting.
The full version is below.
Once again, it seems to be open season on GPs who, this time, stand accused of ‘fobbing off’ pregnant women with severe morning sickness. (Women palmed off by GPs call ambulances over morning sickness, December 18, page 10)
18 December 2018
Non-Invasive MRI Scan for Prostate Cancer Recommended by NICE
NICE has recommended the scan as a first-line investigation for people with suspected clinically localised prostate cancer.
Multi-parametric magnetic resonance imaging (mpMRI) works by creating detailed images of the prostate that enable clinicians to better detect suspected prostate cancer.
Currently, men with suspected cancer are offered a blood test which looks for raised prostate specific antigen (PSA) levels. If these are raised, individuals may be offered a biopsy which involves inserting a needle into the prostate to take tissue samples. The procedure can be uncomfortable and unnecessary for those with low-risk cancer and comes with the risk of infection.
11 December 2018
NHS Workers Have 'Lost Confidence' In Capita, Says RCGP After Latest Screening Blunder
Responding to new information about administrative errors made in the NHS cervical cancer screening programme, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said:
"This is simply not good enough. Less than a month since we initially heard about this cervical screening error, we are now hearing it is more serious, and has affected thousands more women.
11 December 2018
New Funding Scheme Supporting Clinical Research Capacity
The MRC has launched a new funding scheme today which will provide full-time NHS consultants, who are research-qualified but not active, the opportunity to participate in high-quality, collaborative, research partnerships.
The Clinical Academic Research Partnership (CARP) scheme will enable clinicians to contribute to research programmes as part-time co-investigators rather than programme leads.
10 December 2018
GPs Want to Be at the Forefront of Technology but Need Significant Investment in Core IT Services, Says RCGP
Responding to the NHS decision to phase out fax machines in hospitals, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said: "It's highly ironic that the world is in the middle of a technical 'tsunami' and yet the NHS is still reliant on equipment such as fax machines.
"However, while fax machines may be terribly old-fashioned, they do work and remain a highly valued and reliable form of communication between many GP surgeries and their local hospitals, nursing homes and pharmacies.
6 December 2018
Antibiotics Should Be Restricted For COPD
Healthcare professionals should consider the risk of antimicrobial resistance when deciding whether antibiotics are needed for treating or preventing a flare up of symptoms of chronic obstructive pulmonary disease (COPD).
These new recommendations come as NICE publishes antimicrobial prescribing guidance (APG) and a separate update to its 2010 clinical guideline on diagnosing and managing COPD in over 16s.
The antimicrobial guidance recommends that antibiotics should be offered to people who have a severe flare up of symptoms, also known as a severe acute exacerbation.
5 December 2018
GPs Concerned About Being Able to Deliver Patient Care This Winter
A recent survey of RCGP Northern Ireland members has revealed that GPs are concerned that pressures on the health service will negatively affect their ability to deliver patient care this winter.
89% of GPs surveyed are concerned that their increased workload during the winter months will negatively affect their ability to deliver patient care.
This figure is unsurprising given that 95% of GPs agreed that their workload increases over winter.
27 November 2018
More Stroke Patients to be Offered Life-Saving Procedure
Patients with acute ischaemic stroke should be offered a procedure to remove the blood clot up to 24 hours after the onset of symptoms.
This procedure, called a thrombectomy, should be offered alongside clot-busting drugs, if there is potential to salvage brain tissue, says NICE in draft updated guidance.
Currently, thrombectomy is only offered to people with stroke up to 12 hours after onset.
24 November 2018
Royal College of GPs Backs 'People's Vote' on Brexit
The Royal College of General Practitioners' governing Council has today passed a motion in support of a second referendum – commonly known as a 'People's Vote' – on Brexit negotiations.
The Council also passed a motion to oppose the UK's exit from the European Union.
The full text of the motion that was passed was:
20 November 2018
Innovative Skin Cancer Drug Available on Cancer Drugs Fund
Patients with a type of advanced skin cancer have a new treatment option as pembrolizumab, also known as Keytruda, has been recommended for use on the Cancer Drugs Fund.
This recommendation applies to adults who have melanoma that has spread to the lymph nodes, an important part of the body’s natural defence system.
Pembrolizumab would be offered to patients who have already had surgery to remove the cancer. Called an adjuvant immunotherapy, it aims to remove any cancer left behind.
18 November 2018
Responsibility for Tackling Antimicrobial Resistance Lies with Society Not Just GPs, Says College
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, has responded to a new campaign about antimicrobial resistance.
She said: "Antibiotics are excellent, vital drugs when used appropriately - and for many bacterial infections there is often no alternative treatment available.
13 November 2018
Poxvirus Tricks Cells into Moving to Spread Infection
Vaccinia virus – a poxvirus closely related to smallpox and monkeypox – tricks cells it has infected into activating their own cell movement mechanism to rapidly spread the virus, according to a new study led by scientists at the MRC Laboratory for Molecular Cell Biology at UCL.
8 November 2018
GPs Need More Time to Discuss Lifestyle Changes with Diabetes Patients, Says College
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, has responded to a new report from NHS Digital about diabetes care.
She said: "Prescribing is a core skill for GPs, and we are highly-trained to make decisions about a patient's care based on their individual needs, in their best interests, and in conversation with them.
30 October 2018
Many Cases of Dementia May Arise from Non-Inherited DNA ‘Spelling Mistakes’
Only a small proportion of cases of dementia are thought to be inherited – the cause of the vast majority is unknown. Now, a team of scientists, led by MRC-funded researchers at the University of Cambridge, believe they may have found an explanation: spontaneous errors in our DNA that arise as cells divide and reproduce.
The findings, published today in the journal Nature Communications, suggest that for many people with neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease, the roots of their condition will trace back to their time as an embryo developing in the womb.
23 October 2018
College Launches Innovation Initiative for Primary Care
Five GPs who have come up with problem-solving ideas to help improve patients' experience of primary care have been selected to join the Royal College of General Practitioners' new Innovators Mentorship Programme (IMP).
The scheme is the first of its kind for the College and aims to encourage, empower and enable family doctors to find solutions to unmet needs in general practice, such as cutting patient waiting times or finding innovative ways to use technology in general practice to benefit patient care.
23 October 2018
Cancer Trial Shows Treating the Prostate with Radiotherapy Improves Survival
Treating the prostate with radiotherapy alongside standard treatment led to a three-year survival rate of 81%, compared to 73% in those who didn’t receive radiotherapy, for some men with advanced prostate cancer, a study based at the MRC Clinical Trials Unit at University College London has found.
These findings, from one of the largest ever clinical trials for the disease, are being presented at the 2018 ESMO Annual Meeting in Munich, Germany, and published in The Lancet.
19 October 2018
Supporting Patients at the End of Life Is an ‘Essential Part’ of General Practice, Says College
Dr Victoria Tzortziou Brown, RCGP Joint Honorary Secretary, has responded to a new report by the Royal College of Physicians about the importance of talking to patients about end of life care.
She said: “The entire relationship between GP and patient is based on good communication, and we have a unique role in the NHS of caring for our patients from when they are born to the end of their lives.
16 October 2018
NICE Says Non-Surgical Options Should Be Offered First for Stress Urinary Incontinence or Pelvic Organ Prolapse
Women should be offered the treatment option of her choice, in discussion with her clinician
A full range of non-surgical options should be offered to women for stress urinary incontinence or pelvic organ prolapse before any operations, NICE has said.
15 October 2018
Loneliness Strategy Is a ‘Great Result’ For GPs and Patients, But We Need More Detail on Funding and How it Will Work In Practice, Says College
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, has responded to the launch of a new Loneliness Strategy from the government today.
She said: “Today’s announcement is a great result for GPs and for patients. The College has been at the forefront of campaigning to highlight the adverse health implications of loneliness and this shows how much impact we have had in a short space of time.
9 October 2018
Patients to Be Offered Choice Over Setting and Type of Dialysis Treatment, NICE Says
Dialysis choice allows patients to live the life they want to
People being treated with dialysis after kidney failure are to be offered a choice over where and what type of treatment they have.
New recommendations say patients, in discussion with their clinician, can choose which type of dialysis is right for them and where they can have their treatment.
6 October 2018
Patient Reaction to 'Shared Appointments' Has Been Very Positive, Says RCGP
RCGP Chair, Professor Helen Stokes-Lampard, said: "We are already aware of practices that are offering 'shared' appointments for patients with similar conditions and the feedback has been very positive.
2 October 2018
Double Check Patients With ‘Penicillin Allergy’ To Avoid Increased MRSA Risk
People who incorrectly believe they are allergic to penicillin are unnecessarily put at an increased risk of developing MRSA or C difficile, NICE warns today.
Healthcare staff should be aware of this and ensure that only people with a true allergy to penicillin are documented as such, NICE is urging.
Incorrectly identifying people as allergic could also contribute to antimicrobial resistance, as these people are likely to instead be given broad-spectrum antibiotics.
1 October 2018
Role of Social Media in Perpetuating Loneliness is 'Unsurprising', Says RCGP
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, has responded to a BBC study on loneliness, which found that 16-24-year-olds experience loneliness more often than any other age group.
She said: "Loneliness is often seen as something that affects elderly people, but actually it can affect anyone and any point in their lives, as this study has shown.
"Online friends and communities can be a source of support for some people, but often these links are more superficial than genuine 'offline' friendship where more meaningful connections occur, so it is unsurprising to hear that these don't always make people feel less lonely.
25 September 2018
Mitochondrial Diseases Could Be Treated with Gene Therapy, Study Suggests
Researchers have developed a genome editing tool for the potential treatment of mitochondrial diseases: serious and often fatal conditions which affect 1 in 5,000 people.
The study, led by scientists from the MRC Mitochondrial Biology Unit at the University of Cambridge, applied an experimental gene therapy treatment in mice, and successfully targeted and eliminated the damaged DNA in mitochondria, which causes the devastating conditions.
25 September 2018
Patients Should Disclose All Medications and Supplements to their GP, Says RCGP
Responding to the new British Journal Of General Practice study on natural remedies interfering with prescription medications, Chair of the Royal College of GPs Prof Helen Stokes-Lampard said: "Our ageing population means that more people are living longer, often with more than one long-term condition and as a result, they are often, quite appropriately, taking multiple prescribed medications in order to treat and manage these conditions.
18 September 2018
Patients with High-Risk Skin Cancer Have New Treatment Option
Hundreds of patients with a type of advanced skin cancer are set to benefit from a new treatment, dabrafenib plus trametinib.
NICE’s positive recommendation applies to adults who have stage III BRAF V600 mutation-positive melanoma that has spread to nearby lymph vessels or lymph glands, which make up an important part of our immune system.
Dabrafenib plus trametinib would be given to patients who have already had surgery to remove the tumour and associated lymph glands. Called adjuvant therapy or treatment, it aims to remove any residual cancer left behind.
14 September 2018
GPs on 'Permanent Alert' For Signs of Meningitis, Says College
Responding to a new report by the Meningitis Research Foundation, Chair of the Royal College of GPs Prof Helen Stokes-Lampard said: "GPs know all too well that meningitis and indeed any form of sepsis can lead to serious complications, and in some cases can be fatal, if not recognised and treated in a timely manner. But the challenge for all clinicians is that initial symptoms often present in exactly the same way as common viral illnesses such as flu, making both conditions very hard to spot in the early stages of disease.
11 September 2018
Liver Tissue Implants Made from Stem Cells Show Promising Support of Liver Function
Stem cells transformed into 3D human liver tissue by scientists from the MRC Centre for Regenerative Medicine at the University of Edinburgh show promising support of liver function when implanted into mice with a liver disease.
The scientists say that in addition to being early-stage progress towards developing human liver tissue implants, it could also reduce the need for animals in research by providing a better platform to study human liver disease and test drugs in the lab.
In this study, published in the journal Archives of Toxicology, the scientists took human embryonic stem cells and induced pluripotent stem cells (adult cells that have been induced to turn back into stem cells) and carefully stimulated them to develop the characteristics of liver cells, called hepatocytes. They grew these cells as small spheres in a dish for over a year.
11 September 2018
Connection Between Lifestyle Factors and Overall Health 'Remains Clear', Says College
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, has responded to the new health profile report by Public Health England.
She said: "It's testament to the tremendous efforts of our NHS and public health services that more people are now living longer, but with this achievement comes the reality that more of us are also living with multiple, long-term conditions, such as diabetes, heart disease and dementia.
3 September 2018
New “Life Changing” Procedure Can Be Offered to Adults with Severe Asthma on NHS
Procedure could be an option for adults with severe asthma whose symptoms cannot be adequately controlled with drugs
NICE draft guidance published today (31 August) says a potentially life changing treatment for some adults with severe asthma is safe and effective enough for use on the NHS, depending on commissioning arrangements.
Bronchial thermoplasty for severe asthma takes place under sedation or general anaesthetic and short pulses of radiofrequency energy are applied to the airway wall.
27 August 2018
Better Access to Mental Health Therapists Promises to 'Radically Change' Care, Says College
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, has responded to new guidance from NHS England, which encourages doctors to place mental health therapists in practice surgeries.
She said: "As a profession, GPs are embracing the development of GP-led multi-disciplinary teams, working together in the best interests of patients – and the skills that mental health therapists bring to the general practice team are very welcome."
28 August 2018
Feedback Encouraged to Allow Use of Life Extending Treatment on NHS for Those with Blood Cancer
CAR-T considered to be an exciting innovation which can cure some patients but very expensive
NICE has invited comments and further evidence on a new treatment for aggressive subtypes of non-Hodgkin lymphoma called diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma that could lead to it being made available for use on the NHS.28 August 2018
Better Communication Between Hospitals and GPs Could Have 'Huge Impact' on Heart Care, Says College
Dr Mike Holmes, Vice Chair of the Royal College of GPs, has responded to new research funded by the British Heart Foundation.
He said: "Heart failure is a very serious condition and one that GPs are acutely attuned to look out for in patients - but in the early stages of the disease, some symptoms can be vague and more likely to indicate other, more common conditions.
21 August 2018
NICE Would Welcome Further Discussions About Access to Spinal Muscular Atrophy Drug Nusinersen
NICE hopes for further talks over nusinersen for treating a rare genetic disorder; spinal muscular atrophy (SMA).
Draft guidance does not recommend nusinersen, also called Spinraza and made by Biogen, for routine use on the NHS because of uncertainties over its long-term effectiveness and its extremely high cost.
The committee concluded that, based on its list price, the cost-effectiveness estimates for nusinersen ranged between £400,000 and £600,000 per year of quality adjusted life (QALY) gained. Even with a proposed confidential price reduction the cost of nusinersen is too high for it to be considered a cost-effective use of NHS resources.
17 August 2018
Flexible Working Helps GP Workforce, Says RCGP
Responding to a survey of GP trainees' career plans, published today by the King's Fund, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said: "We have a record number of doctors in GP training and the moment, and that is brilliant – they are the future of the profession, and are already making a vital contribution to patient care.
"It's not a surprise to see that more GP trainees are planning to either work part-time, or opt for portfolio careers – meaning that they undertake work in other areas of healthcare, as well as clinical work. The intense resource and workforce pressures facing general practice at the moment, mean that full-time working as a GP is often regarded as untenable.
14 August 2018
Factoring in BMI and Sex Can Help Avoid Harmful Side Effects in Type 2 Diabetes
Clinicians can match people with type 2 diabetes to the right drug to improve control of blood sugar and help avoid damaging side-effects, simply by factoring in characteristics such as sex and BMI into prescribing decisions, new MRC-funded research suggests.
The University of Exeter study could dramatically reduce the risk of potentially harmful side-effects such as weight gain and hypoglycaemia, at no additional cost to the NHS.
9 August 2018
GP Patient Survey Results 'Testament to the Great Efforts' of Practice Teams, Says RCGP
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said: "Hardworking GPs and our teams will be so encouraged to hear that despite the extreme resource and workforce pressures they are working under, 95.6% of patients have confidence and trust in the healthcare professional they saw.
"This truly is testament to the great efforts and dedication to patient care being shown by GP practice teams across the country. It highlights the fact that patients value general practice greatly, and that urgent steps need to be taken to shore up our service, so that we achieve similar high levels of satisfaction in future years.
7 August 2018
Launch of New Master’s Degree in Evaluation of Health Care Interventions and Outcomes
A new master’s degree in healthcare decision making has been launched by London School of Economics and Political Science (LSE) in collaboration with NICE.
The MSc, which takes 2 years to complete, will offer skills in health services research, health economics, outcomes research, and health policy.
It is aimed at professionals from a wide range of backgrounds, including the medical professions, pharmaceutical and medical devices industries, healthcare management, government and non-governmental organisations.
7 August 2018
Companies Using Legal Loopholes to Bypass Inspection 'Putting Patient Safety at Risk', Says RCGP
Commenting on a BBC Panorama investigation into websites providing primary care services, due to be broadcast this evening, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said: "It's deeply concerning to hear reports of patients buying prescription medication from unverified online providers with minimal security checks, or from websites whereby the prescribers involved don't have access to their full medical records when prescribing potentially dangerous medications.
31 July 2018
New System Can Identify Drugs to Target "Undruggable" Enzymes Critical in Many Diseases
A new drug discovery system allows scientists to specifically target members of an important family of enzymes, called phosphatases, which were previously considered mostly "undruggable".
Scientists from the MRC Laboratory of Molecular Biology demonstrated the capabilities of the new system by identifying a molecule that could successfully target a phosphatase to reduce the accumulation of Huntington’s disease-associated proteins in the brains of mice.
30 July 2018
Access to Additional GP Services Must Be Tailored to Local Patient Need Not to Meet Targets
In response to the BBC report on GP access, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said: "General practice is facing intense resource and workforce pressures at the moment – our workload has increased exponentially in terms of volume and complexity, but the share of the NHS budget we receive is less than it was a decade ago, and GP numbers are actually decreasing.
24 July 2018
NICE Guideline Set to Address Variation in Provision of Services for Adults with Cerebral Palsy
NICE has published a draft guideline on the care and support adults with cerebral palsy should receive.
It outlines the steps needed to address the variation in the provision of specific services for adults with cerebral palsy and aims to help local and regional services to provide consistent clear pathways of clinical and social care.
21 July 2018
New Antidepressants Data Highlights 'Interesting Trends', but Shouldn't 'Automatically Be Seen as a Bad Thing', Says RCGP
Responding to figures on antidepressants prescribing, published in The Times, today, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said: “It’s important that these figures aren’t automatically seen as a bad thing. They may indicate that more patients now feel able to disclose mental health problems and seek medical care and that negative stigma too often associated with mental health conditions is reducing in society.
17 July 2018
Cancer Drug for Children Recommended After Becoming Cost Effective for NHS Patients
Around 60% of children with high-risk neuroblastoma could be treated with dinutuximab beta
Seriously ill children battling high-risk neuroblastoma - a rare type of cancer that mainly affects children and young people – are to be offered a drug which has potential to extend their lives.
A National Institute for Health and Care Excellence (NICE) appraisal committee has recommended dinutuximab beta in final draft technology appraisal guidance published today.
13 July 2018
College Treating Data Investigation Involving Publishers of Emma's Diary 'Very Seriously'
"The College has had a long-running relationship with the publisher of Emma's Diary, and the publisher is co-operating fully with the ICO investigation. The RCGP provides medical guidance for the publication but does not hold or receive data and has had no involvement in the case being investigated."
3 July 2018
Funding Boost for Volunteer Infection Studies to Help Combat Infectious Diseases
Nine research teams are each receiving around £100,000 of seed-funding to help set up new volunteer infection studies. These awards aim to improve understanding of these diseases in order to find better ways to prevent or treat them.
The funding comes from the HIC-Vac network, a joint initiative between the MRC, the Biotechnology and Biological Sciences Research Council (BBSRC), and the Global Challenges Research Fund (GCRF). The HIC-Vac network is directed by Professor Peter Openshaw and led from Imperial College London. The Deputy Director, Professor Andrew Pollard, is based at the University of Oxford.
2 July 2018
New NHS App Has Potential but Safeguards Must Be in Place Says College
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said: "Apps are increasingly a vital part of our everyday lives and as technology adapts in the 21st century, the healthcare service must remain up to date with the technologies that the public – and thus our patients – are using.
"The new free NHS app that is being rolled out to patients represents a significant and constructive step forward in the way care is managed and is intended to offer a range of services including more streamlined booking of GP appointments, ordering prescriptions, and recording organ donor preferences - and a way of updating patients registration details at their GP practice.
26 June 2018
People with Dementia Should Be Involved in Discussions About Their Care, Says NICE
NICE has updated its guidance for the support of people living with dementia.
Professor Gillian Leng, deputy chief executive at NICE, reflects upon the difficulties people with dementia can experience, and how she hopes the guidance will help them, their family and their carers:
Dementia is a highly complex and challenging condition. It can present differently from person to person, having a huge impact on the patient, their family and their carers.
26 June 2018
Stigma Around Women's Health Must Be Addressed, Says RCGP
Responding to a new report on reproductive health published by Public Health England today, Chair of the Royal College of GPs and a GP with a long term interest in women's health, Professor Helen Stokes-Lampard said:
"Reproductive health conditions affect women's health and emotional wellbeing on a daily basis and can range in severity in terms of the impact their condition has on their everyday life.
19 June 2018
Kidney Cancers Caught Stealing Genes from Other Cell Types in Order to Spread
A study has identified how kidney cancers may develop the ability to spread around the body by hijacking genes from other cell types and ‘stealing’ their functions.
The study, led by scientists from the MRC Cancer Unit at the University of Cambridge, suggests that this may also help to explain how other types of cancers spread – or metastasise – and provide new targets for cancer therapies.
To metastasise, cancer cells need to develop the ability to break away from the original tumour, survive moving around the body in the blood stream, invade another organ and form a secondary tumour.
17 June 2018
PM Announcement 'Welcome and Encouraging' But General Practice Must Receive A Substantial Share, Says RCGP
Responding to Prime Minister Theresa May's announcement of £384m extra a week, in real terms, for the NHS by 2023, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said:
"The Prime Minister's announcement recognises the exceptional work that our national health service has done over the last 70 years, in the best interests of our patients, and is welcome confirmation that the Government is committed to continuing this.
12 June 2018
Therapy Offered Within One Month to Prevent PTSD, Says NICE
People who have suffered trauma and are at risk of post-traumatic stress disorder (PTSD) should be offered therapy within one month, NICE says in new draft guidance.
The updated guidance gives recommendations on preventing and manging PTSD. Adults who are at risk of PTSD should be offered individualised cognitive-behavioural therapy within a month of experiencing a stressful event. Children can be considered for group therapy after shared trauma to reduce the risk of developing PTSD, the guidance says.
8 June 2018
New Report Provides 'Fascinating Insight' Into Progress Of GPFV, Says College
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said: "NHS England's GP Forward View makes more than 100 pledges, each of which, if implemented correctly should benefit general practice, and make our working lives easier, in the best interests of the care we are able to deliver for patients.
"The BMA has provided a fascinating insight on the progress of the GPFV, and we will take their report into account when we release our own comprehensive analysis, and recommendations, in the coming months."
5 June 2018
Improving Heart Health Could Prevent Frailty in Old Age
New research, funded by the MRC, found that older people with very low heart disease risks also have very little frailty, raising the possibility that frailty could be prevented.
The largest study of its kind found that even small reductions in risk factors helped to reduce frailty, as well as dementia, chronic pain, and other disabling conditions of old age.
The study analysed data from more than 421,000 people aged 60-69 in both GP medical records and in the UK Biobank research study. Participants were followed up over 10 years.
31 May 2018
GPs Leaving Profession at 'Incredibly Worrying' Rates Says College
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, has responded to a survey by the University of Manchester, which found that the number of GPs who say they are likely to quit direct patient care within five years rose to 39% in 2017 from 35% in 2015.
She said: "It's incredibly worrying to hear that so many GPs are thinking about leaving the profession within the next five years, but it certainly isn't surprising, given the intense pressures family doctors are facing – something about which the College has long been raising concerns.
29 May 2018
NICE Approves Multiple Sclerosis Drugs After Prices Are Reduced
Reductions to the price of three multiple sclerosis (MS) drugs mean NICE is now able to recommend them for routine NHS funding.
NICE has published draft guidance recommending interferon beta-1b (Extavia, Novartis), glatiramer acetate (Copaxone, Teva UK Ltd), and interferon beta-1a (Avonex, Biogen Idec Ltd, and Rebif, Merck Serono Ltd) – as treatment options for people with a type of MS called relapsing-remitting MS.
23 May 2018
New Round of Clinical Priorities Announced By College
The Royal College of GPs has announced its latest round of clinical projects to support frontline GPs and their teams as they deliver quality care for their patients.
These will focus on: Dermatology
- Efficient Multimorbidity Management
- Lyme Disease
- Menstrual Wellbeing
22 May 2018
UK Biobank Data Reveals New Alzheimer’s Risk Gene
An international research team funded by the MRC and led by scientists at the University of Edinburgh and the University of Queensland, has identified three new genes linked to the risk of Alzheimer’s disease. The study, which also involved researchers from the Icahn School of Medicine at Mount Sinai, is published today (18 May) in the journal Nature Translational Psychiatry.
18 May 2018
Almost One in Three GPs Are So Stressed They Feel They Cannot Cope At Least Once A Week
To mark Mental Health Awareness Week, RCGP Wales has published the figures to raise awareness of the impact of rising workloads on GPs' own mental health and wellbeing.
Almost one in three GPs are so stressed they feel they cannot cope at least once a week
To mark Mental Health Awareness Week, RCGP Wales has published the figures to raise awareness of the impact of rising workloads on GPs' own mental health and wellbeing.
15 May 2018
New Guidance Will Help Combat Drug Resistant Urinary Tract Infections, Says NICE
NICE has published new guidance to help healthcare professionals optimise the treatment of urinary tract infections (UTIs).
NICE says healthcare professionals should ask patients about the severity and regularity of their symptoms before they prescribe antibiotics.
This should include asking them about the steps they have taken to manage their illness (such as taking painkillers) and may also include asking them for a urine sample so that this can be tested for infection. The results can then be used to identify which antibiotic will work best.
10 May 2018
College Welcomes 'Sophisticated' Safety Measures to Help Reduce Medication Errors
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, has responded to the introduction of a new safety system to help the NHS monitor and prevent medication errors.
She said: "The data published today should reassure patients that in the vast majority of cases, prescriptions issued from their GP surgery are made appropriately and accurately.
8 May 2018
Scientists Develop a New Test to Safely and Accurately Diagnose Peanut Allergies
MRC scientists have developed a new laboratory test to diagnose peanut allergy. The test has 98% specificity and, unlike current options, it doesn’t run the risk of false-positives or causing allergic reactions such as anaphylactic shock.
The simple blood test is five times more cost-efficient compared to the oral food challenge (OFC) – the standard food allergy test – and could be adapted to test for other food allergies.
4 May 2018
RCGP Calls on Government to Facilitate 'Social Prescribing' For All Practices
Every GP surgery should be funded to have access to a dedicated social prescriber in a bid to tackle crippling GP workload, and free up their time for those patients most in need of medical care, according to a report by the Royal College of GPs (RCGP), published today.
The report assesses NHS England's Time for Care Programme - specifically, its 10 High Impact Actions, which aim to cut workload in general practice.
1 May 2018
A New Option for Men with Enlarged Prostate
Men suffering with symptoms from an enlarged prostate could be offered a new type of nonsurgical treatment thanks to changes in NICE guidance.
NICE – the National Institute for Health and Care Excellence – has updated its guidance for using Prostate Artery Embolisation (PAE) as a treatment of benign prostatic hyperplasia.
The prostate is a small walnut sized gland found only in men. It produces the fluid component of semen and grows naturally with age. Problems occur when the change in size puts pressure on the tubes that drain urine from the bladder.
27 April 2018
New Research on The Impact of Climate Change on Health a 'Stark Warning', Says RCGP
Commenting on the Lancet Countdown's report on air pollution and the health benefits of the UK's Climate Change Act, published in The Lancet Planetary Health, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said: "Climate change is a clear risk to the health and wellbeing of the British population.
24 April 2018
People Growing Older with Learning Disabilities Should Get Regular Health Checks, Says NICE
NICE says people growing older with learning disabilities need to have annual health checks to help them manage conditions that can quickly affect them as they grow older.
New guidance from NICE, advises health and social care workers to help organise regular health assessments for older people with learning disabilities because they may find it difficult to express their needs and be heard.
Older people with learning disabilities are more likely to develop serious health problems such as, epilepsy or pneumonia. They are more likely to die from these conditions because of late diagnosis. They may also find it hard to access health services because of hearing or sight problems.
23 April 2018
Young Women Should Be Reassured to Feel Comfortable Speaking to Their GP About Periods, Says College
Commenting on Plan International UK’s study which found nearly 80 per cent of girls have been concerned about symptoms related to their period but haven't seen a health professional, Prof Helen Stokes-Lampard, Chair of the Royal College of GPs and a GP with long term interest in women's health said:
"Puberty is a critically important stage in a young woman's life when they are adapting to lots of changes in their bodies and naturally some girls may feel hesitant to seek medical help as they struggle to understand these.
17 April 2018
Drinking More Than 100g/Week of Alcohol - 5-6 Glasses of Wine - May Be Linked to a Shorter Life Expectancy
Recommended alcohol limits in many countries should be lowered to around 100g/week for men and women, according to an analysis of data from nearly 600,000 current drinkers in 19 countries, published today in The Lancet.
A 100 g/week limit is equivalent to 5-6 standard UK glasses of wine or pints of beer per week or 12.5 units. Recommended limits in Italy, Portugal, and Spain are almost 50% higher than this, and in the USA, the upper limit for men is nearly double this (196 g/week or 11 glasses; 98 g/week for women). The findings from the study are in line with UK guidance which was recently lowered to 6 glasses a week for men and women.
15 April 2018
GP Patient Data Must Not Be Treated Like The Yellow Pages, Demands College
Responding to the Health Select Committee's report into the Memorandum of Understanding on data-sharing between NHS Digital and the Home Office, published today [Sunday 15 April], Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said:
"The Home Office is displaying a blatant disregard for the trusted and vital GP-patient relationship, and its casual approach to confidential patient data risks alienating highly vulnerable patients.
10 April 2018
Help People Make Informed Decisions When They Want to Quit Smoking, Says NICE and Public Health England.
NICE and Public Health England have published updated guidelines for health practitioners and stop smoking services on the best ways to help people quit smoking.
NICE and Public Health England have published updated guidelines for health practitioners and stop smoking services on the best ways to help people quit smoking.
The new guideline recommends prioritising specific groups who are at the highest risk of harm from smoking, such as women who are pregnant and people with mental health problems.
9 April 2018
'Bureaucracy Getting in the Way of Common Sense' - RCGP Verdict on GP Trainee Facing Deportation
Responding to reports that GP trainee Dr Luke Ong is facing deportation due to a delay in his visa process, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said: "The NHS is severely short of GPs – we simply don't have enough to go around, and our patients are waiting longer for appointments as a result."
3 April 2018
Potential Genetic Link in Sudden Infant Death Syndrome Identified
Rare genetic mutations associated with impairment of the breathing muscles are more common in children who have died from sudden infant death syndrome (SIDS) than in healthy controls, according to new research co-authored by Medical Research Council scientists.
The findings, published in The Lancet, suggest a possible genetic element of the disorder (also known as ‘cot death’). The research was co-funded by the MRC.
29 March 2018
RCGP Welcomes New NHS England Move on Prescriptions for Over-The-Counter Medicines
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said: "Prescription costs are a massive expense for the NHS, and the College has always been supportive of plans to take safe, sensible measures to reduce these costs.
"However, we have previously expressed our concerns about blanket bans being imposed, and GPs losing their freedom to make decisions in the best interests of individual patients, taking into account the unique physical, psychological and social factors affecting their health.
27 March 2018
NICE Medtech Early Technical Assessment Tool to Form Part of Government Grant Application Process for Healthcare Product Developers
The Medtech Early Technical Assessment (META) tool has been selected, as an option, to form part of the application process for a £1million grant for developers of innovative medicines, diagnostics and regulated digital technology in a real world clinical setting.
This follows the recent announcement from the Office for Life Sciences in partnership with Innovate UK that it will invest up to £1million to help small and medium sized companies generate an evidence base for their products so they can be evaluated for use within the NHS. The support will enable companies to collect and analyse clinical performance and cost effectiveness data within an NHS setting.
23 March 2018
A Healthy Lifestyle Doesn't Need to Be Boring, Says RCGP
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, has responded to a study by Cancer Research UK, which found that more than 135,000 cases of cancer a year in the UK could be prevented through lifestyle changes.
She said: "Living healthier lifestyles is the obvious route to better health outcomes for patients – and as GPs, who want our patients to live as long and healthy lives as possible, we will always encourage our patients not to smoke, to only drink alcohol in moderation, to be mindful of their diet and where possible to be more active.
20 March 2018
10,000 More Women to Be Offered Test to Identify the Cause of Heavy Periods
Hysteroscopy has been recommended as a first line diagnostic test for women with heavy menstrual bleeding (menorrhagia), in updated NICE guidance.
The update makes new recommendations for diagnosing and treating the condition, which is estimated to affect around a quarter of women of a reproductive age.
The guideline recommends that women with symptoms and/or risk factors for gynaecological diseases or conditions, such as persistent bleeding between periods, should be offered hysteroscopy.
12 March 2018
GPs Will Not Prescribe Opioids as a 'Quick Fix' Solution, Says RCGP
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said:
"High blood pressure, or hypertension, already affects a very large number of patients in the UK. Lowering the threshold for making the diagnosis of any condition is a significant decision, that will affect thousands, if not millions of patients, and must not be taken lightly.
13 March 2018
Decision to Extend Blood Pressure Drugs to More Patients 'Should Not Be Taken Lightly', Says RCGP
Responding to a BBC investigation into opioid prescribing in the NHS, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said:
“GPs take prescribing any medication incredibly seriously and will do so based on the physical, psychological and social factors potentially impacting on the health of the patient in front of them, and in line with current clinical guidelines – they will never prescribe simply as a ‘quick fix’ solution.12 March 2018
RCGP Welcomes Solutions Suggested in Latest NHS Reality Check Report
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, has responded to a report by the Royal College of Physicians about the current pressures facing the NHS, and how they can be alleviated.
She said: "We have huge empathy with our hospital colleagues, and we know that GPs around the UK would echo their sentiments around increasing workload, and concerns for patient safety. Our NHS is operating under immense pressures and we're sure that everyone working in the health system can relate to this report in one way or another.6 March 2018
NICE Sets Out Measures to Reduce Suicide Attempts in Public Spaces and Prisons
Physical barriers such as nets and fences at bridges and stations could reduce suicides, NICE says.
The draft guideline advises local businesses, community services and prisons on the support people considering suicide need. It says physical barriers like fences and netting in problem areas may be enough to make people reconsider their intentions. Using CCTV could also allow staff to monitor when people may need help.
2 March 2018
Latest RCGP Statement on Bawa-Garba Case
Following extensive discussion of Dr Hadiza Bawa-Garba's case at UK Council on Friday 23 February, RCGP Chair, Professor Helen Stokes-Lampard has made this statement:
Dr Bawa-Garba's case has shaken the entire medical community in the UK - it is now essential that lessons are learnt from this case, and are used to shape the future of medical practice in the best interests of NHS staff and patient care.
27 February 2018
Alternative Treatments for People with Thyroid Cancer to be Offered Routinely on the NHS, Says NICE
The new guidance recommends three drugs, treating two types of thyroid cancer to be made routinely available in the NHS.
Cabozantib, also known as Cometriq, made by Ipsen and sorafenib, known as Nexavar made by Bayer have been recommended by NICE to come off the Cancer Drugs Fund and into routine use. Lenvatinib, or Lenvima made by Eisai has also been recommended for routine NHS use.
It is estimated by the companies that approximately 1,300 people could benefit from these treatments over the next five years.
26 February 2018
RCGP Calls for an End to Referral Management Centres That 'Prioritise Cost-Savings Over Patient Care'
Referral management centres, which are primarily designed to reduce GP total referral numbers to hospital should not be introduced – and where they already exist, it must be demonstrated that they are safe for patients and cost-effective to the whole NHS, recommends the Royal College of GPs in a new report published today.
20 February 2018
Scientists Create Functioning Kidney-Like Tissue from Stem Cells
Scientists have successfully produced human kidney-like tissue within a living organism, which is able to produce urine. The study authors, led by Professors and from the University of Manchester, said it greatly advances our progress toward using stem cells to repair damaged kidneys.
15 February 2018
Latest GP Workforce Figures Are 'Very Disappointing', Says College
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, has responded to news that GP numbers are down 0.6% from September 2017 to December 2017, to 33,872.
13 February 2018
Once a Day Pill for Ovarian Cancer Could Be Made Available On the CDF
NICE has invited Tesaro to submit a proposal for including niraparib (Zejula) in the Cancer Drugs Fund (CDF), for treating some types of recurrent ovarian cancer.
According to company estimates up to 850 women in England and Wales could benefit from this new treatment.
In this draft guidance niraparib was appraised for the treatment of women with relapsed ovarian, fallopian tube and peritoneal cancer who have had 2 or more courses of platinum based chemotherapy.
12 February 2018
Consider the Pharmacist, but Worried Parents Should Trust Their Instinct, Says College
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, has responded to the launch of an NHS England campaign encouraging parents to take their children to the pharmacy before seeing a GP.
She said: "GPs and our teams across the country are currently facing intense resource and workforce pressures, and patients can certainly help to ease this pressure by seeking advice from a pharmacist where appropriate, before making an appointment to see their GP.
6 February 2018
Bacteria Block Transmission of Zika and Dengue Viruses
Scientists at the University of Glasgow’s MRC Centre for Virus Research (CVR) have found a bacterial strain which blocks dengue and Zika virus transmission from mosquitoes.
In a new study, published in PLOS Pathogens, the scientists show that a novel strain of the inherited bacteria, called Wolbachia, strongly blocks transmission of dengue and Zika virus in infected mosquitoes. This finding could offer a potential alternative to strains already being tested as virus control tools.
3 February 2018
GP Workforce in 'Precarious State' and Needs Urgent Increase in GP Numbers, Says RCGP
Responding to research from the University of Exeter on reasons GPs leave the workforce, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said: "This research provides important understanding into why GPs are leaving the profession – and hammers home why the College's calls for thousands more GPs must be heard and acted upon.
23 January 2018
First ‘Cell Map’ Of 20,000 Cells in Mammalian Embryo
Scientists at the Wellcome - MRC Cambridge Stem Cell Institute have used cutting-edge technology to profile over 20,000 individual cells to produce the first ‘cell map’ describing all the major cell types present at the early stage of mammalian embryo development. The researchers used the map to identify an important new pathway involved in blood cell development and say the map could open up new avenues for medicine and drug development.
18 January 2018
Flu Rates Up Over 150% Since Start Of 2018 Show RCGP Figures
Flu presentations in general practice have risen 152.9% since the start of the year and 42% in a week according to the latest figures (up to 14 January) from the Royal College of GPs' Research and Surveillance Centre (RSC).
16 January 2018
How Incurable Mitochondrial Diseases Strike Previously Unaffected Families
Researchers have shown for the first time how children can inherit a severe – potentially fatal – mitochondrial disease from a healthy mother. The study, led by researchers from the MRC Mitochondrial Biology Unit at the University of Cambridge, reveals that healthy people harbour mutations in their mitochondrial DNA and explains how cases of severe mitochondrial disease can appear unexpectedly in previously unaffected families.
10 January 2018
RCGP Welcomes 'Timely and Sensible' Decision by Care Quality Commission to Pause Routine Inspections of GP Practices
Professor Helen Stokes Lampard, Chair of the Royal College of GPs, said: "This will be music to the ears of hard pressed GPs who are working flat out to care for patients in the face of winter pressures.
9 January 2018
NICE Final Draft Guidance Recommends Gene Therapy for Rare ‘Bubble Baby Syndrome’
Strimvelis, a treatment for an ultra-rare inherited immune deficiency condition that has been dubbed ‘bubble baby syndrome’ has been approved by NICE in final draft guidance.
Children with ADA-SCID, severe combined immunodeficiency due to adenosine deaminase deficiency, are extremely vulnerable to infection and usually live in isolation to minimise the risk, hence the nickname ‘baby in a bubble’.
5 January 2018
GP Data Shows Increased Flu Presentations Across England
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said: "The latest data from our Research and Surveillance Centre (until 31 December 2017) is showing that more patients are presenting to GP practices with flu-like symptoms than earlier in 2017. Whilst this is currently within seasonally-expected levels, we are also hearing anecdotal reports of increased demand at surgeries this week.
2 January 2018
Community-Based Screening Can Substantially Reduce Hip Fractures in Women
The risk of hip fractures in women could be reduced through a community screening programme, a new study has shown.
Published in The Lancet and involving scientists from the MRC Lifecourse Epidemiology Unit (LEU) at the University of Southampton the study, known as SCOOP (SCreening for Osteoporosis in Older women for the Prevention of fracture’), compared a screening approach, which involved a questionnaire, bone mineral density measurements in some patients, fracture risk calculated using the online “FRAX” tool and subsequent treatments, to routine care.
It found that there was a 28% reduction in hip fractures over five years in older women who took part in the screening programme.
29 December 2017
'3 Before GP': New RCGP Mantra to Help Combat Winter Pressures in General Practice
Patients are being asked to adopt a new three-step 'mantra' to help relieve pressures on GP services this winter.
The Royal College of GPs' '3 before GP' refers to three questions patients should ask themselves before booking an appointment with their GP.
27 December 2017
Support People to Make Decisions if They Have Capacity but Find it Difficult, NICE Says
Health and social care professionals should support people to make decisions who find it difficult, NICE says in new draft guidance.
They should support people even if they make a decision that they may disagree with. Making an ‘unwise’ or ‘risky’ choice does not mean that a person lacks capacity and decisions need to be made on their behalf, the draft guidance says.
Using visual aids or involving friends and family can help a person communicate their wishes, NICE says.
26 December 2017
Patients' Underlying Problems Not Always Medical, Says RCGP
Commenting on a drive by NHS England to implement more social prescribing, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said: “Social prescribing is something good GPs have always done – it’s just the actual descriptive term didn’t exist before.
“Across the UK, GPs and our teams will see over 1m patients today – and sometimes, what people need isn’t traditional medical care. They might benefit more, for example, from an exercise class, or in the case of lonely patients perhaps a community group, than any medication – and GPs will readily recommend them, if these options are appropriate and available.
19 December 2017
Mesh for Vaginal Wall Prolapse Should Only Be Used In the Context of Research, Says NICE
Updated advice says current evidence on the safety of the procedure shows there are serious, but well-recognised safety concerns.
The evidence for long term efficacy is inadequate in quality and quantity. Therefore, the procedure should only be used in the context of research. This does not constitute a ban on the use of the procedure, as has been suggested in some media reports.
NICE has published eight pieces of interventional procedure guidance (IPG) on mesh. They give advice on the use of mesh as a treatment for stress urinary incontinence (SUI), or pelvic organ prolapse (POP).
16 December 2017
Letter to The Telegraph on Impact on NHS Without General Practice
The Telegraph published Chair Prof Helen Stokes-Lampard's letter to the editor on 16 December 2017 in response to Philip Johnston's proposal that the NHS can survive without general practice.
As one of the country's GPs, who will collectively see over a million patients today alone, I am flabbergasted – as I'm sure our patients will be – by Philip Johnston's ludicrous proposal that the NHS could survive without general practice (Here's an idea to save the National Health Service: get rid of GPs, 13 December).
12 December 2017
Placing the UK at the Forefront of Mental Health Research
Today, the government publishes its Framework for Mental Health Research, a document which the MRC has helped to shape along with other public and charity funders of mental health research. Setting out ten recommendations to improve the impact of mental health research over the next decade, the Framework focuses on prevention and early intervention, increased patient and public engagement, user-led research and stronger connections between physical and mental health research. The guidance also points to harnessing advances in technology, broadening the skill base and encouraging the wider life-science community to invest in mental health research.
7 December 2017
Obese Children Face Lifetime of Health-Related Problems, Says RCGP
In response to findings on childhood obesity by the Millennium Cohort Study, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs said:
"This alarming finding that that one in five young people are obese by the age of 14 should strike a chord in all of us. The stark truth is that overweight and obese children face a lifetime of health-related problems, including increased risk of conditions such as cancer and diabetes, if their weight is not addressed.
5 December 2017
New Ways to Diagnose and Manage Asthma Can Improve Care, Says NICE
New tests to help diagnose asthma and a change in how medicines are offered can help people take control of their asthma, NICE says in new guidance.
NICE is recommending objective tests, which include spirometry and FeNO, to help confirm a diagnosis of asthma. This can achieve more accurate diagnosis and therefore more effective treatment, says NICE.
Spirometry tests assess how well someone’s lungs work by measuring how much air they inhale and exhale, and how quickly.
28 November 2017
Good Progress but More to be Done on GP Fill Rates, Says RCGP
Responding to the latest GP fill rates for medical school placements from Health Education England, Professor Kamila Hawthorne, Vice Chair of the Royal College of GPs, said: "More junior doctors have chosen to specialise in general practice than last year, so progress is being made, but it's clear there is much more to do.
"Our report, Destination GP, demonstrates that by their final year at university 76% medical students have heard negative comments about general practice at some point during their medical training. This immediately needs to be addressed if we are to secure the GP workforce of the future that we so desperately need.
27 November 2017
Remove Earwax If a Build-Up is Causing Hearing Loss Problems, NICE Tells Primary Care
GP surgeries or community clinics should offer to remove earwax if a build-up is contributing to someone’s hearing loss.
This means patients do not need to be referred to a specialist ear, nose and throat (ENT) service for the same procedure, new draft guidance from NICE says.
Earwax can be removed using an electronic machine that pumps water into the ear at a controlled pressure, known as ear irrigation.
Patients should be given ear drops to soften the wax before irrigation, the draft guidance says.
27 November 2017
RCGP and Medical Schools Council Call for Action to Address Negative Perceptions of General Practice to Tackle GP Workforce Shortage
More than three quarters (76%) of medical students report hearing negative comments about general practice from clinicians, educational trainers, and/or academics by the time they reach their final year at university, according to a new report from the Royal College of General Practitioners and the Medical Schools Council.
More than three quarters (76%) of medical students report hearing negative comments about general practice from clinicians, educational trainers, and/or academics by the time they reach their final year at university, according to a new report from the Royal College of General Practitioners and the Medical Schools Council.
21 November 2017
New Technique ‘Trim-Away’ Targets and Rapidly Destroys Proteins in Cells
A new technique, called ‘Trim-Away’, directly and quickly depletes proteins from any cell type in culture. As Trim-Away can also distinguish between different variants of the same protein, it opens up new opportunities to understand the role of proteins in disease, say the scientists from the MRC Laboratory of Molecular Biology (LMB) and the Max Planck Institute (MPI) for Biophysical Chemistry in Germany.
17 November 2017
RCGP Response to Journal of Public Health Study on Obesity and Cancer
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs has responded to a study published in the Journal of Public Health which shows the majority of people in the UK don't understand the connection between weight issues and cancer.
She said: "GPs are working hard to ensure patients are aware of how their lifestyle might be affecting their health and wellbeing – including how making often-simple lifestyle changes can help prevent or delay serious conditions, such as cancer.
14 November 2017
Use Antibiotics Effectively to Reduce Drug-Resistance
Good management of antibiotics can half the number of people picking-up drug-resistant infections in hospital, new data suggests.
Research, published in the Lancet, has found antibiotic stewardship programmes can reduce the number of hospital infections caused by multidrug-resistant bacteria by 51%. It also shows the number of people experiencing drug-resistant infections decreases further when infection control measures, such as good hand hygiene, are followed.
NICE says, healthcare professionals should select the dose, length of treatment and type of administration (for example, tablets or injection) that is right for the person and the infection. This stewardship helps to fight resistance because it preserves the usefulness of antibiotics.
10 November 2017
RCGP Welcomes BMA Report on Protecting the Future of General Practice
In response to the launch of the British Medical Association's new report, Saving general practice, Royal College of GPs Chair, Professor Helen Stokes-Lampard said:
"We welcome this new report which backs up what we've been saying on the severe workload and workforce pressures facing general practice and our calls for further investment and resources to support hardworking GPs and their teams.
7 November 2017
Inherited Risk of High Cholesterol Should be Identified and Treated as Early as Possible, NICE Says in Updated Guidance
Medical records should be checked to identify people who may be at risk of common inherited cholesterol disorder familial hypercholesterolaemia (FH), NICE says.
The guideline recommends those at risk of FH should be offered DNA tests to confirm they have the condition. Previously, low density lipoprotein cholesterol (LDL-C) levels have been used but they are not always accurate.
6 November 2017
New GP App Could Lead to Patients Being ‘Cherry Picked’ and Create ‘Twin Track’ General Practice, Warns RCGP
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said: “Some patients will see this as a ‘golden ticket’ to get quick and easy access to a GP - and for younger, healthier commuters it could prove a solution to long waiting times for an appointment.
“Technology can achieve wonderful things when used properly, but we are really worried that schemes like this are creating a twin-track approach to NHS general practice and that patients are being ‘cherry-picked’, which could actually increase the pressures on traditional GPs based in the community.
31 October 2017
Scientists Unveil Structure of Protein Critical for Gene Expression and Targeted by Influenza
The technique of cryo-electron microscopy - for which MRC scientist Dr Richard Henderson won a Nobel Prize earlier this month - has now been used to solve the structure of a protein complex critical for gene expression.
In the paper, published in Science, the researchers say the structure points to how the human influenza virus is able to disrupt cells’ gene expression machinery.
The study, led by Dr Lori Passmore from the MRC Laboratory of Molecular Biology, is the first to reveal the structure of an important part of the protein, called cleavage and polyadenylation factor (CPF).
24 October 2017
Patients Should be Reassured GPs are Highly-Trained to Prescribe Statins, Says RCGP in Response to New BJGP Research
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, has responded to a study published in the BJGP today on statin prescribing.
She said: "Patients should be reassured that GPs are highly-trained to prescribe statins and base their decisions on the circumstances of the individual patient sitting in front of them, including physical, physiological and social factors that might be affecting their health.
24 October 2017
NICE Approves Gene Therapy for Rare ‘Bubble Baby Syndrome’
Strimvelis, a treatment for an ultra-rare inherited immune deficiency condition that has been dubbed ‘bubble baby syndrome’ has been approved by NICE in draft guidance.
Children with ADA-SCID, severe combined immunodeficiency due to adenosine deaminase deficiency, are extremely vulnerable to infection and usually live in isolation to minimise the risk, hence the nickname ‘baby in a bubble’.
Up until now the only treatment has been a stem cell transplant but these are risky and it is not always possible to find a good match.
23 October 2017
Antibiotics Must Not Be a 'Catch All' For Every Illness, Says RCGP as it Supports New Public Awareness Campaign to Reduce Society's 'Dependency'
Antibiotics must not be a 'catch all' for every illness, says RCGP as it supports new public awareness campaign to reduce society's 'dependency'
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said: "Antibiotics are highly-effective drugs when used appropriately, but we have become too dependent on them as a society – and if we don’t tackle this, it will have a terrible impact on patients' health globally."
17 October 2017
Genes Critical for Hearing Identified
Fifty-two previously unidentified genes that are critical for hearing have been found by testing over 3,000 mouse genes. The newly discovered genes will provide insights into the causes of hearing loss in humans, say scientists from MRC Harwell, who led the analysis by the International Mouse Phenotyping Consortium (IMPC).
The study, published in Nature Communications, tested 3,006 strains of ‘knock-out’ mice for signs of hearing loss. ‘Knock-out’ mice have one gene from their genome inactivated, which helps researchers to uncover the functions of that gene. The IMPC aims to generate a ‘knock-out’ mouse for every gene in the mouse genome.
The hearing thresholds of the knock-out mice were assessed with rising volumes of sound at five different frequencies – mice were considered hearing impaired if they could not hear the quieter sounds for two or more frequencies.
12 October 2017
Loneliness Can Be as Bad for Health as a Chronic Long-Term Condition, Says GP Leader
Loneliness and social isolation, particularly for older people, can be on a par with suffering from a chronic long-term condition, the UK’s top GP will tell a conference of 2,000 health professionals in Liverpool.
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, spoke about the older patients who are seeing their GP because they are lonely and want human contact or someone to talk to.
10 October 2017
Test Children’s Urine Before Prescribing Antibiotics For Utis, Says NICE
NICE is advising healthcare professionals use dipstick urine tests to decide whether to give children antibiotics for suspected urinary tract infections (UTI).
NICE – the National Institute for Health and Care Excellence – has updated its guidance for diagnosing and managing UTIs in children.
The new recommendations give clear advice to GPs and healthcare professionals about how they can accurately test children’s urine for an infection.
This will help to give them a better indication of whether the child needs antibiotics or not. Therefore assisting in the fight against antibiotic resistance, which can be caused by the misuse of medicine.
6 October 2017
Anxiety and Depression Serious Mental Health Conditions for Patients of All Ages Says RCGP
RCGP Chair Professor Helen Stokes-Lampard has welcomed new Age UK research on the worrying number of over 55s experiencing a mental health condition.
She said: "Older people are potentially vulnerable and we have to be careful that we don't normalise depression and anxiety as a routine part of ageing.
3 October 2017
Over 60s Not Using Public Transport Despite Health Benefits
Two thirds of adults over 60 rarely or never use public transport, even though it’s often free or discounted and brings health benefits, according to a study co-funded by the MRC and the Economic and Social Research Council (ESRC). The study published in BMJ also found that older people who used public transport regularly, walked faster.
2 October 2017
Leading GP Says Budget is Missed Opportunity for Patient Care
The Royal College of General Practitioners has described the budget agreed by Welsh Government and Plaid Cymru as a missed opportunity for patient care.
The budget, announced on Sunday, includes a deal which will provide £210m in extra funding for a range of services over the next two years.
Responding to the budget, RCGP Wales Chair, Dr Rebecca Payne, said: "This budget is a missed opportunity. I am deeply disappointed that the Government have not grasped the opportunity to improve patient care by investing in general practice.
26 September 2017
NICE Sets Out How to Diagnose and Treat Lyme Disease
New NICE guidance will help GPs, specialists and other health professionals spot a potential diagnosis of Lyme disease.
It outlines when doctors can diagnose Lyme disease without the need for tests and when they should investigate further.
Lyme disease spreads to humans through an infected tick bite. It affects up to 3,000 people a year in England and Wales, according to Public Health England.
25 September 2017
Care Navigators Such as Receptionists are not Replacements for GPs
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said: "Care navigators are not replacements for GPs – or practice nurses, pharmacists, or any other healthcare professional working in primary care – and if a patient really needs to see a GP, then they will be able to. Care navigation simply means helping people to get to the best person and place to receive timely care – this could be medical or in some cases identifying non-medical sources of help.
19 September 2017
More Than a Million People Should be Offered Lifestyle Tips as a Way to Avoid Type 2 Diabetes
People at the highest risk of type 2 diabetes should be given intensive exercise and weight loss help by the NHS, NICE has recommended.
Healthcare professionals, from GPs to community nurses and pharmacists, should refer people with elevated blood sugars to exercise classes and nutrition courses, NICE has said in updated guidance.
NICE has identified 1.7 million people as having the highest risk of developing type 2 diabetes. This is based upon them having a fasting glucose between 6.5-6.9mmol/l.
14 September 2017
GP Pressures Will Inevitably Cause Frustration for Patients
Professor Helen Stokes-Lampard has responded to data published by NHS England on written patient complaints in the NHS. She said: “GP practices actively encourage patients to submit feedback and raise complaints if they feel that the care and services they have received are below their expectations. It is through patient feedback that GP teams can improve the care they deliver to their patients.
12 September 2017
New NHS Alliance Calls for National Policy Changes to Help Close the Gap Between North-South Mortality Rates
Research findings on ‘North-South disparities in English mortality 1965– 2015: longitudinal population study’ by Manchester Academics, show that large and disturbing differences in premature mortality have emerged since 1995 – particularly in the age group 35-44 and also in the age group 25-34.
12 September 2017
Prevention Crucial in Fight Against Cardiovascular Disease, Says RCGP
Responding to NHS England's announcement on initiatives to prevent heart attacks and strokes, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said:
"GPs right across the country are only too aware of the terrible health impact that cardiovascular disease has on our patients, so we welcome any initiative that can support us to help prevent this, as long as it is properly resourced, and in the best interests of the patient in front of us.
5 September 2017
NICE Says Benefits of Breast Cancer Drug Fulvestrant too Uncertain to Make It Cost Effective
NICE has published draft guidance saying the evidence on using fulvestrant to treat a type of breast cancer does not prove it prolongs survival more than existing, less expensive treatments.
The draft guidance focuses on postmenopausal women who have oestrogen-receptor-positive, locally advanced breast cancer or breast cancer that has spread to other parts of the body, who have not already had treatment with hormonal therapy (aromatase inhibitors or tamoxifen).
31 August 2017
Society-Wide Approach Needed to Achieve Parity of Esteem Between Mental and Physical Health, Says College
Responding to NHS Digital figures on mental health related fit notes, Dr Steve Mowle, Honorary Treasurer for the Royal College of GPs, said:
"Mental health related issues are making up an increasing amount of the GP caseload, so these figures are not surprising. They might possibly indicate a positive move towards greater awareness and reduced stigma of mental health in society – with people being more open and willing to discuss their mental health conditions.
29 August 2017
New Imaging Technique Could Predict Whether Primary Breast Cancer Will Spread to the Lung
Scientists funded by the MRC, Breast Cancer Now and other collaborators have developed an innovative imaging technique that could predict whether breast cancer will spread to the lung.
In the study, published in Theranostics, researchers have demonstrated in mice that a new non-invasive imaging method can be used to detect changes in the lungs that signal breast cancer may soon spread there – before any metastases are visible.
If validated in humans, this approach could enable patients to be offered more intensive therapy earlier, to potentially prevent breast cancer spread.
22 August 2017
Encouraging Upsurge in GP Recruitment - But Must Not Rest on Our Laurels, Says RCGP
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, has responded to latest workforce figures from NHS Digital.
She said: "There is no doubt that there is a long way to go before we have the number of GPs we really need – or the number pledged in NHS England's GP Forward View – but it is important that we do recognise success when we find it, and an increase of 321 more GPs in the workforce over a three month period is certainly not to be sniffed at."
22 August 2017
Patients Getting Faster Access to Cancer Drugs as NICE Approves Three Quarters of the Cancer Drugs Fund
Liver cancer drug, sorafenib has been approved for routine NHS use, marking three quarters of the way through the Cancer Drugs Fund (CDF) without a negative decision.
NICE has recommended sorafenib, also known as Nexavar, made by Bayer to be routinely available for some patients on the NHS.
Sorafenib is one of the 24 drugs NICE was asked to appraise from the CDF, and all have been approved so far for routine NHS use.
Its positive recommendation means that NICE is three quarters of the way through the CDF with 18 drugs now approved.
21 August 2017
Colleges Join Forces to Make Young People's Mental Health a Priority
The Royal Colleges of GPs (RCGP), Paediatrics and Child Health (RCPCH), and Psychiatrists (RCPsych) have committed to five shared principles that they hope will lead to tangible actions to improve the care and support of children and young people (CYP) with mental health problems.
15 August 2017
MRC Forges Two New Deals with Industry to Speed Drug Discovery
Academic groups working in discovery science will have two new opportunities to access state-of-the-art industry facilities from today.
Building on the MRC’s strong track record in establishing innovative collaborations with industry, the MRC has formed partnerships with two global pharmaceutical companies, UCB and AstraZeneca.
The deals will help speed translation of discovery research into potential therapies by giving academic researchers the chance to use industry infrastructure and expertise to further their discovery science research.
11 August 2017
RCGP will Continue to Push for Longer GP Training Programme Despite Review Recommendation
In response to the Shape of Training report, published today, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said:
"It is the clearly stated position of the College that GP training should be a minimum of four years in length - and that the extra training time should be spent based in general practice. This was reconfirmed at our governing Council meeting in February, and the idea of a '3+1' model - whereby an additional year could be undertaken after the mandatory CCT training programme - was rejected, so we are disappointed with the outcome of this report today.
8 August 2017
Pancreatic Cancer Patients to Have Routine Access to Life Extending Drug After New Deal, Says NICE
NICE has recommended nab-paclitaxel for routine NHS use after the company agreed a confidential price discount and provided more evidence on its effectiveness.
Nab-paclitaxel, also known as Abraxane, made by Celgene will be routinely available as an option for patients with pancreatic cancer that has progressed.
When Abraxane is added to a standard chemotherapy, called gemcibatine the evidence has found it extends life by an average of 2.4 months.
7 August 2017
Labour's Analysis of GP Access Backs Up Previous College Warnings
Labour's analysis of the latest GP Patient Survey backs up previous College warnings on GP access, says Chair of the Royal College of GPs Professor Helen Stokes-Lampard.
She said: "This analysis backs up the warnings that the College has been making for some time - that as a result of years of underinvestment in general practice, our patients are finding it increasingly difficult to make a GP appointment.
1 August 2017
Low-Cost Drugs Package Saves Lives of People Starting HIV Treatment Late
Treating people who start HIV treatment late with a package of low-cost drugs to prevent serious infections saves three lives for every 100 people treated, according to the findings of a trial led by the MRC Clinical Trials Unit at UCL.
31 July 2017
GP Forward View Falling Short on Workforce But it is Still the Lifeline General Practice Needs
NHS England’s General Practice Forward View is falling short in its pledge to build the GP workforce by 5,000 more full-time equivalent family doctors by 2020, the Royal College of GPs has concluded today.
The College’s Annual Assessment of the plan, that was launched in April 2016, recognises that NHS England is making progress in delivering many of its approximately 100 pledges – and that the commitment to spend an additional £2.4 billion each year on general practice by 2020/21 is on track.
25 July 2017
NICE Approves More Tolerable Treatment for Blood Cancer
Around 2,200 patients a year with multiple myeloma are to benefit from a new, tolerable treatment on the NHS following approval by NICE.
Carflizomib does not cause serious side effects, such as chronic pain from damaged tissue, to the same extent as current treatments, the independent committee at NICE found.
The drug, also called Kyprolis and manufactured by Amgen, treats patients with multiple myeloma whose cancer has come back after one round of treatment. Previous treatment must not include a drug called bortezomib.
21 July 2017
Safe, Sensible Measures to Reduce NHS Prescription Costs Should Be Encouraged, Says RCGP
Responding to NHS England's announcement today on low-value medicines, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said:
“Our population is growing and ageing, and our patients’ needs are changing rapidly, so we are already thinking about different ways of working - and that means looking right across the health service. The College is keen to work with NHS England and equivalent bodies in the devolved nations to make this a success.
17 July 2017
Strensiq New Deal Paves Way for NICE Approval of Life Saving Drug
An agreement has been reached that means more people with a rare life threatening disease can be offered an innovative new drug.
NICE has published draft guidance recommending the drug asfotase alfa (also called Strensiq and made by Alexion Pharma UK) for people with paediatric-onset hypophosphatasia.
The extremely rare inherited condition affects between 1 and 7 babies each year in England.
A new agreement between the company and NHS England on price and access to the drug means NICE can now widen the group of people eligible for treatment on the NHS.
Previous NICE draft guidance recommended the treatment for only babies with the most severe form.
17 July 2017
Practices Being Forced to Close Will Impact Patients and Wider NHS, Says RCGP
Responding to NHS Digital figures on GP practices opening, closing and merging, released today, Professor Helen Stokes-Lampard, chair of the Royal College of GPs, said:
“It’s not clear with these figures why practices have closed – some may have merged, and others may have closed as a result of working ‘at scale’, which can bring benefits for patients through pooling resources to provide additional services or better appointment access.
11 July 2017
A New Treatment Option for People with Kidney Cancer
People with advanced kidney cancer are set to benefit from a new treatment, after NICE has said cabozantinib should be available on the NHS.
The National Institute for Health and Care Excellence (NICE) recommends cabozantinib as an option for people with advanced renal cell carcinoma (RCC).
The NICE appraisal committee were unable to recommend cabozantinib following their initial assessment of the drug in February 2017. This was because they felt some of the clinical evidence presented by the company was unreliable.
30 June 2017
RCGP Launches Strategic Plan
Our strategic plan sets out the College’s four main objectives for the next three years. And it defines 12 ‘values’, applicable to College members and employees that will shape how we achieve these goals.
Great doctors, great care sets out the College’s four main objectives for the next three years. It also defines 12 ‘values’, applicable to College members and employees, that will shape how we go about achieving these goals.
4 July 2017
NHS Needs More Advanced Paramedics to Ease A & E Pressure, Says NICE
Paramedics with advanced training can reduce the number of patients admitted to hospital unnecessarily, says NICE.
NICE is recommending the NHS provides more advanced paramedic practitioners (APPs) to relieve pressure on emergency departments, in new draft guidance.
Evidence reviewed by NICE shows that using APPs can reduce hospital admissions by 13% compared with standard paramedics.
APPs are able to treat patients in the community, refer them to a GP or decide if they should go to hospital. They can administer stronger pain relief compared with standard paramedics and are able to assess if a wound need stitches.
30 June 2017
Spike in Summer Hay Fever Cases, Show RCGP Figures
Hay fever cases in England have reached their highest level so far this year, and are just under 50% higher compared to this time in 2016, the latest weekly figures from the Royal College of General Practitioners’ Research and Surveillance Centre show.
The figures reveal a spike in the number of patients seeing their GP for hay fever type symptoms - or allergic rhinitis - since the start of June, with family doctor visits more than tripling from 11,353 to 37,568* in England. The equivalent of 20.25 to 67.00 consultations per 100,000 patients.
This represents a huge 230% increase.p;
27 June 2017
Academy of Medical Sciences Report Calls for Action to Prevent Confusion Over Medicines
The new report highlights the significant difficulties patients and some healthcare professionals face in using evidence from research to judge the benefits and harms of medicines, and calls for concerted action to improve the information patients receive.
The AMS report was instigated following public debate around the benefits and harms of treatments such as statins, hormone replacement therapy and Tamiflu. It calls for a range of actions including significant improvements to patient information leaflets, better use of medical appointments and a bigger role for NHS Choices as the ‘go to’ source of trusted information online for patients and carers, as well as healthcare professionals.
26 June 2017
Saddening to Hear of Patient Dissatisfaction with NHS Care, Says RCGP
Professor Helen Stokes-Lampard, Chair of the RCGP, has responded to a new poll by the British Medical Association (BMA) which reveals that more people are dissatisfied with NHS care than satisfied.
She said: "It's saddening to hear that so many patients are not satisfied with the services they are now getting from the NHS, particularly as we know how much our patients love the health service, and historically satisfaction rates have been much higher.
20 June 2017
New Type of Treatment for Crohn’s Disease is Approved by NICE
Following NICE recommendations, patients with Crohn’s disease will have routine NHS access to drug ustekinumab, which offers a new way of treating the condition.
Ustekinumab (also called Stelara, manufactured by Janssen) will be available for patients with moderate to severe Crohn’s disease.
It is recommended by NICE as an option for treating the disease in adults who have had littleor no response, or an intolerance to existing therapies.
Crohn’s disease is an inflammatory bowel disease, and can affect any part of the digestive system. Symptoms can include stomach cramps, diarrhoea and fatigue. It is a chronic condition which means that is it lifelong.
15 June 2017
College Supports National Clean Air Day
The College is supporting the work of the UK Health Alliance on Climate Change to promote National Clean Air Day.
Professor Helen Stokes-Lampard, Chair of the RCGP, said: “Air pollution puts our patients at higher risk of developing serious health problems, such as lung cancer and cardiovascular disease - or making existing conditions worse. It is vital that action is taken to significantly improve air quality right across the country, in the best interests of our patients’ long term health and wellbeing.
13 June 2017
WHO Update of the Essential Medicines List Should Benefit Doctors and Patients
Responding to the World Health Organisation's update of the Essential Medicines List, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said:
“Growing resistance to antibiotics is a serious threat to our patients’ health worldwide, so we welcome the World Health Organisation taking action to help curb this.
9 June 2017
Where Patient Safety is a Concern, it Must Be Addressed Swiftly and Effectively, Says RCGP
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, has responded to a BJGP study published today on patients' experience of safety in general practice.
She said: “It is human nature to report a bad experience of a service than a good one, so the fact that most patients who responded to this survey had a positive perception of safety in their GP practice is really encouraging. However, it is important that where patient safety is a concern, it is identified and addressed swiftly and effectively.
6 June 2017
Predictions of 'Rocketing' Patient Demand Really Concerning for Already Hard-Pressed GPs, Says RCGP
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, has responded to predictions of 'rocketing' patient demand and appointment waiting times in general practice by 2022.
She said: “Hard pressed GPs around the country are already running on empty so these predictions are really concerning. As well as huge increases in the volume of patient numbers, disease management is also becoming much more complex and we simply cannot do any more without a significant injection of investment in general practice, including a significant influx of GPs.
2 June 2017
New Workforce Figures 'Seriously Concerning', Says RCGP
Responding to the latest NHS Digital figures on GP workforce in England and Wales, published today, Professor Helen Stokes-Lampard, RCGP Chair, said:
“It’s frustrating that we can’t make a direct comparison between these figures, and those from the same time last year, given changes in the way the data has been collected – very soon this is going to be necessary in order to fairly evaluate the progress of NHS England’s GP Forward View, and the promise that was made to us for 5,000 more full-time equivalent GPs by 2020.
30 May 2017
NICE to Launch New Evidence Tool for Medtech Product Developers
NICE is launching an online tool to help medtech companies get their products to patients faster.
NICE’s Scientific Advice service is launching an online tool to help developers of medical devices and diagnostics understand and generate the evidence needed to show their products are clinically and cost effective. This will help companies prepare for a dialogue with health technology assessment organisations and payers and potentially speed up time to market.
26 May 2017
Quality of Life Must Be Ensured as Patients Live Longer, Says RCGP
Responding to research in The Lancet Public Health on the UK's growing ageing population, published today, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said:
“There seems to be a common theme with almost every new research paper about the future of health and social care published; we desperately need more investment across our NHS and social care system to cope with the growing and changing demands of our ageing population.
23 May 2017
UK Dementia Research Institute Takes Huge Leap Forward
Six of the UK’s leading research universities have been awarded centre status in the landmark UK Dementia Research Institute (UK DRI), laying the foundation for an eventual research community of more than 400 researchers dedicated to addressing the challenge of defeating dementia.
The initial UK DRI funding worth £55 million, which will be supplemented by a further £20 million from the institutions hosting the centres, will get the institute up and running and kick-start research that will provide answers to some of the most pressing questions in the field of neurodegenerative disease.
23 May 2017
GPs Doing What We Can to Increase Take-Up of Meningitis Vaccine, Says RCGP
Professor Helen Stokes-Lampard, Chair of the RCGP, has responded to a report by the Meningitis Research Foundation.
She said: “GPs are always on the alert for signs of meningitis and we are doing everything we can to increase awareness and take-up of the MenACWY immunisation programme.
“However, there are different rules and responsibilities for vaccinating specific age groups, which has made it confusing for GPs and schools, as well as for our young patients and their parents.
16 May 2017
‘Staggering’ GP Vacancy Problem Must Be Addressed as a Matter of Urgency, Says RCGP
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said: “We know that practices across the country are finding it really difficult to recruit GPs to fill vacant posts, and the degree to which this problem has increased over the last six years is staggering. In the most severe cases, not being able to recruit has forced practices to close, and this can be a devastating experience for the patients and staff affected, and the wider NHS.
11 May 2017
New Data to Support GPs Refer Cancer Patients Appropriately Should Be Welcomed, Says RCGP
Professor Helen Stokes-Lampard, Chair of the RCGP, has responded to a new, upcoming study by Cancer Research UK which aims to find out if patients' prescription history can support GPs in diagnosing cancer earlier.
She said: “We know that timely diagnosis of cancer leads to better outcomes for our patients, so any new data that can support GPs refer patients appropriately should be welcomed – but we also need much better access to reliable, diagnostic tools in the community.
9 May 2017
NICE Says Head and Neck Cancer Drug is Not Cost Effective
NICE has published draft guidance saying the cost of using nivolumab to treat head and neck cancer is too high for routine NHS use.
NICE have assessed the benefits of using nivolumab to treat different types of cancer. For some types, such as kidney cancer, NICE has been able to recommend the drug.
For others, such as head and neck cancer, the evidence is not as strong and NICE has therefore not recommended it to be offered routinely on the NHS.
Professor Carole Longson, director of the health technology evaluation centre at NICE, said: “We understand that treatment options in this area are limited, and it’s important to patients that treatments both extend and improve their quality of life.
8 May 2017
New Round of Clinical Priorities Announced by College
The Royal College of GPs has announced its latest round of clinical projects to support frontline GPs and their teams as they deliver quality care for their patients.
2 May 2017
MRC Launches New Mental Health Strategy
The Medical Research Council’s neuroscience and mental health board has today launched a completely updated mental health strategy (PDF, 750KB) to drive forward discovery science in the field.
Mental health issues, such as anxiety and depression, are estimated to affect approximately one in six people at any time in the UK and have a significant and long-term impact on the lives of individuals and their families. Mental disorders cost the UK economy an estimated £70-100 billion annually.
27 April 2017
Sexual and Reproductive Health Must Not Become the 'Cinderella' Service of the NHS, Says RCGP Chair
Years of improvement in the quality of sexual and reproductive healthcare being delivered to patients – including a halving of teenage pregnancy rates over the last decade and steadily increasing uptake rates of long acting reversible contraceptives (LARCs) – is at risk due to the bureaucratic, financial and training barriers facing GPs and practice teams, the Royal College of GPs is warning today.
25 April 2017
Terminally Ill Children Should Have Access to Around-the-Clock Homecare, Says NICE
NICE has published a draft standard aiming to improve end of life care for children in England.
It says families who are caring for terminally ill children at home should have 24-hour access to specialist medical support and advice.
Estimates suggest there are close to 40,000 terminally ill children and young people in England.
24 April 2017
Crucial That Any Future Government Delivers the Investment and Support GPs And Patients Right Across UK Need, Says RCGP
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, has responded to the Prime Minister Theresa May's announcement today of a snap general election, which could take place on 8 June.
She said: "It is vital that patient care is kept at the forefront of debate over the coming weeks. Once the new government is formed, we will continue to press for the urgent delivery of all the pledges made in NHS England's GP Forward View - and for equivalent investment in GP services in Scotland, Wales and Northern Ireland.
18 April 2017
New NHS Alliance Highlights an Opportunity for NHS England Area Teams to Engage Community Pharmacy in Providing Flu Vaccination to Reception and School Age Children
The aim is to produce community immunity through immunisation. Over the years, we have struggled to hit WHO or Public Health targets – the New NHS Alliance believe that we must do better. Community Pharmacy has contributed a significant number of immunisations and joint working with General Practice is becoming more common. The flu letter for 2017 – 2018 has arrived and introduces the immunisation of reception and school age children for the first time.
12 April 2017
Pharmacists Playing Increasingly Vital Role Within GP-Led Practice Teams
Responding to NHS England's announcement of plans to place pharmacists in over 700 more GP practices, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said:
“With family doctors are currently facing unprecedented resource and workforce pressures, we are grateful for the support of pharmacists who are playing an increasingly vital role within some GP practice teams. They should not be seen as substitutes for GPs but they are highly-skilled and well-trusted healthcare professionals who carry out important tasks such as medication reviews and managing repeat prescriptions for patients with long-term conditions.
11 April 2017
Councils and Sexual Health Services Should Consider Providing Free Condoms to Reduce STIs, Says NICE
Condoms should be more widely available to reduce rates of sexually transmitted infections (STIs), NICE has said in new guidance.
The guidance recommends providing a range of condom distribution schemes to meet the needs of different people to help reduce STI rates.
NICE also recommends local authorities consider giving free condoms to people at high risk of getting an STI, such as those who are involved in increased rates of risky sex (for example, they may have multiple partners or frequently change partners). These condoms could be distributed through pharmacies, sexual health charities, and universities.
07 April 2017
Too Many Practices Being Forced to Close Due to Workload and GP Shortages, Says RCGP
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, has responded to figures on GP practice closures and the subsequent impact this is having on patients' access to their local family doctor.
She said: “GP practices are the lifeblood of our local communities so the complete closure of any practice will always be a last resort when all other options have proved unworkable.
04 April 2017
New NHS Alliance Responds to NHS Guidelines And Review of Prescriptions
The New NHS Alliance welcomes yesterday’s announcement of the new NHS guidelines and widespread review of prescriptions. We are glad that the government is responding to elements within our report – ‘Supporting the Development of Community Pharmacy Practice within Primary Care’ * – and we wait for further recommendations to be taken forward.
Mark Robinson, NNHSA Executive, Special Advisor – Medicines, Pharmacy and Medicines Optimisation, comments:
28 March 2017
Prescription Clampdown Must Not Disadvantage Vulnerable Patients, Says RCGP
Responding to comments made by NHS England Chief Executive Simon Stevens in the Daily Mail this morning, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said:
“Our population is growing and ageing, and our patients’ needs are changing rapidly, so we are going to have to think about different ways of working - and that means looking right across the health service. The College is keen to work with NHS England and equivalent bodies in the devolved nations to make this a success.
28 March 2017
HIV Testing Should be Seen as Routine Practice, Says NICE in New Draft Quality Standard
Millions of people could be offered HIV tests during routine appointments as outlined by NICE.
The new draft quality standard aims to improve the uptake of HIV testing among adults (aged 18 and over) and young people (aged 16-18) who may have undiagnosed HIV. This would mean they could have timely treatment to reduce the risk of onward transmission.
Professor Gillian Leng, Deputy Chief Executive and Director of Health and Social Care at NICE, said: “There can be stigma and fear around having an HIV test. This needs to change so that HIV testing is seen as routine practice. This new draft quality standard sets out clear, practical steps to help encourage and increase the uptake of HIV testing.”
27 March 2017
GPs Will Always Take Womens’ Health Conditions Seriously, Says RCGP
Responding to the All-Party Parliamentary Group on Women’s Health’s ‘Informed Choice Evidence Report’ published today, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said:
“Women’s health constitutes around a quarter of a GP’s workload; we know that both endometriosis and fibroids can cause women considerable pain and distress, and these are both conditions that GPs and our teams are aware of and take seriously.
21 March 2017
New 3D Spheres Replicate Human Cells to Better Study Infection
A new 3D system has been developed to enable researchers to more effectively study human infections in the laboratory.
A diverse team of infectious disease researchers, engineers and bioinformaticians from the University of Southampton and University College London came together to better understand the bacteria that cause tuberculosis (TB).
They used a technique known as electrostatic encapsulation to make tiny spheres of collagen – a connecting tissue in the body – within which human cells are infected with tuberculosis (TB) bacteria to generate conditions that more closely reflect events in patients than similar 2D techniques.
17 March 2017
Report Highlights Extra Resources GPs Need to Carry Out Further Training in Managing Suicide Risk, Says RCGP
Professor Helen Stokes-Lampard, Chair of the RCGP, has responded to an inquiry into adult suicide by the Health Select Committee.
She said: “Patients identified at high risk of suicide need specialist care and given the delicate nature of their wellbeing, cases must be managed appropriately to secure their safety first and foremost.
14 March 2017
Treat Life-Threatening Sepsis Within the Hour, Says NICE
NICE is urging hospital staff to treat people with life-threatening sepsis symptoms within one hour.
In a new draft quality standard, NICE says people showing signs of sepsis must be checked carefully. Once someone is classed as high-risk they should be seen by senior staff and given the right treatment within an hour.
Professor Gillian Leng, NICE deputy chief executive, said: “Severe symptoms can develop in sepsis very quickly. If high-risk patients are not identified and treated promptly, people can be left with debilitating problems. In the worst cases, they may die.
13 March 2017
Cervical Screening Important Regardless of Sexual Orientation, Says RCGP
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said: “Millions of women every year are appropriately screened for cervical cancer – and it’s safe to say that this national programme is one of the great successes of the modern NHS.
6 March 2017
International Study Finds Education Does Not Protect Against Cognitive Decline in Later Life
A European-wide study published today in the journal Neuroepidemiology has found that whilst older people with a higher level of education have better memory function, it does not protect them from cognitive decline as they age.
03 March 2017
Buying Medication Online Can Seem Convenient but it is Not Without Risk, Says RCGP
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, has responded to warnings from the Care Quality Commission about buying medication online.
She said: “Whether a patient is accessing care in the community, in hospital or online, they should be confident that it is being delivered safely and in their best interests.
“It’s incredibly concerning to hear reports of patients buying prescription drugs online with minimal security checks in place – so it’s good to see the CQC and others recognising this, and taking the issue seriously.
28 February 2017
NICE Is Producing New Guidelines to Help People Who Work with Children Spot and Stop Abuse or Neglect
It outlines how social workers, teachers and police officers, along with others working outside healthcare, can spot the signs of abuse or neglect and how they should act faced with a range of differing circumstances.
The guidelines include physical, mental and sexual abuse as well as newly recognised forms of abuse such as female genital mutilation (FGM), sexual exploitation, child trafficking and forced marriage.
27 February 2017
GPs are Trained in All Aspects of Mental Health, Including Eating Disorders, Says RCGP
Responding to figures from Beat, published today, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said:
"Eating disorders can have severe consequences for patients, and GPs - who will often be the first port of call for patients when seeking medical advice whether specifically about their eating disorder, or not - take them very seriously.
21 February 2017
New NHS Alliance Calls for Closer Collaboration to Achieve Better Community Outcomes for Health and Social Care Integration
The New NHS Alliance (NNHSA) view is that the recent report from the National Audit Office on health and social care integration has bought into sharp focus how important it is for organisations across the health and social care sectors to be working more closely and cohesively together for the benefit of local communities and patients. The NNHSA further contend that funding should flow in a different way – one which focuses on the benefits to patients and throughput rather than purely on cost savings to the NHS.
17 February 2017
Online Access to Antibiotics Undermines GPs' Hard Work to Tackle AMR, Says RCGP
Responding to a study by Imperial College London on online-only pharmacies that don’t require prescriptions for antibiotics, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said:
“Resistance to antibiotics is a growing global health issue – one of the most serious of our time. Antibiotics are excellent drugs when they are used appropriately, and for many bacterial infections there is no alternative so we must work together and do what we can to safeguard their effectiveness.
14 February 2017
NICE Recommends Controlled Use of Targeted Breast Cancer Radiotherapy Treatment Alongside Further Research
NICE has recommended the Intrabeam Radiotherapy System for people with early breast cancer in limited circumstances with additional data collection.
The recommendation for further data to be collected is because it is not yet certain whether Intrabeam, marketed by Carl Zeiss UK, is as effective as conventional radiotherapy in stopping the cancer coming back. However, the independent appraisal committee heard the risk of this happening is low in the patients who would receive Intrabeam and that people may be prepared to accept some uncertainty if it means they don’t need radiotherapy after their surgery.
11 February 2017
Surgery Times Don't Give the Full Story of What's Happening in General Practice, Says RCGP
Responding to figures on GP surgery opening hours published in the Daily Telegraph today, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said:
“These figures don’t give the full story of what’s happening in general practice – they only take into account planned surgery times, not the times that the practice is actually open and providing care.
“Obviously, a large part of a GP’s work is seeing patients in face to face consultations, but there is a lot more involved in day to day general practice – and just because actual surgeries aren’t taking place, it doesn’t mean patient care isn’t being delivered via telephone or online consultations, or by making home visits.
7 February 2017
Discovery Sheds Light on How Nerve Cells Self-Repair
MRC-funded researchers have discovered how a protein in the body enables nerves to repair themselves after injury. The finding could ultimately lead to treatments for those whose peripheral nerves (those outside the brain and spinal cord) have been damaged, for example through traumatic injuries or diabetes.
The scientists, from Plymouth University Peninsula Schools of Medicine and Dentistry, discovered that a protein called Merlin, which was known to play a part in suppressing the growth of nerve tumours, is also vital to the process by which nerves repair themselves.
7 February 2017
BBC Health Check on General Practice - RCGP Responds
As part of the BBC Health Check week, the BBC have published two stories about general practice. The first exploring public opinion on charging for missed GP appointments and the second looking at the standard 10-minute GP-patient consultation. Our responses:
On charging patients for missed GP appointments:
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said: “When patients don’t turn up for booked appointments it can be incredibly frustrating, especially at a time when demand for appointments is so high and some patients are having to wait a month to see their GP.
31 January 2017
NICE Seeks to Improve Diagnosis and Treatment of Cerebral Palsy
NICE publishes first guideline on cerebral palsy
NICE’s first guideline on cerebral palsy aims to improve diagnosis and treatment across the country.
Last year 192 of 209 CCGs, responding to a survey by charity, Action Cerebral Palsy, did not have specific care pathways for children and young people with cerebral palsy, but 14 did.
The new guideline focuses on the causes of cerebral palsy and how to treat common comorbidities such as saliva control, pain, mental health and communication issues.
30 January 2017
RCGP Welcomes NHS GP Health Service
Responding to the launch of the NHS GP health service, and news of developments in NHS England's GP Career Plus scheme, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said:
“Being a GP can be an incredibly stressful job, so it’s no wonder that the intense resource and workforce pressures currently facing our profession are increasingly taking their toll on the mental health and wellbeing of family doctors.
24 January 2017
MRI Scans Prior To Prostate Biopsies Can Help Around a Quarter of Men Avoid Biopsy
The Prostate MRI Imaging Study (PROMIS) also showed that the detection of aggressive cancers can be almost doubled by carrying out an MP-MRI, followed by a biopsy. This is because if the scan is suspicious, the MP-MRI can give information about where the cancer is and its size.
19 January 2017
Open Letter to Party Leaders from RCGPNI Chair
RCGPNI Chair Dr Grainne Doran has written an open letter today to all Political Party Leaders ahead of the election in March, calling for them to commit their Party's support to the future of general practice, regardless of the outcome.
17 January 2017
NICE Approves Kidney Cancer Drug for NHS Use
Patients with advanced kidney cancer will have routine NHS access to the drug everolimus following recommendations by NICE, rather than apply to the Cancer Drugs Fund (CDF).
The National Institute for Health and Care Excellence (NICE) has approved everolimus (also called Afinitor, and manufactured by Novartis Pharmaceuticals) for routine use on the NHS as an option for patients with advanced renal cell carcinoma (RCC).
Everolimus is one of a series of drugs that has gone through a reappraisal process, where NICE is assessing the cost and clinical effectiveness of drugs currently in the old CDF.
16 January 2017
UK Organisations Unite Against Conversion Therapy
Major UK organisations have been working against Conversion Therapy for a number of years, publishing a Memorandum of Understanding against the practice (2015) and updating the document to warn against conversion therapy in relation to gender identity and sexual orientation (including asexuality).
Aware of concerns regarding the future of Conversion Therapy in the USA, and pleased that Malta has banned the practice and that Taiwan has drafted legislation to ban the practice, we are publicising the following statement in solidarity with like- minded healthcare organisations in the USA:
10 January 2017
The MRC Supports Preprints
The MRC requires that the results of the research it funds are published, ideally in peer-reviewed journals; also that all such articles, whether published in an open access or subscription-based journal, must be archived in Europe PubMed Central (Europe PMC) and made freely available as soon as possible, and in any event within six months of the first on�line publication.
09 January 2017
Urgent Action Needed to Make Aspirations for Mental Health Care a Reality, Says RCGP
Responding to Prime Minister Theresa May's speech on mental health services today, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said:
“It’s encouraging to see mental health, particularly that of our children and young patients, being taken seriously by the Prime Minister. A lot needs to be done, and urgently, to make these aspirations a reality and make genuine progress towards parity of esteem between mental and physical health.
3 January 2017
NICE Says Liver Cancer Treatment to Stay Within the Cancer Drugs Fund, but not Recommended for Routine NHS Use
The drug, sorafenib (also known as Nexavar), which is used for treating advanced hepatocellular carcinoma, is not value for money, NICE has said in new draft guidance.
The committee found that sorafenib does not provide enough benefit to patients to justify its high cost, even when special considerations were applied.
However, having concluded that it could not be recommended for routine use, but recognising the unmet need for patients with this condition, the committee agreed that sorafenib should continue to be recommended for use within the Cancer Drugs Fund (CDF).
01 January 2017
Seven Day GP Service Could not be Achieved Without 'Serious Impact' on Weekday Services, Says RCGP
Number of GPs has not kept pace with patient demand
Professor Helen Stokes-Lampard, Chair of the Royal College of General Practitioners said:
"GPs are working flat out to do the best they can for their patients, but with a severe shortage of family doctors already seeing record numbers of people, there is no way that a seven day routine service could be delivered without having a serious impact on services through the week."
28 December 2016
New NICE Guideline to Help People Take Control of Their Asthma Could Save the NHS Millions
NICE has issued draft guidance setting out what medicines adults, young people and children with asthma should take to control symptoms and reduce asthma attacks.
The draft guidance, now out for public consultation, calls for a change in how medicines are offered, a move NICE says could save the NHS millions of pounds.
According to Asthma UK the NHS spends around £1 billion a year treating and caring for people with asthma. And around 4.5 million people in England are receiving treatment for the condition.
26 December 2016
GPs Need Better Access to Community Treatment Services for Patients Diagnosed with Alzheimer's, Says RCGP in Response to Survey
Professor Helen Stokes-Lampard, Chair of the RCGP, said: “Dementia can have a devastating effect on patients, their families and their carers - and GPs are witnessing the impact of this progressive disease more and more frequently.
“It is testament to the hard work and dedication of GPs across the country that in times of intense workload and workforce pressures, the diagnosis of dementia has increased so significantly."
20 December 2016
New NHS Alliance Calls for Adoption of Health Creating Practices in Health and Care
The new permission to front-load the Council Tax precept to 3% per year for the first two years will raise totally inadequate levels of funds for social care in the face of budget cuts and the growing demand for social care, says New NHS Alliance. Not only that, but it will exacerbate already large inequalities because it will raise the least funds in those areas with the greatest need and least ability to pay. This would frustrate efforts by the Secretary of State and other health bodies to ‘have regard to the need to reduce health inequalities’ (Health and Social Care Act 2012).
16 December 2016
Patients Always Able to See a GP When They Need to, Says RCGP
Chair of the RCGP, Professor Helen Stokes-Lampard, has responded to a front-page story in the Dail Mail today about out-of-hours care in general practice, claiming that millions of patients still aren't able to see their GP during these times.
She said: "Extending GP surgery opening hours means taking staff and other resources away from our routine service, which is already stretched incredibly thinly due to years of decline in investment.
12 December 2016
NICE Recommends New Lung Cancer Drug Pembrolizumab
Hundreds of people with advanced lung cancer will now have access to new drug pembrolizumab, also known as Keytruda, after NICE recommends it for routine NHS use.
Pembrolizumab works by targeting a specific protein on the surface of cells which is involved in the body’s immune response to cancer.
In draft guidance NICE has said that adults with advanced lung cancer, that test positive for this protein, should have access to pembrolizumab.
December 2016
Patients Can Improve Their Physical Health and Mental Wellbeing by Doing Regular Exercise, Says RCGP
Dr Zoe Williams, RCGP Clinical Champion for Physical Activity and Lifestyle, has responded to research by the University of Oxford which claims that certain sports can cut the risk of dying prematurely by almost half.
She said: “Regular exercise, even moderate amounts, has been shown to significantly improve our patients’ physical health and mental wellbeing.
6 December 2016
Genetic Differences in Amino Acid Metabolism are Linked to a Higher Risk of Diabetes
A study published today in the journal PLOS Medicine has identified the five genetic variants associated with higher levels of the branched-chain amino acids isoleucine, leucine and valine. The researchers also found that these genetic variants were associated with an increased risk of type 2 diabetes.
The researchers, led by the MRC Epidemiology Unit at the University of Cambridge, used large-scale genetic data together with detailed measurements of the branched-chain amino acids and their metabolites in the blood of more than 16,000 volunteers*.
1 December 2016
GPs Need Support to Increase HIV Testing in Primary Care
Responding to new NICE guidelines on HIV care, published today, RCGP Clinical Lead for HIV, sexual and reproductive health, Dr Philippa Matthews, said:
“Treatments for HIV now ensure that it is possible to live a long and healthy life with the infection. Yet, around a quarter of people with HIV in the UK are undiagnosed, so do not have access to this life-saving treatment.
29 November 2016
NICE Recommends Extra ‘Triple Therapy’ Drug for Treating Type 2 Diabetes
NICE has published final guidance recommending dapagliflozin for treating type 2 diabetes in ‘triple therapy’
Dapagliflozin can be added as a third drug where two drugs for type 2 diabetes are not controlling a person’s blood sugar.
25 November 2016
Relentless GP Workload is a Threat to Our Patients' Safety, Says RCGP
Professor Helen Stokes-Lampard has responded to a new survey out today from the British Medical Association which highlights the relentless workloads in general practice and the danger this is posing to our patients' safety.
She said: “This echoes much of what the College has been saying for some time now – the relentlessness of the workload in general practice is a threat to our own health and our patients' safety.
22 November 2016
NICE Welcomes Landmark Fall in Antibiotic Prescriptions
Fewer antibiotics are being prescribed by doctors in England for the first time, new data shows.
The increase in antibiotic use has been reversed for the first time in England. Doctors prescribed 2.2 million less antibiotics between 2014 to 2015 – reducing from 40.7 million to 38.5 million, data from Public Health England (PHE) shows.
The 4.3% decline in antibiotic prescriptions is the first time a reduction in antibiotic use has been seen across the whole healthcare system, the 'English Surveillance Programme for Antimicrobial Utilisation and Resistance’ (ESPAUR) report, said.
21 November 2016
Realistic Messages are Important for Patients to be Healthier, Says New RCGP Chair
Clarifying comments reported in the media this weekend, Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said:
"Five a Day is an excellent initiative; we want our patients to be healthier, and we want them to eat far more fruit and veg. We should certainly be aiming for this - and more - but the fact is that it remains an aspiration for many patients and as GPs we sometimes need to tailor our advice to the patient in front of us, based on their individual circumstances.
15 November 2016
New NHS Alliance Responds to Announcements to Reduce the Pharmacy Bill
New NHS Alliance is disappointed to hear of the announcement to reduce the pharmacy bill by more than £2m over the next two years.
We have long supported the role of community pharmacy. Our recent support for the role of community pharmacy includes:
- Supporting the development of community pharmacy practice within primary care
- Call for a community pharmacy forward view
- Dispensing Health Equality;
- Skill mix: Can pharmacists and community pharmacy rescue general practice?
14 November 2016
RCGP Launches New Brain Tumours in Children Toolkit
A new resource to support GPs, their teams, and parents to spot signs of brain tumours in children and young people has been launched today by the Royal College of GPs, in partnership with the University of Nottingham’s HeadSmart campaign.
The toolkit has been developed as part of the College’s clinical spotlight project on Brain Tumours in Children, which began in June, recognising that brain tumours account for a quarter of all UK childhood cancers, and are currently the commonest cause of cancer death in children.
8 November 2016
Life-Extending Breast Cancer Drug Approved by NICE in Draft Guidance
People with advanced breast cancer are set to benefit from a life-extending drug as NICE says it should be available on the NHS.
After considering new evidence that has become available since its 2012 guidance, NICE has said the drug should be an option for people with locally advanced breast cancer or breast cancer that has spread despite them having had at least 2 prior chemotherapy treatments.
Eribulin is recommended only if the company provides it with the discount agreed in the patient access scheme.
4 November 2016
New Report Highlights Gaps in Healthcare for Increasing Number of Patients Living with Multiple Conditions
A new report reviewing how effectively the current health system serves patients living with multiple long-term conditions, has been published by the Royal College of General Practitioners today.
Responding to the needs of patients with multimorbidity: A vision for general practice comes on the back of College analysis that revealed the number of people living with one or more serious, long-term conditions in the UK will increase by nearly 1m to 9.1m by 2025.
1 November 2016
Parent-Led Early Intervention Reduces Autism Symptoms
An early intervention for autism aimed at helping parents communicate with their child has been shown to have an effect on reducing the severity of autism symptoms, and this reduction continued for six years after the end of treatment, according to a study published in The Lancet.
The MRC-funded study, led by the University of Manchester, King’s College London and Newcastle University, is the first to identify a long-term effect of an early intervention for autism, and is consistent with UK guidance supporting the use of early intervention.
25 October 2016
Health Professions Calling for Greater Leadership and Action to Tackle Early Deaths of People Living with Severe Mental Illness
A joint report published today by the Royal College of Psychiatrists and the Academy of Medical Royal Colleges sets out essential actions to improve the physical health of adults with severe mental illness across the NHS.
Although the health of the general population in the UK has improved significantly over the past 50 years, the life expectancy of adults with severe mental illness (SMI) in 2016 is lagging behind. Nearly half (46%) of people with SMI have a long-term physical health condition and are at risk of losing on average 10-20 years of their lifespan due to physical ill-health.
25 October 2016
NICE Recommends Wider Use of Tests to Detect Cancer-Causing Genetic Condition
In draft guidance published today for consultation NICE has recommended that everyone who is diagnosed with colorectal cancer should be tested for an inherited genetic condition called Lynch syndrome (LS).
LS is the most common cause of hereditary bowel cancer and people with it also have an increased risk of developing other cancers including womb, ovarian and stomach. Testing for the condition helps to identify whether the patient’s family may also be at increased risk of cancer, meaning they could be monitored more closely if needed.
The draft guidance recommends that microsatellite instability (MSI) testing or immunohistochemistry (IHC) should be used to detect abnormalities that might mean the presence of LS.
25 October 2016
Health Professions Calling for Greater Leadership and Action to Tackle Early Deaths of People Living with Severe Mental Illness
A joint report published today by the Royal College of Psychiatrists and the Academy of MedicalRoyal Colleges sets out essential actions to improve the physical health of adults with severe mental illness across the NHS.
Although the health of the general population in the UK has improved significantly over the past 50 years, the life expectancy of adults with severe mental illness (SMI) in 2016 is lagging behind. Nearly half (46%) of people with SMI have a long-term physical health condition and are at risk of losing on average 10-20 years of their lifespan due to physical ill-health.
18 October 2016
Genetic Signature Linked to Cancer Prognosis Identified
Researchers from the Medical Research Council (MRC) Cancer Unit at the University of Cambridge have identified a genetic signature related to metabolism associated with poor patient prognosis. The results of the analysis of 8,161 tissue samples could in the future help clinicians decide how best to treat a patient as well as aid the development of new targeted treatments.
13 October 2016
Vulnerable Practices Should Be Supported - Not Allowed to 'Wither On The Vine', Says RCGP in Response to Claims That Practices in Yorkshire and the Humber are Closing
Chair of the RCGP, Dr Maureen Baker, has issued a statement on behalf of the RCGP in response to a leaked NHS England document which states that some vulnerable GP practices in England will be allowed to fail and close.
She said: “GP practices are at the heart of our local communities, our patients rely on them, and it is wrong to suggest that, because practices are vulnerable, they do not provide high quality care or are resistant to change."
4 October 2016
A Urine Test for Creutzfeldt-Jakob Disease May Be Possible
Researchers at the MRC Prion Unit at UCL have found that it may be possible to determine whether or not a person has sporadic Creutzfeldt-Jakob Disease (sCJD) by testing their urine for the presence of abnormal prion proteins.
Prions are infectious agents that cause invariably fatal brain diseases such as CJD in humans, scrapie in sheep and BSE (bovine spongiform encephalopathy or ‘mad cow disease’) in cattle. They are a rare but important cause of dementia and it is increasingly recognised that the fundamental process involved in these diseases – prion proteins changing shape and sticking together to form fibres or polymers that damage the brain – is also what happens in the much more common dementias such as Alzheimer’s disease, Parkinson’s disease and other neurodegenerative diseases.
1 October 2016
Online Antibiotics Risk Efforts to Curb Growing Global Resistance, Warns RCGP
Responding to research by 5 Live Investigates, Professor Maureen Baker, Chair of the Royal College of GPS, said:
“Resistance to antibiotics is a global and growing threat and we need to work together as a society to raise public awareness that antibiotics are not always the answer to minor, self-limiting conditions.
“GPs are working hard to reduce antibiotic prescribing with notable success – we saw a reduction of 2.6m prescriptions by GPs last year alone – so it's concerning that patients are increasingly turning to other means to obtain antibiotics, and the ease with which patients can get prescriptions through online pharmacies and online doctors will only serve to hinder our ongoing efforts.
27 September 2016
Retaining GPs Must Be as Big a Priority as Recruiting New Ones, RCGP Urges Government
Professor Maureen Baker, Chair of the Royal College of GPs, has written to Health Secretary in England Jeremy Hunt, urging him that he must make retaining the GP workforce a priority.
In the letter she acknowledges the pledge made in NHS England’s GP Forward View to increase the number of doctors working in general practice by 5,000 by 2020 - but emphasises that this cannot be achieved through recruitment initiatives alone.
23 September 2016
NICE Says Yes to Another Hepatitis C Drug
A new drug which effectively treats more genotypes of hepatitis C has been recommended for use in the NHS.
NICE has published new draft guidance which recommends sofosbuvir-velpatasvir – an anti-viral drug that offers patients with chronic hepatitis C a potential cure.
Sofosbuvir-velpatasvir – a tablet taken once daily – works by blocking the virus from multiplying and infecting new cells. Trials of the drug showed cure rates of 89% and above for all genotypes.
20 Sep 2016
New NHS Alliance Welcomes Forward View for Community Pharmacy
New NHS Alliance whole-heartedly support Pharmacy Voice’s Forward View for Community Pharmacy. We have long held the view that community pharmacy is an essential element to reduce the demand on general practice and to share the workload through effective partnership. Our recent support for the role of community pharmacy includes:
- Supporting the development of community pharmacy practice within primary care;
- Call for a community pharmacy forward view;
- Dispensing Health Equality;
- Skill mix: Can pharmacists and community pharmacy rescue general practice?
19 September 2016
Patients Should Be More Involved in Decisions About Their Care, Says NICE
A new collaborative, made up of the UK’s leading health care organisations including NICE, has set out plans that will help get patients more involved in decisions about their care.
Research has shown that when clinicians and health care professionals work together with their patient, more appropriate decisions are made about their care.
Professor Gillian Leng, deputy chief executive and director of health and social care at NICE, said: “This can lead to improved patient safety, better patient satisfaction and more efficient use of resources.”
13 Sep 2016
More Options to Be Made Available to Treat Hepatitis C
Another ‘potential curative’ drug for people with chronic hepatitis C will be made available on the NHS.
New draft guidance published today from NICE recommends elbasvir-grazoprevir - one of the newer hepatitis C antiviral drugs that can offer patients more effective treatment.
In clinical trials, elbasvir-grazoprevir showed cure rates above 90% for people with genotypes 1 and 4. The cure rate is dependent on the genotype, treatment history and presence of liver damage.
8 September 2016
Good to See a Study That Cuts Through the Controversy Around Statins, Says RCGP
Responding to a review of evidence around the effectiveness of statins, published in The Lancet, Dr Maureen Baker, Chair of the Royal College of GPs, said:
“This study cuts through a lot of the controversy surrounding statins; it recognises the benefits that these drugs have for many patients, but also the potential side-effects that any prescribing healthcare professional should be aware of."
05 Sep 2016
Babies Born with a Low Birth Weight May Be Less Active in Later Life
Individuals who are born with a low birth weight are less likely to be good at sports at school or participate in exercise later on in life.
The study, published in the journal Medicine & Science in Sports & Exercise, used data from the MRC National Survey for Health and Development, a unique birth cohort that closely monitors a group of people all born in the same week in March 1946. This particular research involved data from 2,739 of study participants.
01 September 2016
New Tool Supporting Antibiotic Prescribing Could Be Highly Valuable for Our Young Patients, Says RCGP
Dr Maureen Baker, Chair of the RCGP, has responded to a study in the Lancet on a new tool designed to support GPs and their teams when prescribing antibiotics for young patients with Respiratory Tract Infections.
She said: “GPs are working hard to reduce antibiotic prescribing with notable success – a reduction of 2.6m prescriptions by GPs last year alone – so a tool that can support GPs and other prescribers to identify when antibiotics are the appropriate course of treatment would be highly valuable."
30 August 2016
NICE Set to Recommend Device to Help Spot Heart Disease Using 3D Models of Blood Vessels
Medical software that creates 3D models of blood vessels in the heart to help clinicians diagnose heart disease is the subject of NICE’s latest draft medical technologies guidance.
Provisional recommendations from the NICE medical technology advisory committee support using the new software called HeartFlow FFRCT in patients with stable recent chest pain that’s thought to be heart-related and who have an intermediate risk of heart disease.
26 August 2016
When Prescribed in Small Doses and for a Short Time, HRT is an Effective Form of Treatment, Says RCGP
Honorary Treasurer at the RCGP, Dr Helen Stokes-Lampard responds to new research out today from the British Journal of Cancer, on the link between Hormone Replacement Therapy (HRT) and increased risk of breast cancer.
She said: “The menopause can cause great distress for many women – and for some specific symptoms, such as hot flushes, hormone replacement therapy is the only medical treatment for which we have good evidence.
23 August 2016
World's Most In Depth Study to Detect Early Signs of Alzheimer's Disease
A new multimillion pound study, which will see the most thorough and rigorous series of tests to detect Alzheimer’s disease ever performed on volunteers, is announced today. The Deep and Frequent Phenotyping study is funded by the National Institute of Health Research and the MRC and hopes to dramatically improve the success rate of clinical trials for treatments in Alzheimer’s disease.
This landmark £6.9million research project has been designed to identify measurable characteristics, known as biomarkers, which can detect the occurrence of Alzheimer’s disease very early on in the progression of the disease - when a person may have no obvious symptoms.
18 August 2016
Measures to Address Diet and Lifestyle Essential to Tackle Childhood Obesity, Says College
Dr Helen Stokes-Lampard, spokesperson for the Royal College of GPs, said:
“We are currently seeing a dangerous epidemic of childhood obesity across the country – the tragedy being that overweight children invariably have a life marred by ill-health, and increased risk of conditions such as cancer and diabetes ahead of them.
“The College has been leading the way in getting something done about this – we wrote to the Chief Medical Officer almost two years ago highlighting the issue - so we welcome the aspirations of this strategy report today.
16 August 2016
Thousands to Benefit as NICE Set to Recommend Drug to Prevent Heart Attacks and Strokes
NICE has published draft guidance recommending anti-clotting drug ticagrelor 60 mg with aspirin for people who have had a heart attack.
In 2012/13 there were around 140,000 hospital admissions for heart attacks in England.
Heart attacks and strokes are caused by the build-up of fatty material in artery walls to form a plaque. If the plaque ruptures it can cause a blood clot which can block blood flow to heart muscles causing a heart attack.
If the blood clot dislodges it can travel in the blood stream and block blood flow to the brain causing a stroke.
11 August 2016
Mind Finds ‘Worrying’ Levels of Stress Among Primary Care Staff
Mind has today released research¹ revealing that almost nine in ten (88%) primary care workers find their work life stressful, significantly higher than the wider UK workforce (56%)². The poll of over 1,000 NHS workers in primary care, including GPs, practice nurses, practice managers and their colleagues, also showed that work is currently the most stressful area of their lives, ahead of their finances, health, family life and relationships.
9 August 2016
New Health Research 'Explainer' Tool
The MRC/CSO Social and Public Health Sciences Unit, based at the University of Glasgow, today launches a free, interactive website designed to explain complex health research.
The Understanding Health Research website is the creation of a collaboration between the MRC/CSO Social and Public Health Sciences Unit and an advisory panel of academics.
8 August 2016
Clarity RCGP Appraisal Toolkit for GPs Experiencing Technical Difficulties
We are aware that the Clarity/RCGP Appraisal Toolkit for GPs is currently unavailable due to a technical issue.
2 August 2016
NICE Publishes Final Guidance Recommending Ataluren for Children with Duchenne Muscular Dystrophy
NICE has published final guidance recommending ataluren for treating children aged 5 and over with Duchenne muscular dystrophy (DMD) caused by a nonsense mutation.
Today's guidance follows the announcement on 7 July that NHS England and the company, PTC Therapeutics, have successfully negotiated a ‘managed access agreement’ that established financial and clinical details surrounding the use of ataluren.
This ‘managed access agreement’ was a condition for making the drug available imposed by NICE in its April draft guidance.
27 July 2016
Regular Physical Activity, Spread Across the Day, Should Be Encouraged, Says RCGP
Dr Zoe Williams, RCGP Clinical Champion for Physical Activity and Lifestyle, has responded to a report in The Lancet on the possible health benefits of doing one hour of physical activity, spread across the day, on a daily basis.
She said: “GPs want their patients to live healthy lives for as long as possible, but without regular physical activity patients could be putting themselves at a greater risk of life-threatening diseases, including diabetes, cardiovascular disease, obesity and cancer."
26 July 2016
Controlling ADAM33 Gene Could Stop Asthma
Scientists at the University of Southampton have discovered a potential and novel way of preventing asthma at the origin of the disease, a finding that could challenge the current understanding of the condition.
The research, published in the Journal of Clinical Investigation Insight, analysed the impact of the gene ADAM33, which is associated with the development of asthma.
ADAM33 makes an enzyme, which is attached to cells in the airway muscles. When the enzyme loses its anchor to the cell surface, it is prone to going rogue around the lung causing poorer lung function in people who have asthma.
23 July 2016
Patients to Wait More Than One Week to See GP On 100m Occasions by 2020 - Endangering the Health of Thousands of Patients
Patients will have to wait to see their GP on almost 100m occasions by 2020/21, endangering the health of thousands of patients, if the Government fails to implement promises, signed off by David Cameron, to increase support for general practice.
The new analysis published today by the Royal College of GPs show that, if recent trends continue, the number of occasions when patients will have to wait longer than a week to see their GP will increase by more than 28m occasions from 2015/16, when patients had to wait to see a GP on just over 69m occasions, to 98m in 2020/21.
19 July 2016
New Competency Framework for All Prescribers
A new and updated Competency Framework to support healthcare professionals to prescribe effectively has been published.
Developed by the Royal Pharmaceutical Society in collaboration with NICE, the Framework sets out competencies central to effective performance needed by all prescribers, regardless of their professional background.
14 July 2016
New Guidelines on Diabetes in Children Admirable - But Need Adequate Resourcing, Says College
RCGP Diabetes Lead, Dr Stephen Lawrence, has responded to new NICE guidance on diabetes in children and young people.
He said: “Diabetes – both type 1 and type 2 - are debilitating, long term conditions for patients, and can lead to other serious conditions, such as cardiovascular, eye and kidney disease, and the prevalence of both is increasing in patients of all ages.
“When we spot signs in children, it’s a priority for GPs to act quickly in order to give our young patients the best chance of maintaining a healthy, high quality of life for as long as possible."
12 July 2016
New Insights into Blood Cancer that Develops Before Birth
Researchers from the Medical Research Council (MRC) Centre for Regenerative Medicine at the University of Edinburgh have identified the cells responsible for a form of leukaemia that can develop while a baby is in the womb. The research, published in Cell Reports, adds to our knowledge of how this aggressive type of cancer advances and will help identify future therapies.
6 July 2016
Nursery School Policies Should be in Line with Clinical Guidance, Says College
Responding to research published in the British Journal of General Practice today, Dr Maureen Baker, Chair of the Royal College of GPs, said:
“We understand the concerns that childcare providers have in admitting children with acute infective conjunctivitis (AIC), as they don’t want to put other children in their care at risk. But policies to exclude children with AIC are not in line with official clinical guidelines, and this has a number of serious implications for patients, their families and wider society.
5 July 2016
Thousands of Men with Enlarged Prostates Could be Helped by New NICE Guidance on Laser Device
Laser treatment recommended in new NICE guidance could benefit more than 13,000 men with a benign enlarged prostate.
The guidance recommends the GreenLight XPS laser system for patients who aren’t at high risk of complications from treatment, such as those men without urinary retention or an increased risk of bleeding, and whose prostates are smaller than 100ml.
The NICE committee found that men benefit from a quicker return to normal activity following treatment and a shorter period of time in hospital because the Greenlight XPS procedure can be done as a day-case. The NHS also benefits: NICE estimates up to an estimated £3 million could be saved by using this device when compared with the commonly used procedure transurethral resection of the prostate (TURP) because TURP requires an overnight stay in hospital.
28 June 2016
Decisions on Statins Must be Made Between Doctors and Patients, Says RCGP
Dr Maureen Baker, Chair of the RCGP, responds to BMJ paper on statins controversy and says patients shouldn't stop taking medication out of fear of reports.
Dr Maureen Baker, Chair of the Royal College of GPs, said: “It goes without saying that when an issue receives media attention, and the way things are reported in the media, it will impact on people’s opinions and behaviour – and this can influence the decisions they make about their health.
28 June 2016
New NHS Alliance Calls for Community Pharmacy ‘Forward View’
A new paper, published today by New NHS Alliance: “Supporting the Development of Community Pharmacy Practice within Primary Care” argues that community pharmacy in England, with approaching 11,700 pharmacies, represents health on the high street and within our communities.
The NHS needs clinical pharmacists within general practice, urgent care and out of hours, nursing homes and many other multidisciplinary teams. But, New NHS Alliance argues, the NHS also needs clinical pharmacists within a community pharmacy setting and a strategy for community pharmacy to deliver its potential.
27 June 2016
Physical Activity and Lifestyle Announced as a Clinical Priority by the RCGP
The RCGP has announced that Physical Activity and Lifestyle will be a clinical priority for the next three years, running from 2016-2019.
Physical Activity and Lifestyle is the latest clinical priority to be announced by the Royal College of GPs, aiming to support primary care professionals with reliable, evidence-based information to prevent and manage lifestyle-related diseases.
23 June 2016
NICE Bronchiolitis Guidance Will Reassure Parents and Help Reduce Antibiotic Prescribing, Says RCGP
New guidance from Nice on bronchiolitis in children will reduce anxiety among parents and will help reduce antibiotics prescribing says Maureen Baker, chair of the RCGP.
Dr Maureen Baker, chair of the RCGP, said: “Bronchiolitis can be a very nasty illness for babies and young children - and very distressing and alarming for their parents."
22 June 2016
Improving Home Care Services for Older People
Home care services need to prioritise older people’s needs and wishes so they are treated with dignity, a new NICE quality standard says.
NICE has issued a new quality standard which highlights how social care providers can help older people maintain their independence for as long as possible.
Around 470,000 people used local authority funded home care services in England last year. The majority of these will be people aged over 65 years old.
7 June 2016
Three New Treatment Options for Type 2 Diabetes Recommended By NICE
Tens of thousands of people with type 2 diabetes will be eligible for new treatments under new guidance from NICE.
The drugs will help to control blood sugar in those patients who cannot take more commonly prescribed medicines meaning their condition remains stable for longer.
An estimated 31,000 people may be eligible for the three recommended treatments: canagliflozin (Invokana), dapagliflozin (Forxiga) and empagliflozin (Jardiance).
The three drugs can all be used on their own if a person can’t use metformin, sulfonylurea or pioglitazone, and diet and exercise alone isn’t controlling their blood glucose levels.
1 June 2016
RCGP Announces Liver Disease as a Clinical Priority
The Royal College of GPs has announced today that Liver disease will be a clinical priority starting this year and running until 2019. During this period, the College will be supporting GPs and healthcare professionals in delivering quality care to patients suffering from this disease.
31 May 2016
Major Funders Collaborate to Produce First In-Depth Guide on Evaluating Healthcare System Innovations
An e-book published today is the first to comprehensively address the challenges faced by healthcare providers in evaluating system-level innovations in healthcare services in an evolving landscape.
If innovations can be better evaluated then better, evidence-based decisions can be made by healthcare providers to improve the quality of health services in the UK.
25 May 2016
RCGP Response to NHS Improvement Figures on Antibiotics Prescribing
Dr Maureen Baker, Chair of the Royal College of GPs, said: "These figures show that healthcare professionals across the UK are taking our warnings about growing resistance to antibiotics, and its terrible consequences, seriously and are working hard to address them.
"Such a significant drop in prescribing shows that the work the College is doing to support appropriate prescribing and urge healthcare professionals to say 'no' is taking effect, despite the pressure GPs often face from patients to prescribe antibiotics."
24 May 2016
Resources to Support GPS Deliver Care to Autistic Patients Sent to Every Practice in England
Resource packs to support GPs and their teams to make their surgeries more visibly friendly for patients with an Autism Spectrum Disorder have been sent to every GP practice in England this week.
The packs, developed by the Royal College of GPs (RCGP), aim to support GP practices to meet the commitments in the RCGP Autism Patient Charter, which provides a framework for making GP surgeries more visibly friendly for those on the autistic spectrum.
19 May 2016
Antimicrobial Resistance: A Call to Action
Antibiotic resistance could kill ten million people a year by 2050, a stark government report has warned.
Lord Jim O’Neill, former chairman of Goldman Sachs has set out his final report on the global challenge of resistance to commonly used drugs.
Lord O’Neill was commissioned by David Cameron in 2014 after dire warnings that drug resistance would send modern medicine back to the dark ages, making routine operations too risky and even minor scratches life threatening.
17 May 2016
Lithium May Be Better Than Newer Drugs at Reducing Self-Harm in Bipolar Disorder
A large Medical Research Council (MRC)-funded study of 6,671 patients with bipolar disorder has found that using lithium reduces levels self-harm and unintended injury when compared to three other common and newer medications prescribed for the condition. It is thought this is because lithium reduces aggressiveness and impulsive behaviour.
Bipolar disorder is a mental health condition that mostly affects mood. People with the condition experience severe mood swings from extreme highs to lows with episodes lasting up to weeks. People can experience several highs before a low and vice versa. It can affect up to one in 100 people during their lifetime.
13 May 2016
In The Bag - Making Moving Between Hospital and Social Care Better
A simple ‘red bag’ has helped to speed up and improve the transfer of patients between hospital and care home settings.
Sutton Clinical Commissioning Group (CCG) developed the simple and novel approach to follow NICE guidance on the transition between hospital and care home settings. Each person moving between hospital and care home is given a red bag to store their paperwork, medicines and belongings. Using the bags has improved care and ironed out potential problems for patients and their carers that can cause confusion and delay.
Delays in the discharge of patients place a huge burden on the NHS. Figures show that more than a million hospital days were lost due to delayed discharges in 2015. In 2012-13, more than a million people were readmitted to hospital as an emergency within 30 days of discharge. This costed the NHS £2.4 billion.
10 May 2016
Action is Needed to Address Inequalities in End of Life Care
Failure to recognise individuals’ needs means patients are receiving poor quality end of life care, a highly critical report by the Care Quality Commission has found.
Elderly patients are being kept in hospital for their final days despite many preferring to die at home or in a hospice, and patients diagnosed with a mental health problem or dementia are not receiving the individualised care they need, the CQC found.
9 May 2016
RCGP Comment on Eating Disorders in Males
RCGP spokesperson, Dr Clare Taylor, responded to a BBC Newsbeat story on eating disorders and its prevalence in males compared to females.
Dr Clare Taylor, spokesperson for the Royal College of GPs, said: “Eating disorders can lead to dangerous consequences for our patients, their families and carers, and research suggests that they are more prevalent in women compared to men."
3 May 2016
Historic £100 Million Charity Backing for UK Dementia Research Institute
Two major UK charities have announced £100m of new partnership funding for the UK’s first Dementia Research Institute – one of the single biggest financial commitments to dementia research in the history of both charities. Alzheimer’s Society and Alzheimer’s Research UK have pledged £50m each towards the work of the Institute, led by the Medical Research Council, making the total commitment over a quarter of a billion pounds.
Announced by the Prime Minister last year, the Institute will bring together scientists and experts from across the globe to transform the landscape of dementia research and firmly secure the UK’s reputation as a world leader in research and development against these devastating diseases.
28 April 2016
RCGP Response to RCP Report on E-Cigarettes
Dr Tim Ballard, Vice Chair of the Royal College of GPs, has responded to the Royal College of Physicians’ report Nicotine without smoke: tobacco harm reduction released today.
He said: “Smoking and smoking related conditions lead to a number of serious long-term conditions and premature death for many patients, and cost the health service a huge amount of money so whatever can be done to help people stop smoking should be encouraged.
26 April 2016
Renewed Call to Tackle Antimicrobial Resistance
A long-term solution to antibiotic resistance can only be achieved if we act now, an expert has warned.
The comment comes as NICE launches a new quality standard which aims to help healthcare professionals and organisations tackle the problem.
Antimicrobial resistance to antibiotics is one of the greatest dangers to our health. Dame Sally Davies, the UK Chief Medical Officer, has described the threat as “catastrophic”. It could lead to people dying from ordinary infections, and routine operations such as hip replacements becoming deadly due to the risk of infection.
21 April 2016
College Campaign Triggers Major NHS England Announcement on General Practice
The Royal College of General Practitioners has declared that NHS England’s General Practice Forward View, announced today (Thursday 21 April) is the ‘most significant announcement for general practice since the 1960s.’
In her response to the long-awaited document, which answers the major calls of the College’s Put patients first: Back general practice campaign, College Chair Dr Maureen Baker, said: "For too long GPs – and our members – have been undervalued, underfunded, and not recognised for the essential role we play in keeping the NHS sustainable and safe for patients. We genuinely hope that today's news marks a turning point for general practice and the health service."
19 April 2016
Using Cellular Components to Treat Drug Overdose
It may be possible to treat paracetamol overdose in the future using microRNAs to silence transcription of genes that lead to the production of toxic metabolites. This is according to a proof-of-concept study carried out using stem cell models by researchers at the Medical Research Council (MRC) Centre for Regenerative Medicine at the University of Edinburgh.
The study published in Stem Cells Translational Medicine also found that liver cells grown from stem cells acted as a good model for analysing drug toxicity in the human liver.
15 April 2016
RCGP Response to Reform Report on General Practice
Dr Maureen Baker, Chair of the Royal College of GPs, said, “This support for seven-day general practice services flies in the face of our own research – and the fact that a number of surgeries that have piloted seven-day working have had to scale-down services due to a lack of patient demand at weekends.
“Access to general practice services is undoubtedly important, but patients recognise that prioritising weekend and evening access must not come at the expense of access and services during normal hours. They have better things to do on a Sunday afternoon than have their ears syringed."
11 April 2016
Antibiotic Resistance 'High Among Children With Urinary Tract Infections'
Up to half of samples of urinary tract infections in children are resistant to common antibiotics, new research has shown.
The analysis found high levels of antibiotic resistance in infections caused by Escherichia coli (E. coli).
Antimicrobial resistance is as big a risk to global public health as terrorism, Dame Sally Davies, the UK Chief Medical Officer has said. Without urgent action routine operations such as hip replacements could become life threatening, cancer treatment would be impossible and organ transplants too risky, it has been warned.
NICE has a range of guidelines aimed at tackling inappropriate use of antibiotics, including in children.
10 April 2016
Take a Break Before you Reach Breaking Point to Keep Patients Safe, College Warns GPs
A new poster campaign urging family doctors to take regular breaks in order to keep their patients safe is launched today by the Royal College of General Practitioners.
The College says that general practice - like aviation and long haul driving - is a ‘safety critical industry’ and that the rules for preventing fatigue in pilots and train drivers should also apply to GPs in their surgeries.
1 April 2016
RCGPNI Response to Revised Termination of Pregnancy Guidance
Dr John O’Kelly, Chair of the Royal College of General Practitioners NI, said: “The revised termination of pregnancy guidance is a step forward for helping family doctors to provide compassionate care to women facing crisis pregnancies and provides improved clarity to GPs. However, uncertainty still remains around particular aspects relating to pregnancy terminations.
31 March 2016
Research Funders Join Forces to Tackle Zika Virus With £3.2m
The MRC, the Newton Fund and the Wellcome Trust have joined forces to tackle the global threat posed by the Zika virus.
Following the Zika Rapid Response Initiative launched by the MRC in February, which saw £1m of funding made available through the Government’s Global Challenges Research Fund, an additional £1m and up to £2m was contributed by the Wellcome Trust and the Newton Fund respectively, totalling up to £4m worth of funding. This was further aligned with additional support in Brazil provided by the São Paulo Research Foundation FAPESP.
29 March 2016
New Drug Shows Promise against Muscle Wasting Disease
A new drug to treat the muscle wasting disease inclusion body myositis (IBM) reverses key symptoms in mice and is safe and well-tolerated in patients, finds a new study led by the MRC Centre for Neuromuscular Diseases at University College London (UCL) and the University of Kansas Medical Center.
The study, published in Science Translational Medicine, found that the new drug Arimoclomol reversed the disease’s effects at the cellular level and improved muscle strength in mice. A safety trial in 24 IBM patients conducted in London and Kansas found that the drug was safe and well-tolerated.
24 March 2016
RCGPNI Response to NI Health Minister Announcement on Plans to Restructure Health and Social Care
Dr John O’Kelly, Chair of the Royal College of General Practitioners NI, said: “Any attempt to streamline and reduce complexity within the health and social care system to improve care for patients is to be welcomed.
“Unfortunately the changes which the Minister for Health has announced today have introduced a further element of uncertainty for general practice."
22 March 2016
Faster Access to Effective Cancer Treatments through New Cancer Drugs Fund
Proposals will see new clinically and cost effective cancer drugs approved for use on the NHS earlier than any other country in Europe.
New arrangements for the Cancer Drugs Fund (CDF), approved today by NICE’s Board, will see patients benefitting as promising new and innovative treatments are considered earlier.
NICE will now be able to make decisions on cancer drugs faster than ever before.
For the first time NICE will issue draft guidance on new cancer drugs or significant new licence indications before they have received marketing approval in the UK. Any drug that receives a positive draft recommendation would then be funded from the point of licence.
18 March 2016
RCGP Response to Autistica Report on Premature Death in Autism
Dr Carole Buckley, Clinical Champion for Autism for the Royal College of GPs, said: “It is becoming increasingly clear that autism can have significant implications on a patient’s physical and mental health and wellbeing – sometimes, as this report today shows, with tragic consequences.
“With 90% of NHS patient contacts delivered in general practice, it is essential for GPs and our teams to have good awareness and understanding of autism, and the steps we can take to make our autistic patients’ experience of general practice as comfortable and supportive as possible."
15 March 2016
Vitamin D Supplements in Pregnancy May Help Babies' Bones
Vitamin D supplementation during pregnancy may lead to stronger bones in babies born during the winter months, a new study has shown.
Researchers from the MRC Lifecourse Epidemiology Unit, University of Southampton, recruited over 1,000 pregnant women across Southampton, Oxford and Sheffield to the MAVIDOS study, a randomised, double-blind, placebo-controlled trial of vitamin D supplements in pregnancy.
Women were randomised to take either 1000 units (25 microgrammes) of vitamin D every day or a matched placebo capsule from 14 week’s gestation until delivery of the baby.
9 March 2016
RCGP Response to PAC Report on Access to General Practice in England
Dr Maureen Baker, Chair of the Royal College of General Practitioners said:
“We are pleased that the Public Accounts Committee have listened to the College and recognised the enormous resource and workforce pressures currently facing our profession.
“This report echoes what we have been saying for a long time through our Put patients first: Back general practice campaign - that urgent measures need to be taken to reverse declining investment in our service and address the recruitment crisis in general practice.
8 March 2016
NICE Approves Sickle Cell Device That Could Save NHS £13m per Year
NICE has recommended a new device for managing sickle cell disease that makes treatment for the condition easier and quicker, and could save the NHS around £13 million per year.
NICE has recommended a new device for managing sickle cell disease that makes treatment for the condition easier and quicker, and could save the NHS around £13 million per year.
In latest guidance, NICE recommends the Spectra Optia Apheresis System for red blood exchange in patients with sickle cell disease who require regular transfusion.
7 March 2016
A Story of Medicine Told in the Home of General Practice
The NHS is a British institution, universally loved amongst patients and globally coveted - and general practice is its lifeblood with 90% of patient contacts in the health service being made by GPs and their teams.
1 March 2016
Metabolism 'Rewiring' Can Lead to Aggressive Lung Cancer
Scientists have discovered that lung cancers with extra copies of a cancer causing gene-defect ‘rewire’ their energy supply, helping them to survive and making them more likely to spread.
Researchers at the MRC Cancer Unit at the University of Cambridge studied lung cancers with mutations in their Kras genes, which are found in around 30 per cent of adenocarcinomas - the most common type of primary lung cancer. They found that the number of copies of Kras mutations had a profound impact on the disease, as those with extra copies undergo a change in their metabolism.
26 February 2016
RCGP Response to RPS Report on Pharmacists in Care Homes
Responding to the Royal Pharmaceutical Society’s report ‘The Right Medicine - Improving Care in Care Homes’, Dr Maureen Baker, Chair of the Royal College of GPs, said:
“We welcome the opportunity to further develop the constructive and valuable relationship that GPs have with our pharmacist colleagues, in a way that can increase our patients’ safety and save the NHS money.
23 February 2016
Improving and Standardising Care for People with Incurable Blood Cancer
Latest NICE guidance aims to help improve and standardise the diagnosis, treatment and monitoring of myeloma.
The recommendations cover a range of areas including offering communication and support, imaging tests, and palliative care services.
Myeloma is a form of cancer that arises from plasma cells – a type of white blood cell made in the bone marrow. The cancer affects a number of organs including the bones, kidneys, blood and immune systems.
18 February 2016
RCGP Response to the Lancet Study on Antibiotics Prescribing
Dr Maureen Baker, Chair of the Royal College of GPs, said: “When used appropriately antibiotics are excellent drugs, but as a society we have become too dependent on them, resulting in growing global resistance to the bacteria that antibiotics have been so effective at fighting.
“GPs can come under huge pressure from patients to prescribe antibiotics, even when we know they are not the best course of action. Our patients need to realise that this is dangerous for each and every one of us, not just 'other people'.
16 February 2016
Global Scientific Community Commits to Sharing Data on ZIKA
Leading global health bodies including academic journals, NGOs, research funders and institutes, have committed to sharing data and results relevant to the current Zika crisis and future public health emergencies as rapidly and openly as possible.
Organisations including the Bill and Melinda Gates Foundation, Médecins Sans Frontières, the US National Institute of Health and the Wellcome Trust, along with leading academic journals including Nature, Science and the New England Journal of Medicine, have signed a joint declaration and hope that other bodies will come on board in the coming weeks.
11 February 2016
RCGP Response to Government Decision to Impose Junior Doctors' Contract
Dr Maureen Baker, Chair of the Royal College of GPs, said: “We are shocked and dismayed at the Government’s decision to impose a contract on our dedicated and committed junior doctors.
“Imposing a deal on junior doctors is wrong-headed, will inevitably damage morale across the NHS – and may damage patient care.
“We had hoped that ministers would ensure an agreement could be reached in a professional and amicable way, so that the two sides could bridge their differences in a constructive manner."
9 February 2016
Consultation Open on Potential New NICE Indicators
Indicators focused on atrial fibrillation, diabetes care, and weight management are proposed for the latest NICE indicator menu.
Based on NICE guidance and quality standards the potential indicators, now open for consultation, aim to improve healthcare by supporting both national frameworks and local quality improvement initiatives.
They are developed to be used by GP practices and CCGs for service development and improvement as well as for the Quality and Outcomes Framework (QOF) and the CCG Outcome Indicator Set (CCG OIS).
8 February 2016
RCGP Comment on Charging for Missed Appointments
Dr Maureen Baker, Chair of the Royal College of GPs, has responded to the results of a poll commissioned by the Astellas Innovation Debate.
She said: “GPs and our teams are making in excess of 370m patient consultations a year – 60m more than five years ago – but our workforce has remained relatively stagnant and as a result, our patients are still finding it increasingly difficult to make a GP appointment.
“When patients don’t turn up for appointments, it can be frustrating– for both GPs and for patients who could have had the appointment otherwise – but charging a penalty for this is not the answer.
2 February 2016
Study Finds Paracetamol Use in Pregnancy Can Cut Female Fertility
A study led by the MRC Centre for Reproductive Health at the University of Edinburgh and published in the journal Scientific Reports, has found using painkillers in pregnancy may reduce fertility in subsequent generations.
Tests in rats found that when a mother was given painkillers during pregnancy, her female offspring had fewer eggs, smaller ovaries and smaller litters of babies than those not exposed to the drugs.
30 January 2016
New NHS Alliance Responds to Predicted Pharmacy Closures
In response to the announcement that Alaistair Burt believes up to 3,000 high street pharmacies could close because of 6% budget cuts Dr Mark Spencer, co-chair designate of New NHS Alliance, and a GP in Fleetwood, said:
“This policy appears to be extremely short-sighted. The proposed £170m cut will save roughly 0.14% of the annual NHS budget, but the services and expertise we risk losing have the potential to save far greater NHS resource in the long run.
26 January 2016
Updated Tuberculosis Guidelines Will Help Target Most Vulnerable
Updated tuberculosis (TB) guidelines call for greater education and prevention to help target people from socially deprived backgrounds who are most vulnerable to contracting the infection.
The guidelines also raise the upper age limit for the treatment and diagnosis of latent TB from 35 to 65 years and under.
TB is an infection that can be caught by breathing in bacteria from someone who has infectious TB.
While the incidence of TB in the UK has remained relatively since 2005, it remains high when compared with other western European countries.
19 January 2016
RCGP Response to Commonwealth Fund GP Survey
Professor Nigel Mathers, Honorary Secretary for the Royal College of GPs, said: “Such high levels of stress amongst GPs in the UK compared to other countries is bad news for the NHS and for our patients, as growing numbers of family doctors are becoming dissatisfied with their working circumstances and consider leaving the profession.
“But the findings today are not surprising. GPs and our teams across the country are working harder than ever, doing more consultations than ever, to meet the increasing demand of our growing and ageing population. This year we will do in excess of 370m patient consultations – 60m more than we did five years ago.
19 January 2016
Study Shows Beneficial Effects of Blocking Brain Inflammation in an Experimental Model of Alzheimer's
A study, published today in the journal Brain, has found that blocking a receptor in the brain responsible for regulating immune cells could protect against the memory and behaviour changes seen in the progression of Alzheimer’s disease. The research was jointly funded by the MRC and Alzheimer’s Research UK.
It was originally thought that Alzheimer’s disease disturbs the brain’s immune response, but this latest study adds to evidence that inflammation in the brain can in fact drive the development of the disease. The findings suggest that by reducing this inflammation, progression of the disease could be halted.
18 January 2016
RCGP Response to Labour Analysis of GP Patient Survey
Dr Maureen Baker, Chair of the Royal College of GPs, said: “GPs and our teams are working harder than ever, making more consultations than ever, to meet the increasing demand of our growing and ageing population.
“But resources into general practice have been decreasing over the last ten years to the point where our service now receives just over 8% of the overall health service budget – despite making 90% of all NHS patient contacts, and our work becoming greater in both volume and complexity. This is not safe for us, and it is not safe for our patients.
12 January 2016
New Recommended Drinking Guidelines Welcomed by NICE
NICE has welcomed proposed new guidelines on alcohol which aim to limit the health risks that result from drinking.
The proposed guidelines, published by the Department of Health and out for consultation, make 3 main recommendations on safe levels of alcohol consumption.
Alcohol is one of the biggest avoidable risks for disease and death. Between 2010 and 2011, alcohol misuse led to 1.2 million hospital admissions 15,000 deaths.
7 January 2016
RCGP Response to Latest GP Patient Survey Results
Dr Helen Stokes-Lampard from the Royal College of GPs, said: “Over 91% of patients have trust and confidence in their family doctor – as a profession, that is truly something that we should be very proud of, particularly against a backdrop of such intense resource and workforce pressures.
“However, the GP Patient Survey results continue to highlight the growing difficulty that our patients are facing when trying to make a GP appointment and this needs to be addressed as a matter of urgency.
5 January 2016
RCGP Response to HEE's Figures Showing More Doctors Being Accepted for GP Training
Health Education England report an increase in the number of trainees who have been accepted for the third round of GP training in 2015.
Dr Maureen Baker, Chair of the Royal College of GPs, said: “It is excellent news that we are seeing more doctors entering general practice, particularly at a time when we have a chronic shortage of GPs and soaring patient demand.
31 December 2015
Funding award for Centres of Excellence in Neurodegenerative Disease Research
The Centres of Excellence in Neurodegenerative disease (CoEN) initiative, launched in 2010, funds collaborative research in the field of neurodegenerative disease, spanning age-related disorders such as Alzheimer’s, Parkinson’s and Motor Neuron Disease. Under the third CoEN funding call, £3.6m (€4.9m, CA$7.4m) has been awarded for 11 international ‘Pathfinder’ projects, constituting innovative and creative proof of principle studies which, if successful, will provide a step change in neurodegeneration research.
29 December 2015
First Evidence to Suggest That Screening for Ovarian Cancer May Save Lives
New results from the world’s biggest ovarian cancer screening trial suggest that screening based on an annual blood test may help reduce the number of women dying from the disease by around 20 per cent.
The research, published in the Lancet, also cautions that longer follow up is needed to establish more certain estimates of how many deaths from ovarian cancer could be prevented by screening. Estimates from the results so far are promising, but the exact figures remain uncertain.
24 December 2015
New Guidelines to Improve Care for People at the End of Life
NICE has launched the first guidelines for the NHS on improving care for people who are in their last days of life.
The guidelines aim to put the dying person at the heart of decisions about their care, so that they can be supported in their final days in accordance with their wishes.
Around 500,000 people die each year in the UK. Of these deaths 75% are not sudden, but expected.
While a recent report has ranked end of life care in the UK as the best in the world, there are areas where care can be improved and made more consistent.
22 December 2015
Kadcyla Too Costly For Use on the NHS
Final guidance on the use of Kadcyla (trastuzumab-emtansine) says the drug is too high in price for routine use on the NHS.
Kadcyla is a treatment for HER2-positive breast cancer which has spread to other parts of the body that cannot be surgically removed and has stopped responding to initial treatment. The drug costs around £90,000 per patient at its full list price.
Earlier this year, Roche the manufacturer of the drug, agreed a significant price discount with NHS England to stop the drug being removed from the Cancer Drugs Fund. The manufacturer offered smaller, different discount to NICE for use in this appraisal.
18 December 2015
RCGP Response to HEE's Figures Showing More Doctors Being Accepted For GP Training
Health Education England report an increase in the number of trainees who have been accepted for the third round of GP training in 2015.
Dr Maureen Baker, Chair of the Royal College of GPs, said: “It is excellent news that we are seeing more doctors entering general practice, particularly at a time when we have a chronic shortage of GPs and soaring patient demand."
15 December 2015
Progressing Clinical Academic Careers in the UK
An MRC-led review exploring the experiences of early-career clinical academics across the UK has highlighted that while many successfully advance to research leadership positions, widespread barriers to both clinical and academic progression are faced by many of those aspiring to pursue a clinical academic career.
The review details the experiences of more than 400 clinicians who applied for clinical research training fellowships or clinical scientist fellowships from the MRC, the Academy of Medical Sciences, the British Heart Foundation, Cancer Research UK, the National Institute for Health Research or the Wellcome Trust, and explores how past fellowship applicants had become interested in research, the career pathways they have pursued, and their experiences of enablers and barriers to progression as a clinical academic.
14 December 2015
Another NICE Disappointment
Filed under Mark Robinson
I read NICE Guidance (NG19) – Diabetic foot problems: prevention and management. It comes after attending a diabetes meeting in which I had to walk past 135 single shoes to get to my seat. That is a powerful message to identify that we must try and reduce the number of amputations.
8 December 2015
Ensure People with Type 2 Diabetes are Involved in Decisions about Their Care
Healthcare professionals should involve people with type 2 diabetes in decisions about their care such as managing blood glucose levels, NICE says.
Updated guidelines stress the need for individualising care for people with type 2 diabetes, and include new recommendations on managing blood glucose, effective drug treatments and lifestyle interventions.
The vast majority of people who have diabetes have type 2 diabetes, a form of the condition that tends to appear in people over 40, but that is increasingly being seen in younger people due to rising obesity levels.
7 December 2015
RCGP Response to BJGP Study on Antibiotics Prescribing
Dr Tim Ballard, Vice Chair of the Royal College of GPs, said: “Patients want to feel as though they are taking something away from their GP appointment, especially as in many cases, they will have had to wait a long time to secure one – and family doctors are under pressure to prescribe accordingly.
“It’s concerning that patients associate a prescription for antibiotics with a satisfactory visit to their GP, particularly as we know that in many cases antibiotics are not appropriate forms of treatment and could actually do more harm than good, so it may be better not to prescribe."
1 December 2015
Liver Cell Therapies Closer as Study Reveals Key to Mass Production
Scientists from the MRC Centre for Regenerative Medicine at the University of Edinburgh have developed a new technique for growing liver cells from stem cells.
The new approach is cost-effective and could be adapted for mass production of clinical grade cells, aiding the quest to produce treatments for patients with liver damage.
27 November 2015
Royal College of General Practitioners Launch New 'Consequences of Cancer' Toolkit
The Royal College of General Practitioners, in partnership with Macmillan Cancer Support, has today launched an innovative toolkit to support primary care professionals to deliver high quality care to people living with the consequences of cancer and their subsequent treatment.
The ‘Consequences of Cancer’ toolkit brings together best practice advice, clinical guidance and patient resources in one place on the RCGP website.
24 November 2015
Reduce Waste by Carrying Out Blood Transfusions Only When Necessary
Blood transfusions should only be carried out when necessary to help avoid waste in the NHS and prevent risk to patients, says NICE.
In new guidance, NICE makes a number of recommendations to help reduce variation in practice, increase patient safety, and prevent needless use of resources.
Blood transfusions are common procedures that tend to be safe and result in a small likelihood of harm. Yet recent studies have highlighted variation in their use and that at least a fifth of transfusions are unnecessary.
NICE’s latest guideline on blood transfusion aims to address these concerns through recommendations that help standardise practice and improve patient safety.
23 November 2015
Poll Results Show General Practice Struggling to Cope With Tsunami of Increased Patient Demand, Says RCGP
Dr Maureen Baker, Chair of the Royal College of GPs, has said that general practice - and the NHS as we know it – is in danger of disintegrating unless the Chancellor urgently increases investment in the family doctor service to meet the tsunami of increasing patient demand.
In a message to the Chancellor she said: “Fail to invest in general practice in the Spending Review, and general practice and the whole of the NHS is in danger of disintegrating before the end of the current parliament. It’s as simple as that.”
17 November 2015
Colour-Changing Burns Dressing Will Help Fight Against Antibiotic Resistance
A ‘smart’ medical dressing developed by scientists at the University of Bath that changes colour when it detects infection will improve treatments for burns patients and help combat the global problem of antibiotic resistance by reducing the unnecessary use of antibiotics.
Children with burn wounds are particularly susceptible to bacterial infections because of their immature immune systems. Such infections can slow wound healing, leading to longer hospital stays as well as increased risk of permanent scarring. In severe cases, burn infection can lead to sepsis, which can kill.
16 November 2015
More Than 400 Pharmacists to be Recruited to GP Surgeries by Next Year
More than seven million patients will soon have access to expert advice from a clinical pharmacist when they visit their GP, thanks to the expansion of a new scheme to fund, recruit and employ pharmacists in local practices.
NHS England has more than doubled funding from £15m to £31m for its clinical pharmacists in general practice pilot, due to an overwhelmingly positive response from GP surgeries. NHS England, Health Education England, the Royal College of General Practitioners and the BMA are today announcing the 73 applications that will receive a share of the funding, which will cover 698 GP practices and include 403 clinical pharmacists.
10 November 2015
Integrated Care "Critically Important" for Older People with Social Care Needs and Multiple Long-Term Conditions
Health and social care services should work more closely together to ensure older people with social care needs and multiple long-term conditions receive effective care, says NICE.
In latest social care guidance, NICE calls for care to be integrated so that better, more person-centre care can be provided for the growing number of older people with social care needs and multiple long-term conditions.
Many long-term conditions such as dementia, diabetes, heart disease, and cancer are linked with age. Since the population is ageing, the number of people with long-term conditions is set to rise by about 1 million in the next 3 to 5 years.
6 November 2015
RCGP Response to BJGP Paper on Seven Day Working
The Royal College of GPs has responded to a paper published in the British Journal of General Practice showing a lack of demand for routine weekend opening of GP practices.
Dr Maureen Baker, Chair of the RCGP, said: “This adds even more weight to the argument against routine Sunday opening for GP practices. Not only will it be of little benefit to our patients - but they themselves do not want it."
3 November 2015
Withdrawing Dementia Drug Doubles Risk of Nursing Home Placement
Withdrawing a commonly-prescribed Alzheimer’s disease drug from people in the advanced stages of the disease doubles their risk of being placed in a nursing home within a year, according to research published today in The Lancet Neurology.
Researchers funded by the Medical Research Council and Alzheimer’s Society followed 295 people with moderate to severe Alzheimer’s disease to monitor the effects of continuing or discontinuing the drug donepezil - which is typically withdrawn in the later stages of the disease because of a lack of perceived benefit by clinicians. The participants were randomly selected to either continue donepezil or withdraw from the drug by receiving a placebo. These two groups were then each divided to test the effect of receiving another dementia drug, memantine, or a placebo.
29 October 2015
A Healthy Community Pharmacy Strategy
Filed under Mark Robinson
I am doing some research for a ‘Healthy Communities’ meeting I have been invited to. Lots of clever people will be there – you know counsellors and politicians, but I doubt there will be a pharmacist.
27 October 2015
Leading a Healthier Lifestyle Can Delay Dementia, Disability and Frailty in Later Life
People should be encouraged to stop smoking, be more physically active, reduce their alcohol consumption, and adopt a healthy diet to help lower the risk of developing dementia, disability and frailty in later life.
24 October 2015
GPs Back Levy on Sugary Drinks in Battle to Curb Obesity
GPs are backing calls for a levy on popular sugary drinks, ahead of today’s Health Select Committee where public health chiefs will be asked to explain why a report making the case for a ‘sugar tax’ has not been made available to MPs.
The Royal College of General Practitioners is calling on the Government to release the findings of the report prepared by Public Health England for Health Secretary Jeremy Hunt.
It wants Ministers to take urgent action to halt the use of sugar – or the ‘hidden enemy’ – that is a major contributor to obesity-related health problems and is costing the health service around £5bn a year.
20 October 2015
Study Finds Inflammation in the Brain is Linked to Risk of Schizophrenia
A study, published in the American Journal of Psychiatry, is the first to find that immune cells are more active in the brains of people at risk of schizophrenia as well as those already diagnosed with the disease.
The finding could completely change our current understanding of schizophrenia, raising the possibility that testing people most at risk of the disorder ahead of time could allow them to be treated early enough to avoid its most severe symptoms.
16 October 2015
GPs Call for Greater Access to Diagnostics for Detecting Cancer
RCGP response to BMJ study claiming that ‘slow’ referrals are driving up death rates
Dr Richard Roope, Cancer Lead for the Royal College of GPs and Cancer Research UK, said:
"Across the UK, GPs are already doing a good job of appropriately referring our patients that we suspect of having cancer – 75% of patients found to have cancer are referred after only one or two GP consultations.
13 October 2015
Antibiotics Not Effective For Rare Heart Infection
Antibiotics should not be prescribed to prevent infective endocarditis - a potentially fatal heart infection, NICE has reaffirmed.
Research published in The Lancet last year suggested that rates of infective endocarditis had increased in England after NICE advised against giving antibiotics to prevent the infection.
After the introduction of the NICE guideline in 2008, antibiotic prescribing fell significantly from an average of 10,900 prescriptions per month from January 2004 to March 2008, to only 2,236 prescriptions per month from April 2008 to March 2013.
12 October 2015
RCGP Response to Health Foundation’s Review into Quality Indicators for General Practices Across England
Scorecard approach to improving quality outcomes would be counter productive for GPs
Dr Maureen Baker, Chair of the Royal College of GPs, said: "We are pleased to see that common sense has prevailed and that the Health Foundation is advising against the introduction of a ‘GP scorecard’ as a way of measuring the quality of care in general practice.
29 September 2015
Cell 'Switch' Discovered That Could Shed Light on Cancer
Biologists, physicists and computational scientists have come together to solve the atomic structure of a protein which controls how cells make 'decisions' - giving clues for the design of new cancer drugs.
The protein, IKK-gamma, lies at the heart of a cobweb-like network of proteins which talk to one another inside the cell, determining how the cell will respond to its environment and to signals sent by other cells. The team’s findings suggest that tiny movements effectively switch the protein on and off, driving changes in cell behaviour.
25 September 2015
New Campaign Launched to Inspire Young Medics to Choose General Practice
Four of the country’s leading health bodies have joined forces to launch a new campaign to encourage more young doctors to become GPs.
The campaign forms one strand of the 10 point action plan ‘Building the Workforce – the New Deal for General Practice’ published in January 2015 and is aimed at increasing the number of doctors choosing to pursue a career as a GP
22 September 2015
RCGPNI Response to End of Private Contracts ‘Helped to Fuel NHS Waiting Crisis’
The RCGPNI would only view the use of the private sector as a stop gap measure
Responding to the latest news that Northern Ireland is the only region in the UK that is not using the private health sector to clear hospital waiting lists, Dr John O’Kelly, Chair of the Royal College of GPs Northern Ireland, said:
"It is deeply worrying to hear about the rise in hospital waiting times. As a GP, I regularly encounter patients who spend months waiting on much needed operations and can understand the discomfort and distress that this can cause to patients and their families.
18 September 2015
Helping GPS Make an Early Diagnosis of Cancer
Thousands of lives in England could be saved each year if the NHS follows updated guidance to help it diagnose cancer earlier. Here we outline what the guidance means for GPs.
NICE’s updated suspected cancer guideline covers the recognition and selection for referral or investigation in primary care of people of all ages, including children and young people, who may have cancer.
14 September 2015
NICE Joins Project to Make Development of New Treatments More Efficient
NICE is partner of a new public-private project which aims to identify activities that can make the development and regulation of medicines more efficient.
Called the Accelerated Development of Appropriate Patient Therapies (ADAPT SMART), and funded by the EU Innovative Medicines Initiative, the project is a collaboration between 32 international partners that includes regulators, patients, academia, and industry representatives.
10 September 2015
New Clinical Study Strengthens the Possibility that the Dissemination of Misfolded Proteins May Contribute to Alzheimer's Disease
A study published in Nature presents an interesting observational study on a small number of patients who had acquired CJD following treatment with growth hormone derived from human brain tissue - human-derived growth hormone has not been used since 1985.
8 September 2015
RCGP Response to Simon Stevens' Speech on Occupational Health Services for GPs
Dr Maureen Baker, Chair of the Royal College of GPs, said: “GPs are working harder than ever to meet increasing patient demand with limited resources and this unrelenting workload pressure undoubtedly puts our physical and mental health at risk.
“Fatigue, stress – and eventually burnout - among family doctors is increasing, to the detriment of their own health, and this could have a devastating impact on the care that our patients receive.
7 September 2015
Researchers Develop Novel Test Which Can Tell How Well a Person is Ageing
A new molecular test, which can indicate how well a person is ageing, could transform the way ageing is approached in medical research by assessing a person’s ‘biological age’ rather than the number of years they have lived.
The findings, published today in Genome Biology, could help improve management of age-related disease by identifying people most at risk of diseases affected by age, as well as improve the way anti-ageing treatments are evaluated.
1 September 2015
Stricter Blood Glucose Targets for People With Diabetes
New diabetes guidance includes tighter targets for blood sugar levels to help reduce variation in the management and care of condition.
Nearly 400,000 adults in the UK are affected by type 1 diabetes, and around 27,000 children and young people have either type 1 or type 2 diabetes.
Currently, most adults with type 1 diabetes are not maintaining the level of glucose in the blood. This means they are at increased risk of a range of complications over time such as blindness, kidney failure, heart disease and foot problems that can lead to amputation.
28 August 2015
Police – The New Health Workers?
Just by way of introduction, I have been invited to become the police special adviser on the NHS Alliance National Executive. I am a retired police officer with considerable experience in achieving health outcomes in disadvantaged neighbourhoods whilst working towards policing objectives. I am an honorary fellow at the University of Exeter Medical School and a Council of Europe “Expert” in the field of access to social rights.
25 August 2015
RCGP Response to BMJ Study on Alcohol and Cancer
Dr Richard Roope, Royal College of GPs’ Clinical Lead for Cancer, said: “We have known about the strong link between alcohol and cancer for sometime, but this study serves as a useful reminder about how pronounced this is, especially when coupled with smoking, and when people have a family history of cancer.
22 August 2015
Heart Attack Deaths could be cut if Hospitals Stuck to Guidelines
Fewer heart attack patients die after treatment in Swedish hospitals than in UK ones, and that could be down to differences in how patients are treated, MRC research suggests.
The researchers looked at data on how hospitals in the UK and Sweden treated patients who had suffered the most severe form of heart attack (ST elevation heart attack), and how many of these patients survived for 30 days after their attack.
18 August 2015
Calls for NHS to Curb Inappropriate Antibiotic Prescribing
Healthcare professionals should encourage sensible use of antibiotics and cut back on unnecessary prescribing of the drugs to help tackle the rise in antibiotic resistance, says NICE.
Antibiotics are a vital tool for modern medicine and not just for the treatment of infections, such as pneumonia, meningitis and tuberculosis, but also for preventing infections from occurring during surgical procedures and cancer treatment.
However, the more antibiotics are used the less effective they become. This is because overuse gives resistant bacteria a greater chance to survive and spread.
The problem of antibiotic resistance is compounded by the fact that the discovery of new antibiotics is at an all-time low.
14 August 2015
NHS Alliance presents Communites of Care, a programme with ITN Productions
ITN Productions are a long term and valued partner of NHS Alliance and its communications network. Building on our rich heritage of collaboration, we are again producing a news and current affairs-style programme exploring key issues, and showcasing good practice and innovation within healthcare in this vital year.
Communities of Care will be an in-depth, online programme specifically aimed at those within the sector. The programme will look at the efforts being taken to create a responsive and responsible system. Policies affecting primary care and initiatives to support the future of a proactive and preventative system will also be examined.
3 August 2015
Guideline on Deadliest Form of Skin Cancer to Reduce Variation in Care
NICE’s latest guideline aims to improve survival rates and reduce variation in the care of patients with melanoma, currently the fastest growing form of cancer.
The guideline covers the full pathway of care, and includes recommendations on managing low vitamin D levels, and the use of sentinel lymph node biopsy for staging.
Melanoma is a form of skin cancer that occurs when cells in the skin develop abnormally. It accounts for more deaths from cancer than all other skin cancers combined.
29 July 2015
RCGP Response to NICE Draft Guidance on End of Life Care
Dr Catherine Millington-Sanders, Clinical Lead for End of Life at the Royal College of GPs, said: “It is crucial that patients approaching the end of their lives receive high quality and compassionate care that is tailored to their own needs and wishes. This guidance highlights how important it is for people to be involved in having discussions about their care."
28 July 2015
Regular Consumption of Sugary Drinks Associated With Type 2 Diabetes
Sugar sweetened drinks may give rise to nearly 2 million diabetes cases over 10 years in the US and 80,000 in the UK.
Regular consumption of sugar sweetened drinks is positively associated with type 2 diabetes independent of obesity status, finds an MRC-funded study published in The BMJ this week.
Artificially sweetened drinks and fruit juice also showed a positive association with type 2 diabetes, but the quality of evidence was limited. None the less, the authors warn that neither artificially sweetened drinks nor fruit juice are suitable alternatives to sugar sweetened drinks for the prevention of type 2 diabetes.
27 July 2015
RCGP Response to the Roland Commission Report on Primary Care Workforce
In response to ‘The future of primary care: Creating teams for tomorrow’, Professor Maureen Baker, Chair of the Royal College of GPs, said:
“Patients – and the wider NHS – depend on the care of GPs in their local communities, but we have a severe shortage of family doctors and this will have a disastrous impact on future generations unless urgent action is taken to stem the tide.
21 July 2015
Offer Anticoagulants Instead Of Aspirin for Stroke Prevention
Adults with atrial fibrillation (AF) should be prescribed newer medications instead of aspirin for the prevention of stroke, says NICE.
AF is a condition that affects the heart, causing it to beat irregularly and too fast. When this happens, blood does not flow properly through the heart and the rest of the body.
This means that people with AF may be at increased risk of blood clots. Clots can block blood vessels, and a stroke can occur if a blood vessel in the brain is blocked by a clot.
19 July 2015
RCGP Response to the Independent Cancer Taskforce Report
Dr Maureen Baker, Chair of the Royal College of GPs, said: “GPs play a vital role in diagnosing patients with cancer and providing the care they need to help them live with the disease – and more support to allow us to do this effectively is essential.
“The Taskforce report outlines a number of recommendations, which if implemented properly – and resourced appropriately - have the potential to save thousands of lives.
“GPs are already doing a very good job of appropriately referring our patients who we suspect of having cancer, considering the relative rarity of presentations - an average GP might see eight new cases of cancer for every 8,000 patient consultations - and the limited resources available to us.
14 July 2015
Landmark 69-Year Study to Provide Window into Dementia
A landmark Medical Research Council (MRC) study that has been following a group of people since their birth in the same week in March 1946 is now turning its focus to the risk factors and early signs of dementia. A multi-disciplinary team of researchers based at UCL (University College London) is studying 500 members of the unique MRC National Survey of Health and Development as volunteers approach their 70thbirthday, to gain crucial insight into Alzheimer’s and other dementias. The study is funded by the MRC Dementias Platform UK, Alzheimer’s Research UK, Iceland Foods Charitable Foundation, and the Wolfson Foundation.
13 July 2015
Alcohol Abuse Has Devastating 'Domino Effect', Says RCGP in Response to Report from the Institute of Alcohol Studies
Policymakers should take heed of this important report
Dr Maureen Baker, Chair of the Royal College of General Practitioners, said:
“Everyday in our surgeries, GPs are dealing with the fallout of alcohol abuse in some of our patients’ lives, and this report really hammers home the devastating ‘domino effect’ on families and the wider community.
07 July 2015
RCGP Response to Alzheimers Society Report
Responding to today's report by the Alzheimer's Society, Professor Nigel Mathers, Honorary Secretary of the Royal College of GPs, said:
“This report demonstrates the scale of the challenge that GPs are facing every day in our surgeries in trying to care for the increasing numbers of patients whose lives are affected by this dreadful disease.
03 July 2015
New Standard to Help Reduce the Harm from Smoking
NICE’s latest quality standard sets out advice to help reduce tobacco-related harm for people who are unwilling or not ready to stop smoking.
Smoking is the single greatest cause of preventable illness and early death in England. Around half of all life-long smokers die prematurely losing about 10 years of life on average.
In 2012-13 smoking is estimated to have led to 460,900 NHS hospitable admissions in England alone among people aged 35 or over. This accounts for 5 per cent of all hospital admissions in this age group, and costs the NHS an estimated £2 billion per year.
30 June 2015
NHS Alliance Responds to Jeremy Hunt’s Speech on a New Deal for General Practice
Dr Michael Dixon, chair of NHS Alliance, said: “NHS Alliance welcomes today’s speech from the Secretary of State. I have long believed general practice is the jewel in the NHS crown, and today’s affirmation of this indicates we are likely to see a new dawn for general practice and primary care.
26 June 2015
Bloodless Malaria Test Passes First Test in Humans
A new laser test that can detect malaria in seconds with a simple skin scan is the first in-human device to diagnose the disease without drawing blood.
The device works by sending a safe laser pulse through the skin to a blood vessel. Here, if present, tiny parts of malaria parasites (called hemozoin) absorb the laser light. This causes them to instantly heat up and produce a microscopic vapour ‘nanobubble’. When this transient vapour bubble bursts, it produces an acoustic ‘pop’ which is detected through the skin by a sensor, indicating the presence of malaria.
23 June 2015
Reducing Variation in the Care of People with Osteoarthritis
NICE’s latest quality standard on osteoarthritis includes eight statements designed to tackle variation in the care of people with osteoarthritis.
Osteoarthritis is the most common form of arthritis and a leading cause of pain and disability. It has a higher prevalence in women than men and affects around 7.3 million people in England with– a figure that is likely to rise due to an ageing population and increasing rates of obesity.
19 June 2015
RCGP Response to Health Secretary's Announcement on 'First Step in a New Deal for GPs'
RCGP pleased Secretary of State publicly acknowledging the value of general practice, with the College credited for making compelling case for more investment in general practice
RCGP Chair Dr Maureen Baker said:
“We are really pleased that the Secretary of State is publicly acknowledging the value of general practice and the sterling job done by hardworking GPs up and down the country every day on behalf of their patients – after years of GPs being used as a whipping post by successive governments.
16 June 2015
Mother’s Environment Periconception May Affect Her Child's Life Long Risk of Disease
Scientists have shown for the first time that a mother’s environment before and around the time of conception, a period known as periconception, could permanently change the function of a gene influencing immunity and cancer risk in her child.
Diet is likely to play a role in this process, according to the study published in Genome Biology.
This is the latest discovery by an international collaboration led by researchers at the Medical Research Council (MRC) Unit in The Gambia, West Africa, and the MRC International Nutrition Group at the London School of Hygiene & Tropical Medicine together with a team at Baylor College of Medicine in Houston, Texas.
11 June 2015
RCGP Response to Seven-Day GP Access Pilot Decision
Responding to the decision by NHS Hambleton, Richmondshire and Whitby Clinical Commissioning Group to suspend seven-day access due to a lack of patient demand, Professor Maureen Baker, Chair of the Royal College of GPs, said:
“Seven day access to GP surgeries will be used and valued in some areas, but not everywhere, which is why it is essential that Clinical Commissioning Groups have the autonomy to tailor services to the needs of their local population."
9 June 2015
NHS England Asks NICE to Suspend Safe Staffing Programme
NHS England has asked NICE not to begin new activity in its safe staffing programme.
NHS England will now take forward the issue of staffing work as part of a wider programme of service improvement. It is looking at alternative approaches to helping NHS providers to achieve the right levels and mix of staff.
The chief executive of NHS England, Simon Stevens, told delegates at the NHS Confederation Annual Conference in Liverpool that they would review how staffing levels were determined across the NHS: "I have asked Jane Cummings, the chief nursing officer, to take a look at whether it would make more sense in respect of the new staffing guidelines that are being proposed for various parts of the health service, to instead remit that to our new urgent and emergency care vanguards and the mental health taskforce and various others – so a different approach to answering those questions."
5 June 2015
RCGP Response to RCEM and Patients Association Report on Urgent Care
Responding to the Royal College of Emergency Medicine (RCEM) and the Patients Association report ‘Time to Act – Urgent Care and A&E: the Patient Perspective’, launched today, Professor Maureen Baker, Chair of the Royal College of GPs, said:
“Family doctors already make a valuable contribution to Emergency Departments, both by working in them – and by treating patients in the community, keeping them out of hospital.
2 June 2015
RCGP Response to International Cancer Benchmarking Partnership Findings on Cancer Referral
Responding to research published by Cancer Research UK in the BMJ Open today, Dr Richard Roope, Clinical Lead for Cancer at the RCGP said:
“GPs see hundreds if not thousands of patients with potential cancer symptoms – but only an average of eight will be diagnosed with the disease. Data suggests that one-year survival rates are improving and three quarters of those found to have cancer are referred after one or two consultations.
26 May 2015
Michael Dixon’s Three Point Plan
Filed under Dr Michael Dixon
Increasing pressures and demand, with reduced real and relative funding over many years, have left general practice in poor heart. Early retirement of the 27% of GPs over 55, lack of young doctors to fill the insufficient training places, difficulties in recruiting other staff, and some GP practices going out of business altogether, all call for a radical review of general practice – what we expect of it and how we can enable it to deliver what patients and Government want and expect. Below is a practical three point plan to help general practice on its feet and enable GPs to shed the siege mentality, which has been an adaptive response to an increasingly undoable job. It will enable general practice to restore good family medicine and, with the right resources, meet wider aspirations of extended service and access.
26 May 2015
New Support for Clinical Audit from NICE
Quality standards will be the focus of a new range of audit support packages being developed by NICE.
A new tool being developed will help health and social care organisations audit the improvements they are making to their services, as part of a redesign of the audit support NICE provides.
"We have changed our approach to audit support to focus on NICE quality standards, as the statements they contain are designed to drive measurable service improvements," said Sally Chisholm, NICE’s programme director for adoption and impact. "We have developed a template that allows those who are undertaking an audit to measure either one or more quality standard at the same time.
20 May 2015
Paracetamol in Pregnancy May Lower Testosterone in Unborn Boys
Prolonged paracetamol use by pregnant women may reduce testosterone production in unborn baby boys, research has found.
Researchers at the Medical Research Council (MRC) say their findings could help to explain reported links between paracetamol use in pregnancy and reproductive health problems in young boys.
19 May 2015
RCGP Response to Prime Minister's Speech on 'Seven Day' NHS
Access to GP services important but weekend and evening access must not come at expense of access and services during normal hours making patients worse off
RCGP Chair Dr Maureen Baker said:
14 May 2015
Community Pharmacy – Back to the Future
Filed under Mark Robinson
I tried to explain at the Clinical Pharmacy Congress that Pharmacy ethos needs to change. We need to start with the person and work from there. A pharmacist asked me what I meant – so I visited their pharmacy and showed them what I was saying. I must say that there are others that think like me – it is clear with the Dispensing Health and the self-care pharmacy initiatives that some community pharmacists are on the same track.
12 May 2015
NICE Consults on Changes to Interventional Procedures Guidance Programme
Proposals now out for consultation seek to formalise the involvement of medical device manufacturers
NICE is updating the way it develops Interventional Procedures guidance to increase the speed and efficiency with which new surgical techniques and other technologies can be safely introduced into the NHS.
8 May 2015
New Screening Technique Could Pick up Twice as Many Women with Ovarian Cancer
A new screening method can detect twice as many women with ovarian cancer as conventional strategies, according to the latest results from the largest trial of its kind.
The method uses a statistical calculation to interpret changing levels in women’s blood of a protein called CA125, which is linked to ovarian cancer. This gives a more accurate prediction of a woman’s individual risk of developing cancer, compared to the conventional screening method which uses a fixed ‘cut-off’ point for CA125.
5 May 2015
NHS Alliance Announce the Launch of a New General Practice Nurse Network
NHS Alliance announces today the launch of a new nurse-led General Practice Nurse (GPN) network. The network is designed to promote and strengthen the role of nurses in primary care. It will also enable nurses working in primary care to connect with each other, and with wider primary and community colleagues, as well as patients’ carers and residents.
The network is the initiative of the co-vice chair of NHS Alliance, Heather Henry, a Queen’s Nurse and former GPN, and Louise Brady, the newly appointed GPN special adviser at NHS Alliance. Louise is a GPN at Donneybrook Medical Centre in Hyde and is also the GPN Clinical & Strategic Development Lead for the three NHS Manchester Clinical Commissioning Groups.
5 May 2015
RCGP Response to Economist Intelligence Unit Report on the NHS
Dr Maureen Baker, Chair of the Royal College of General Practitioners, said:
"The UK NHS has long been the envy of the world and the standard setter for other countries to follow so this is very disappointing.
"However, we strongly refute the claims that 'expensive' self-employed doctors will prohibit future recruitment.
"UK GPs are incredibly good value for money - providing 90% of patient contacts in the NHS - and boosting the number of GPs is the solution to so many of the problems currently besetting the health service."
28 April 2015
RCGP Response to BJGP Paper on Physician Associates
Responding to research published in the British Journal of General Practice today [Monday 27 April], Dr Helen Stokes-Lampard, Honorary Treasurer of the Royal College of GPs, said:
“Physician Associates must never replace GPs, but they can play a vital role in supporting doctors and other practice team colleagues.
"Widening the general practice team to include more Physician Associates and other roles - such as pharmacists working in practices as we proposed last month - is beneficial for patients and for general practice."
24 April 2015
Make Healthy Choices a Life-Long Habit to Prevent Early Death
Ensuring people develop healthy habits from an early age can help prevent long-term disease and early death, says NICE.
The advice comes from NICE’s three new quality standards, which together aim to encourage healthier lifestyles and reduce the economic and health burden of long-term illness.
The standards on tackling physical activity, preventing harmful alcohol use, and cutting smoking, provide advice to the NHS and local authorities on ways of improving the health of their communities.
21 April 2015
RCGP Response to BMA Survey on GP Workforce
Dr Maureen Baker, Chair of the Royal College of GPs, said: “These findings confirm what the College has been saying for some time about the chronic lack of family doctors across the country, and the devastating impact this could have on the future of general practice, the wider NHS, and most importantly, our patients.
16 April 2015
NICE Recommends Rivaroxaban to Prevent Blood Clots in Patients Who Have Had a Heart Attack
Rivaroxaban (Xarelto), in combination with clopidogrel and aspirin, or with aspirin alone, can now be used as an option for preventing blood clots in people who have had an acute coronary syndrome, following latest guidance.
People who have had a heart attack are at increased risk of further complications. In 2009/10 admissions for heart attacks in England, with 28,000 subsequent heart attacks.
14 April 2015
New Film Puts Hep C in the Primary Care Spotlight
A new film to raise awareness and increase knowledge of hepatitis C among GPs and other primary care practitioners has been launched today by the Royal College of GPs, the Hepatitis C Trust and HCV Action.
Hepatitis C affects around 214,000 people in the UK and the virus can lead to liver disease and cancer, making it a significant public health issue.
10 April 2015
Ensuring People with Autism Get the Best Treatment and Care
Health and social care practitioners can ensure they are delivering the best treatment and support for people with autism by following NICE’s quality standard, according to a leading expert.
“On World Autism Awareness Day it is worth remembering that autism is a condition that affects both adults and children, and while it has no cure, early access to specialist treatment can help,” said Jonathan Green, Professor of Child and Adolescent Psychiatry at the University of Manchester, and a member of the committee that developed the quality standard.
7 April 2015
NHS Alliance Backs RCGP and RPS Proposals on GP Practice Based Pharmacists
Speaking after today’s announcement from the RCGP and RPS, Mark Robinson, medicines, pharmacy and medicines optimisation lead at NHS Alliance, said: “NHS Alliance welcomes today’s announcement from the RCGP and RPS. The proposed plan highlights the need for a mixture of skills within the evolving general practice model, and sheds some light on how pharmacists could provide a timely addition to the practice team. The news builds upon work that NHS Alliance has been doing over the past six months, much of which has demonstrated that patients value the ability to choose between a practice nurse, practice pharmacist, or a GP, depending on their needs.
6 April 2015
Building on the Success of Brain Research
The MRC Anatomical Neuropharmacology Unit at the University of Oxford (MRC ANU) will close on 31 March after 30 years of world leading research on the complex networks of the brain. Under the leadership of director Professor Peter Somogyi and associate director Professor Paul Bolam, the MRC ANU has played a vital role in understanding healthy brain function and disorders such as Parkinson's disease.
24 March 2015
New Images of the Brain Show the Forgetful Side Effect of Frequent Recall
A study by the MRC (Medical Research Council) Cognition and Brain Sciences unit in Cambridge has shown how intentional recall is beyond a simple reawakening of a memory; and actually leads us to forget other competing experiences that interfere with retrieval. Quite simply, the very act of remembering may be one of the major reasons why we forget.
20 March 2015
Pharmacists Set to Work in GP Surgeries in Radical Move to Ease Pressures on General Practice and Improve Patient Care
Radical proposals calling for pharmacists to work in GP surgeries will be unveiled at a summit in London today (Tuesday 17 March).
The Royal College of General Practitioners (RCGP) and the Royal Pharmaceutical Society (RPS) have come up with the plans in a bid to ease current pressures in general practice and address the severe shortage of GPs.
They say that the move will improve patient safety and care and, crucially, reduce waiting times for GP appointments.
17 March 2015
Most Home Care Visits Should Be At Least Half an Hour
Home care visits to elderly people should last for at least half an hour and be centred around personalised care rather than a “one-size fits all” service, says NICE.
Last year, an investigation by Unison found that the number of councils in England commissioning 15 minute home care visits is on the rise.
In 2013/14, 470,000 people used home care funded by local authorities in England, with the vast majority, 79 per cent, people aged 65 or older.
13 March 2015
Medical Royal Colleges urge future governments to invest in the NHS
Chairs and Presidents of six Medical Royal Colleges have signed the following letter, which has been published in the Guardian today.
Dear Sir,
Recent polls showing that the NHS will be the number one issue for many voters in the forthcoming general election reflect how much our health service is valued by all sections of society, but also how worried the public is about its future.
10 March 2015
Combination Cell-Gene Therapy for Lung Cancer to be Tested in UK Patients
A pioneering new combined cell-gene therapy to treat lung cancer will be tested in NHS patients this year, after receiving £2m of Biomedical Catalyst funding from the Medical Research Council (MRC).
Researchers led by Professor Sam Janes at UCL/UCLH will carry out the first UK clinical trial of a combined stem cell and gene therapy for the disease which kills around 34,000 people a year in the UK.
7 March 2015
RCGP Chair Comment on Easter Opening
Dr Maureen Baker, Chair of the Royal College of GPs, has commented on plans for GP practices to open over the Easter holiday.
She said: “It is vital that patients have access to the appropriate GP services at holiday times and, as happened at Christmas, many GPs and their teams will be working flat out to provide care for patients over the Easter period."
3 March 2015
Women in Established Labour Should Receive One-To-One Care
Women in established labour should receive supportive one-to-one care to ensure they have a safe experience of giving birth, NICE says.
The recommendation comes from NICE’s second guideline on safe staffing in the NHS, which gives advice on midwifery safe staffing levels for women and their babies on whatever setting they choose.
2 March 2015
RCGP Response to Leonard Cheshire Disability Research
Dr Maureen Baker, Chair of the Royal College of GPs, has commented on research by Leonard Cheshire Disability showing that GPs spend 15,000 hours a month caring for disabled and elderly patients who have suffered health problems because of their inaccessible homes.
Dr Baker said: “GPs treat the whole person, so we are only too aware that inaccessible or inadequate housing can have a negative impact on our patients’ physical and mental health.
24 February 2015
Unhealthy Eating Habits Outpacing Healthy Eating Patterns in Most World Regions
Worldwide, consumption of healthy foods such as fruit and vegetables has improved during the past two decades, but has been outpaced by the increased intake of unhealthy foods including processed meat and sweetened drinks in most world regions, according to the first study to assess diet quality in 187 countries covering almost 4.5 billion adults, published in The Lancet Global Health journal, and funded by the Medical Research Council and the Bill and Melinda Gates Foundation.
24 Feb 2015
GPS Facing 'David Versus Goliath' Battle to Provide Out of Hours Care
GPs who want to run out of hours services in their local areas should be awarded contracts without facing a ‘David versus Goliath’ struggle with large private companies, according to a report launched today by the Royal College of General Practitioners.
The College says that the regulations for awarding contracts should be clarified, and legislative changes made if necessary, to enable practices or groups of practices to take back their out of hours service without having to go through a competitive tender.
17 February 2015
Tackling Variation in the Care of Patients With COPD
Improving access to specialist care and smoking cessation support are among actions that can help reduce variation in the care of patients with COPD, according to a new report.
The report recommends following NICE’s quality standard on chronic obstructive pulmonary disease (COPD) to help measure improvements made and standardise care.
COPD is a term used to describe a range of lung diseases that include chronic bronchitis, emphysema and chronic obstructive airways disease. People with COPD have difficulties with breathing, which can impact on their quality of life.
13 Feb 2015
RCGP Response to Report on the Health Benefits of Exercise
Responding to the Academy of Medical Royal Colleges’ report, Dr Maureen Baker, Chair of the Royal College of GPs, said:
“There is no doubt that exercise is beneficial for our patients’ physical and mental health – but the extent of the benefits, as outlined in this report, are astounding."
10 February 2015
New League Table Reveals GP Shortages Across England, as Patients Set to Wait Week or More to See Family Doctor on 67m Occasions
A new ‘league table’ of projected GP shortages across England shows that some parts of the country will need substantial increases in the number of family doctors employed locally by 2020, to meet the growth of the population.
Figures produced by the Royal College of General Practitioners (RCGP) today show that certain areas of the country will need at least a 50% increase in the number of GPs working in the community over the next five years - due both to the growing population, and shortages of family doctors that already exist locally.
06 Feb 2015
Babies with More Frequent Eye Movements Are More Likely To Develop ASD
Researchers funded by the Medical Research Council (MRC) have found that babies who move their eyes more often than their peers at the age of six months are more likely to meet criteria for Autism Spectrum Disorder¹ (ASD) as children.
In everyday life, babies are constantly making fine eye movements which are barely visible. The frequency of these movements has been thought to show how engaged an infant is with what they are looking at, and how quickly they process what they are seeing.
3 February 2015
Draft Guideline to Improve Asthma Diagnosis
Spirometry should be used as the first-line investigation for diagnosing asthma in children over 5 and adults, says NICE.
The draft guideline – NICE’s first on asthma – reinforces recommendations made in the 2014 BTS/SIGN asthma guideline which also supports spirometry as the preferred initial test to assess the presence and severity of airflow obstruction.
Currently, there is no gold standard test available to diagnose asthma and it is diagnosed principally on the basis of a thorough history taken by an experienced clinician.
29 January 2015
Minister Announces £14m Investment in Stratified Medicine
Minister for Life Sciences George Freeman today announced a further £13.7 million investment in stratified medicine collaborations funded by the Medical Research Council (MRC).
These four new awards bring the total of stratified medicine consortia funded by the MRC to thirteen with investment totalling over £52 million – part of the government’s £130 million commitment to stratified medicine set out in the UK Life Sciences Strategy.
27 January 2015
New Genetics Study Identifies Possible Target for Epilepsy Treatment
A single gene that coordinates a network of about 400 genes involved in epilepsy could be a target for new treatments, according to research.
Epilepsy is a common and serious disease that affects 1 in 200 people. The mortality rate among people with epilepsy is two to three times higher than the general population. It is known that epilepsy has a strong genetic component but the risk is related to multiple factors that are ‘spread’ over hundreds of genes. Identifying how these genes are co-ordinated in the brain is important in the search for new anti-epilepsy medications. This requires approaches that can analyse how multiple genes work in concert to cause disease.
26 January 2015
£10 Million Investment Boost to Expand General Practice Workforce
Health leaders have today announced a £10 million investment to kick start a new plan to expand the general practice workforce.
NHS England funding will be used to develop a range of initiatives in collaboration with Health Education England (HEE), the Royal College of General Practitioners (RCGP) and the BMA to increase the number of GPs and develop the role of other primary care staff such as nurses and pharmacists.
20 January 2015
NICE Sets out Draft Safe Staffing Guidance For A&Es
NICE has outlined draft guidance to help A&E departments ensure there are enough nursing staff available to provide safe care at all times to patients.
The number of A&E visits increased in 2014 by more than 40,000, with many hospitals currently declaring 'major incidents' as they struggle to cope with demand.
The figures published by NHS England revealed that there were over 14.6m visits to A&E in 2014 - an increase of 446,049 on 2013.
19 January 2015
European Boost to Dementia Research
People at risk of dementia will benefit from a £50 million initiative to improve drugs that could prevent the condition.
Scientists from the UK will collaborate in a new European initiative to identify people at high risk of developing Alzheimer’s disease and invite them to participate in trials of new drugs that could slow its onset.
13 January 2015
Researchers’ Help Needed For Crowdsourced Map of UK Science Landscape
The Prime Minister’s Council for Science and Technology is looking at the UK science landscape. The aim of this project is to build a picture of the whole research landscape in the UK and to develop a stronger evidence base. This evidence base will help to inform future strategic decision-making and help the UK to maintain and develop its excellence in research.
11 January 2015
RCGP Statement on NHS England Cancer Taskforce
Dr Maureen Baker, Chair of the Royal College of GPs, said: “For the first time ever, the number of people living with cancer is equal to those dying from it. This is a great achievement but UK survival rates are still lagging behind the European average. The new taskforce will help to address this and it is crucial that GPs are at the centre of its work.
6 January 2015
Address Gaps in Mental Health Care for New Mothers
By Sanjay Tanday
Women who have experience of, or are at risk of mental health problems, should get extra support before, during and after their pregnancy, says NICE.
Between 10 and 20 per cent of women develop a mental illness during pregnancy or within the first year after having a baby.
31 December 2014
GPs and Physicians Want Care Based on Patients' Needs Rather Than Buildings
A new joint statement on integrated care issued today by the Royal College of Physicians and the Royal College of General Practitioners supports the provision of new models of care based on the needs of patients, service users and communities, rather than buildings.
The statement, which is also supported by other medical Royal colleges and faculties, sets out the values, vision and commitments of both colleges in working together at a national level to promote person-centred care, integrated care and collaboration.
30 December 2014
NICE Greenlights Dabigatran for Treatment of Blood Clots
Patients at risk of recurrent blood clots can now be offered dabigatran (Pradaxa) as an alternative to warfarin, says NICE.
In latest guidance, NICE recommends the drug as an option for treating and preventing recurrent deep vein thrombosis (DVT) and pulmonary embolism in adults.
Around 1 in every 1000 people in the UK is affected by DVT, a condition that increases in risk with age. Further risk factors include a previous DVT or pulmonary embolism, obesity and the presence of comorbidities such as heart disease.
26 December 2014
Major Initiative to Encourage People to Apply for Places in General Practice Training
RCGP Chair, Dr Maureen Baker, has today written to thousands of trainee doctors in England, encouraging them to apply for a career as a GP.
This is the first time that the Chair of the RCGP has ever taken such a step on this scale, in a bid to address the chronic shortage of GPs in England.
23 December 2014
Cognitive Abilities Age at Different Rates Because Our Brains Age Differently
Some skills may ‘go’ quicker than others
Researchers at the Medical Research Council’s Cognition and Brain Sciences Unit have discovered that specific mental abilities – such as problem-solving or multi-tasking – decline with age at different rates because individuals’ brains age differently.
This challenges the previously held idea that, as we get older, these types of mental abilities all decline at the same rate. Given the number of people who are now living well into old age, this has important implications for our understanding of declining mental ability.
19 December 2014
RCGP Response to GMC-Commissioned Review ‘Doctors Who Commit Suicide While Under GMC Fitness to Practise Investigation’
RCGP Chair Maureen Baker said: “Patient safety must be paramount in any fitness to practise process, but it is also essential that GPs and all doctors are investigated fairly and sensitively. It is shocking that so many of them have taken their own lives while investigations have been ongoing.
16 December 2014
RCGP Response to Care Data Report
Response to the report on Care.data by the All Party Parliamentary Group for Patient and Public involvement in Health and Social Care and the Patients Association
RCGP Honorary Secretary Nigel Mathers says:
“This report reinforces everything we have been calling for and adds weight to the need for a more cautious roll-out and for patients to be able to actively opt out.
“We also support the recommendation for open consultation on the data sets that will eventually be used.
4 December 2014
Public to Shape How NICE Balances Fairness with Efficiency
Dignity, collective responsibility, and safeguarding the vulnerable are among the values that should be considered when making decisions about how resources should be spent both fairly and efficiently.
The recommendation comes from the latest report by the NICE Citizens Council, which is a group of members of the public that provides input into NICE’s work.
Given the climate of increasing resource pressures in health and social care, it is often difficult to find ways of balancing an efficient use of resources – where the most is done with what’s available – with equity, where they are fairly distributed.
9 December 2014
UK Clinical Research Collaboration Establishes New National Tissue Directory and Research Collaboration
UK Clinical Research Collaboration establishes new National Tissue Directory and Research Collaboration
The Medical Research Council is pleased to announce on behalf of the UK Clinical Research Collaboration (UKCRC)* the establishment of a National Tissue Directory and Coordination Centre, led by University College London in collaboration with Nottingham University.
3 December 2014
NHS Alliance and RPS Report Suggests Pharmacists Hold Solution to Workforce Crisis in General Practice
The NHS Alliance and the Royal Pharmaceutical Society have produced a new report, Pharmacists and general practice: A practical and timely part of solving the primary care workload and workforce crisis, on pharmacists and the role that they could play in general practice.
2 December 2014
RCGP Statement on Flu Vaccinations
Dr George Kassianos, RCGP Immunisation Lead, said: “Flu can have potentially serious consequences and young children - particularly those under the age of five years - are one of the groups who are most at risk, so we are concerned that the uptake of the vaccine is lower than last year and that such a large number of parents are still unaware that it is now available in a nasal spray.
27 November 2014
Offer Weight Loss Surgery to Obese People With Diabetes
The NHS should offer weight loss surgery to thousands more people in order to tackle an epidemic of type 2 diabetes, says NICE.
A quarter of the UK population is now obese, fuelling a rise in cases of type 2 diabetes, as well as heart disease, fatty liver disease and cancer.
One in 20 people in the UK has type 2 diabetes. It is a progressive disease that causes heart disease, stroke, blindness, kidney failure and limb amputations.
25 November 2014
New National Research Centre to Tackle Musculoskeletal Disorders in the Workplace
A major new research centre to tackle the impact of musculoskeletal disorders on people’s ability to work has been announced by two leading medical research bodies.
Researchers at the £1.4m Arthritis Research UK/MRC Centre for Musculoskeletal Health and Work, led by the University of Southampton, aim to find cost-effective ways of reducing the impact of conditions that affect the muscles, joints and bones on people’s employment and productivity, with benefits for patients, employers and society as a whole.
21 November 2014
Summit on World Diabetes Day Aims to Reduce Variation in Quality of Care
To mark World Diabetes Day, The Diabetes Exchange, NHS Alliance and Novo Nordisk have joined together to hold the first Diabetes Exchange Summit. The event will investigate how we can solve the challenges we face as levels of diabetes continue to rise, and look at how we can reduce variation in the quality of care, as well as stimulate the development and adoption of new models of out-of-hospital care.
18 November 2014
RCGP Response to Care Quality Commission's Intelligent Monitoring for GP Practices
Dr Maureen Baker, Chair of the Royal College of General Practitioners, said: “Every patient has a right to expect high quality and consistent care from their local GP practice, and it is crucial that we urgently address any variations in quality of care.
“But patients should be assured that the vast majority of practices are doing an excellent job of delivering care to the highest possible quality standards. Over 75% of practices show little cause for concern, with more than half identified as ‘lowest priority’.
11 November 2014
NICE Guidance on Smoking Cessation in Hospitals Could Have a Major Impact on Cutting Smoking Rates
Clinicians should make better use of opportunities to help people quit smoking when they present to hospitals in England, and have the potential to prevent hundreds of thousands of premature deaths by reaching 1.1 million smokers each year, say researchers.
It is estimated that around 460,000 adult admissions to NHS hospitals in England every year are due to smoking. Treating diseases caused by smoking costs the NHS more than £5 billion per year, about 5 per cent of its annual budget, despite the fact that smoking is preventable and treatable.
11 November 2014
UK Tobacco Controls a Success In Cutting Smoking Among Adolescents
A new study has revealed a significant drop in the number of young people taking up smoking over the last 20 years, as the UK has introduced a range of tobacco controls.
However the research findings also show inequalities in starting smoking across different economic backgrounds, despite these regulations.
The figures, taken from the period between 1990 and 2012, show a fall of 50 per cent in the numbers of 15 years-olds who try smoking for the first time, and around a 50 per cent decrease in the likelihood of young people progressing to becoming occasional or daily smokers after initiation.
7 November 2014
NHS Alliance Produces Briefing On Primary Care And Housing
The NHS Alliance has produced a new ‘Viewpoint’ briefing on primary care and housing for members of the Housing LIN (Learning and Improvement Network), titled Breaking Boundaries: reinventing primary care www.housinglin.org.uk/PrimaryCare_Viewpoint.
4 November 2014
Psoriasis is 'More than Just a Skin Condition'
Healthcare professionals should be aware that psoriasis can affect a person’s psychological and social wellbeing, and not just their physical health, says NICE.
Psoriasis is a long-term condition that is characterised by red, flaky, patches of skin covered with silvery scales, affecting around 1.8 million people in the UK.
While psoriasis can begin at any stage in life, most cases start before the age of 35, and peak between the ages of 50 and 60.
31 October 2014
RCGP Launches 'Common Sense' Guide to Ebola For GPs And Their Teams
A step-by-step guide to help GP practices prepare for and deal with the Ebola outbreak is published today by the Royal College of General Practitioners (RCGP).
The guidance – presented in the form of a card index – has been designed to ensure that patients receive the best and speediest care possible whilst protecting practice teams from possible contamination, in the event of the virus reaching the UK.
28 October 2014
RCGP Comment on Patient De-Registration
The RCGP have commented on an article in Pulse on GP catchment areas.
Dr Maureen Baker, Chair of the Royal College of General Practitioners, said: “This is an extremely distressing situation for patients and for GPs and their practice teams. Every patient should be able to see their family doctor when they need to, and GPs want to provide the best possible access and high quality care for all their patients.
21 October 2014
Co-Commissioning Primary Care: An Opportunity For Community Led Co Design?
Over the last year, clinical commissioning groups have been busy developing their five year strategies. Prompted by NHS England’s calls to action around primary care, they have simultaneously been thinking about how GP care in particular needs to change. It is perhaps not surprising then that when invited, just under 90% of CCGs expressed an interest in co-commissioning primary care.
20 October 2014
People with Dementia ‘Will Experience Poor Care’
People with dementia will experience poor care at some point while living in a care home or being treated in hospital, the Care Quality Commission (CQC) has warned.
The CQC carried out a specific review of the care of people living with dementia as they moved between care homes and acute hospitals in England during 2013 and 2014. The review included 129 care homes and 20 hospitals from 22 local authority areas.
Although the CQC found more good care than poor care in the care homes and hospitals that were inspected, the quality of care for people with dementia varied greatly. At present, a person living with dementia will experience poor care at some point along the care pathway, they concluded.
13 October 2014
New Cancer Drug To Begin Trials In Multiple Myeloma Patients
Scientists at Imperial College London have developed a new cancer drug which they plan to trial in multiple myeloma patients by the end of next year.
In a paper published today in the journal Cancer Cell, the researchers report how the drug, known as DTP3, kills myeloma cells in laboratory tests in human cells and mice, without causing any toxic side effects, which is the main problem with most other cancer drugs. The new drug works by stopping a key process that allows cancer cells to multiply.
14 October 2014
RCGP Response to Public Health England Report on Antibiotics
The Royal College of General Practitioners (RCGP) has responded to the first annual report of PHE’s English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR), published today
Dr Maureen Baker, Chair of the Royal College of GPs, said: “It is clear that GPs and other healthcare professionals have further to go in promoting efforts to reduce our population’s resistance to antibiotics.
9 October 2014
Ambitious New Studies Will Give New Insights into Parkinson’s, Addiction and The Immune System
Three ambitious new research programmes, which aim to deliver a step-change in our understanding of disease by using human volunteers in experimental studies, have been funded as part of a £60m investment from the Medical Research Council (MRC).
7 October 2014
New Public Health Quality Standards Announced
NICE is to develop over 70 new public health quality standards on topics ranging from antibiotic prescribing to domestic violence, following the latest topic referral from the Department of Health.
NICE quality standards describe high-priority areas for quality improvement in a defined care or service area. They are derived either from NICE guidance or NICE accredited sources, and apply right across the NHS, social care and public health in England.
6 October 2014
Integrated Thinking for Integrated Care – NHS Alliance and Foundation Trust Network Form New Collaboration
Two leading representative bodies for organisations providing services to the NHS across both primary and secondary care, have formed a strategic partnership with a vision to explore and break down some of the historic silos and tensions that continue to hinder innovation in the health service.
30 September 2014
Modest Effect of Statins on Diabetes Risk and Bodyweight Related to Mechanism of Action
The mechanism by which statins increase the risk of type 2 diabetes has been investigated in a large-scale analysis from an international team led by researchers from UCL and the University of Glasgow, using information from genetic studies and clinical trials. Published in The Lancet, the work received support from a number of funders including the Medical Research Council, British Heart Foundation, Rosetrees Trust and National Institute for Health Research University College London Hospitals Biomedical Research Centre.
Among nearly 130 000 participants from clinical trials that previously tested the effect of statins on heart disease and stroke (major vascular events), those assigned statins vs. placebo, or higher vs. lower doses of statins, were noted to have a small increase in risk of developing type 2 diabetes of about 12% over a four-year period, and also to gain an excess of 240g (around half a pound) in weight.
26 September 2014
Waiting Times to See a GP Now a 'National Crisis'
More than half of Britons think that waiting times to see a GP are now a 'national crisis’, as latest predictions from the Royal College of General Practitioners (RCGP) show that on 60m occasions over the next year, patients will have to wait a week or longer to see their GP or practice nurse.
23 September 2014
RCGP Response to Scottish Referendum
Dr Maureen Baker, Chair of the RCGP, and Dr John Gillies, Chair of RCGP Scotland, said:
“Following the fervent and passionate debate that has taken place over the question of Scottish independence, the Royal College of General Practitioners takes note of the decision of the Scottish electorate to stay in the UK, and will continue to ensure that all of its members in Scotland – and England, Wales and Northern Ireland – are given a strong voice on the key issues affecting the future of general practice, including the urgent need to increase funding for excellent patient care.”
22 September 2014
NICE Approves Jaw Replacement Surgery, in 500th IP
NICE has recommended the use of jaw replacement surgery for people who have pain and difficulty opening their mouth and are unable to eat a normal diet.
Temporomandibular joint disorders are problems that affect the joint between the lower jaw and the base of the skull. TJDs are relatively common and can occur in approximately 20-30 per cent of the adult population. Symptoms may occur at any age but are more common in women and in early adulthood.
16 September 2014
Nearly 800,000 Patients Face Struggle to See Their GP in Three Years' Time, Warns Royal College
An estimated 800,000 patients in Wales will find it difficult to secure a convenient appointment with their local GP by 2017 because surgeries are buckling under the strain of rising workloads and falling resources, the Royal College of General Practitioners (RCGP) has warned.
According to new research published by the RCGP, more than 650,000 people found it difficult to get a GP appointment last year and it is estimated that this number could rise to 800,000 by 2017.
12 September 2014
NICE to Seek Greater Access to Clinical Trial Data When Appraising Drugs
NICE will ask for access to clinical trial data from the European regulatory authorities if pharmaceutical companies fail to supply all the relevant data.
The move follows calls for increasing transparency from pharmaceutical companies and comes after Roche was criticised for its handling of data for the pandemic flu drug Tamiflu.
The AllTrials group was set up in the UK on the back of the Tamiflu revelations to call for all past and present clinical trials to be registered and their full methods and summary results reported. To date, 79,855 people and 507 organisations have signed the AllTrials petition including NICE and patients involved in NICE (PIN).
9 September 2014
40 Per Cent of Women with Severe Mental Illness Are Victims of Rape or Attempted Rape
Women with severe mental illness are up to five-times more likely than the general population to be victims of sexual assault and two- to three-times more likely to suffer domestic violence, reveals new research led by UCL and King’s College London funded by the Medical Research Council and the Big Lottery.
5 September 2014
NHS Alliance responds to the Policy Exchange’s new report: ‘The Estate We’re In’
The NHS Alliance welcomes this report highlighting as it does the poor social, health and well- being outcomes and the life experiences endured by residents in some, but by no means all, disadvantaged estates. We agree that heavy financial investment is not the answer and the most successful and lasting solutions occur when residents are supported by service providers towards self-management of their communities, as echoed in the case studies used.
2 September 2014
Hospitals Urged to Tackle Incorrect Use of Drips
Every hospital should appoint an intravenous (IV) fluids lead to help ensure that patients receive the correct dosage and type of fluid, says NICE.
This follows concerns that as many as 1 in 5 patients on IV fluids and electrolytes suffer complications due to inappropriate administration, according to figures from the National Enquiry into Perioperative Deaths report.
31 August 2014
Health Leaders Declare 'State of Emergency' on Childhood Obesity
GPs are calling for a COBRA-style emergency taskforce to be set up to tackle the rising epidemic of childhood obesity.
Health Leaders are warning that unless urgent action is taken now, an entire generation will be ‘destroyed’ by a diet of junk food and sugary drinks - and the NHS will be completely overwhelmed as a result.
26 August 2014
New Funding to Advance Use of Existing Studies in Neurodegeneration and Dementia Research
The EU Joint Programme - Neurodegenerative Disease Research (JPND) - has awarded funding for ten groups of leading international scientists to produce guidelines and frameworks to open up the use of existing population studies for research into neurodegenerative disease.
The award scheme was led by the Medical Research Council (MRC), as part of a series of JPND activities designed to maximise the impact of research by aligning and building upon national programmes and initiatives, and to bring a more wide-ranging and multidisciplinary approach to research into the causes, treatment and prevention of neurodegenerative disorders.
26 August 2014
RCGP Response to Public Health England Figures on Cancer Survival Rates
The RCGP has responded to Public Health England figures that show an increase in the number of patients surviving for at least one year after being diagnosed with cancer.
Dr Richard Roope, Cancer Lead for the Royal College of GPs (RCGP), said: “These figures are an indication of the excellent efforts made by GPs – and health professionals right across the NHS – to identify cancer at the earliest possible opportunity and to raise awareness of the disease and its symptoms amongst our patients. These findings are testament to recent Be Clear On Cancer campaigns and the increasing primary care engagement undertaken by GP Cancer Leads.
19 August 2014
Thousands of Doctors Prevented from Returning to GP Workforce by Red Tape
Up to 5,000 family doctors who have emigrated or opted for early retirement are being prevented by needless red tape from returning to the GP workforce if they wish to – at a time of a growing crisis in general practice, according to new research.
The Royal College of General Practitioners and the British Medical Association (BMA) say that the rules governing the eligibility of family doctors to work in England are being interpreted in such a bureaucratic way that thousands of qualified GPs who would like to return to work after extended periods of maternity leave or practising medicine abroad are effectively being disbarred from the GP workforce without good reason.
18 August 2014
Annual Diabetes Checks among Indicators Proposed For Latest NICE QOF Menu
A series of annual checks to monitor and improve the health of people with diabetes are among measures proposed by NICE for its latest Quality and Outcomes Framework (QOF) indicator menu.
The QOF is a voluntary incentive scheme for GP practices in the UK, rewarding them for how well they care for their patients, and helping them target resources for where they are most needed. It consists of groups of indicators against which practices score points according to their level of achievement.
12 August 2014
Scientists Unlock Key to Blood Vessel Formation
Scientists from the University of Leeds have discovered a gene that plays a vital role in blood vessel formation; research which adds to our knowledge of how early life develops.
The discovery could also lead to greater understanding of how to treat cardiovascular diseases and cancer. The research, funded by the Medical Research Council, Wellcome Trust and the British Heart Foundation (BHF), is published in scientific journal Nature.
Professor David Beech, of the School of Medicine at the University of Leeds, who led the research, said: “Blood vessel networks are not already pre-constructed but emerge rather like a river system. Vessels do not develop until the blood is already flowing and they are created in response to the amount of flow. This gene, Piezo1, provides the instructions for sensors that tell the body that blood is flowing correctly and gives the signal to form new vessel structures.
5 August 2014
NHS Alliance Response to NICE’s Public Health Draft Guideline on Risks Associated with Cold Homes
The NHS Alliance has issued a response to NICE’s public health draft guideline on
Excess winter deaths and morbidity and the health risks associated with cold homes.
Key points raised in the submission include:
- The impact of cold homes on people’s health and mortality is now proven and it is refreshing to see such an important matter being addressed by the NHS in such a comprehensive way. We are particularly pleased that the guidance emphasises treatment of the causes of ill health and mortality ie, how to make the cold housing warmer, rather than focus on the medical symptoms.
5 August 2014
Crisis Hit GP Surgeries Forced to Turn Away Millions of Patients
GP surgeries are so overstretched due to the lack of investment in general practice that in 2015 on more than 51.3m occasions patients in England will be unable to get an appointment to see a GP or nurse when they contact their local practice, according to new research.
According to the Royal College of General Practitioners (RCGP), the number of occasions during which patients have to wait more than a week to see their GP or practice nurse are set to go through the 50m barrier for the first time ever following successive rises in previous years: up from 41.9m occasions in 2013 and 46m occasions this year.
28 July 2014
Reducing the Spread of Hepatitis B
NICE’s quality standard for hepatitis B can help to reduce the spread of the infection by ensuring that people who are at increased risk are offered testing and vaccination.
Testing should be offered in a range of settings such as at GP practices including new registrations, prisons or immigration removal centres, drug services, and sexual health and genitourinary medicine clinics.
29 July 2014
Prevention Not Cure: Health on The High Street Key to NHS Survival According to New Report
A new cross-sector paper, We Are Primary Care, published today by a broad spectrum of primary care health professionals, urges the public and policy makers to look beyond general practice as the only alternative to hospital care. The paper highlights the political drive to address the extreme demand and fiscal pressure on the NHS by taking care out of hospital and into the community, but argues that this can only be successful if people have a clear understanding that GPs are not always the most appropriate first contact. It further argues that reducing demand is an imperative and that high street health specialists have a key role to play in tackling public health challenges like smoking and obesity.
25 July 2014
Seven Pharma Companies Offer up Compounds to UK Researchers
UK researchers will be granted access to a ‘virtual library’ of deprioritised pharmaceutical compounds through a new partnership between the Medical Research Council (MRC) and seven global drug companies, announced today by Business Secretary Vince Cable.
AstraZeneca, GlaxoSmithKline, Janssen Research & Development LLC*, Lilly, Pfizer, Takeda and UCB will each offer up a number of their deprioritised molecules for use in new studies to improve our understanding of a range of diseases, with a view to developing more effective treatments.
22 July 2014
RCGP Response to NICE Guidelines on Lipid Modification
RCGP Chair says new guidance has major implications for patients and for general practice. GPs and practice teams do their best for patients, but workload implications of new guidance are immense
18 July 2014
Wider Use of Statins Could Cut Deaths from Heart Disease
Up to 8,000 lives could be saved every three years by offering statins to anyone with a 10 per cent risk of developing cardiovascular disease (CVD) within a decade, says NICE.
In an update to the 2006 guideline on lipid modification, NICE recommends that the threshold for starting preventative treatment for CVD should be halved from a 20 per cent risk of developing CVD over 10 years to a 10 per cent risk.
14 July 2014
Spine-Straightening Device Approved by NICE
A device that can straighten and lengthen curved spines in children, and reduce the need for repeat surgery, has been green-lit by NICE under new guidance.
A device that can straighten and lengthen curved spines in children, and reduce the need for repeat surgery, has been green-lit by NICE under new guidance.
Scoliosis is a condition diagnosed in childhood, where the spine curves and bends to one side. In most cases, the curvature corrects itself in as the child grows. Treatments are also available to stop the spine from curving further, such as a back brace, or an external plaster cast.
11 July 2014
NHS Alliance Announces Strategic Partner Programme
NHS Alliance has established a partnership with Capita and diabetes leader Novo Nordisk to support the delivery of a series of strategic initiatives to drive improved integrated care and services, and help inform its activities throughout 2014 and beyond.
The Alliance is working closely with its two strategic partners, its members, and networks throughout health and social care, on large-scale projects to define new models of primary care. Work will focus on strategies for integrated services and practical work to overcome some of the barriers to the delivery of services at scale outside hospitals – moving towards a collaborative, community-based model of care.
8 July 2014
Who Will Binge-Drink at Age 16?
An international collaboration of scientists leading the world’s largest longitudinal adolescent brain imaging study to date has learned that it is possible to predict teenage binge-drinking. The research, published in Natureopens, found that aspects of life experience, personality and brain structure are strong determinants of future alcohol misuse. New simplified versions of the tests are being developed so that children who are at risk of alcohol misuse can be identified and given help.
This is the first comprehensive analysis of potential influences involved in teenage binge drinking. The researchers used a model which incorporated factors known or believed to be relevant for the development of adolescent substance abuse. These include personality, history/life events, brain physiology and structure, cognitive ability, genetics and demographics – in total 40 different variables were investigated.
7 July 2014
Health Workers Urged to Get Tough on Antibiotics
Doctors, nurses and pharmacists are being urged to get tough on antibiotics, and say ‘no’ to patients who ask for prescriptions to treat minor illnesses.
Health chiefs warn that the current ‘better safe than sorry’ approach to prescribing antibiotics is no longer effective – and can be dangerous in the long-term.
They say that a radical new approach is needed if antibiotics are to remain effective to combat more serious illnesses and diseases in future.
1 July 2014
People with HIV Must Receive Earlier Diagnoses
Ensuring that people with HIV receive earlier diagnoses will reduce transmission and prevent thousands of further cases, accordingto NICE.
HIV is a virus most often transmitted through unprotected sex, leaving people less able to fight infections. In 2012, an estimated 98,400 people in the UK were living with HIV. Yet up to 21,900 people with HIV were unaware that they were infected.
Testing for the virus is key in preventing its transmission. This is because more than half of new cases are estimated to be due to people who are undiagnosed having unprotected sex. People who do not know their HIV status are believed to be 3 times more likely to pass on the infection those who know their status. They are also twice as likely to have unprotected sex.
27 June 2014
RCGP Response to BJGP Research on A&E Attendances
Dr Maureen Baker, Chair of the Royal College of GPs, has responded to research by Imperial College London published in this month's British Journal of General Practice.
She said: “Every patient should be able to see their family doctor when they need to, and GPs want to provide the best possible access and high quality care for all their patients.
17 June 2014
RCGP Urges Patients Not To Panic On Statins
Dr Maureen Baker, Chair of the Royal College of GPs, said: “With the on-going debate about statins in the media, the most important thing is for patients not to panic and to continue acting on the advice of their GP and taking the medication they have been prescribed.
10 June 2014
Realistic Weight Loss Goals Better Than Quick Fixes
Losing even a small amount of weight can help to improve the health of people who are overweight or obese and lower their risk of developing type 2 diabetes, heart disease and cancer, says NICE.
The number of people who are overweight or obese in England continues to rise with more than a quarter of adults now classified as obese and a further 42% of men and a third of women classed are overweight. The long-term consequences of obesity place a huge strain on the NHS costing around £5.1 billion each year.
10 June 2014
Molecular ‘Scaffold’ Could Hold Key to New Dementia Treatments
Researchers at King’s College London have discovered how a molecular ‘scaffold’ which allows key parts of cells to interact, comes apart in dementia and motor neurone disease, revealing a potential new target for drug discovery.
The study, published today in Nature Communications, was funded by the Medical Research Council, Wellcome Trust, Alzheimer’s Research UK and the Motor Neurone Disease Association.
9 June 2014
NICE Guidance to Help Tackle Transition From Children's to Adult Services
NICE is developing guidance to help tackle the gaps in care sometimes experienced by young people with health needs, as they move from children's to adult services.
More than 40,000 people in England aged under-18 have complex health needs caused by physical disabilities, special education needs, or life-limiting or life-threatening conditions.
Such young people often rely on a range of therapies and treatments, which can get complicated as they move from children's and adult services.
3 June 2014
NICE Guidance on Ustekinumab for Psoriatic Arthritis
NICE has published final guidance today which does not recommend ustekinumab (Stelara) for psoriatic arthritis.
Psoriatic arthritis is an inflammatory disease affecting the joints and connective tissue, and is associated with psoriasis of the skin or nails. It is a progressive disorder, ranging from mild synovitis (inflammation of the tissue lining joints such as the hip or shoulder) to severe progressive erosion of the joints.
29 May 2014
GPs Warnings Over Impact of Funding Cuts on Patient Care
Patients will find it increasingly difficult to book an appointment with their GP without urgent investment in general practice, the Royal College of GPs NI (RCGPNI) today warns.
Commenting today on new figures published by the Patient and Client Council, which highlighted how over a quarter (26.5%) of patients surveyed were dissatisfied with the access they had to their GP, the College warned how this situation is only set to get worse without the vital funding the profession needs.
27 May 2014
JPND Rapid Action Call for Working Groups on Longitudinal Cohort Studies for Neurodegenerative Disease
MRC is a leading partner in The EU Joint Programme - Neurodegenerative Disease Research (JPND). JPND has recently launched a rapid action call for leading scientists in the field to establish working groups to enhance the use of existing longitudinal cohort studies for neurodegenerative disease research and UK scientists are encouraged to apply.
22 May 2014
A New Route to Good Dementia Care
A new online tool to help people with dementia access care in their local area is launched today by the Royal College of General Practitioners (RCGP).
Aimed at doctors and providers of community care, the Dementia Roadmap is a comprehensive ‘one stop shop’ designed to reflect a patient’s needs as they progress through the disease and signpost them to relevant local resources at the right time, from diagnosis onwards.
20 May 2014
Court Warns CCG over Disagreeing with NICE Guidance
Clinical Commissioning Groups (CCGs) cannot choose not to follow NICE guidance because they merely disagree with it, even where there is no statutory duty to do so, a court has ruled.
This follows the case of Elizabeth Rose, a 25 year old woman who has suffered from a severe form of Crohn's disease since she was 14. Her condition had deteriorated and her doctors recommended bone marrow transplantation and chemotherapy to hopefully bring the disease into remission. This treatment can, however, lead to infertility and the early onset of the menopause.
16 May 2014
RCGP Supports BMA Campaign Your GP Cares
Dr Maureen Baker, Chair of the Royal College of GPs, said:
“General practice is the cornerstone of the NHS but it is teetering on the brink of collapse as the number of patient consultations soars to an all-time high while funding for general practice has dropped to an historic low."
13 May 2014
Discovery of Anti-Appetite Molecule Released by Fibre Could Help Tackle Obesity
New research has helped unpick a long-standing mystery about how dietary fibre supresses appetite.
In a study led by Imperial College London and the Medical Research Council (MRC), an international team of researchers identified an anti-appetite molecule called acetate that is naturally released when we digest fibre in the gut. Once released, the acetate is transported to the brain where it produces a signal to tell us to stop eating.
11 May 2014
Eight in Ten GPs Fear Missing Serious Illness in Patients Due to Workload
Around eight in ten GPs (84%) say they worry about missing a serious condition in a patient due to their workloads, according to new research published today.
The findings are contained in a poll commissioned by the Royal College of General Practitioners (RCGP), which also shows that 91% of family doctors feel that general practice does not have sufficient resources to deliver high quality patient care.
6 May 2014
RCGP Response to NRAD Report on Asthma
The RCGP said:
"Patients and GPs will be concerned - and very distressed - by these findings and we must do more to ensure that patients with asthma are cared for more effectively in primary care.
"Patients must also be reassured that asthma is a condition that affects milllions of people and in the majority of cases, it is managed well with the right treatment and appropriate monitoring.
1 May 2014
NICE to Support the NHS in Gaining Free Trial Access to Medical Research
NICE is participating in a pilot trial which aims to support the NHS in gaining free access to the latest high-quality clinical and scientific research.
The year-long pilot will make some of the latest research and trials published in medical and scientific journals available to NHS staff across England, Scotland, Wales and Northern Ireland.
29 April 2014
Artificial Skin Layer Grown in Lab
An international team led by King’s College London and the San Francisco Veteran Affairs Medical Center (SFVAMC) has developed the first lab-grown epidermis – the outermost skin layer - with a functional permeability barrier akin to real skin.
The new epidermis, grown from human induced pluripotent stem cells (iPSCs), offers a cost-effective alternative lab model for testing drugs and cosmetics, and could also help to develop new therapies for rare and common skin disorders.
25 April 2014
Dr Michael Dixon Tells CCGs we Need to Reduce Rules and Restrictions for Commissioners and GPs
At a meeting today, between Ashford and Canterbury and Coastal CCGs in Kent, Dr Michael Dixon will say: “If we want to bring back personal doctoring and continuity to our frail patients and those with complex diseases, we need to free up our clinicians to do this, and not restrict them with an over-prescriptive model of how to do it.”
22 April 2014
Intelligent Prosthetic Liners Could Ease Pain for Lower Limb Amputees
A new device could help to relieve the pain and discomfort experienced by thousands of amputees as a result of poorly fitting replacement lower limbs. Researchers have been awarded Biomedical Catalyst funding to develop a prototype of the world’s first prosthetic ‘intelligent’ liner with integrated pressure sensors, which could be available to NHS patients in as little as three years.
18 April 2014
Limit Spread of Blood-Borne Viruses Among Steroid Users
Needle and syringe programmes should support the growing number of image and performance enhancing drug users so they can be offered sterile equipment to reduce the spread of blood-borne viruses and infections from contaminated needles, says NICE.
This has long been considered a “grey area” for needle and syringe services around England that are traditionally geared up to help hard drug users, such as those who use heroin or crack.
15 April 2014
RCGP Response to Government Announcement on 'Transforming Primary Care'
Measures to give GPs more resources to deliver flexible opening hours and personalised care show that the Government is beginning to address the chronic lack of investment in primary care, the RCGP has said.
9 April 2014
Simple Test to Help Diagnose and Manage Asthma
A simple test that measures the levels of nitric oxide a person is breathing out to help with the diagnosis and management of asthma has been given the green light by NICE.
NICE recommends three devices - NIOX MINO and NIOX VERO (Aerocrine), and NObreath (Bedfont Scientific Ltd) - to measure nitric oxide levels which are raised in people with asthma.
8 April 2014
NHS Alliance Response to Inquiry into Winter Pressures
The NHS Alliance has submitted its response to the Primary Care and Public Health All Party Parliamentary Group’s inquiry into winter pressures on health services.
The response includes evidence from a range of people working in different sectors across the country, as well as a number of key points and recommendations for the future of winter pressures, including:
2 April 2014
Men Who Started Smoking Before Age 11 Had Fatter Sons
Men who started smoking regularly before the age of 11 had sons who, on average, had 5-10kg more body fat than their peers by the time they were in their teens, according to new research from the Children of the 90s study at the University of Bristol. The researchers say this could indicate that exposure to tobacco smoke before the start of puberty may lead to metabolic changes in the next generation.
1 April 2014
NICE Seeks Views on how it Assesses Drugs and Other Technologies for the NHS
NICE is beginning a public consultation on proposed changes to the way it makes recommendations on new medicines and other treatments for use in the NHS.
NICE assesses the clinical and cost effectiveness of new technologies to help ensure that patients have access to effective treatments and the NHS makes the best use of its resources.
The new proposals include ways to take into account more systematically and explicitly the severity of a disease, as well as the effect that diseases and conditions have on our capacity to engage in society.
25 March 2014
Resources for GPs to Help Young Patients with Mental Health Problems Will Make a ‘World of Difference’ says RCGP
Children and young peoples’ mental health and wellbeing is fundamental to their physical health and the vast majority of NHS care for children and young people is delivered by general practice teams.
A poll conducted for MindEd of 2105 adults found that 87% would turn to their GP for help and advice if they thought a child had a mental health issue and so it is clear that GPs have a crucial role to play in improving the mental health of younger people.
25 March 2014
Annual Health Checks for Young People with Learning Disabilities are Vital, says RCGP
The Royal College of General Practitioners (RCGP) is urging GPs to be at the ready to offer young people with learning disabilities in England, aged 14-17, a comprehensive annual health check from April this year.
The decision to extend the Directly Enhanced Service (DES) already provided to adults with learning disabilities has been made as a result of recommendations following last year's Confidential Inquiry into premature deaths of people with Learning disabilities (CIPOLD).
The Inquiry found that three times as many people with learning disabilities die before the age of 50 compared to the general population.
21 March 2014
More Than One in 30 in the UK Participate in Cohort Studies
The Medical Research Council (MRC) today publishes the first review of the UK’s largest cohort studies. The Strategic Review of the Largest UK Population Cohort Studies, which looks at cohorts funded by the MRC and other funders, has found that more than 2.2 million people (3.5 per cent of the population or one in 30) are a participant in a cohort study.
18 March 2014
Scientists Trace ‘Bad’ Fat Back to its Roots
It’s widely accepted that having too much fat is unhealthy, but it’s the hidden fat surrounding our vital organs that poses the biggest threat. Scientists now believe they’ve discovered where this ‘bad’ (visceral) fat comes from, which may have important implications for our future understanding and treatment of obesity and its health consequences.
The research, led by scientists in the Medical Research Council (MRC) Human Genetics Unit at the University of Edinburgh, is published today in the journal Nature Cell Biology.
14 March2014
Give Care Home Residents a Greater Say in Decisions about Their Treatment
NICE has called for care home residents to be given the same involvement in decisions about their care and support as those who do not live in care homes.
People who are admitted to care homes often have diverse needs, and depend on a range of health and social care services, meaning management of their medical treatment can be complex.
11 March 2014
New NICE Quality Standard Aims to Improve Recognition and Assessment of Jaundice in Newborn Babies
The National Institute for Health and Care Excellence (NICE) has issued standards to improve the recognition and management of jaundice in newborn (from birth to 28 days) babies.
Caused by a raised level of bilirubini and characterised by yellow colouration of the skin and the whites of the eyes, neonatal jaundice is one of the most common conditions needing medical attention in newborn babies. It is estimated that more than 430,000 babies - around 60% of all term and 80% of all pre-term babies - develop jaundice in the first week of life.
5 March 2014
RCGP to Develop Unique Online Info Hub to Help GPs Support Carers
The Royal College of General Practitioners (RCGP) has been awarded more than £380,000* from the Department of Health to develop a unique online information 'hub' to help GPs improve the support and services they provide for carers.
The hub will collate all the information GPs, primary healthcare staff, practice teams, commissioners and Health & Wellbeing Board representatives might need to identify and support carers, bringing together RCGP resources as well as signposting to external resources. Health professionals will be able to use it free of charge.
4 March 2014
Scientists Identify New Huntington Disease Pathway
An international group of researchers has identified a major new pathway thought to be involved in the development of Huntington disease. The findings, published in the Proceedings of the National Academy of Sciences journal, could eventually lead to new treatments for the disease, which currently has no cure.
Scientists at the BC Cancer Agency Research Centre and the Centre for Molecular Medicine and Therapeutics in Vancouver, Canada, and the MRC Toxicology Unit in Leicester, UK, studied mice and human tissue and found that the HACE1 gene is essential for mopping up toxic molecules during periods of oxidative stress, where harmful ‘reactive oxygen species’ build up in the cell.
1 March 2014
RCGP Statement on care.data
Commenting on government plans to take on board concerns raised by GPs about the implementation of care.data, Professor Nigel Mathers, Honorary Secretary of the Royal College of GPs, said:
"We are very grateful to the Government for listening to the concerns of GPs and for meeting the assurances sought by the RCGP in order to ensure that patients' data is protected.
25 February 2014
RCGP Announces Continued Opposition to Change in Law on Assisted Dying
The Royal College of General Practitioners (RCGP) is to remain opposed to any change in the law on assisted dying, it has been revealed today following one of the most comprehensive consultations of its members.
21 February2014
Offer Talking Therapies to People at Risk of Psychosis and Schizophrenia
People considered to be at increased risk of developing psychosis should be offered cognitive behavioural therapy (CBT) as opposed to antipsychotic medication, according to updated guidelines from NICE.
Around 1 in 100 people will develop psychosis and schizophrenia over the course of a lifetime. In most cases a first episode of psychosis is preceded by a ‘prodromal period', where a person may exhibit a range of behavioural and psychological symptom. These include shortened attention spans, short periods of low intensity psychotic symptoms, withdrawal, and displays unusual behaviour and ideas.
18 February 2014
Boris Bikes: Health Benefits Outweigh Risks from Injury and Pollution
The London cycle hire scheme has had a positive overall effect on the health of its users by increasing physical activity within the capital. These benefits outweigh the potential negative impacts from injuries and exposure to air pollution, according to the results of a large-scale modelling study published today in the BMJ.
13 February 2014
Achieving Commissioning Excellence Develops Tool to Help Commissioners and Providers Bring ‘Triple Value’ to Heart Failure Services
Achieving Commissioning Excellence, a partnership between NHS Alliance and Novartis, has developed a tool which looks at what commissioners and providers can do to improve heart failure services in their area, and how they can achieve ‘triple value’ for patients, delivering better outcomes, better patient experience and better productivity.
11 February 2014
RCGP Calls on Clinical Commissioners to Deliver First Wave of Extra Funding for General Practice
Dr Maureen Baker, Chair of the Royal College of General Practitioners, has today written to all 211 Clinical Commissioning Groups in England urging them to use their funding powers wisely to reverse the decline in general practice and deliver improvements in patient care - including the move towards an 'accountable GP' for vulnerable elderly people.
The RCGP has identified three 'pots' of Government funding - two of which are overseen by CCGs - that have the potential to inject much-needed and long-overdue investment into general practice, and transform the care that GPs can provide for their patients.
10 February 2014
Minimum Pricing for Alcohol 'Effectively Targets Harmful Drinkers'
A minimum price per unit of alcohol, as recommended by NICE, effectively targets high-risk drinkers while having little impact on moderate drinkers, according to a new study.
The study published in the Lancet, estimated how people from various income brackets and socioeconomic groups would change their drinking habits if a minimum price for alcohol of 45p per unit was implemented.
4 February 2014
NHS Alliance Forms Partnership with Network Locum
NHS Alliance, the leading representative organisation for provision in primary care, has formed a strategic partnership with Network Locum, the UK’s leading online community for GP locums.
The partnership will allow NHS Alliance members to receive a discount on the use of Network Locums services, as practices will be charged a 10% commission instead of the usual 15%, saving them a third of the cost. Additionally, each new practice will receive a £50 voucher off the first post filled using the organisation. The offer will extend to all practices that are currently members of NHS Alliance and to those that join within the next year.
30 January 2014
Success for Trial of Peanut Allergy Therapy
A new therapy for peanut allergy has been successful in the majority of the 99 children who took part in a trial conducted by researchers at Addenbrooke’s Hospital in Cambridge, UK.
The results of the largest single trial of its kind worldwide are published in The Lancet today. Allergy experts found that 84 and 91 per cent of the two groups of children treated with this new form of immunotherapy could eat at least five peanuts a day.
28 January 2014
Latest Topics for NICE Social Care Programme Announced
Service user experience of social care, the care and support of older people with learning disabilities, and helping people regain independence are among the latest topics referred to NICE for its social care work programme.
Last year the Department of Health ran a consultation to identify social care topics suitable for developing into NICE guidelines and quality standards.
27 January 2014
More Than 1000 GP Practices Now 'Research Ready'
Around one in eight GP practices across the UK are now ‘Research Ready’, after signing up to an initiative by the Royal College of General Practitioners (RCGP) to encourage GP teams and patients to get involved in primary care research.
1006 GP practices have now completed the online self-assessment designed to ensure that practices are aware of their responsibilities to both themselves and their patients when they get involved in research.
21 January 2014
Branching for Food: How Nutrients Remodel Fruit Fly Vessels
Research in fruit flies suggests a new mechanism explaining how diet may affect cancer, obesity and adaptations to malnutrition.
New research from the MRC Clinical Sciences Centre suggests that nutrients in the diet may play a role in changing the architecture of blood vessels in the gut and other organs. The study, in fruit flies, found that small changes in their diet alter the nerve signalling guiding branching of new oxygen-delivering tubules – a process reminiscent of adaptive angiogenesis. In turn, this affects how the fly handles and stores different nutrients from its diet.
15 January 2014
GPs Make Youth Mental Health a Priority
Dr Maureen Baker, Chair of the Royal College of GPs (RCGP) said:
“The majority of GPs are skilled at supporting young people and families in their generalist role but fewer than half of GPs are given the opportunity to undertake a paediatric or psychiatry training placement during their training.
"The vast majority of NHS care for children and young people is delivered by general practice teams and so GPs have a crucial role to play in improving the mental health of younger people. It is also important that children and young patients feel comfortable approaching their GP and that their GP is sufficiently prepared to discuss what are often sensitive issues with confidence."
14 January 2014
NICE Responds to Telegraph Article on Value Based Assessment
Sir Andrew Dillon, Chief Executive of NICE, said:
"We have no intention of introducing a change to our methods that would disadvantage older people."
Professor Carole Longson, Director for the Centre for Health Technology Evaluation at NICE, said:
"In making recommendations about which treatments to recommend for use in the NHS, NICE does not and will not make decisions based on the likely age group of patients. It would be wrong morally and legally to consider an older patient as somehow of less value to society.
08 January 2014
RCGP Response to BBC Story on Repeat A&E Attendees
The RCGP has responded to BBC research showing that some patients are attending A&E departments up to 50 times a year.
Dr Maureen Baker, Chair of the Royal College of General Practitioners, said: “Patients who repeatedly attend A&E for problems that could be dealt with by other NHS services is a challenging issue, but to blame GPs for avoidable A&E visits is inaccurate, misguided and unfair.
07 January 2014
RCGP Response to BMJ Investigation of NHS 111 Service
RCGP Chair says GPs want successful service despite expanded workload
Responding to reports by the British Medical Journal (BMJ) that NHS England are planning to give patients fast-track GP appointments through the NHS 111 service, Chair of the Royal College of General Practitioners, Dr Maureen Baker, said:
"GPs want to work with NHS England to ensure NHS 111 is a success, but they are already drowning under the weight of ever ballooning workloads - due to increasing patient demand and declining resources.
07 January 2014
NHS Alliance Launches New NHS Confidence Index
New research by YouGov commissioned by NHS Alliance shows public confidence in the health service is stable, while confidence in politicians and the media to portray the NHS in a balanced light is low
The NHS has been in the eye of the media storm as never before in 2013 but new research from YouGov, commissioned by NHS Alliance, the leading voice for organisations providing care outside hospitals, reveals that public trust in the national health service remains stable.
The NHS Alliance’s new annual index, NHS Temperature Check, which launches today, seeks to gauge the public’s confidence in the NHS. According to the 2013 research (undertaken 19th-20th December 2013), of the 1886 adults polled by YouGov, 53% said that their feelings were no different than a year ago, they still trust the NHS to look after them, while 8% said they trusted the NHS more to look after them if they were ill than they did a year ago. Just one in five (20%) said they trusted the NHS less than they did a year ago.
31 December 2013
RCGP Comment on Government Plans for Visitor and Migrant NHS Access
RCGP pleased GP access free at point of need
Responding to the latest on Government plans to charge visitors and migrants who wish to use NHS services, Royal College of General Practitioners spokesperson, Dr Helen Stokes-Lampard, who is a GP in Birmingham, said:
"We are grateful that the Government appears to have made some concessions to its original proposals and we are pleased that access to a GP will remain free at the point of need.
30 December 2013
Green Light for New Device to Treat Complex Disease of the Main Heart Artery
NICE has recommended the use of the E-vita open plus stentgraft system for treating complex aneurysms and dissections of the thoracic aorta.
Some people might normally need a two stage repair operation because of the extent of disease or damage affecting their aorta, but using the device could remove the need for a second procedure and the associated risk of serious complications.
24 December 2013
NICE Pathway on Common Mental Health Disorders a 'One-Stop-Shop' for Advice
GPs now have quick and easy access to everything NICE has to say on common mental health disorders following the publication of a new NICE Pathway on the topic.
Mental health disorders, such as depression, generalised anxiety disorder and obsessive-compulsive disorder, are thought to affect 15 per cent of the population at any one time. While GPs encounter patients with such issues on a regular basis, the identification and recognition of these disorders can vary, meaning patients are not always receiving appropriate treatment.
20 December 2013
RCGP Response to Seven Day Working Proposals
The RCGP has responded to Professor Sir Bruce Keogh's seven-day working proposals.
Dr Maureen Baker, Chair of the Royal College of GPs, said: "Seven-day working is a good thing in principle - but it can only work if it is properly funded.
"There are questions to be answered about where the funding would come from to implement the proposals being put forward by Professor Sir Bruce Keogh, but it is not an option to take it from general practice when we are already struggling to cope due to chronic underinvestment.
17 December 2013
MRC Unveils New UK Dementias Research Platform
The Medical Research Council (MRC) today announced a multi-million pound programme to accelerate progress in dementias research.
Launching in April 2014, the MRC UK Dementias Research Platform (UKDP) is a public-private partnership that will unite a wealth of partners and knowledge in a fresh drive to understand neurodegenerative disease onset and progression. The Platform will combine a broad conceptual approach with cutting-edge technologies and significant statistical power, integrating UK strengths in neuroscience, population science and clinical research capability.
12 December 2013
RCGP Response to CQC Announcement on GP Practice Inspections
The RCGP has responded to the CQC announcement today on GP practice inspections
Dr Maureen Baker, Chair of the RCGP, said:
"Patients should expect high quality and consistent care from their GP practice, and the vast majority of practices do an excellent job of delivering quality care while maintaining the highest possible standards.
10 December 2013
RCGP Response to Latest HSCIC Figures on Unnecessary A&E Attendances
In response to HSCIC figures on unnecessary A&E attendances released earlier this week, RCGP Chair, Maureen Baker, said: "We recognise the struggle that patients are facing in trying to get an appointment with their family doctor, but to blame GPs for avoidable A&E visits is inaccurate, misguided and unfair.
"GPs are working harder and longer than ever before as we try to do more for our patients but with declining budgets.
10 December 2013
NHS Patients on Drips at Risk of Serious Errors
Patients' lives are being put at risk because of errors in intravenous (IV) fluid care, warns NICE.
Despite being an extremely common treatment, a lack of training for healthcare professionals has resulted in patients receiving too much or too little fluid, or even the wrong type of fluid.
It is thought that as many as 1 in 5 patients on IV fluids and electrolytes suffer complications due to inappropriate administration, according to figures from the National Enquiry into Perioperative Deaths.
3 December 2013
NHS Urged to Become Smoke-Free
NHS hospitals and clinics should become completely smoke-free to create a culture where smoking is no longer considered the norm, says NICE.
Patients who smoke should be offered smoking cessation drugs, nicotine patches, and counselling as soon as they are admitted to an acute, maternity or mental health setting to encourage them to quit.
26 November 2013
A Gene Mutation for Excessive Alcohol Drinking Found
UK researchers have discovered a gene that regulates alcohol consumption and when faulty can cause excessive drinking. They have also identified the mechanism underlying this phenomenon.
The study showed that normal mice show no interest in alcohol and drink little or no alcohol when offered a free choice between a bottle of water and a bottle of diluted alcohol. However, mice with a genetic mutation to the gene Gabrb1 overwhelmingly preferred drinking alcohol over water, choosing to consume almost 85 per cent of their daily fluid as drinks containing alcohol.
26 November 2013
RCGP Letter in Response to Daily Mail Article on 'GP Mistakes'
RCGP Chair, Dr Maureen Baker, wrote the following in response to an article in the Daily Mail. This was originally sent as a letter to the editor, but was not published.
22 November 2013
NHS Alliance Forms Partnership with Provider of Mandated Friends and Family Test, iWantGreatCare
NHS Alliance, the leading representative organisation for provision in primary care, has formed a strategic partnership with iWantGreatCare, the UK’s only service allowing patients to rate and review their doctors, hospitals and GP practices. The agreement comes as NHS Employers and the General Practitioners Committee of the BMA announce changes to the GMS contract in England for 2014/15, which include the introduction of the Friends and Family Test in primary care in December 2014.
9 November 2013
NHS Urged to Tackle Antibiotic Resistance
The NHS is being urged to tackle the rise in antibiotic resistance by cutting back on unnecessary use of the drugs.
The Department of Health has warned that there are few public health issues of greater importance than antibiotic resistance.
"The increasing threat from antibiotic-resistant infections is so serious that in 20 years' time we could be back to how it was in the 19th century when routine operations could be fatal as a result of everyday infections," said Professor John Watson, Deputy Chief Medical Officer for England.
14 November 2013
Resting Pulse Rates of UK Pre-teens Have Risen During Past 30 Years
The resting pulse rate of UK pre-teens is estimated to have risen by up to two beats a minute during the past 30 years, but the rise does not seem to be linked to the overall weight gain seen in this age group, according to a Medical Research Council funded study, published in theArchives of Disease in Childhood.
While this rise may seem modest, resting pulse rate is a predictor for general physical fitness and cardiovascular health, say the authors, and it could translate into higher risks of diabetes and heart disease in later life.
12 November 2013
Response to the Royal Pharmaceutical Society’s commission Now or Never: shaping pharmacy for the future
The NHS Alliance is proud to have contributed to the Royal Pharmaceutical Society Commission for future models of care delivered through community pharmacy. We are also pleased that the NHS Alliance will be represented at the launch of the report ‘Now or Never: shaping pharmacy for the future’.
11 November 2013
RCGP Response to Monitor Report on Closure of Walk-in Centres
The RCGP has responded to a report by health sector regulator, Monitor, on the closure of NHS walk-in centres.
Chair Elect of the Royal College of GPs, Dr Maureen Baker, said: "The development of walk-in centres was an attempt to provide convenient access to certain groups of patients with predominantly urgent health needs, and to help alleviate the pressures on A&E. While they have proved popular with some groups of patients, walk-in centres have generally not had an impact on the attendances at A&E or on the increasing demand on GPs. Local commissioners are best placed to re-design and integrate their urgent and emergency care systems from a whole system perspective. However, greater clarity is needed in some centres where the walk-in element is the responsibility of local clinical commissioning groups (CCGs) and if there is a registered list this is the responsibility of NHS England.
5 November 2013
Innovative Ideas for Improving Patient Care
Hard-pressed GPs who have bright ideas for improving patient care - but no time or funding to put them into practice - can apply to become 'Innovation Fellows' in an exciting initiative launched today by the Royal College of General Practitioners (RCGP) in collaboration with the Peter Sowerby Foundation.
The RCGP CIRC Sowerby Innovation Fellows programme has been set up to support time-poor GPs who are keen to be innovative but cannot take their ideas forward because they are trying to cope with the dual pressures of ever-increasing workloads and funding shortages.
1 November 2013
Call to Use Screening Tests for Alcohol Disorders
Using NICE-recommended screening tests in primary care can help ensure people with alcohol-use disorders are identified and offered appropriate treatment, according to latest research.
More than a million adults aged 16 to 65 are dependent on alcohol in England, yet around 940,000 are not receiving treatment due to healthcare professionals missing symptoms, or because specialist services are not available.
29 October 2013
NICE Guidance To Cover Cost-Effectiveness of 'Free Vitamins For All Children'
Forthcoming NICE guidance will cover whether it is cost-effective to provide vitamin D supplements to all children under-five.
Earlier this week the Chief Medical Officer, Professor Dame Sally Davies, published a report on children's health, which highlighted the problem of vitamin D deficiency.
Vitamin D is essential for skeletal growth and bone health in children and babies. A lack of vitamin D can impair development and lead to conditions such as rickets, a preventable condition that is increasingly common.25 October 2013
RCGP Response to Pulse Article on MRCGP Exam
The RCGP has responded to a Pulse article on the MRCGP exam
They said:
"The recent independent and official review of our exam commissioned by the General Medical Council found no evidence of discrimination. As the review highlights there are indeed differences in the pass rates between doctors who are from white ethnic backgrounds and those who are from minority ethnic backgrounds, particularly international medical graduates. These are differences that exist across many medical specialities and in higher education more generally.
22 October 2013
GPs Should Not Be Turned Into "New Border Agency"
The Royal College of GPs (RCGP) has responded to the Department of Health's plans to restrict health care to foreign nationals.
Dr Clare Gerada, Chair of the RCGP, said:
“It is good that the Department of Health have commissioned this research. The more clarity we have regarding this issue, the better. However, it is important to remember that many of the statistics in the report are based on approximate figures and should be treated with caution.
15 October 2013
Dr Michael Dixon: CCGs Must Control Primary as well as Secondary Care Budget if the NHS is to be Sustainable
In a speech at the Westminster Health Forum today, Dr Michael Dixon, chairman of the NHS Alliance and president of NHS Clinical Commissioners, will outline his vision for the future of the NHS, highlighting the need for CCGs to control the primary as well as secondary care budget.
15 October 2013
Wasted Medicine Costing the NHS Millions
The RCGP Annual Conference moves onto the final day with Jan James, CEO of Medicine Waste Campaign, and Dr Manir Hussain, Head of Medicines Management, discussing patients stockpiling medicine and others return theirs unused. There is a session on obesity, Communication between prison and primary health care and Camila Batmanghelidjh discusses youth engagement
9 October 2013
Medical Research Council Scientists Discover Compound That Arrests Neurodegeneration in Mice
Researchers at the Medical Research Council (MRC) Toxicology Unit at the University of Leicester, who last year identified a major pathway leading to brain cell death in mice, have used an orally-administered compound to block the pathway, and prevented neurodegeneration in the mice.
8 October 2013
Response to King’s Fund Commission on the Future of Health and Social Care in England
The NHS Alliance has responded to the King’s Fund’s call for evidence on the ‘commission on the future of health and social care in England’. The two leads on the response have commented below:
Dr Donal Hynes, vice chair, NHS Alliance said: “The principles of the NHS remain more critical to our nation than ever. But in order that those principles can be safeguarded, we need a step-change away from our traditional concentration on the disease and the individual. The overriding centre of attention must be on health and communities. The NHS will no longer be focused on treating disease but on maintaining health.
2 October 2013
NICE Draft Guidance Recommends Tests to Help Target Treatments for Bowel Cancer
In draft guidance published today NICE, the independent body responsible for improving quality and encouraging excellence in health and social care, has recommended a number of tests to help doctors target treatments more effectively for people with advanced (metastatic) colorectal cancer.
Colorectal cancer (also called bowel cancer) is the third most common cancer in the UK after breast and lung cancer, with around 40,000 new cases each year. Colorectal cancer is the second most common cause of cancer death in the UK and the 5-year survival rate for metastatic colorectal cancer is less than 7%.
1 October 2013
Government to Extend Cancer Drugs Fund Until 2016
The Prime Minister, David Cameron, has announced an extension to the Cancer Drugs Fund for two years. Since 2011, the fund has ring-fenced £200 million a year of the NHS budget for cancer treatments which may not yet have been assessed by NICE or which have been found not to be cost or clinically effective enough for wider use on the NHS. The Government's extension will make the fund available until 2016.
27 September 2013
RCGP Response to the Independent Review of the Clinical Skills Assessment of the MRCGP Examination
RCGP responds to Independent Review of MRCGP exam saying there is no evidence of racial discrimination and all International Medical Graduates are assessed equally to graduates from the UK
The RCGP welcomes this independent report and its key findings which show there is no evidence of subjective bias due to racial discrimination and that IMGs are assessed in exactly the same way as those from the UK.
24 September 2013
Greater Options for Women with Urinary Incontinence
Women could be offered botox as a treatment option for urinary incontinence if medication has not been effective, according to updated NICE guidance.
Urinary incontinence is a common symptom that can affect women of all ages, with a wide range of severity and nature. While rarely life-threatening, incontinence may seriously influence the physical, psychological and social wellbeing of affected individuals.
New methods of managing urinary incontinence have become available on the NHS since the publication of NICE's 2006 guideline, with botulinum toxin A now more commonly used for treating overactive bladder (OAB) symptoms.
19 September 2013
RCGP Responds to Health Secretary's Speech on Future of Primary Care
The RCGP have responded to Health Secretary Jeremy Hunt's speech on the future of primary care at the King's Fund.
RCGP Chair, Dr Clare Gerada, said: "We welcome the Health Secretary's intention to shift the focus from hospitals to primary care, which is essential if we are to restore the NHS to a sustainable footing.
17 September 2013
£25m to Kick-Start ‘Industrial Revolution’ in Regenerative Medicine
Three UK Research Councils are to invest £25m in research and equipment to support the development of regenerative medicine therapies for a range of applications, including Parkinson’s disease, cardiovascular disease, wound and musculoskeletal repair, eye disorders and deafness.
10 September 2013
Response to the Secretary of State’s Engagement Event on the Vulnerable Older People’s Plan
The NHS Alliance welcomes the Secretary of State’s decision to bring primary, social and community care representatives together to discuss and develop the vulnerable older people’s plan. We are entirely supportive of the Secretary of State’s plans to introduce a named doctor, the need for more joined up working between the three sectors, and for there to be better access to patient records. We are also pleased to see that the Mr Hunt is moving from focusing on the disease agenda to the patient agenda, looking at the whole patient’s needs and emphasising the importance of continuity of care.
10 September 2013
GPs Should Proactively Ask Their Patients Whether They Smoke
Proactively asking patients whether they smoke and offering advice on how to stop can help them quit the habit, according to NICE.
Tobacco consumption remains the UK's single greatest cause of preventable illness. While the number of people who smoke has been falling steadily in recent years, a fifth of the population still smokes.
6 September 2013
Stop Blaming GPs For A&E Crisis, Says RCGP
The RCGP features in Sky News coverage about A&E, and comments on why more investment for GPs is required for patient care.
The Royal College of GPs features in Sky News coverage of the A&E situation this weekend. Read more about the pressures on general practice and why major investment is needed so that GPs can provide more service to patients in their communities.
3 September 2013
3D Tissue Grown From Stem Cells Provides a New Model System for Brain Development
An international team of researchers has used stem cells to create a 3D structure that mimics early human brain development. The group showed that these “cerebral organoids” can be used as a model system to analyse the origins of the human genetic disorder microcephaly, in which brain size is significantly reduced.
28 August 2013
RCGP Response to NICE Guidelines on Acute Kidney Injury
The RCGP has responded to new NICE guidelines on Acute Kidney Injury.
Dr Kathryn E Griffith, Royal College of General Practitioners Clinical Champion for Kidney Care, said:
“GPs can play a key role in identifying and treating patients with Acute Kidney Injury (AKI) and the RCGP welcomes the publication of the NICE Acute Kidney Injury guidelines, which highlights this.
19 August 2013
Longer Waiting Times for GP Appointments Predicted as Concerned GPs Raise Fears About the Impact of Cuts for Patient Care
Over 70% of GPs are forecasting longer waiting times for GP appointments within the next two years - as nearly half (47%) reveal that they have cut back on the range of services they provide for their patients.
In the latest survey by the Royal College of General Practitioners (RCGP) highlighting the growing crisis in general practice, more than 80% of respondents said that they now have insufficient resources to provide high quality patient care.
As well as the reduction in patient services, 39% of respondents to the ComRes poll also said they had cut practice staff and over half had experienced difficulty recruiting and retaining GPs.
15 August 2013
Avoid Drug Treatment for Children and Young People with Moderate ADHD
NICE advises against using drugs as a first-line treatment for children and young people with moderate attention deficit hyperactivity disorder (ADHD), as latest figures suggest a sharp rise in the number of drugs prescribed for the condition.
ADHD is the most common behavioural condition in the UK, affecting between 2 to 5 per cent of school-aged children and young people. It is characterised by hyperactivity...
13 August 2013
New Type of Blood Stem Cell Could Help Solve Platelet Shortage
Scientists funded by the Medical Research Council (MRC) have identified a new type of bone marrow stem cell in mice that is primed to produce large numbers of vital blood-clotting platelets. The breakthrough may eventually lead to the development of new treatments to restore platelets in patients who have undergone chemotherapy or a bone marrow transplant. The research, published in Nature, was led by the MRC Weatherall Institute of Molecular Medicine (WIMM), at the University of Oxford.
9 August 2013
Test to Detect Spread of Breast Cancer Could Help Avoid Further Surgery
A test used during surgery to detect whether breast cancer has spread can help avoid further operations and allow treatments such as chemotherapy to begin earlier, according to NICE.
In current practice, patients having breast cancer surgery to remove the main tumour, often have some of the lymph nodes from their armpit removed at the same time
A biopsy test is then carried out on the lymph nodes to determine whether cancer cells have spread from the main breast tumour. It can take up to 15 working days to receive results from this biopsy, which if positive, could lead to a second operation to remove the remaining lymph nodes.
6 August 2013
RCGP Response to NHS Direct Decision to Withdraw from NHS 111 Services
The RCGP issued a statement following NHS Direct withdrawing from NHS 111
"This is a really unfortunate situation but we are pleased that decisive action is being taken and that GP commissioners will be taking over responsibility. The immediate and most important consideration must be to our patients and the public who now need more reassurance then ever that they can rely on the service while the changes are taking place.
12 March 2013
RCGP and Arthritis Research UK Launch New e-Learning Module on MSK
Musculoskeletal Care (MSK) is the focus of a new e-learning course launched this week by the Royal College of General Practitioners (RCGP) in collaboration with the charity Arthritis Research UK.
The module is the latest addition to the RCGP’s rapidly-expanding Online Learning Environment (OLE) and it is free to all healthcare professionals - not just members of the College. It aims to improve GPs’ and GP trainees' core skills in diagnosing and managing MSK conditions.
8 March 2013
NICE to Review QOF Indicators for Cardiovascular Disease
The Department of Health has asked NICE to review indicators on cardiovascular disease for the Quality Outcomes Framework (QOF), to help improve outcomes for patients with the disease.
Research published in the Lancet shows that over the last decade, much progress has been made in the treatment and prevention of CVD, with a 40 per cent reduction in the rates of mortality among people under 75, and a narrowing in mortality rates between most and least deprived areas.
5 March 2013
Letter to Earl Howe Regarding Section 75
RCGP Chair Dr Clare Gerada has sent a letter to Earl Howe regarding section 75 of the Health and Social Care Act procurement regulations currently before Parliament.
The letter sets out the RCGP's serious concerns that, in contradiction to assurances given by Ministers during the Act's passage through Parliament, the regulations will severely restrict CCGs' freedom to decide not to expose services to competition.
27 February 2013
Improving the Diagnosis and Treatment of Asthma
NICE has developed a quality standard for asthma that can help GPs improve the diagnosis and treatment of people with the condition.
Around 5.4 million people in the UK currently receive treatment for asthma, 1.1 million of whom are children.
The NICE quality standard for asthma contains 11 statements of measures for high quality care, such as ensuring that patients with newly diagnosed asthma are diagnosed in accordance with BTS/SIGN guidance.
26 February 2013
Biomedical Research in the UK is to Benefit from a £25.5m Cash Injection to Boost the Resolution Revolution Taking Place in Microscope Technology
Three of the UK's research councils - the Medical Research Council, the Biotechnology and Biological Sciences Research Council and the Engineering and Physical Sciences Research Council – have invested £20.1m, £2.4m and £2m respectively, to establish 17 microscopy platforms that will bring about ground breaking advances in biological and biomedical research.
20 February 2013
Fertility Treatments Should be 'Appropriate, Effective and Timely' says NICE
GPs should offer appropriate and effective fertility treatments in a timely manner for women having problems with conception, according to latest guidelines from NICE.
Around 1 in 7 heterosexual couples are affected by fertility problems, with both the number of people affected and those seeking help increasing over the past decade.
GPs should refer women of reproductive age for further clinical assessment and investigation along with their partners if they have not conceived after 1 year of unprotected vaginal sexual intercourse, and in the absence of any known cause of fertility, says NICE.
19 February 2013
Personal Health Budgets: A Guide for GPs
A practical guide to personal health budgets (PHBs) for GPs in England has been published by the Royal College of General Practitioners.
In November following a three-year pilot programme, the Government confirmed that PHBs will be rolled out across England.
The easily accessible guide covers what PHBs are, which patients are eligible, and how they can be used effectively. It has been produced with input from GPs and PHB managers with first-hand experience of using PHBs at the pilot sites.
13 February 2013
Statement of Collaboration Between NICE and Public Heath England
NICE and Public Health England and have agreed to collaborate on:
- Communicating with and supporting the local public health system
- Reviewing evidence and providing evidence-based guidance and other products
- Providing access to evidence about public health
- Providing support to put guidance into practice
- Creating a standard public health taxonomy.
NICE's functions relate to the giving of advice or guidance, provision of information, or making recommendations about, any matter concerned with the provision of public health services. This includes public health guidance, QOF indicators for the public health domain and Briefings for Local Government.
12 February 2013
Dementia, Stroke and Cancer Among Potential Indicators for Latest CCG Outcomes Indicator Set
Dementia, stroke, cancer, and end-of-life care are among 32 new indicators put forward for inclusion in the Clinical Commissioning Group Outcomes Indicator Set (CCG OIS).
Formerly known as the Commissioning Outcomes Framework, the CCG OIS aims to support clinical commissioning groups (CCGs) and improve the quality of patient care across England.
7 February 2013
Gene Responsible for Increased Severity of Influenza in Chinese Populations
Researchers part-funded by the Medical Research Council at the MRC Human Immunology Unit at Oxford University and Beijing Capital Medical University have found a genetic variant which explains why Chinese populations may be more vulnerable to the H1N1 form of flu, commonly known as swine flu.
5 February 2013
No Reduction in HIV Levels in Men who Have Sex with Men Despite a Decade of Prevention Work
Despite a significant increase in HIV testing and treatment, the number of new HIV infections in men who have sex with men (MSM) has remained unchanged over the last 10 years in England and Wales, according to a new study by the Medical Research Council (MRC) and Health Protection Agency (HPA). The research also reports undiagnosed HIV infections remained high and annual new diagnoses rose steadily from 2001-2010. These results show that HIV transmission amongst MSM remains a significant public health issue.
31 January, 2013
Primary Care Predicts Future of Substance Misuse Recovery
The Royal College of General Practitioners (RCGP) and Substance Misuse Management in General Practice (SMMGP) have issued a joint paper considering the future impact of the changing commissioning environment on primary care drug and alcohol treatment.
The paper explores how primary care can proactively contribute to the rapidly developing recovery systems of care, by building on its strong legacy of safe, holistic and clinically effective care closer to home. It also includes checklists on how to evidence that services are working towards these themes. The paper is being presented at a joint RCGP and National Treatment Agency conference in York this week to an audience of over 200 clinicians, commissioners and service providers.
29 January 2013
Experts Dismiss Claims NHS Drug Decisions are "Flawed"
Leading experts have dismissed claims that the formula used by NICE to recommend which drugs are funded on the NHS is “flawed” and say that it is still the best available method for assessing drugs.
A European Commission-funded study says that the method used by NICE called quality-adjusted life years (QALY) for assessing the value of new drug treatments does not reflect variations in views on illness and disability.
25 January, 2013
RCGP Response to Alzheimer's Society Report
RCGP Chair, Professor Clare Gerada responds to a report by the Alzheimer's Society.
Professor Clare Gerada, Chair of the Royal College of GPs said
“The RCGP is committed to improving the care GPs provide to patients with dementia but diagnosing patients as having dementia is difficult, especially in the early stages when patients are likely to visit their GP with concerns."
22 January 2013
Bacteria’s Hidden Weapon Could Pave Way for Stem Cell Treatments
A discovery about the way in which bugs spread throughout the body could help to develop stem cell treatments. Researchers from the Medical Research Council (MRC) Centre for Regenerative Medicine, at the University of Edinburgh, have found that leprosy bacteria are able to change the make-up of supporting cells of the nervous system, called Schwann cells, so that they take on the properties of stem cells.
Because stem cells can develop into any of the different cell types in the body – including liver and brain cells – mimicking this process could aid research into a range of degenerative conditions and could help scientists develop new tools for regenerative medicine.
16 January, 2013
Medical Bodies Unite to Combat Addiction to Medicines
Addiction to Medicines Consensus Statement
The Royal College of General Practitioners (RCGP) and the Royal College of Psychiatrists (RCPsych) today publish a signed consensus statement aimed at reducing patient addiction to medicines such as tranquilisers and painkillers.
Supported by professional groups, specialist service providers and voluntary bodies representing 17 organisations, it cautions against long-term prescribing of medicines which carry a risk of addiction, except in exceptional circumstances, and recommends rigorous and holistic regular reviews by practitioners with suitable expertise and understanding.
15 January 2013
RCGP Seeks New Clinical Champions
The RCGP is seeking to appoint Clinical Champions to lead on four new clinical priorities for the College.
The College is looking for RCGP members who can work collaboratively to raise the profile and awareness of Chronic Kidney Disease; Epilepsy Care; Eye Health, with a focus on ageing and sight loss; and Youth Mental Health.
10 January, 2013
NICE Consults on New Idiopathic Pulmonary Fibrosis Draft Guidance
The National Institute for Health and Clinical Excellence (NICE) is currently developing a clinical guideline on the management of idiopathic pulmonary fibrosis. As part of this process, draft recommendations have been published on the NICE website today (11 January) for consultation.
8 January 2013
NICE Announces its Collaborating Centre for Social Care
NICE has awarded a contract to the Social Care Institute for Excellence (SCIE), and its partner organisations, to support the development, adoption and dissemination of its social care guidance and quality standards from 1 April, as the NICE Collaborating Centre for Social Care.
Developing social care guidance and quality standards is a new responsibility for NICE, as outlined in the government's Health and Social Care Act (2012).
From 1 April, NICE will expand its remit and to reflect this, will be known as the National Institute for Health and Care Excellence (NICE).
3 January, 2013
NICE Local Formularies Guide will "Reduce Variation in Prescribing"
NICE has produced a good practice guide to help trusts develop and update local formularies, as part of a move to ensure that all patients in England have access to clinically and cost-effective drugs.
Local formularies provide a list of selected or preferred drugs available to local prescribers and have an important role in underpinning safe and effective use of medicines.
However, there is currently no standard process or advice for putting together a local formulary which has led to variations across the country.
1 January 2013
How NICE Can Help Clinical Commissioning Groups Deliver High Quality Care
It's been a busy time of late for Clinical Commissioning Groups (CCGs) as they embark upon the first wave of the authorisation process required to transform them into statutory bodies.
At the same time, CCGs are working hard to ensure that they are ready to meet the clinical challenges that lie ahead from April 2013, and are drawing up detailed plans and agreements between commissioners and trusts.
At NICE we've been working for some time on how we can align our guidance, advice and standards so that they can really help CCGs to successfully deliver clinical and cost effective services for the patients that they serve.
31 December 2012
MRC Invests Over £10m in Stratified Medicine Research
The MRC is to invest £10.6m in three major new collaborations that will advance the emerging field of stratified medicine – investigating why different patients with the same diagnosis respond differently to treatments. The collaborations, announced today by the Prime Minister in a report on UK life sciences, will deliver a better understanding of the mechanisms behind these diseases will one day enable doctors to prescribe drugs and therapies that are tailored to an individual’s genetic make-up, vastly improving their chances of getting better and reducing their risk of experiencing serious side-effects.
24 December 2012
Patient Feedback Improvements Welcomed
The health sector has continued to welcome the NHS Commissioning Board’s publication of its planning guidance for commissioners in 2013/14.
Greater use of patient feedback and transparency are highlighted as good steps forward, although The King’s Fund has raised concerns that the Friends & Family test could be being used to pay for performance.
18 December 2012
RCGP Press Comment on NCB Document
RCGP media comment on NHS Commissioning Board document Everyone Counts: Planning for Patients 2013-14
RCGP Chair Dr Clare Gerada said: "We are concerned that this will create unrealistic expectations, especially at a time when financial constraints are placing a severe strain on our NHS and the care that we can provide for our patients.
18 December 2012
Greater Awareness of Hepatitis B and C Needed
Greater awareness of hepatitis B and C is needed so that more people who are at risk can be tested and treated for the viruses, according to latest guidance from NICE.
Hepatitis B and C mainly affect the liver, and are the second most common cause of liver disease in the UK after alcohol misuse.
Hepatitis B is transmitted by contact with infected blood. It arises primarily from injecting drug use, heterosexual contact with someone who is infected, travel to countries of intermediate or high endemicity, homosexual contact, and contact with someone in the same household who is a carrier and mother-to-child transmission.
14 December 2012
RCGP Stance on Assisted Dying
Following a feature discussing assisted dying by Professor Clare Gerada, Chair of RCGP Council, in the December issue of the British Journal of General Practice, the College would like to reiterate that the piece was written in a personal capacity.
The College's stance on assisted dying remains the same: The RCGP firmly believes that with current improvements in palliative care, good clinical care can be provided within existing legislation.
11 December 2012
More Babies Survive Before 27 Weeks, but Severe Disability Rates Remain Unchanged
The number of babies born before 27 weeks’ gestation who survive and leave hospital increased between 1995 and 2006, but the proportion who experience serious health problems into childhood remained largely unchanged, according to new research funded by the Medical Research Council (MRC).
Two papers from the EPICure cohorts, published today in the British Medical Journal, suggest that while the number of very pre-term babies who survive may continue to rise, it is likely that the number of children and adults with long-term disability caused by complications of premature birth will rise in parallel.
7 December 2012
Computerised Therapy for Insomnia
Research from the December issue of the British Journal of General Practice
Insomnia is the most common psychological complaint in Britain and most drugs available for treating sleeplessness do more harm than good. Cognitive Behavioural Therapy for Insomnia (CBT-I) has been shown to be at least as effective as drugs in the short term and safer in the long term but it is not widely used because of the lack of trained therapists.
The British Journal of General Practice this month publishes research by Jo Middlemass and colleagues from the University of Lincoln who have shown that it is possible to provide this form of therapy via home computers and by using social networks.
4 December 2012
RCGP Response to Government Announcement on Personal Health Budgets
RCGP Chair offers response
RCGP Chair Dr Clare Gerada said:
"Personal health budgets, used in the right circumstances, have the potential to improve patient care and deliver care tailored to patient needs. They can help improve shared decision making and can provide patients with the opportunity to access different services that are better suited to their personal circumstances. But these benefits will be lost, unless they are introduced in the right way…..
28 November 2012
Tackle Obesity Through a ‘Community-Wide’ Approach
Obesity should be tackled by encouraging different organisations to work together through a 'community-wide'approach, according to latest guidance from NICE. The UK is facing an obesity crisis, with prevalence rising among both adults and children In England in 2010, 26 per cent of adults and 16 per cent of children between the ages of 2 and 15 were obese.
By 2050, it is expected that more than half the adult population in England and a quarter of children will be obese.
27 November 2012
Global Research Team Discovers New Alzheimer’s Risk Gene
Scientists have discovered a rare genetic mutation that increases the risk of Alzheimer’s disease, in a study with major implications for understanding the causes of the disease. The scientists studied data from more than 25,000 people to link a rare variant of the TREM2 gene – which is known to play a role in the immune system – to a higher risk of Alzheimer’s.
The findings, which are published in the New England Journal of Medicine on Wednesday 14 November, have the potential to be the most influential gene discovery for Alzheimer’s in the last two decades. Funders for the study included the Medical Research Council (MRC) Alzheimer’s Research UK and the Wellcome Trust.
19 November 2012
Minimum Pricing for Alcohol ‘Will Protect Young People’
Setting a minimum price per unit of alcohol, as recommended by NICE, will protect young people from the dangers of excessive drinking, according to a new report.
The report jointly produced by Alcohol Concern and Balance to coincide with Alcohol Awareness Week, states that cheap alcohol encourages young people to drink to excess, making them susceptible to alcohol-related harm.
20 November 2012
Patients with Psychosis should be Offered Therapy
Clinical Commissioning Groups should commission services for people with schizophrenia and psychosis in line with NICE guidelines, including the use of cognitive behavioural therapy (CBT) for psychosis, say experts.
Currently, just one in ten people who could benefit from the therapy have access to it, despite being approved by NICE.
At the same time, almost half of all practitioners, people using mental health services and their families say that CBT is the most important intervention alongside the use of medication.
15 November 2012
RCGP TARGETs Antibiotics Prescribing
The RCGP has launched a toolkit containing new guidance for GPs and their patients on the appropriate prescription of antibiotics.
The guidance provides a simple, effective, and cost-effective approach to the treatment of common infections to minimise the emergence of bacterial resistance in the community.
13 November 2012
Disrupting Body Fat’s Inbuilt Clock May Lead to Weight Gain
Disrupting body fat's innate clock may lead to weight gain by influencing eating patterns and the rate at which cells store fat, according to a study published online today in Nature Medicine.
Scientists found that switching off the ‘clock’ gene (Arntl) in the fat cells of mice caused them to eat more food when they would normally be asleep, which led to them gaining more weight than normal mice, even when they did not consume more calories. The modified mice also showed changes in the production of hunger-signalling hormones and fat levels in the blood.
10 November 2012
RCGP Response to DH Rotavirus Announcement
Commenting on the announcement today (10/11/12) by the DH that children under four months will be vaccinated against rotavirus from September next year, Dr Clare Gerada, Chair of the Royal College of General Practitioners, said:
"There are around 140,000 cases of rotavirus in under fives every year, many of which result in a visit to the GP. As well making the children unwell, it can be distressing for parents.
6 November 2012
Alcohol Guidance Among Latest Batch of NICE Public Health Briefings
Tackling the harm caused by alcohol and addressing health inequalities are among topics covered in NICE's latest set of local government public health briefings.
From April next year, councils in England will be taking on the new role of improving the public health of their communities.
To help councils with this task, NICE has been developing a range of local government public health briefings.
The briefings provide tailored guidance for councillors and local authority staff to help them provide effective, best value actions to improve the health of people in their area.
1 November 2012
Sessional GPs an Untapped Resource for CCGs
Clinical Commissioning Groups (CCGs) are being encouraged to ensure they include sessional GPs more effectively in their developments, in order to provide the very best services for patients.
Clinical Commissioning Groups (CCGs) are being encouraged to ensure they include sessional GPs more effectively in their developments, in order to provide the very best services for patients, in a project report from the RCGP.
30 October 2012
Suppression and Substitution: Two Opposite Brain Processes That Help us to Forget Unwanted Memories
A team of researchers at the Medical Research Council (MRC) has discovered that the human brain can intentionally forget unwanted memories via two distinct and opposite processes. By improving our understanding of the brain mechanisms underlying these processes, known as ‘memory suppression’ and ‘memory substitution’, these findings may help explain why people can have problems controlling unwanted memories, as seen in Post-Traumatic Stress Disorder (PTSD). Results from the study are published in Neuron.
27 October 2012
RCGP Response to End of Life Care Media Stories This Week
Responding to recent news articles on end of life care, Dr Clare Gerada, RCGP Chair of Council,said:
“The RCGP is appalled at the media coverage in the Daily Mail and elsewhere about planning for end of life care.
“As well as being inaccurate and deliberately misleading, this coverage is creating unnecessary distress and fear for patients who might be nearing the end of their life and for their families.
23 October 2012
NHS Prescribing High Numbers of NICE-Approved Drugs
Uptake of NICE-approved medicines on the NHS to treat cardiovascular disease, diabetes and osteoporosis is higher than expected, latest figures reveal.
The data, published within an experimental report by the Health and Social Care Information Centre(HSCIC), examines the use of NICE-appraised medicines in England and covers prescribing during 2010 and 2011.
22 October 2012
Guide Launched to Improve Services for Patients with Learning Disabilities
A commissioning guide to improve the health of people with learning disabilities has been launched by the Royal College of General Practitioners, to help Clinical Commissioning Groups commission the most appropriate and effective services.
Guide launched to improve services for patients with learning disabilities
A commissioning guide to improve the health of people with learning disabilities has been launched by the Royal College of General Practitioners, to help Clinical Commissioning Groups commission the most appropriate and effective services.
16 October 2012
Diabetes Screening May Not Reduce Deaths
Screening the UK population to pick up undiagnosed cases of type 2 diabetes may not be as effective at preventing deaths as previously thought, according to a new study.
In the first ever randomised controlled trial of diabetes screening, researchers found no evidence that testing people for the disease reduces the number of deaths from any cause, including those unrelated to diabetes, after ten years. The results, published today in The Lancet, contradict several previous studies2, which suggested a widespread screening programme would be effective.
10 October 2012
Help for the Treatment of Crohn's Disease
New guidance from NICE provides GPs and other healthcare professionals with advice on the use of glucocorticosteroids for the remission and management of people with Crohn's disease.
Crohn's disease is a chronic inflammatory disease that mainly affects the gastrointestinal tract.
Around 115,000 people currently have the condition in the UK, with between 3000 and 6000 new cases diagnosed each year.
9 October 2012
A New Report Co-Produced by NHS Alliance and NHS Clinical Commissioners Seeks to Support Commissioners as They Get to Grips with Integrated 24/7 Urgent Care
NHS Alliance and NHS Clinical Commissioners have co-produced a report on urgent care, which supports commissioners as they look to implement effective integrated 24/7 urgent care strategies in their local areas.
The report includes key learnings and discussions taken from two health communities – one in the North West and one in East Kent – that participated in workshops facilitated by the NHS Alliance, and supported by the Department of Health. The workshops aimed to develop understanding of what helps better integration of urgent care, what gets in the way, and what people can do about it.
5 October 2012
First Set of Health and Social Care Quality Standards Referred to NICE
NICE's programme of work is to be significantly extended as it begins developing its first set of health and social care quality standards, which were referred today to the Institute by the Department of Health.
The care and wellbeing of adults and children with autism, and the mental wellbeing of older people in residential care are the first topics quality standards will be developed on.
1 October 2012
Most Baby Boomers ‘Under the Doctor’ at Retirement
The vast majority of the post-war baby boomers have had at least one medical condition requiring regular GP visits in the run-up to retirement, and just one in six was completely condition free, according to the latest findings from the UK’s oldest birth cohort. Diseases affecting more than 10 per cent of those studied included cancer, osteoporosis, chronic respiratory disease and cardiovascular disease.
New research from the MRC National Survey of Health and Development looked at the prevalence of 15 common clinical disorders1 including heart disease, high blood pressure, obesity, diabetes, cancer and osteoporosis, in a group of 2,661 men and women aged 60-64. It is the first study of its kind in the generation born immediately after World War II (the so-called baby boomers), who were the first to grow up in the welfare state.
28 September 2012
Whooping Cough for Pregnant Women
RCGP comment on Department of Health decision to initiate a temporary vaccination programme to protect pregnant women against whooping cough
RCGP comment on Department of Health decision to initiate a temporary vaccination programme to protect pregnant women against whooping cough.
25 September 2012
RCGP Response to Study from National Cancer Intelligence Network
"Patients, whatever their age, should never be afraid of raising concerns about cancer with their GP.
"GPs make an important contribution to saving lives from cancer, including prompt referral of patients who need specialist assessment. The RCGP’s very first audit of cancer diagnosis in primary care published last year revealed that over 70% of patients visiting their GP were referred to a specialist after one or two consultations and nearly 60 per cent of all patients referred attended secondary care within two weeks.
19 September 2012
Overuse of Painkillers Can Make Headaches Worse
Taking medicines such as painkillers over a prolonged period of time to relieve headaches can actually make symptoms worse, according to latest guidelines from NICE.
Headaches are one of the most common complaints presented to GPs and neurologists, with more than 10 million people in the UK experiencing them frequently or at regular intervals.
Many people who suffer from headaches choose to treat them with over-the-counter medicines such as paracetamol, aspirin or triptans.
19 September 2012
Human Stem Cells May Hold Cure for Common Form of Deafness
A cure for deafness is a step closer after scientists funded by the MRC and Action on Hearing Loss used human embryonic stem cells to restore a common form of hearing loss.
Researchers from the University of Sheffield’s Department of Biomedical Sciences developed a method to turn human embryonic stem cells into ear cells.
17 September 2012
Majority of People with Diabetes 'Not Meeting Cholesterol Targets'
More than half of people with diabetes are not having their cholesterol levels adequately controlled, according to a new study.
Charity Diabetes UK analysed figures from the latest National Audit for Diabetes, which revealed 91.6 per cent of people with diabetes are now receiving annual checks for the condition.
11 September 2012
Innovation Scorecards to Highlight Availability of NICE-Approved Drugs
Patients and the public will soon be able to see information on how quickly their local hospitals and primary care organisations are providing NICE-approved treatments and drugs, according to latest government proposals.
From September, every hospital and trust will be rated by an ‘innovation scorecard', allowing patients and the public to see which trusts are adopting the latest NICE-approved treatments and drugs most quickly.
7 September 2012
Improving the Diagnosis and Management of Stable Angina
NICE has produced a quality standard for stable angina that aims to help improve the diagnosis, care and treatment of the condition.
Angina is prevalent in an estimated 1 in every 12 men and 1 in every 30 women aged between 55 and 64 in England, rising to 1 in every 7 men and 1 in every 12 women who are over 65.
4 September 2012
New ‘Traffic Light’ Test Could Save Lives with Earlier Diagnosis of Liver Disease
A new ‘traffic light’ test devised by Dr Nick Sheron and colleagues at University of Southampton and University Hospital Southampton NHS Foundation Trust could be used in primary care to diagnose liver fibrosis and cirrhosis in high risk populations more easily than at present.
28 August 2012
Funding Boost Will Help Patients Reap Benefits of Genetic Revolution
People suffering from illnesses such as cancer and osteoarthritis as well as rare inherited disorders will benefit from a major investment in medical research, announced today.
Almost £60million of awards from the Medical Research Council (MRC) will help scientists gain fresh insights into conditions such as schizophrenia, cystic fibrosis and genetic eye disorders including retinitis pigmentosa, coloboma and anophthalmia.
26 August 2012
Alcohol By-Product Destroys Blood Stem Cells
Scientists at the Medical Research Council (MRC) Laboratory of Molecular Biology have found that stem cells in the body’s ‘blood cell factory’ – the bone marrow – are extremely sensitive to the main breakdown product of alcohol, which causes irreversible damage to their DNA.
New research in mice, published today (26 August) in Nature, shows that this damage is normally kept in check by two vital control mechanisms: an enzyme that mops up the toxic breakdown product (acetaldehyde) and a group of proteins that recognise and repair damaged DNA. Mice lacking both these protective mechanisms develop bone marrow failure, due to obliteration of their blood stem cells.
20 August 2012
New RCGP Headquarters to Open in October 2012
The Royal College of General Practitioners (RCGP) has announced that its landmark headquarters in Euston, London, will now be fully open to members in October 2012, due to slight delays caused by the unseasonal downpours.
Staff will move as planned on 24 September and all membership support services will be fully functional. The Clinical Skills Assessment Centre – where trainees take the MRCGP examination – will also be ready from that date, with its first intake of GP candidates due in November.
17 August 2012
Wellcome Trust and MRC invest in world-class Stem Cell Institute
Two of the UK’s largest funders of medical research are to invest £8 million in a new world-leading centre for stem cell biology and medicine. The Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute will advance our understanding of stem cells and their potential to treat a range of life-threatening conditions that currently have no effective cures.
14 August 2012
Call for Better Diagnosis of Peripheral Arterial Disease
GPs should make an early diagnosis of peripheral arterial disease (PAD) by performing an ankle brachial pressure index measurement, as NICE sets out new guidelines on the diagnosis and management of lower limb PAD.
Peripheral arterial disease is a common condition, affecting 3- 7 per cent of people in the general population and 20 per cent of people over the age of 60, in which the arteries carrying blood to the legs and feet become narrowed or blocked.
13 August 2012
RCGP Unveils New-Look GP Training Curriculum
The RCGP has updated its GP training curriculum to make it more user-friendly and easier to navigate.
The updated curriculum reflects latest developments in general practice, GP training needs and patient expectations.
The changes will apply to trainees beginning their training programme this month (August 2012 ) and are part of the College’s ongoing response to feedback gathered from trainees, trainers and the wider training community.
7 August 2012
Two Effective Treatments for CFS/ME are also Cost-Effective
Two treatments found previously to be the most effective for patients with Chronic Fatigue Syndrome or Myalgic Encephalomyelitis (CFS/ME) have now been found to be the most cost-effective treatments evaluated in a large clinical trial.
The latest results from the PACE trial show that both cognitive behaviour therapy (CBT) and graded exercise therapy (GET), as supplements to specialist medical care, offer good value for money for healthcare providers when the cost of treatment is weighed up against improvement in quality of life.
31 July 2012
Cancer: RCGP Comment on GP Practice and PCT Profiles
Professor Clare Gerada, RCGP Chair, said:
“These practice profiles contain a wealth of information about the important contribution that GPs make to saving lives from cancer, including how well they do in screening for cancer, investigating patients and referring promptly those who need specialist assessment.
31 July 2012
RCGP Calls for More Clarity on Personal Health Budgets
The Royal College of General Practitioners (RCGP) wants to work with the government on finalising the planned roll-out of personal health budgets across England in October.
An RCGP position statement released today states that while it believes that personal health budgets could realise significant benefitsin personalised care and shared decision making for some patients, the implementation of personal health budgets poses challenges that have not yet been addressed by the government.
The RCGP has written to Care Services Minister Paul Burstow MP asking him to address the risks identified in the position statement, prior to the roll-out of personal health budgets.
25 July 2012
Help with Identifying Meningitis in Children and Young People
NICE's latest quality standard on bacterial meningitis in children and young people can help GPs and other primary care professionals spot early signs and symptoms of the condition.
Meningococcal meningitis and meningococcal septicaemia, known collectively as meningococcal disease, remain a leading cause of mortality in early childhood causing death in around 1 in ten cases.
17 July 2012
Breastfeeding Linked with Long-Term Reduction in Obesity
Women who breastfed their children have a lower body mass index (BMI) than those who did not, even decades after giving birth, according to new research funded by Cancer Research UK and the Medical Research Council (MRC).
A study of 740,000 post-menopausal UK women, published in the International Journal of Obesity, found that both childbearing and breastfeeding had significant, but opposite, effects on long-term weight.
12 July 2012
Healthy Diet and Exercise Key to Reducing the Risk of type 2 Diabetes
Simple lifestyle changes, such as increased physical activity or eating more healthily, can prevent or delay type 2 diabetes, says NICE.
Diabetes is an epidemic of global proportions, with 360 million people worldwide currently thought to have the condition.
Nearly 3 million people have diabetes in the UK, which is set to rise to 5 million, nearly 10% of the population, by 2025.
10 July 2012
Dementia 'Not Being Diagnosed'
Fewer than half of people with dementia ever receive a formal diagnosis, according to a new parliamentary report.
Around 800,000 people in the country currently have dementia, with numbers expected to rise to more than a million by 2021.
Early diagnosis of dementia can help both individuals with the condition and their families, by giving people access to treatment and support services, and by providing them with help in planning for their future.
3 July 2012
RCGP Comment on the Centre for Economic Research Report 'How Mental Health Loses Out in the NHS'
Professor Clare Gerada, Chair of the RCGP, said:
"We live in a stressful society and the number of patients with mental health problems presenting to GPs is on an upward spiral. GPs face tremendous challenges in caring for patients with mental health problems in primary care and we welcome any development which will help us improve their care.
3 July 2012
Patients with Blood Clots Should be Treated Within 4 hours, Says NICE
People who present to hospital with blood clots in the legs or lungs should be offered treatment within 4 hours and have their investigative tests including scans within 24 hours, according to latest guidelines.
Those aged 40 and over who develop a blood clot should also be tested to see whether they have an underlying cancer.
26 June 2012
‘Experts in Whole Person Medicine’ – College Makes Compelling Case for Future Role of Generalist
The vital role of the “medical generalist” must be more widely recognised and enhanced if the NHS is to meet the challenges facing it, according to a landmark report launched by the RCGP today.
The College sets out a compelling case for why medical generalists – “experts in whole person medicine” – matter to all healthcare systems. It opens the debate on why the importance and influence of the role needs to be given fresh consideration within a much wider context than general practice and primary care.
25 June 2012
A new practical guide has been launched to assist GPs and other community healthcare professionals in identifying and managing the 3 million people in the UK at risk of disease-related malnutrition.
While poverty is often considered a major factor in malnutrition, disease is actually the primary cause1. More than three million people in the UK are at risk of disease-related malnutrition at any one time2, the vast majority (93%) live in the community. At risk groups include those with chronic disease such as cancer, individuals suffering from dementia, patients with an acute illness and those recently discharged from hospital.
20 June 2012
NHS Alliance Welcomes Greater Flexibility for 111 Implementation
The NHS Alliance has welcomed the announcement by the Department of Health that Clinical Commissioning Groups will be able to extend the deadline for full implementation of the 111 service, originally set for April 2013.
According to the NHS Alliance, CCGs leaders need to have greater freedom for local implementation of urgent care services. CCGs should also learn from the results of the full evaluation on NHS 111, currently being carried out by Sheffield University. A full report is yet to be published by the Department of Health.
19 June 2012
Free BNF Prescribing App Launches
Health and social care professionals can now access the latest up-to-date prescribing information from the British National Formulary (BNF) at the touch of a button.
The official NICE BNF app is available to download for free for users of Android and iPhone smartphones via the Google Play Store and Apple App Store.
The app, which can also run on the iPod touch, will transform the way people access the BNF - the most widely-used medicines information resource within the NHS.
15 June 2012
Launch of GP Guide to Improve Access to Eye Care for People with Learning Disabilities
The Royal College of General Practitioners has commissioned The Royal College of Ophthalmologists to create a Best Practice Guide for GPs on Vision and People with Learning Disabilities.
The guidance, which is launched for all GPs during Learning Disability Week (18 – 24 June) highlights key areas to ensure that people with learning disabilities can access appropriate eye health care. It was created in conjunction with leading eye care charity SeeAbility and will be available online at www.rcgp.org.uk/learningdisabilities.
11 June 2012
Large Waist Linked to Diabetes Risk in Overweight Adults
Overweight people with a large waist are just as likely to develop type 2 diabetes later in life as those who are obese, according to results from the largest international study of its kind to date.
The study, led by the Medical Research Council (MRC) Epidemiology Unit, followed more than 340,000 people from eight European countries to examine their future risk of type 2 diabetes.
7 June 2012
NHS Alliance Calls on the Government to Act on its Commitment to Shared Decision-Making
Following the publication of the consultation paper Liberating the NHS: No decision about me, without me, the NHS Alliance is calling on the government to show real commitment to shared decision-making.
The NHS Alliance’s Patient and Public Involvement Group is clear that, instead of exploring shared decision-making, the consultation paper focuses almost exclusively on mechanisms to ensure patients’ choice of providers, a relevant but small part of the process.
5 June 2012
New Guidance Helps General Practices Respond to Domestic Abuse
New guidance to support GPs and their teams in recognising and responding to signs of domestic violence has been released today.
Responding to Domestic Abuse: Guidance for General Practices, is produced in collaboration with national charity Co-ordinated Action Against Domestic Abuse (CAADA), the Identification & Referral to Improve Safety (IRIS) programme and the Royal College of General Practitioners (RCGP) and was funded by the Department of Health.
28 May 2012
CCGs Want More Information About Commissioning Support Choice
Clinical Commissioning Groups (CCGs) want more information about choices of commissioning support available to them, according to an independent report published today.
29 May 2012
CCGs Want More Information About Commissioning Support Choice
Clinical Commissioning Groups (CCGs) want more information about choices of commissioning support available to them, according to an independent report published today.
The report revealed that 59% of CCGs want more information about choice of commissioning support whilst 61% of respondents want more clarity on the types of services support suppliers are able to provide. A further 64% want more advice about how to procure their support. The survey was commissioned on behalf of the NHS Commissioning Board Authority by NHS Clinical Commissioners, as part of the second checkpoint into the development of NHS Commissioning Support Services (NHS CSS).
25 May 2012
Engaging Sessional GPs in Clinically-Led Commissioning
Hundreds have responded to an RCGP consultation conducted as part of a wider project to ensure sessional GPs are engaged in clinically-led commissioning.
22 May 2012
Health Act Makes NICE Stronger Than Ever Before
NICE will be stronger than ever before under the new Health Act producing quality standards that will be the backbone of commissioning and playing a vital role in value based pricing, the Health Secretary has said.
Addressing delegates at the NICE Annual Conference in Birmingham yesterday, Andrew Lansley said that NICE will be central to developing a NHS based on evidence and will be placed on a firmer footing to do so.
15 May 2012
Enzyme Corrects More than 1 Million Faults in DNA Replication
Scientists from the Medical Research Council (MRC) Institute of Genetics and Molecular Medicine (IGMM) at the University of Edinburgh have discovered an enzyme that corrects the most common mistake in mammalian DNA.
15 May 2012
Listening is the Lynchpin of Good Patient Care, says RCGP Chair
The ability to listen to patients and help them make informed choices about their health remains the true strength of general practice, says RCGP Chair Dr Clare Gerada.
9 May 2012
RCGP Response to Stroke Association Report - Struggling to Recover
"People affected by stroke have every right to expect high quality care following treatment in hospital, and the RCGP is concerned that this has not been the case for the respondents of this survey…….’
8 May 2012
Take a 'Three-Strike' Approach to Teen Cancer Diagnosis, says Charity
GPs should refer teenagers for further investigation after their third visit if they have presented with repeated symptoms of cancer, a charity says.
Research from the Teenage Cancer Trust reveals that a quarter of young people visited their GP four times or more with common cancer symptoms, such as pain, a lump or extreme tiredness, before they were referred to a specialist.
2 May 2012
RCGP Response to GMC Report 'Investigating the Prevalence and Causes of Prescribing Errors in General Practice'
Dr Clare Gerada, RCGP Chair of Council, said:
"There are over one million patient consultations in general practice every day across the UK, and this report demonstrates that in 95% of cases GPs prescribe safely and effectively in the best interests of their patients.
1 May 2012
Clinical Senates’ Key Role to Protect and Foster Localism
In a speech at the Westminster Health Forum – Developing clinical senates and networks: commissioning, integration and efficiency – to be held today in London, Dr Donal Hynes, co-vice chair of the NHS Alliance, will reiterate the need for clinical senates and networks to support CCG’s localism.
According to Dr Hynes, clinical senates should act as a support mechanism for CCGs, rather than undermine their autonomy, by bringing together the clinical community over a relatively wide area to discuss and implement service reconfiguration.
27 April 2012
British Journal of General Practice May 2012
Too many psychotropic (mind-altering) drugs are being prescribed in nursing homes in England and Wales, warn researchers writing in this month’s British Journal of General Practice (BJGP).
Sunil Shah and colleagues from St George’s University, London found that drugs such as antipsychotics, benzodiazepines and anticholinergic antihistamines are prescribed much more frequently in nursing homes than in the community.
24 April 2012
Latest Fellows and Scholars Unveiled
Exploring the use of NICE guidance by out-of-hours GPs, promoting NICE in dentistry, and investigating whether childhood activity guidelines are being followed in schools, are just some of the projects planned by the latest group of fellows and scholars.
NICE has awarded 11 fellowships and 10 scholarships to professionals working in the NHS,social care and public health.
17 April 2012
Targeted Therapy Using Sound-Waves Offers ‘Male Lumpectomy’ for Prostate Cancer
A new type of prostate cancer treatment, which uses sound waves to selectively target individual cancer sites, could provide an alternative to traditional treatment with significantly fewer side effects, according to promising results from a clinical trial.
The study, funded by the Medical Research Council (MRC), is the first to use an experimental treatment known as HIFU (high-intensity focused ultrasound) to treat areas of cancer just a few millimetres in size (focal therapy). Focal therapy is similar in principle to the ‘lumpectomy’ operation commonly used as an alternative to a full mastectomy in breast cancer.
17 April 2012
Kathrin is Named Outstanding New Researcher
National Conference for CCG Leaders
The NHS Clinical Commissioning Coalition is calling on all Clinical Commissioning Groups leaders to be part of a free national conference to discuss the implementation of clinical commissioning.
The event, to be held at the Cavendish Conference Centre in London on the 24th of April, will give CCG leaders the opportunity to express their concerns, share their experience and develop common themes that CCGs would like the NHS Clinical Commissioning Coalition to take up on their behalf.
10 April 2012
New Drug for Stroke Prevention Approved by NICE
Patients with atrial fibrillation can now be offered the drug dabigatran (Pradaxa) as an alternative to warfarin in order to reduce the risk of stroke and blood clots, says NICE.
Atrial fibrillation (AF) is a condition affecting the heart causing it to beat irregularly, and occasionally, too fast. When this happens the heart cannot efficiently pump blood around the body.
5 April 2012
New e-Learning for GPs: Kidney Health in General Practice
Common dilemmas for GPs in identifying, monitoring and managing individual patients with chronic kidney disease (CKD) are addressed in a new e-learning course launched this month.
Kidney Health in General Practice has been produced by the Royal College of General Practitioners (RCGP) in partnership with NHS Kidney Care. The course is free, subject to registration on the RCGP e-learning website. It aims to improve the detection and management of chronic kidney disease.
3 April 2012
Effective and Practical Measures to Prevent Infection Control Outlined by NICE
GPs and other healthcare professionals should decontaminate their hands immediately after direct contact with patients to prevent the spread of infection in healthcare settings, says NICE.
Around 300,000 patients acquire healthcare-associated infections (HCAIs) each year as a result of care on the NHS.
Certain HCAIs can be deadly. Clostridium difficile and the ‘superbug' methicillin-resistant staphylococcus aureus (MRSA) led to approximately 9,000 deaths in hospital and primary care in England in 2007.
30 March 2012
Gene Found in Worms Could Play a Role in Human Cancer
Scientists funded by the Medical Research Council (MRC) have identified a gene, in a simple water-dwelling worm, that might play an important role in the development of cancer.
The researchers, from the University of Nottingham, found that removing the SMG-1 gene in planarian worms* caused their normal cell division to go out of control, leading to lethal growths that display many of the hallmarks of human tumours.
27 March 2012
'Mission Critical': RCGP Calls for UK-Wide Vision on Patient Care
The Chairs of the RCGP's UK Council and Councils in Scotland, Wales and Northern Ireland have today written to the Health Ministers of all four countries calling for a UK-wide vision for the future of the NHS and patient care.
26 March 2012
MRC to Fund Retrieval, Transport and Diagnosis of Donated Brains
The Medical Research Council (MRC) is to commit almost £1.5 million of extra funding to support the UK Brain Banks Network. The funding will be used to enable the collection and transport of tissue to the bank and a primary diagnosis for hospital clinicians, GPs and families. Brain tissue donation must take place as soon as possible after death, ideally within 48 hours in order for it to be useful to researchers.
20 March 2012
Sessional GPs Vital to CCGs Says RCGP
Engaging sessional GPs in clinically-led commissioning is the aim of a pair of surveys launched as part of a new project from the RCGP.
The surveys, one aimed at sessional GPs and the other at those working in emerging Clinical Commissioning Groups (CCGs) seek to identify best practice and models of inclusion, engagement and leadership, and to uncover the existing barriers preventing these things.
16 March 2012
Funding Boost for Cystic Fibrosis Gene Therapy Trial
A pioneering clinical trial that could lead to a potentially life-changing new treatment for cystic fibrosis (CF) has received a £3.1m funding boost from the Medical Research Council (MRC) and the National Institute for Health Research (NIHR).
The research, which has been supported by the Cystic Fibrosis Trust for a decade, had faced an uncertain future due a funding shortfall. Today’s investment by the MRC and NIHR will ensure the next stage of the programme can continue as planned.
13 March 2012
Commonly Used Dementia Drugs Can Help More Patients With Alzheimer’s Disease
Research funded by the Medical Research Council (MRC) and the Alzheimer’s Society has found that the dementia drug donepezil, already widely used to treat mild to moderate Alzheimer’s disease (AD), also helps in moderate to severe patients and extending treatment to this group could help treat twice as many sufferers worldwide. Encouragingly, the drug has greater positive benefits for patients more severely affected than for those in the earlier stages of dementia.
6 March 2012
NHS Clinical Commissioning Coalition: Commissioning Support Survey
In January 2012, the National Association of Primary Care (NAPC) and the NHS Alliance (NHSA) issued a short survey on commissioning support for Clinical Commissioning Groups (CCGs). The following press release highlights some interesting aspects of the results.
Altogether, there were 95 responses received from across the four strategic health authority clusters: NHS London (12.6%); NHS North of England (33.7%); NHS Midlands and East (32.6%) and NHS South of England (21.1%).
6 March 2012
Response to Lord Crisp’s Letter on the Health and Social Care Bill
RCGP Chair Dr Clare Gerada has responded to Lord Crisp's letter to the Times newspaper on the Health and Social Care Bill.
29 February 2012
NICE to Produce 10 New Quality Standards
NICE will develop a range of new quality standards on topics such as autism, caesarean section, rheumatoid arthritis and self harm, after the Department of Health referred its latest topics.
Topics are selected by the Department of Health and put forward to NICE on the basis of a number of factors, including the burden of disease, the impact on resources, and whether there is inappropriate variation in practice across the country.
28 February 2012
NICE "Key" to Delivering Public Health Services
NICE will play a key role in helping local authorities create an integrated public health service underpinned by evidence on what health measures work, say experts.
Local authorities are preparing to take over the role of commissioning some public health services from Primary Care Trusts from April 2013.
24 February 2012
Clinical Commissioning Coalition Response to No10 Summit
In response to the meeting on 21 February 2012 between the Prime Minister, the Health Secretary and an array of health organisations – including NAPC, the NHS Confederation and the NHS Alliance – to discuss the NHS reform agenda and consequent improvements arising from the changes
21 February 2012
Tackle Mental Health Problems Among Those with Long-Term Conditions, says Thinktank
Following NICE clinical guidelines can help improve the care of people with long-term conditions who also have mental health problems, a leading thinktank says.
People with long-term health conditions such as diabetes or heart disease are two to three times more likely to experience mental health problems than the general population.
17 February 2012
Siblings’ Brain Scans Could Hold the Key to Drug Addiction
Researchers funded by the Medical Research Council (MRC) at the University of Cambridge have identified a brain abnormality which is found in drug-dependent individuals as well as their siblings who have had no history of drug addiction. The brain abnormality identified by the researchers makes it more difficult for individuals to exercise self-control. This research will help understanding about why some people with a family history of drug abuse are at a higher risk of addiction than others. The findings are published today in the journal Science.
14 February 2012
Putting Quality at the Heart of Patient Care
Over 150 practices have signed up to the Royal College of General Practitioners’ Practice Accreditation award programme since its launch in early 2011. Those enrolled have begun a process which will mark them out as a forward-thinking and progressive practice.
10 February 2012
Frequent House Moves in Childhood Might be Bad for Long-Term Health
Children who move house frequently when young may be more likely to suffer poor health in adulthood, according to new research from the Medical Research Council (MRC).
The study, published in the Journal of Epidemiology and Community Health, followed 850 individuals over a 20-year period to investigate the association between moving house from birth to age 18 on a broad range of outcomes in adulthood. The researchers looked at links to physical health, psychological distress, and health behaviours including smoking, heavy drinking and illegal drug use.
7 February 2012
Improving Access to NICE-Approved Drugs
NICE is to produce a best practice guide to help trusts develop local formularies, as part of a move to ensure that all patients in England have access to clinically and cost-effective drugs.
Local formularies provide a list of selected or preferred drugs available to local prescribers and have an important role in underpinning safe and effective use of medicines.
6 February 2012
Is the NHS Commissioning Board Really Being Set up to Liberate CCGs?
NHS Alliance/NAPC Clinical Commissioning Coalition’s response to NHS Commissioning Board update.
In the Department of Health’s original guidance Developing the NHS Commissioning Board (July 2011), Sir David Nicholson said: "CCGs will be the engine of the new system and things will only be done at a different level of the system where there is evidence that this produces better results."
31 January 2012
Latest RCGP Statement on Health and Social Care Bill
There has been much talk this week about how the profession as a whole can continue to influence the Health and Social Care Bill as it moves into the Report Stage at the House of Lords.
The College’s position has not changed; our concerns remain the same and we are determined to keep on doing everything that we can to bring about change for the good of our patients.
25 January 2012
NHS 111: Getting Lost in Translation?
The new urgent care telephone number NHS 111 may have the potential to bring real benefits to the health care system but, according to a recent NHS Alliance survey, is in danger of ‘getting lost in translation’. The new clinical commissioners currently feel a lack of engagement with NHS 111, despite the fact that they are the key people responsible for its rapid implementation across England by April 2013.
24 January 2012
Nurses Follow NICE Blood Clot Guidelines
Thousands more nurses and healthcare assistants are following the NICE venous thromboembolism (VTE) guidelines, following a drive by the Royal College of Nursing to raise awareness of the “silent killer”.
It is estimated that 25,000 people who are admitted to hospital die from preventable VTE every year, leading the Department of Health to make prevention a priority across the NHS for the forthcoming years.
16 January 2012
Fluorescent Dye Could Detect Early Oesophageal Cancer
A fluorescent dye that can be sprayed onto the gullet could be used to detect oesophageal cancer earlier and spare patients unnecessary treatment, according to new research from Medical Research Council and Cancer Research UK scientists.
When sprayed onto the oesophagus the dye attaches to normal, healthy cells but is unable to stick to cancer cells or those in the early stages of turning cancerous. This provides doctors a clear signpost to where the cancer is developing. The research is published in the journal Nature Medicine.
17 January 2012
RCGP Members Support Withdrawal of the Bill, says RCGP Survey
Nearly three quarters of respondents to a poll carried out by the Royal College of General Practitioners think that it is appropriate to seek the withdrawal of the Health and Social Care Bill.
13 January 2012
Current Policy on Specialists’ Role in NHS Reforms Inadequate
Policy on the role of specialist doctors in the NHS reforms is not fit for purpose, according to a discussion paper published today by the NHS Alliance.
Specialists in Commissioning: Looking beyond current policydiscusses the views of GPs and specialists on current policy on specialists in Clinical Commissioning Groups. The paper calls for policy to be more inclusive and flexible to allow both groups of doctors to develop positive relationships to enable integrated care across the primary-secondary healthcare boundaries.
10 January 2012
QOF 2013/14 Consultation Opens
Potential new indicators for the 2013/14 Quality and Outcomes Framework (QOF) are now out for public consultation.
Introduced in 2004, the QOF is a voluntary incentive scheme for GP practices in the UK, rewarding them for how well they care for patients.
The QOF contains groups of indicators, against which practices score points according to their level of achievement.
NICE has been asked to focus on the clinical and health improvement indicators in the QOF and has proposed a number of new indicators for the 2013/14 QOF.
4 January 2012
User Experience of NHS Adult Mental Health Services Should be Improved
Adult mental health services in the NHS should be improved to provide person-centredcare that tackles the stigma associated with mental illness, says NICE.
People with mental health issues should have access to mental health services when they need them, and should be actively involved in shared decision-making and supported in self-management.
3 January 2012
A Healthy Diet Can Cost Less Than Junk Food, Says New Research
Parents of some obese children could save up to £6.58 each week by changing their shopping habits and opting for a healthier diet, according to research published in the latest issue of the British Journal of General Practice.
3 January 2012
NAPC/NHSA Coalition Speaks Out on Commissioning Support Guidance
On 14 December, 2011, the Coalition forwarded to the Department of Health its formal response on the Commissioning Support draft guidance Towards Excellence. A copy of the response is attached with this press release.
27 December 2011
MRC Funds £1.6m Research Into CFS/ME
The Medical Research Council (MRC) has awarded more than £1.6m for research into the causes of the debilitating condition chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME).
The investment will fund five new projects to investigate the mechanisms and underlying biological processes involved in the illness, which could eventually lead to better diagnosis and the development of more effective treatments.
21 December 2011
RCGP Canvasses Members’ Views on NHS Reforms
The Royal College of General Practitioners (RCGP) is surveying its membership of over 44,000 GPs for the last time on the NHS reforms.
RCGP Chair of Council, Dr Clare Gerada has written to all Members today asking for responses to the online survey which closes on Friday 6 January.
20 December 2011
New NICE Guideline Published on Anaphylactic Episode
NICE, the healthcare guidance body, has published a new guideline on the initial assessment and referral following emergency treatment for a suspected anaphylactic episode.
An anaphylactic episode (sometimes called an anaphylactic shock) is a severe allergic response that is a generalised or systemic hypersensitivity reaction that is characterised by life-threatening airway, breathing and/or circulation problems. Common causes of anaphylactic reaction, especially in children, include foods such as peanuts, nuts, eggs, shellfish, milk, fish, and some seeds such as sesame. Non-food causes include wasp or bee stings, natural latex (rubber), and penicillin. A significant proportion of anaphylaxis is classified as idiopathic, in which there are significant clinical effects but no identifiable stimulus.
16 December 2011
National Summit Calls for Co-production for Health - A New Model for Health & Wellbeing in a Radically New World
Creating a new co-production model is seen as the best way to delivering better health and wellbeing outcomes at the local level in the context of budget constraint - according to a new report (www.sph.nhs.uk/lgcolloquiumreport).
13 December 2011
Three Quarters of Patients With Cancer are Referred Within One Month, Reveals RCGP Report
Published by the RCGP’s Clinical Innovation and Research Centre (CIRC), the report – the first of its kind – describes the findings of the National Audit of Cancer Diagnosis in Primary Care, undertaken in 2009/2010 as part of the National Awareness and Early Diagnosis Initiative.
12 December 2011
Middle-Aged Drinkers Still Face Peer Pressure
Middle-aged drinkers still face pressure from their friends making it hard for them to stay in control of their alcohol consumption, new research from the Medical Research Council (MRC) suggests.
Evidence from friendship groups of men and women aged 35 to 50 reveals that binge-drinking and drunken behaviour are not unusual among older adults, despite their initial claims that they had become more moderate drinkers with age.
6 December 2011
NICE Consults on Draft Recommendations on the Use of Opioids in Palliative Care
NICE, the healthcare guidance body, is currently developing a new short clinical guideline on the safe and effective prescribing of strong opioids in palliative care. As part of this process, draft recommendations have been published on the NICE website today (2 December) for public consultation.
30 November 2011
Clinical Commissioners Are Ready to Lead
In his opening speech at the 14th NHS Alliance conference, chairman Dr Michael Dixon will talk about concerned CCG leaders, who are being excluded from crucial decision-making about how their organisations will be set up and run.
He will say: “The week before last, I had over 30 emails from concerned CCG leaders. Each told its own story; stories of commissioning support being imposed, of staff being appointed without consultation and of crucial meetings being arranged with less than twelve hours’ notice.
25 November 2011
Three Quarters of Patients with Cancer are Referred Within One Month, Reveals RCGP Report
Published by the RCGP’s Clinical Innovation and Research Centre (CIRC), the report – the first of its kind – describes the findings of the National Audit of Cancer Diagnosis in Primary Care, undertaken in 2009/2010 as part of the National Awareness and Early Diagnosis Initiative.
22 November 2011
Taking a Hard Look at Urgent Care
Creating an integrated urgent care, which is fit for purpose and delivers the best care for patients, requires a hard look at the current system and full involvement of general practice and clinical commissioners, a new report reveals.
21 November 2011
NICE Opens Consultations on Two Medical Devices Set to Benefit Patients and the NHS
NICE, the healthcare guidance body, today (21 November), provisionally supports two innovative medical technology devices, which can benefit both patients and the NHS. The Institute has opened separate consultations on each device: PleurX which can help reduce the severe abdominal fluid retention experienced by some cancer patients, and the Pipeline embolisation device for treating unruptured giant or complex intracranial aneurysms - a bulging blood vessel in the brain.
10 November 2011
Researchers Unveil ‘Bedside’ Solution for Identifying Individuals Wrongly Diagnosed as Vegetative State
Researchers part-funded by the Medical Research Council (MRC) have discovered a practical and cost-effective method for assessing whether some patients who appear to be in a vegetative state may actually be conscious, but simply unable to respond.
10 November 2011
RCGP Launches e-Learning Course on Self Care
The benefits of encouraging patients to self care are explored in an e-learning course launched by the Royal College of General Practitioners (RCGP).
9 November 2011
NICE Consults on New Draft Guidance on Preventing Type 2 Diabetes
NICE has today (Wednesday 9 November) opened a consultation on new draft guidance on identifying people at high risk of developing type 2 diabetes and the provision of clinically and cost effective interventions to help reduce the risk or delay the onset of the condition.
3 November 2011
Adding Radiotherapy to Hormone Treatment Could Prevent Hundreds of Prostate Cancer Deaths a Year
Results from a large study by the Medical Research Council (MRC) in collaboration with the NCIC Clinical Trials Group located at Queen’s University in Kingston, Canada, have shown that combining radiotherapy and hormone therapy in patients with prostate cancer significantly improved men’s survival compared with hormone therapy treatment alone.
2 November 2011
Researchers Confirm That Daily Physical Activity Offsets Genetic Obesity Risk
A huge international study led by researchers from the Medical Research Council (MRC) has confirmed that regular physical activity can in part offset genetic susceptibility to obesity.
Their findings, published in the journal PLoS Medicine, shed more light on the relationship between genes and body weight, and could eventually help to develop treatments for obesity.
31 October 2011
Advice from NICE Aims to Improve Commissioning of Services for People with Common Mental Health Disorders
NICE has today published a guide for commissioners on services for people with common mental health disorders. The guide is the latest in its series of good practice guides to support commissioners in designing high quality, evidence-based services to improve outcomes for patients and to help the NHSmake better use of its resources. The guide draws on the recent NICE clinical guideline on the identification of and pathways to care for common mental health disorders, as well as other relevant NICE guidance and quality standards.
24 October 2011
GPs Go Into Action for Carers
A new guide to help GPs and their teams provide improved support to carers is launched today by the Royal College of General Practitioners (RCGP) and The Princess Royal Trust for Carers.
21 October 2011
Potential New Treatments for a Common Childhood Hearing Disorder
Scientists from the Medical Research Council’s Mammalian Genetics Unit have identified a potential new treatment for ‘glue ear’ – a common inflammatory condition in children that can cause temporary, but often prolonged, hearing loss.
17 October 2011
NICE Recommends Long-Acting Exenatide for Type 2 Diabetes in Draft Guidance
In preliminary recommendations published today (18 October) by NICE, exenatide prolonged release suspension for injection (Bydureon, Eli Lilly) is recommended in triple therapy regimens (in combination with metformin and a sulphonylurea, or metformin and a thiazolidinedionei) as a treatment option for people with type 2 diabetes, when control of blood glucose remains or becomes inadequate (HbA1cii of 7.5% or above, or other higher level agreed with the individual), and the person has:
- a body mass index (BMI) of 35 kg/m2 or higher in those of European family origin (with appropriate adjustment for other ethnic groups) and specific psychological or medical problems associated with high body weight, or
- a BMI below 35 kg/m2, and therapy with insulin would have significant occupational implications or weight loss would benefit other significant obesity-related comorbidities.
17 October 2011
Clinical Commissioning Coalition Demands Equal Relationship With National Commissioning Board
The new Clinical Commissioning Coalition, set up by the NHS Alliance and the the National Association of Primary Care, is demanding a new relationship between the National Commissioning Board and frontline clinical commissioners.
12 October 2011
GPs Tackle the Taboo of Domestic Violence
Innovative e-learning support to help GPs recognise and respond to signs of domestic violence against patients has been produced by the Royal College of General Practitioners (RCGP).
7 October 2011
NICE Provisionally Recommends Wider Use of Tocilizumab in Treating Rheumatoid Arthritis
The National Institute for Health and Clinical Excellence (NICE) has today (7 October 2011) opened a consultation on draft guidance which provisionally recommends the use of tocilizumab (RoActemra, Roche) at additional stages in treating rheumatoid arthritis.
5 October 2011
Scientists Identify a Genetic Link for a ‘Heavy Heart’
An international research team led by the Medical Research Council (MRC) has for the first time pinpointed a single gene associated with one of the leading causes of heart thickening and failure.
28 September 2011
RCGP Consultation on Developing Integrated Care
Integrated care works to ensure that patients are central to the design and delivery of care and that services meet their healthcare needs through apparently seamless, high quality and effective systems.
28 September 2011
Cost-Effective Stop Smoking Treatment May Help Millions to Stop
Health and Social Care Professionals Sought for NICE Fellowships and Scholarships
Secretary of State Supports Clinical Leaders’ Call for a Clear Vision, Local Autonomy and Flexibility
Local focus, with national support – this was one of the key messages coming from clinical commissioning leaders at the first independent national conference for clinical commissioning, organised by the NHS Alliance and NAPC, held in London yesterday.
14 September 2011
NICE Draft Guidance Recommends New "Clot-Busting" Drug to Treat Acute Coronary Syndromes
Final draft guidance published today (16 September) by NICE confirms its previous positive draft recommendation for ticagrelor (Brilique, Astrazeneca). The draft guidance recommends ticagrelor within its licensed conditions (that is, in combination with aspirin and for up to 12 months) as an option to treat adults with acute coronary syndromes (ACS).
13 September 2011
Championing Clinical Commissioning Groups
The NHS has served the population of this country well and, in terms of the quality of primary care delivered, remains among the leaders in world class provision. However, many things have changed since its inception in 1948, including demography, ageing population with multiple co-morbidities, advances in medicine, and the cost of delivery. The NHS is now at a point in its history where general taxation and the prevailing financial environment will no longer be able to continue to support and advance modern service provision without further development of the policy of clinical commissioning.
1 September 2011
Sensory and Learning Disability Access Awareness Sessions for GP Practices
GP practices in England are urged to sign up practice team members for access awareness sessions being held across the country.
30 August 2011
Getting the Most from Your GP Practice
A “one stop shop” guide to help patients get the most from their GP practice is launched today by the Royal College of General Practitioners (RCGP).
26 August 2011
NHS Alliance Calls for More CCG Involvement in Authorisation
NHS Alliance has called on the government to ensure that Clinical Commissioning Groups are fully involved in the authorisation process and modernisation plans. The organisation warns that CCGs are in danger of becoming peripheral and the bottom tier of a commissioning hierarchy
24 August 2011
NICE Issues Final Guidance on Abatacept for Rheumatoid Arthritis
The National Institute for Health and Clinical Excellence (NICE) has today (24 August) issued final guidance to the NHS on the use of abatacept (Orencia) as a second-line treatment for people with rheumatoid arthritis. The guidance does notrecommend abatacept in combination with methotrexate, for treating rheumatoid arthritis in adults whose disease has responded inadequately to one or more conventional non-biological disease modifying anti-rheumatic drugs (DMARDs) including methotrexate. The recommendations say that people currently receiving abatacept for treating rheumatoid arthritis in this circumstance should have the option to continue therapy until they and their clinicians consider it appropriate to stop.
22 August 2011
Breast Cancer Drug Not Good Use of Resources, Says Draft Guidance
An independent committee of experts that develops guidance on behalf of the National Institute for Health and Clinical Excellence (NICE) does not believe that a drug, which can be used to delay the growth of a particular type of advanced breast cancer, represents a good use of NHS resources.
17 August 2011
Price Discount Means NICE Can Recommend a New Drug for Chronic MyeloidLeukaemia
In new draft guidance NICE has recommended nilotinib, also known as Tasigna and made by Novartis, for the treatment of the chronic and accelerated phases of CML (chronic myeloid leukaemia)that is resistant or intolerant to standard-dose imatinib. Dasatinib (Sprycel), made by Bristol-Myers Squibb is not recommended for CML that is resistant or intolerant to standard-dose imatinib, and high-dose imatinib (Glivec), made by Novartis, is not recommended for CML that is resistant to standard-dose imatinib.
17 August 2011
NICE Asks for More Information on New Treatment for People with Common Heart Condition
In preliminary recommendations published today (Wednesday 17 August) NICE is asking Boehringer Ingelheim for more information on its product dabigatran (Pradaxa), for the prevention of stroke and systemic embolism in people with atrial fibrillation.
4 August 2011
Childhood Illness Linked to Less Career Success
Child illness is closely linked to your future health and career prospects, a new study suggests. Researchers, funded partly by the Medical Research Council (MRC) and the British Heart Foundation (BHF), found that people who had spent long periods in hospital as a child, or had low birth weight, were more likely to find themselves passed over for promotion in later life. By middle-age, these people were also more likely to have a greater risk of developing heart disease.
1 August 2011
New NICE Guideline Says Drug Therapy Should Come Before Interventional Procedures for People with Stable Angina
NICE has today (1 August) published its clinical guideline on the management of stable angina. The guideline, which has been jointly developed by the National Clinical Guideline Centre for Acute and Chronic Conditions (NCGCACC), sets out recommendations on what treatment and care the NHS should offer to people with a diagnosis of stable angina, including the use of anti-anginal drug treatment and surgery.
26 July 2011
Break Through! NHS Alliance 2011 Conference
GPs and Pharmacists Working Together to Improve Patient Care
The Royal College of General Practitioners (RCGP) and the Royal Pharmaceutical Society (RPS) have produced a joint statement detailing how GPs and community pharmacists can work together to improve the care provided to patients in the community.
28 July 2011
Scientists Identify ‘Super Antibody’ Against Influenza
Scientists at the Medical Research Council (MRC), the Institute for Research in Biomedicine (IRB) and Humabs BioMed in Switzerland, have found that an antibody called FI6 can combat all influenza A viruses that commonly cause disease in humans and in animals. The finding represents a turning point in the development of emergency flu treatments and in time may help to pave the way for a universal flu vaccine.
25 July 2011
Five Leading Academic Hospitals Install the CyberKnife System for Dedicated Radiosurgery
Adoption Demonstrates Continued Demand for Dedicated Whole Body Stereotactic Radiosurgery Systems at World's Most Renowned Cancer Centers
25 July 2011
First Targeted Treatment Success for Duchenne Muscular Dystrophy
Scientists part-funded by the Medical Research Council (MRC) have made an important breakthrough in the development of a treatment for Duchenne Muscular Dystrophy (DMD), a devastating disease which affects around 100 boys born each year in the UK. The research was led by scientists at the UCL Institute of Child Health (ICH) and co-funded by AVI BioPharma.
18 July 2011
Clinical Commissioning: Securing Better Outcomes for the NHS and its Patients
The NHS Alliance, in partnership with NAPC, has published today a discussion paper, Clinical commissioning: securing better outcomes for the NHS and its patients.
The paper explains how clinical commissioning holds the key to tackle the three major challenges facing the NHS in England over the next five years – improve the health of the population; reduce health inequalities, and create a service that delivers better services to patients whilst achieving ambitious efficiency savings.
12 July 2011
NICE Consults on Updated Clinical Guideline on Prevention of Healthcare Associated Infections in Primary and Community Care
The National Institute for Health and Clinical Excellence (NICE) has today published draft guidelines on the prevention and control of healthcare-associated infections in primary and community care. In taking into account new evidence that has been published since NICE's original guideline in 2003, the draft guideline provides the most comprehensive and up-to-date set of recommendations yet on infection prevention and control precautions that should be applied by all healthcare workers in the care of patients in community and primary care settings, including ambulance services.
8 July 2011
NICE Consults on Device to Improve the Outcome of Heart Bypass Graft Surgery
The National Institute for Health and Clinical Excellence (NICE) today (8 July) opens its consultation on the use of a device that can help improve the outcome of a specific type of heart surgery. The draft medical technology guidance provisionally supports the use of VeriQ, a system that assesses blood flow through a graft during coronary artery bypass graft (CABG) surgery.
6 July 2011
Excess Alcohol Could Damage our DNA
Researchers from the Medical Research Council (MRC) have uncovered for the first time how excess alcohol can cause irreparable damage to our DNA. In a new study published in the journal Nature today, MRC scientists also discovered a two-tier defence system in our cells that limits the threat of permanent genetic damage.
29 June 2011
United Lincolnshire Hospitals NHS Trust Selects Jayex QI Interactive Patient Survey and Information Management Kiosk
Jayex's QI Touch Screen Solution Enables the Trust to Instantly Review Patient Feedback to Assist in the Delivery of High-Quality Patient Centred Care.
27th June 2011
‘Lean Gene’ Increases Risk of Heart Disease and Diabetes
Having a leaner body may not always give you a lower risk of heart disease and diabetes, according to the newest findings of a Medical Research Council (MRC) study. Researchers led by the MRC Epidemiology Unit have identified a gene that is linked with both having less body fat and an increased risk of metabolic diseases such as type 2 diabetes and heart disease.
24 June 2011
NICE Consults on New End of Life Care Draft Quality Standard
NICE has today (24 June) launched a consultation on its draft quality standard for end of life care for adults.
NICE quality standards (QS) are a set of specific, concise statements and measures that act as markers of high-quality, clinical and cost-effective patient care. They are derived from the best available evidence, such as NICE guidance or other sources accredited by NHS Evidence. Quality standards are produced collaboratively with the NHS and social care sectors, along with their partners, service users and carers. They are a pivotal part of the new NHS Outcomes Framework, which defines the aims and objectives in improving patient outcomes in the NHS.
20th June 2011
Clinically-Led Commissioning Must Not Be Set Up To Fail
NHS Alliance has urged the government to ensure that clinical commissioners have sufficient headroom to bring about the urgent changes required by a modern NHS.
“Primary care commissioners must not be overshadowed by centralisation and a secondary care dominated health system, which has, time and again, failed to deliver better services for patients and tax payers,” says NHS Alliance chair Dr Michael Dixon.
16 June 2011
Weight at 18 Linked to Cancer in Men Decades Later
Public health researchers, based at the MRC/CSO Social and Public Health Sciences Unit, have identified a link between men being overweight or obese at age 18 and death from cancer in later life. The study shows the link is apparent even if they reduce their weight during middle age.
10 June 2011
RCGP Calls for Greater Continuity of Care in General Practice
Keeping general practice familiar and local improves continuity of care and can tackle health inequalities more effectively, says a new Policy Paper from the Royal College of General Practitioners (RCGP).
6 June 2011
NICE to Develop New Guideline on Acute Painful Sickle Cell Episode
The National Institute for Health and Clinical Excellence (NICE) is currently in the early stages of developing a short guideline on the management of an acute painful sickle cell episode in hospital. Sickle cell is one of the most common genetic disorders in England, affecting thousands of people.
2 June 2011
Breaking Through - How GP-Led Consortia Can Unlock The Full Potential of The NHS
Dr Michael Dixon, chairman of the NHS Alliance, today called on the Government to speed up the process of NHS reform in areas where GP-led consortia are ready, willing and able to get on with the job of improving services for patients.
13 May 2011
Researchers Uncover How White Blood Cells Carry Out ‘Triage’ on Injured Tissue
Researchers at the University of Edinburgh, funded by the Medical Research Council (MRC), have unearthed the mechanism behind an entirely new kind of inflammation, showing that white blood cells have an additional, previously unknown way to cope with injury and infection. The discovery of a fundamentally different form of inflammation opens up new opportunities to develop drugs that target this process to aid healing and recovery from infection.
12 May 2011
The Government Cannot Afford to Mess it up This Time
“The NHS is facing one of its most severe financial crises yet and, unless clinical commissioning and leadership remains truly at the heart of the health reforms, patients will bear the brunt of a system that will become incapable of delivering better health for better value.” This is the stark message from Dr Michael Dixon at the King's Fund/NHS Alliance conference for GP Commissioning Pathfinder leaders in London today.
10 May 2011
NICE Publishes New Guidance on Preventing Type 2 Diabetes
NICE has published new guidance on preventing type 2 diabetes in the general population, and among high-risk groups. These groups include people of South Asian, African-Caribbean, black African and Chinese descent, and those from a lower socio-economic background, where the incidence of type 2 diabetes is higher than in the general population.
9 May 2011
College Puts Pressure On PM Over Health Reforms
The Royal College of General Practitioners has written to Prime Minister David Cameron listing changes that must be made to the Health Bill to protect the principles of the NHS.
20 April, 2011
Heart Drugs Could Cut Blood Pressure Risks in Pregnancy
Medical Research Council (MRC) funded scientists from four UK universities will test whether heart disease drugs can be used to treat pre-eclampsia, a potentially fatal condition which affects up to eight per cent of pregnant women in the UK.
13 April, 2011
NextGen Sciences Launches Multiplex Protein Plasma Biomarker Assay for Breast Cancer
NextGen Group plc (AIM:NGG) is pleased to announce that its US-subsidiary NextGen Sciences Inc, a leader in biomarker discovery, measurement and qualification, has launched its plasmabreast25 multiplex protein assay, targeting breast cancer (http://www.nextgensciences.com/assays/breast.php) biomarker discovery and qualification. The assay simultaneously measures 25 human plasma proteins that are thought to have potential as biomarkers in breast cancer.
1 April, 2011
NICE Welcomes National Prescribing Centre
From 1 April, the National Institute for Health and Clinical Excellence (NICE) will take over the functions of the National Prescribing Centre (NPC), the organisation responsible for helping the NHS to optimise its use of medicines.
1st April 2011
‘Flawed’ Government Plans Could Compromise Patient Safety and the Medical Profession, Argues RCGP
The RCGP has criticised the Government's proposals to redesign medical training following the DH's Liberating the NHS consultation.
30 March, 2011
New Toolkit to Improve Quality of Urgent and Emergency Care
A learning tool to support the quality of urgent and emergency care services for patients is being launched today at the Royal College of General Practitioners.
22 March, 2011
Protein Could be Used to Treat Alcohol Effects on Pancreas
A Medical Research Council (MRC) study has discovered that a protein provides protection against the effects of alcohol in the pancreas. The findings could lead to the development of new treatments to reduce the chances of people developing pancreatic cancer.
7 March, 2011
Patients and Their Care are not Commodities
Comments by Monitor’s newly appointed chair David Bennett, comparing the NHS to utility companies and being ripe for dismemberment, are simply wrong. They illustrate the huge flaws in some of the more simplistic arguments for more markets in the health sector, warns the NHS Alliance.
1 March, 2011
NICE Requests More Data to Help Appraise Maintenance Treatment for Follicular Non-Hodgkin's Lymphoma
The National Institute for Health and Clinical Excellence (NICE) is currently appraising the use of rituximab (MabThera, Roche Products) as a first-line maintenance treatment for patients with advanced follicular non-Hodgkin's lymphoma. In draft guidance issued today (1 March), NICE is calling for the manufacturer to provide more analyses to address uncertainties in the data relating to the survival benefit of the treatment.
1 March, 2011
People who misuse alcohol to benefit from new guidance
The majority of people who are dependent on alcohol are not currently being treated, partly because health and social care professionals are failing to identify those in need and assisted withdrawal treatments are inadequate. In response, the National Institute for Health and Clinical Excellence (NICE) has published guidance today (23 February) which outlines how the NHS should diagnose, assess and treat the condition.
23 February 2011
New NICE Guideline Places Child and Young Person Food Allergy Management in the Hands of GP's and Other Healthcare Professionals in Primary Care and the Community
The first guideline for food allergy in children and young people issued by the National Institute for health and Clinical Excellence (NICE) recommends the routine use of allergy testing by Specific IgE blood tests or, if the facilities exist, skin prick testing in NHS primary care and community settings to confirm suspected food allergy.
23 February 2011
New treatment to benefit certain patients with leukaemia thanks to new NICE guidance
On 23 February the National Institute for Health and Clinical Excellence (NICE) published final guidance to the NHS recommending the use of a new treatment that can help extend the lives of certain people with the most common form of leukaemia.
23 February 2011
NHS Hearing Aids - Free But at What Price?
In the UK we are fortunate enough to have a free provision of hearing aids by way of the NHS. Over the last few years, the NHS has switched from analogue to digital hearing aids for the majority of patients. These hearing instruments are of a reasonable quality and are programmed to match the patients hearing loss. Fantastic! I hear you say, but there's perhaps a little more to this situation than meets the eye.
22 February 2011
NICE consults on new guideline for diagnosing and treating high blood pressure
In draft guidelines on the diagnosis and treatment of high blood pressure (hypertension) published on 22 February, NICE has made a number of new recommendations that are set to significantly change the way high blood pressure is diagnosed and subsequently treated.
21 February 2011
NICE has launched a new section of its website, designed to help staff in general practice get the most out of evidence and guidance provided by NICE.
Specifically created to support the use of evidence-based medicine and public health practice, this online resource offers solutions to enable the uptake of NICE and other national guidance in primary care, and contains a section on how NICE can help GP consortia.
18 February 2011
UK’s largest CFS/ME trial confirms safe and effective treatments for patients
Two effective treatments benefit up to 60 per cent of patients with Chronic Fatigue Syndrome or Myalgic Encephalomyelitis (CFS/ME), according to a collaborative trial funded by the Medical Research Council (MRC) and UK government departments.
17 February 2011
GPs lack clarity and understanding of how the new public health systems – health improvement, health protection, health services – will come together under the reformed NHS, according to a new report released today
The NHS Alliance, QIPP Right Care Team, and NHS Solutions for Public Health have published the findings from a national summit exploring the relationship between GP consortia and public health, and their shared role in improving health and wellbeing.
16 February 2011
Statutory Regulation Best to Safeguard the Public
The Association of Traditional Chinese Medicine (UK), ATCM, welcomes today's Health Department announcement on statutory regulation of herbal medicine and traditional Chinese medicine practitioners by the Health Professions Council.
9 February 2011
NICE updates guidance on how to treat anaemia in people with chronic kidney disease
Doctors should review how they diagnose and monitor anaemia in people with chronic kidney disease to reduce the risk of strokes and other health complications associated with escalating treatment to achieve high haemoglobin levels in certain individuals.
2nd February 2011
GP concerns over depression questionnaire
English GPs have raised concerns about the questionnaire used to determine severity of depression in patients in a study in this month’s British Journal of General Practice (BJGP).
7 February 2011
LighterLife and the National Obesity Forum Launch The UK Obesity Barometer
LighterLife and the National Obesity Forum have launched The UK Obesity Barometer to track weight gain in the UK.
7 February 2011
New Possibilities for Patients With Difficult to Treat Cancers
For the first time in the UK, cancer patients are starting to receive treatment with Novalis Tx radiosurgery. This device gives the chance of a cure to those with inoperable tumours and offers the possibility to perform precise painless treatment to tumours in a single patient visit.
1st February 2011
Royal College of General Practitioners Survey highlights GP concerns over NHS Reforms
More than half of GPs responding to a snapshot survey carried out by the RCGP are concerned that the proposed health reforms will not lead to improvements in care for patients.
1 February 2011
10,000 Hepatitis C patients could hold the key to better treatment
The Medical Research Foundation, an independent registered charity established by the Medical Research Council (MRC), has donated nearly £2 million to establish a clinical database of 10,000 patients infected with hepatitis C virus (HCV). This will enable a UK-wide network of researchers to find new ways to tackle the deadly infection.
19th January 2011
Royal College of General Practitioners responds to the Health and Social Care Bill
RCGP Chair Dr Clare Gerada has issued the College's response to the Government's Health and Social Care Bill.
17 January 2011
GP Commissioning: It’s not about power, it’s about health care
Committed frontline clinicians and their patients hold the key to a more progressive NHS, says NHS Alliance
14th January 2011
Royal College of General Practitioners questions Government proposals on patient choice
The Royal College of General Practitioners (RCGP) is warning that some Government suggestions on providing more choice in the NHS will cause long-term harm to patients and the NHS, particularly for vulnerable adults and at-risk children.
11 January 2011
Scientists explain link between chlamydia and ectopic pregnancy
Women who have had chlamydia are at greater risk of having an ectopic pregnancy because of a long-lasting effect of the infection, according to a study part-funded by the Medical Research Council (MRC).